{"meta":{"query_hash":"63d93883b4e9","filters":{"venue":"The Journal of Clinical Pharmacology"},"cohort_total":238,"direct_labels_cover":1,"predictions_cover":238,"exported":238,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/63d93883b4e9","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+Journal+of+Clinical+Pharmacology"},"results":[{"id":"W1522242651","doi":"10.1002/jcph.85","title":"The Predictive Value of the In Vitro Platelet Toxicity Assay (iPTA) for the Diagnosis of Hypersensitivity Reactions to Sulfonamides","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Toxicity; Drug; In vitro; Predictive value; Pharmacology; Medicine; Drug reaction; Chemistry; Internal medicine; Biochemistry","score_opus":0.06895118288194685,"score_gpt":0.41296331738252545,"score_spread":0.3440121345005786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1522242651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701846,0.0012725429,0.00053068245,0.000082922736,0.000029693267,0.0000139851545,0.00008802583,0.00001036509,0.0009532846],"genre_scores_gemma":[0.9993155,0.00019455288,0.00029057186,0.000021110629,0.000032153082,0.0000050314397,0.00006303733,9.1962687e-7,0.00007721204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985133,0.0007747533,0.00016150347,0.00012958766,0.0003269577,0.00009382649],"domain_scores_gemma":[0.99310136,0.004732018,0.0011061218,0.00025005307,0.00043572736,0.00037464185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016165029,0.0005254984,0.0005190592,0.0010320314,0.00025683007,0.00052359595,0.00023847667,0.00056671957,0.00092650356],"category_scores_gemma":[0.0074234838,0.0002343366,0.00029876886,0.00046815467,0.000383702,0.0002811701,0.00028913826,0.00068814226,0.00027279783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001352026,0.00011824089,0.9830048,0.00002148373,0.000065945096,0.00028592625,0.00005356147,0.0002807628,0.004480695,0.000038248294,0.00011232112,0.010185933],"study_design_scores_gemma":[0.000057910183,0.0018171524,0.9876009,0.00001810358,0.00014284097,0.0025080324,0.00012736602,0.0030992508,0.00397168,0.0001469113,0.00049731653,0.000012612532],"about_ca_topic_score_codex":0.00048862037,"about_ca_topic_score_gemma":0.00044377355,"teacher_disagreement_score":0.0016165029,"about_ca_system_score_codex":0.00015351878,"about_ca_system_score_gemma":0.00015740925,"threshold_uncertainty_score":0.008549035},"labels":[],"label_agreement":null},{"id":"W1536852940","doi":"10.1002/jcph.491","title":"Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Certolizumab pegol; Pharmacokinetics; Medicine; Population; Volume of distribution; Pharmacodynamics; Internal medicine; Covariate; Pharmacology; Antibody; Gastroenterology; Area under the curve; Immunology; Tumor necrosis factor alpha; Infliximab","score_opus":0.02767867091703045,"score_gpt":0.3688769333228261,"score_spread":0.34119826240579565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1536852940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984566,0.00035784874,0.0008378969,0.00003222735,0.0000027380581,0.00001275489,0.00012895382,0.000013487557,0.00015748497],"genre_scores_gemma":[0.99917275,0.00008481744,0.00037290412,0.000023834471,0.0000055884825,0.000011534955,0.00028185066,0.0000025914908,0.000044101263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907625,0.00045081065,0.00006925151,0.00019138888,0.00016047114,0.000051936382],"domain_scores_gemma":[0.99831676,0.0009186877,0.0003474224,0.00022156036,0.000095318646,0.0001002677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016110819,0.00023549389,0.0008990146,0.00030256208,0.00017550208,0.0006929131,0.00017728271,0.00042426516,0.00036044398],"category_scores_gemma":[0.0040523014,0.0002088841,0.0005511603,0.0004594292,0.0002261696,0.00035034373,0.00021383187,0.00062314805,0.00011507111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009600761,0.00044328358,0.9436411,0.000092749644,0.0013660628,0.00073707785,0.00030846192,0.008363465,0.0060879895,0.00017707718,0.00045290918,0.028729036],"study_design_scores_gemma":[0.00047989027,0.006036119,0.9664886,0.0000126462455,0.0006518129,0.001667078,0.0001308759,0.020501906,0.0019592813,0.00043319716,0.0016032279,0.00003542123],"about_ca_topic_score_codex":0.00077604037,"about_ca_topic_score_gemma":0.0005038528,"teacher_disagreement_score":0.0016110819,"about_ca_system_score_codex":0.0003720268,"about_ca_system_score_gemma":0.00041761406,"threshold_uncertainty_score":0.008520305},"labels":[],"label_agreement":null},{"id":"W1547449781","doi":"10.1002/jcph.131","title":"Investigation of an alternative generic model for predicting pharmacokinetic changes during physiological stress","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Defence Research and Development Canada","funders":"","keywords":"Pharmacokinetics; Stress (linguistics); Medicine; Pharmacology; Econometrics; Mathematics","score_opus":0.29991110018548345,"score_gpt":0.5003994818088313,"score_spread":0.20048838162334787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1547449781","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13124667,0.00032854307,0.8609739,0.0003518826,0.00013735142,0.00022799734,0.00047533723,0.0019218196,0.0043364526],"genre_scores_gemma":[0.88993895,0.00052451465,0.105388455,0.00012386616,0.000030691503,0.00033758156,0.00045110204,0.00010885098,0.0030959516],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99980754,0.000051118855,0.000020095364,0.000046209178,0.000052671174,0.000022342994],"domain_scores_gemma":[0.99954754,0.00015662407,0.00008145722,0.000051248175,0.00014255618,0.000020590425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004595262,0.00062441017,0.0005063617,0.00028419343,0.00021470095,0.00055199495,0.00096653926,0.000779807,0.00145486],"category_scores_gemma":[0.0013387946,0.00019335895,0.00057532743,0.00022190016,0.00021226329,0.000593782,0.000357506,0.00056493393,0.00035461364],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001959121,0.00011389437,0.0026678995,0.00026628928,0.00007377047,0.00025885613,0.000111119014,0.9383845,0.023508029,0.0034261683,0.00078988046,0.030203694],"study_design_scores_gemma":[0.0000119244705,0.0001001124,0.00045691885,0.0000073991246,0.000018932946,0.000048132264,0.000010619518,0.99465007,0.0031669908,0.0004149718,0.0011060411,0.000007918367],"about_ca_topic_score_codex":0.0045342906,"about_ca_topic_score_gemma":0.0031144724,"teacher_disagreement_score":0.0045342906,"about_ca_system_score_codex":0.00037579113,"about_ca_system_score_gemma":0.00088003924,"threshold_uncertainty_score":0.009015799},"labels":[],"label_agreement":null},{"id":"W1558836596","doi":"10.1002/jcph.326","title":"Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: A randomized, multicenter, open‐label, phase I study","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Pasireotide; Acromegaly; Medicine; Tolerability; Pharmacokinetics; Adverse effect; Pharmacodynamics; Internal medicine; Octreotide; Gastroenterology; Somatostatin; Randomized controlled trial; Pharmacology","score_opus":0.035298104734325035,"score_gpt":0.4234314662478706,"score_spread":0.38813336151354555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1558836596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978756,0.00054920197,0.00042264088,0.000077482386,0.000029504681,0.0005571392,0.00015391633,0.000037061018,0.00029752954],"genre_scores_gemma":[0.9971341,0.0003697259,0.00079636584,0.00019512248,0.00008342576,0.00066760497,0.00033205256,0.000011580039,0.00040991878],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993574,0.00033256388,0.000041185995,0.00009726785,0.000081699836,0.000089778936],"domain_scores_gemma":[0.9990392,0.00022828854,0.00027347016,0.000089703375,0.000051118754,0.00031834497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017197129,0.0010413919,0.0017216016,0.0002425707,0.0002841173,0.0006749797,0.00043737487,0.00071526616,0.0016633833],"category_scores_gemma":[0.0013068334,0.00056647224,0.0010704502,0.00025517328,0.0010014833,0.0007843341,0.00021051141,0.0017730886,0.00037193854],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82663566,0.050418854,0.006636761,0.00035233353,0.0007954533,0.00018906542,0.00023830873,0.002033439,0.05894079,0.00015873407,0.00088264764,0.052717917],"study_design_scores_gemma":[0.3503517,0.6269371,0.015536688,0.000016005954,0.00038059865,0.00020775253,0.000050787366,0.0019501242,0.003551801,0.000118713324,0.0008594858,0.000039264825],"about_ca_topic_score_codex":0.00039513985,"about_ca_topic_score_gemma":0.00066690025,"teacher_disagreement_score":0.0017216016,"about_ca_system_score_codex":0.00056574785,"about_ca_system_score_gemma":0.0008914388,"threshold_uncertainty_score":0.009094834},"labels":[],"label_agreement":null},{"id":"W1591834330","doi":"10.1002/jcph.180","title":"The effects of colesevelam HCl on the single‐dose pharmacokinetics of glimepiride, extended‐release glipizide, and olmesartan medoxomil","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Olmesartan; Glimepiride; Glipizide; Pharmacokinetics; Pharmacology; Medicine; Chemistry; Endocrinology; Metformin; Insulin; Blood pressure","score_opus":0.02845270087263498,"score_gpt":0.3576267358791634,"score_spread":0.3291740350065284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591834330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986449,0.0007244811,0.00026130315,0.000028871522,0.000013074905,0.000044317465,0.000054674896,0.000016543367,0.00021190965],"genre_scores_gemma":[0.9983688,0.000495976,0.0005948733,0.00003327459,0.000022110722,0.00003458918,0.00009336309,0.000007776649,0.00034923188],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996184,0.00016038453,0.00003140777,0.000060223752,0.0000828139,0.000046633715],"domain_scores_gemma":[0.99909794,0.00031881974,0.0002525415,0.000077293655,0.000069638736,0.00018374133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044258113,0.00035016326,0.0007943745,0.00018109595,0.00009686753,0.00038661994,0.00022382296,0.0003566487,0.0011352255],"category_scores_gemma":[0.0012880922,0.00026503994,0.00054863584,0.00015592466,0.00023374302,0.00036453654,0.00013598953,0.0009168525,0.00015530354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12936532,0.010903758,0.011989727,0.0005084754,0.0010480287,0.00036846852,0.00022088629,0.0012308445,0.70642686,0.00011213098,0.00038149775,0.13744392],"study_design_scores_gemma":[0.014200281,0.4312359,0.15655632,0.000035660232,0.0008013688,0.0014241114,0.0001537926,0.0047003613,0.38762617,0.00011608632,0.0030816037,0.000068301495],"about_ca_topic_score_codex":0.0002840929,"about_ca_topic_score_gemma":0.00069997093,"teacher_disagreement_score":0.0011352255,"about_ca_system_score_codex":0.0002074811,"about_ca_system_score_gemma":0.00030253464,"threshold_uncertainty_score":0.00379771},"labels":[],"label_agreement":null},{"id":"W1603001808","doi":"10.1002/jcph.247","title":"Pharmacokinetic characterization of baclofen in patients with chronic kidney disease: dose adjustment recommendations","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University Health Centre; Université de Montréal; inVentiv Health Clinical","funders":"","keywords":"Renal function; Pharmacokinetics; Kidney disease; Cmax; Medicine; Urology; Creatinine; Baclofen; Internal medicine; Pharmacology; Agonist","score_opus":0.026204088362263345,"score_gpt":0.36025406803543925,"score_spread":0.3340499796731759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1603001808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66373765,0.096690364,0.15194581,0.02251645,0.0006285813,0.0040279897,0.0038167455,0.0026905057,0.053945906],"genre_scores_gemma":[0.88896275,0.013730181,0.08605668,0.004337665,0.000274178,0.0012374582,0.0017824046,0.00020328072,0.0034153634],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960821,0.0018442558,0.0007312655,0.00029095888,0.0009665619,0.00008492577],"domain_scores_gemma":[0.99642855,0.0013462781,0.0009402939,0.00026972263,0.0009039821,0.00011128648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004698479,0.0005523328,0.001309183,0.0008477313,0.00041280323,0.0011853481,0.0007970079,0.0009966979,0.0009577619],"category_scores_gemma":[0.014110594,0.00025641682,0.0006877938,0.00093220774,0.00030645073,0.00074854423,0.0003392591,0.0010486331,0.00077466277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070166136,0.0012524162,0.22387336,0.0018781874,0.0009099981,0.00050805183,0.0005326572,0.0060164817,0.03014649,0.0016112045,0.01872871,0.7075259],"study_design_scores_gemma":[0.0021728945,0.009987135,0.7838433,0.0022840502,0.0015591697,0.0038869367,0.0005142876,0.029432394,0.04579222,0.0034685142,0.11680271,0.0002563709],"about_ca_topic_score_codex":0.0022886097,"about_ca_topic_score_gemma":0.002551218,"teacher_disagreement_score":0.004698479,"about_ca_system_score_codex":0.00082803104,"about_ca_system_score_gemma":0.0009996122,"threshold_uncertainty_score":0.024848282},"labels":[],"label_agreement":null},{"id":"W1627148868","doi":"10.1177/0091270011433327","title":"An Algorithm to Detect Adverse Drug Reactions in the Neonatal Intensive Care Unit","year":2012,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Neonatal intensive care unit; Intensive care unit; Drug reaction; Drug; Algorithm; Medicine; Adverse drug reaction; Intensive care medicine; Computer science; Pharmacology; Pediatrics","score_opus":0.17150234742303946,"score_gpt":0.537568988025676,"score_spread":0.3660666406026365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1627148868","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12603495,0.0019759564,0.8426432,0.0018960309,0.00043214497,0.008062333,0.0014750442,0.006828261,0.010652124],"genre_scores_gemma":[0.10134287,0.00042735305,0.8929708,0.0003054842,0.00006016617,0.0022499037,0.0010627321,0.000098653734,0.001482051],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9934083,0.002636904,0.0013993257,0.00069023896,0.0016898134,0.00017546062],"domain_scores_gemma":[0.98218405,0.0075588166,0.0022771708,0.00063011015,0.006918169,0.0004316662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008366437,0.0014471593,0.0012256451,0.0058086365,0.00079236313,0.0016325387,0.0016991106,0.0010302048,0.0029698687],"category_scores_gemma":[0.036974262,0.00051350915,0.0009967188,0.0018149188,0.00043651913,0.0015988126,0.0013628547,0.0010923544,0.0015636672],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014406636,0.0009689431,0.12541233,0.0006554603,0.0004190751,0.0004710629,0.00034197752,0.01340708,0.0052871634,0.0024328872,0.01712927,0.83203405],"study_design_scores_gemma":[0.0017585523,0.0036432352,0.20460775,0.0010843843,0.0011221307,0.009540571,0.0009232547,0.68670505,0.02206837,0.014264169,0.053780068,0.00050251884],"about_ca_topic_score_codex":0.0031853877,"about_ca_topic_score_gemma":0.0044872877,"teacher_disagreement_score":0.008366437,"about_ca_system_score_codex":0.0010663047,"about_ca_system_score_gemma":0.0034725184,"threshold_uncertainty_score":0.044246495},"labels":[],"label_agreement":null},{"id":"W1681527344","doi":"10.1002/jcph.27","title":"Precision, Bias, and Clinical Utility of the Sheiner‐Tozer Equation to Guide Phenytoin Dosing in Critically Ill Adults","year":2013,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Interior Health","funders":"","keywords":"Phenytoin; Dosing; Critically ill; Econometrics; Computer science; Statistics; Pharmacology; Psychology; Medicine; Intensive care medicine; Economics; Mathematics; Neuroscience; Epilepsy","score_opus":0.2860625489160071,"score_gpt":0.5491888987463954,"score_spread":0.26312634983038835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1681527344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029920502,0.8264112,0.11872088,0.0061247665,0.0023038974,0.0004283761,0.0029959327,0.0010425074,0.012052062],"genre_scores_gemma":[0.4584394,0.37823817,0.14507718,0.004788768,0.0018266441,0.0010405928,0.003203273,0.0005682027,0.006817808],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9822212,0.006845923,0.002524084,0.0019278798,0.0063428753,0.0001380318],"domain_scores_gemma":[0.94586295,0.040153112,0.0046709115,0.0015339244,0.0076079513,0.00017117891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03043427,0.0011939512,0.0035986037,0.0027881796,0.00036192356,0.0026428127,0.0021558078,0.0022391481,0.003163996],"category_scores_gemma":[0.07427002,0.00065379747,0.0016091503,0.0023444446,0.0009103839,0.0012813336,0.0011020718,0.0019662404,0.0012619542],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001565087,0.00011393767,0.0425921,0.0061072637,0.0034622797,0.0001671018,0.00040707755,0.0065293107,0.0014987827,0.0054149614,0.021246238,0.9108958],"study_design_scores_gemma":[0.0018912714,0.004432296,0.30904236,0.026396733,0.02076003,0.01510306,0.0010050159,0.20202857,0.02833366,0.052494694,0.33740783,0.0011043805],"about_ca_topic_score_codex":0.0036363169,"about_ca_topic_score_gemma":0.0037644892,"teacher_disagreement_score":0.03043427,"about_ca_system_score_codex":0.0013175242,"about_ca_system_score_gemma":0.0020814736,"threshold_uncertainty_score":0.1609537},"labels":[],"label_agreement":null},{"id":"W1887924821","doi":"10.1177/0091270012445207","title":"Comparing the Pharmacokinetics of Doxylamine/Pyridoxine Delayed‐Release Combination in Nonpregnant Women of Reproductive Age and Women in the First Trimester of Pregnancy","year":2012,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pharmacokinetics; Medicine; Pregnancy; Pyridoxine; Obstetrics; Pharmacology; First trimester; Gestation; Internal medicine; Biology","score_opus":0.07674815769701003,"score_gpt":0.4130702307158978,"score_spread":0.3363220730188878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1887924821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979494,0.0016364718,0.000088247114,0.000032571286,0.000008912362,0.000043480082,0.000023391454,0.0000022551822,0.00021534313],"genre_scores_gemma":[0.9984503,0.000804132,0.00029846982,0.00008155961,0.000017109476,0.00006773302,0.00005919086,0.0000015828682,0.00021980602],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995956,0.00023309921,0.0000244931,0.000050191535,0.00006330377,0.000033271088],"domain_scores_gemma":[0.9991617,0.00038633263,0.00024333972,0.00003965107,0.000041136955,0.00012790882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086084445,0.00015390673,0.0006302933,0.00013191022,0.00010863566,0.00024202022,0.00013661337,0.0003447475,0.0006760281],"category_scores_gemma":[0.0023034788,0.00023439445,0.00026937874,0.00011703814,0.00021270393,0.00017114134,0.0001171518,0.00034831092,0.0000912362],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4080503,0.0037156888,0.3075908,0.00076799165,0.0015400881,0.0011711369,0.001260045,0.0009142211,0.10759342,0.00021604268,0.0005182194,0.1666621],"study_design_scores_gemma":[0.027786084,0.40725386,0.53861946,0.00007808546,0.0017906945,0.0027689654,0.00050838833,0.0025679055,0.013739362,0.00017103237,0.0046727587,0.000043405103],"about_ca_topic_score_codex":0.0007827094,"about_ca_topic_score_gemma":0.0012378242,"teacher_disagreement_score":0.00086084445,"about_ca_system_score_codex":0.00033011747,"about_ca_system_score_gemma":0.00030435203,"threshold_uncertainty_score":0.004552603},"labels":[],"label_agreement":null},{"id":"W1888845836","doi":"10.1002/jcph.272","title":"Breast milk concentrations of amiodarone, desethylamiodarone, and bisoprolol following short‐term drug exposure: Two case reports","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta","funders":"","keywords":"Bisoprolol; Amiodarone; Medicine; Drug; Pharmacology; Term (time); Anesthesia; Internal medicine; Atrial fibrillation; Heart failure","score_opus":0.07865113999192373,"score_gpt":0.4848256383696994,"score_spread":0.40617449837777564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1888845836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98956865,0.0019714285,0.0021498362,0.0009687811,0.0001467804,0.00010304486,0.00009536446,0.00008866645,0.0049074986],"genre_scores_gemma":[0.99512994,0.0011292704,0.0010215973,0.00052271615,0.00025580614,0.000046093322,0.00007333051,0.000023553821,0.0017976587],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9990589,0.00014475198,0.0001039602,0.00016662884,0.0002182636,0.00030747624],"domain_scores_gemma":[0.99653023,0.0012723327,0.0011055926,0.0003772081,0.00020835016,0.000506212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006160755,0.0019443573,0.0007349265,0.0014931167,0.0013384186,0.0012595124,0.0012630642,0.0042808014,0.0015265341],"category_scores_gemma":[0.0064200163,0.0014071641,0.001060661,0.0008267234,0.0019869239,0.00088465016,0.0014344287,0.002715449,0.0006996978],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012618054,0.00007815729,0.02161777,0.00003393598,0.000017042354,0.9741743,0.000715616,0.000050755974,0.0010649587,0.00012827804,0.00019132083,0.0018016293],"study_design_scores_gemma":[0.000019137196,0.00025242617,0.011795225,0.000014604757,0.000025713654,0.98480797,0.00033817693,0.00014626524,0.0017633863,0.000077172124,0.00074584666,0.000014058981],"about_ca_topic_score_codex":0.0025193598,"about_ca_topic_score_gemma":0.0017175203,"teacher_disagreement_score":0.0042808014,"about_ca_system_score_codex":0.001203518,"about_ca_system_score_gemma":0.00056682405,"threshold_uncertainty_score":0.0087322},"labels":[],"label_agreement":null},{"id":"W1896423628","doi":"10.1002/jcph.369","title":"Studying the antiemetic effect of vitamin B6 for morning sickness: Pyridoxine and pyridoxal are prodrugs","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"Duchesnay","keywords":"Pyridoxine; Antiemetic; Pyridoxal; Vomiting; Pyridoxal phosphate; Pharmacology; Medicine; Nausea; Placebo; Internal medicine; Endocrinology; Vitamin; Active metabolite; Chemistry; Prodrug; Anesthesia; Pharmacokinetics; Biochemistry; Cofactor; Phosphate","score_opus":0.05338428958410776,"score_gpt":0.44640226233767777,"score_spread":0.39301797275357003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1896423628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898196,0.008295094,0.0002571829,0.00011428063,0.000036236015,0.0006597704,0.00012720178,0.000005391065,0.0006851876],"genre_scores_gemma":[0.99350923,0.0037138658,0.00088284543,0.00017338379,0.00006164786,0.00053803995,0.00017886965,0.000002760155,0.0009393316],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99941707,0.0003594771,0.000056051405,0.000055606513,0.00006311869,0.000048765323],"domain_scores_gemma":[0.99927133,0.0003399612,0.00019840668,0.000045808643,0.00005787735,0.0000865746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014870572,0.0002544578,0.00108694,0.00016638175,0.00021547452,0.0002927707,0.00028174033,0.0006510762,0.0016926829],"category_scores_gemma":[0.0014241711,0.00021400627,0.0006480854,0.0002794458,0.00031242394,0.00031442716,0.00016163947,0.0006764863,0.00019457885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6486863,0.018551614,0.02120474,0.003683145,0.002069959,0.00033674442,0.0005837691,0.00055306975,0.13733695,0.00031963785,0.0006058408,0.16606826],"study_design_scores_gemma":[0.109405436,0.7939999,0.058758497,0.00012824318,0.0018056269,0.000745866,0.00011520173,0.0004684556,0.029760238,0.00014190096,0.004643057,0.00002766334],"about_ca_topic_score_codex":0.0007493008,"about_ca_topic_score_gemma":0.001379486,"teacher_disagreement_score":0.0016926829,"about_ca_system_score_codex":0.00036338024,"about_ca_system_score_gemma":0.0005940109,"threshold_uncertainty_score":0.007864416},"labels":[],"label_agreement":null},{"id":"W1898813812","doi":"10.1002/jcph.524","title":"Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"U.S. Food and Drug Administration","keywords":"Pharmacokinetics; Medicine; Pharmacodynamics; Population; Clinical trial; NONMEM; Pediatrics; Pharmacology; Internal medicine","score_opus":0.4984036333877825,"score_gpt":0.5614764744840787,"score_spread":0.06307284109629618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1898813812","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3376824,0.0097273225,0.63958097,0.0025648277,0.00010969045,0.0007180636,0.003831559,0.0009006921,0.0048845224],"genre_scores_gemma":[0.91994846,0.003778632,0.07113548,0.0010725003,0.00009795162,0.00067558326,0.0023592014,0.000084961466,0.00084733206],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99311996,0.005363801,0.00036467388,0.00038807656,0.00063513516,0.00012844914],"domain_scores_gemma":[0.96948326,0.025608612,0.002323463,0.0012408289,0.001069334,0.00027446417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017547479,0.0008284102,0.002225748,0.0007300249,0.00016487887,0.0017012998,0.0009775059,0.0010282046,0.0010915721],"category_scores_gemma":[0.050449416,0.0004913056,0.0013238575,0.00060023484,0.00029457774,0.001485779,0.0006224052,0.0028200424,0.0006595901],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030170046,0.00054933043,0.17984556,0.00094460044,0.0025504697,0.0010339372,0.00030919898,0.5689612,0.008824512,0.0039293957,0.0041564004,0.22587837],"study_design_scores_gemma":[0.00033371217,0.005846588,0.056614723,0.00038104437,0.0013490837,0.0016226118,0.00017612703,0.89839107,0.0096684,0.013648503,0.011806531,0.00016156885],"about_ca_topic_score_codex":0.0013982514,"about_ca_topic_score_gemma":0.0014801825,"teacher_disagreement_score":0.017547479,"about_ca_system_score_codex":0.0007143789,"about_ca_system_score_gemma":0.0016046598,"threshold_uncertainty_score":0.092801034},"labels":[],"label_agreement":null},{"id":"W1900044360","doi":"10.1002/jcph.616","title":"Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update","year":2015,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian College of Naturopathic Medicine; Hospital for Sick Children; SickKids Foundation; University of Toronto; Western University; Mount Sinai Hospital","funders":"","keywords":"Folic acid; Medicine; Fortification; Pregnancy; Folic acid supplementation; Food fortification; Family planning; Population; Environmental health; Food science; Internal medicine; Chemistry; Research methodology; Biology","score_opus":0.3434866197943854,"score_gpt":0.610873603915441,"score_spread":0.2673869841210556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1900044360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004676219,0.99358153,0.00012738895,0.0021658177,0.0008796353,0.000026834461,0.00047329068,0.000020852034,0.0022569175],"genre_scores_gemma":[0.0017323449,0.9950028,0.0003105781,0.0012014247,0.0007670508,0.000027407204,0.00052064774,0.0000045953943,0.00043313784],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99939275,0.00012356606,0.00022844557,0.00006993004,0.00015463447,0.00003064261],"domain_scores_gemma":[0.9975502,0.0011170171,0.00056739117,0.000033168035,0.00058049866,0.00015173471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010207255,0.0006122998,0.0011252285,0.004293507,0.00027539147,0.0009462901,0.0007390097,0.0013734938,0.007059827],"category_scores_gemma":[0.00565036,0.00031085967,0.0009461337,0.0030938056,0.00021939939,0.0014404277,0.0009458132,0.0013524275,0.0012794068],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016006314,0.000070507245,0.0015296064,0.030651418,0.0001729522,0.00030649581,0.00013234364,0.0001476707,0.0003106271,0.0008678712,0.08892792,0.8767226],"study_design_scores_gemma":[0.000085012165,0.00015079253,0.0076762885,0.05051161,0.0011915745,0.0029311008,0.00015268721,0.00016297532,0.00021398875,0.0006961948,0.93618697,0.000040814924],"about_ca_topic_score_codex":0.0075583677,"about_ca_topic_score_gemma":0.013894171,"teacher_disagreement_score":0.0075583677,"about_ca_system_score_codex":0.0011355577,"about_ca_system_score_gemma":0.0027038034,"threshold_uncertainty_score":0.023617446},"labels":[],"label_agreement":null},{"id":"W1937204132","doi":"10.1002/jcph.132","title":"Expression of Membrane Drug Efflux Transporters in the Sigmoid Colon of HIV‐Infected and Uninfected Men","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Maple Leaf Medical Clinic; St. Michael's Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario HIV Treatment Network","keywords":"Efflux; Multidrug resistance-associated protein 2; Abcg2; Transporter; Drug resistance; P-glycoprotein; Drug; Multiple drug resistance; Downregulation and upregulation; Medicine; Biology; Immunology; Pharmacology; ATP-binding cassette transporter; Microbiology; Gene; Biochemistry","score_opus":0.025651267423343727,"score_gpt":0.36077684542340727,"score_spread":0.33512557800006354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937204132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994311,0.00033243114,0.000029517323,0.000007747254,0.0000011933137,0.0000022540332,0.000045642784,8.7009033e-7,0.0001493118],"genre_scores_gemma":[0.99928254,0.00026698786,0.00008419994,0.000014057742,0.000002376093,0.0000040765717,0.00006699408,7.71534e-7,0.00027808477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999223,0.000019423309,0.0000058150954,0.000021953394,0.000013077615,0.000017331075],"domain_scores_gemma":[0.99989927,0.000023430095,0.000031215335,0.000006128928,0.000011532054,0.000028374057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097454475,0.00009736892,0.00012080736,0.00031775076,0.00020745085,0.00024775532,0.00005075732,0.0001435518,0.0010048642],"category_scores_gemma":[0.0003415354,0.00015830272,0.00009620667,0.00018925886,0.00019494414,0.00013901778,0.0001397329,0.000109966815,0.000120442164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029455204,0.00012696633,0.7053028,0.00016201667,0.00007433087,0.001964421,0.0015751851,0.00014286376,0.27286026,0.00012955995,0.00011515908,0.014600881],"study_design_scores_gemma":[0.000010698086,0.0006844771,0.9919572,0.000007651478,0.000018932227,0.0015485558,0.0005556248,0.00010697101,0.0047161607,0.000023834182,0.000366247,0.0000036382369],"about_ca_topic_score_codex":0.001443437,"about_ca_topic_score_gemma":0.0014961739,"teacher_disagreement_score":0.001443437,"about_ca_system_score_codex":0.00012460607,"about_ca_system_score_gemma":0.0001272409,"threshold_uncertainty_score":0.0033616424},"labels":[],"label_agreement":null},{"id":"W1957828017","doi":"10.1002/jcph.638","title":"Redefining the Recreational Drug User Population in Human Abuse Potential Studies","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vale (Canada)","funders":"","keywords":"Recreational Drug; Recreation; Drug; Recreational drug use; Medicine; Population; Drug user; Substance abuse; Drugs of abuse; Recreational use; Medical emergency; Pharmacology; Psychiatry; Environmental health; Biology","score_opus":0.2175119726011147,"score_gpt":0.5085854943548442,"score_spread":0.2910735217537295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1957828017","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24312992,0.38327277,0.109000966,0.1429494,0.015546794,0.011560122,0.019132009,0.0002891716,0.07511891],"genre_scores_gemma":[0.61856365,0.14104177,0.14322615,0.053435124,0.013245428,0.017274125,0.007044993,0.00027348674,0.00589516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9352231,0.047231738,0.007841478,0.0024228485,0.0062060393,0.0010747779],"domain_scores_gemma":[0.94196415,0.038527813,0.005995756,0.0038552936,0.0070705,0.0025864562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.052961588,0.00050441816,0.0014440439,0.00594784,0.0020041524,0.0038935295,0.003538251,0.0024649068,0.004758428],"category_scores_gemma":[0.07565742,0.0006325461,0.00074961147,0.006550585,0.0028355143,0.006891165,0.0057020346,0.005763175,0.0011298879],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012615644,0.00058953336,0.3578339,0.016433556,0.00063179544,0.0037018156,0.03251169,0.00045917812,0.001507538,0.078239456,0.13120398,0.37562603],"study_design_scores_gemma":[0.00020552862,0.0009436319,0.3128491,0.03314232,0.00057665346,0.0069659194,0.01610002,0.0013625866,0.0010722235,0.040246118,0.5863122,0.00022369147],"about_ca_topic_score_codex":0.0062971814,"about_ca_topic_score_gemma":0.014842829,"teacher_disagreement_score":0.052961588,"about_ca_system_score_codex":0.0013614687,"about_ca_system_score_gemma":0.003963567,"threshold_uncertainty_score":0.280091},"labels":[],"label_agreement":null},{"id":"W1969996376","doi":"10.1177/0091270010365553","title":"Pediatric Cancer Rates After Universal Folic Acid Flour Fortification In Ontario","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health; Western University; St. Michael's Hospital; University of Toronto; Pediatric Oncology Group; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); Pediatrics; Confidence interval; Population; Cohort; Cancer; Food fortification; Internal medicine; Folic acid; Environmental health","score_opus":0.05833098450042797,"score_gpt":0.4459191695096926,"score_spread":0.3875881850092647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969996376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920908,0.00053681445,0.00006446896,0.00029633584,0.000009700219,0.000019573055,0.004379042,0.000018575065,0.0025847217],"genre_scores_gemma":[0.99431497,0.0005666664,0.000100417776,0.000055361586,0.0000074422987,0.000016967913,0.003229769,0.0000071536265,0.001701339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935645,0.000030227791,0.000030749372,0.00006794109,0.00028362995,0.00023099584],"domain_scores_gemma":[0.99840456,0.00006144717,0.00063741184,0.000058452522,0.00058998086,0.0002480935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035058812,0.00013457482,0.00027932276,0.0005700027,0.0007235745,0.0005289012,0.00056361896,0.00025527304,0.0016980805],"category_scores_gemma":[0.001954515,0.00023532107,0.00043474653,0.0017450126,0.00028742815,0.0002326755,0.0004407409,0.0003895361,0.00018459227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014690502,0.000013016447,0.99292165,0.000019330393,0.000023398097,0.00013528983,0.0005502727,0.00010825467,0.0003071464,0.000065688335,0.001019177,0.004689916],"study_design_scores_gemma":[0.000006280011,0.000018527058,0.9988288,0.0000048934994,0.000009765877,0.000055750872,0.00018242946,0.00006442929,0.00006042432,0.000006204533,0.00076027145,0.0000022545557],"about_ca_topic_score_codex":0.9708656,"about_ca_topic_score_gemma":0.9800535,"teacher_disagreement_score":0.029134393,"about_ca_system_score_codex":0.013838937,"about_ca_system_score_gemma":0.012758839,"threshold_uncertainty_score":0.10040903},"labels":[],"label_agreement":null},{"id":"W1971397614","doi":"10.1177/0091270009333487","title":"Predictors of Prenatal Multivitamin Adherence in Pregnant Women","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; York University; University of Toronto","funders":"","keywords":"Multivitamin; Medicine; Nausea; Vomiting; Pregnancy; Prenatal care; Constipation; Regimen; Obstetrics; Pediatrics; Population; Internal medicine; Environmental health; Vitamin","score_opus":0.06304768107717455,"score_gpt":0.44691062513871876,"score_spread":0.3838629440615442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971397614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876535,0.00045937215,0.000086331456,0.00017297929,0.0000062933473,0.000008252537,0.0000514948,0.000002507724,0.000447455],"genre_scores_gemma":[0.9995622,0.00019687471,0.000117030715,0.000026011601,0.000005025813,0.000005015993,0.000026924252,7.210314e-7,0.00006019711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994498,0.0002478611,0.000060344315,0.000049307477,0.000120903656,0.00007178487],"domain_scores_gemma":[0.9970715,0.0014796361,0.0009208901,0.00009698236,0.00015971721,0.00027123012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007172436,0.000120844925,0.0002263271,0.0003052226,0.0002882223,0.00026779054,0.00013221901,0.00040042648,0.00097323494],"category_scores_gemma":[0.008325831,0.00018978852,0.00026805978,0.00044039782,0.00020139283,0.00016786325,0.00018395972,0.0006080884,0.00008072779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005655965,0.00003213097,0.9968708,0.0000068715094,0.0000181607,0.000047090583,0.00008437762,0.000023519271,0.00008184557,0.00000949212,0.0000294462,0.0027397268],"study_design_scores_gemma":[0.0000052129576,0.00018903034,0.9988741,0.000016982465,0.00003107346,0.00019189458,0.0001434897,0.00032481508,0.000076172364,0.000031072927,0.00011352539,0.0000026488167],"about_ca_topic_score_codex":0.005430123,"about_ca_topic_score_gemma":0.0051190862,"teacher_disagreement_score":0.005430123,"about_ca_system_score_codex":0.00018002595,"about_ca_system_score_gemma":0.0004119339,"threshold_uncertainty_score":0.010797024},"labels":[],"label_agreement":null},{"id":"W1972752819","doi":"10.1177/009127002401102803","title":"Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Amprenavir; Pharmacokinetics; Bioequivalence; Pharmacology; Prodrug; Bioavailability; Crossover study; Medicine; Chemistry; Protease; Biochemistry","score_opus":0.08639558196707112,"score_gpt":0.4306749514898969,"score_spread":0.3442793695228258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972752819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974808,0.0005807676,0.00056065735,0.00005156879,0.0000571339,0.0003495714,0.00039294636,0.000055067834,0.00047147158],"genre_scores_gemma":[0.9959188,0.0003474901,0.0009911413,0.0002559335,0.00008192484,0.00039108485,0.0004750614,0.000020896223,0.0015175956],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995704,0.00014369644,0.00002463806,0.00013057234,0.00006853919,0.00006213094],"domain_scores_gemma":[0.9995757,0.00009639032,0.00008107828,0.000056903056,0.000053793257,0.0001363021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064471434,0.0010846411,0.0013710877,0.0002687374,0.00053492404,0.00037417212,0.00021636988,0.00092982996,0.0021633694],"category_scores_gemma":[0.0011406416,0.00080517697,0.0007238404,0.00023544855,0.0006662215,0.00066527864,0.0002594621,0.001092394,0.0007433851],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49257788,0.033255156,0.032525875,0.00067497935,0.001128991,0.00063239224,0.0016048112,0.00090915966,0.34282932,0.0002557097,0.0025903932,0.091015406],"study_design_scores_gemma":[0.06386673,0.6482898,0.23145582,0.000027526807,0.0015486504,0.0012204526,0.00035324565,0.0031026946,0.04432385,0.0003782012,0.005252689,0.00018034084],"about_ca_topic_score_codex":0.00083400204,"about_ca_topic_score_gemma":0.0008629987,"teacher_disagreement_score":0.0021633694,"about_ca_system_score_codex":0.00022390812,"about_ca_system_score_gemma":0.00028514443,"threshold_uncertainty_score":0.0072372556},"labels":[],"label_agreement":null},{"id":"W1974773091","doi":"10.1177/00912700222011607","title":"Clinical Pharmacokinetics of Verteporfin","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QLT (Canada)","funders":"","keywords":"Verteporfin; Pharmacokinetics; Cmax; Macular degeneration; Choroidal neovascularization; Medicine; Metabolite; Ophthalmology; Pharmacology; Urology; Internal medicine","score_opus":0.1711532709707249,"score_gpt":0.5130131808709297,"score_spread":0.3418599099002048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974773091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835003,0.0062106615,0.0014608933,0.000161211,0.000017204058,0.000067576664,0.0002941665,0.00007445437,0.0033637607],"genre_scores_gemma":[0.9975916,0.00074085087,0.00041687192,0.000107665146,0.000029692437,0.000046816982,0.00025887945,0.000011671586,0.0007959961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997706,0.000086435,0.000012327204,0.000046274985,0.000058861984,0.000025564614],"domain_scores_gemma":[0.9996853,0.000081607715,0.00009072943,0.00001895867,0.000055869492,0.000067601446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033268798,0.00017533066,0.000317682,0.00009423769,0.00017529905,0.00031904387,0.00009064001,0.00021794885,0.0013393194],"category_scores_gemma":[0.0015643202,0.00010765987,0.00011926717,0.00015219649,0.00014999851,0.00014431131,0.00008194214,0.0003459415,0.00040217914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05565855,0.0013799593,0.42063054,0.00039803286,0.00041251263,0.0018817664,0.0006232968,0.0020859747,0.20720325,0.00071588816,0.005263548,0.3037466],"study_design_scores_gemma":[0.0016319508,0.02082282,0.91724235,0.000056202225,0.00026966835,0.007408641,0.00017412606,0.003641347,0.026880214,0.00046314823,0.02136471,0.000044892884],"about_ca_topic_score_codex":0.0011531514,"about_ca_topic_score_gemma":0.00073996815,"teacher_disagreement_score":0.0013393194,"about_ca_system_score_codex":0.00046302157,"about_ca_system_score_gemma":0.00035973973,"threshold_uncertainty_score":0.004480481},"labels":[],"label_agreement":null},{"id":"W1978188503","doi":"10.1177/0091270011399577","title":"Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Overeating; Inverse agonist; Pharmacokinetics; Pharmacodynamics; Pharmacology; Endogenous opioid; Opioid; Agonist; Taste; Opioid receptor; Medicine; Receptor; Endocrinology; Chemistry; Internal medicine; Obesity; Food science","score_opus":0.1585381157846783,"score_gpt":0.33448284111702187,"score_spread":0.17594472533234357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978188503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974081,0.0008522504,0.00072437583,0.00009603648,0.000023299595,0.00018869946,0.00018046347,0.000047332367,0.00047937437],"genre_scores_gemma":[0.9964772,0.00085394614,0.0012895352,0.00007995403,0.000025119885,0.00017644852,0.00027165568,0.000012906313,0.0008132194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971443,0.00010967113,0.000022806202,0.00004520415,0.00006296718,0.000044950688],"domain_scores_gemma":[0.99966073,0.00008062352,0.0001076914,0.00005042126,0.00003074639,0.00006971624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005482375,0.0006825546,0.0010735983,0.00030768762,0.00023316519,0.00042129026,0.0004769583,0.00068645144,0.001423782],"category_scores_gemma":[0.00076245226,0.0005178124,0.00068048266,0.0002453152,0.00046199854,0.0005164743,0.00016434757,0.0012504023,0.00033694523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0692881,0.009778501,0.004036181,0.00043473905,0.00042780198,0.00036516105,0.00021262483,0.0007276282,0.8466398,0.00024638043,0.0006343675,0.06720865],"study_design_scores_gemma":[0.024586799,0.42836532,0.06585497,0.000046121047,0.0009799236,0.002873641,0.00017101616,0.0051587257,0.46734104,0.00023683248,0.004284841,0.00010082941],"about_ca_topic_score_codex":0.0004435422,"about_ca_topic_score_gemma":0.0015033445,"teacher_disagreement_score":0.001423782,"about_ca_system_score_codex":0.00035883204,"about_ca_system_score_gemma":0.0005396694,"threshold_uncertainty_score":0.004763007},"labels":[],"label_agreement":null},{"id":"W1978332054","doi":"10.1177/0091270010373928","title":"Patterns of Antidepressant Medication Use Among Pregnant Women in a United States Population","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Child and Family Research Institute","funders":"","keywords":"Antidepressant; Bupropion; Pregnancy; Medicine; Population; Telephone interview; Obstetrics; Pediatrics; Psychiatry; Environmental health; Smoking cessation","score_opus":0.05618413982299384,"score_gpt":0.4272779569408325,"score_spread":0.3710938171178386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978332054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892455,0.00027946464,0.000044057946,0.00006901546,0.0000032805954,0.000005756795,0.00037107887,0.0000050566637,0.0002976969],"genre_scores_gemma":[0.9990526,0.00024442532,0.00009302898,0.000049987717,0.0000048920665,0.000010521451,0.00045679946,0.0000012543634,0.00008645896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968195,0.000107184445,0.000054093405,0.000057400157,0.00006357892,0.00003574217],"domain_scores_gemma":[0.9992286,0.00015920427,0.00036853226,0.000040736722,0.00010077043,0.000102111546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031199976,0.00012652077,0.00022687847,0.00082386995,0.00022737459,0.00033715958,0.00018316964,0.0003432854,0.0004907914],"category_scores_gemma":[0.001725428,0.00021392263,0.00021568642,0.000741111,0.00017417442,0.00025089813,0.00022531064,0.00027390546,0.00011008862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028568003,0.0000144336655,0.9980405,0.000005213527,0.00002806663,0.00006675052,0.000107279746,0.000018874805,0.00018393851,0.0000060380576,0.00008531482,0.0014150498],"study_design_scores_gemma":[0.0000015314235,0.00003140032,0.999426,0.0000034889674,0.000007451454,0.00023709585,0.00012918923,0.00006415893,0.000024571409,0.0000047429007,0.00006859376,0.0000017900364],"about_ca_topic_score_codex":0.011458384,"about_ca_topic_score_gemma":0.016903521,"teacher_disagreement_score":0.011458384,"about_ca_system_score_codex":0.000270333,"about_ca_system_score_gemma":0.00019595737,"threshold_uncertainty_score":0.022783399},"labels":[],"label_agreement":null},{"id":"W1980311708","doi":"10.1177/0091270009334376","title":"Statin Effects on LDL and HDL Cholesterol in South Asian and White Populations","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; William Osler Health System; Canadian Respiratory Research Network; St. Michael's Hospital","funders":"","keywords":"Statin; Ldl cholesterol; Medicine; Cholesterol; White (mutation); Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Atorvastatin; Pharmacology; Endocrinology; Biology; Biochemistry","score_opus":0.05706845570309015,"score_gpt":0.43436605115318583,"score_spread":0.37729759545009567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980311708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338704,0.0022297467,0.00025422577,0.0002482062,0.000027307902,0.000034540706,0.00014751253,0.000008255505,0.0036632349],"genre_scores_gemma":[0.9969958,0.001165596,0.00034875594,0.0002996187,0.000025243264,0.000025111061,0.00017452754,0.0000058039077,0.00095963833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995896,0.00017069715,0.00004756876,0.000052160078,0.00010245155,0.00003749254],"domain_scores_gemma":[0.9994367,0.0001340576,0.00013275266,0.000059441198,0.00011204649,0.00012509649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00134953,0.00020291709,0.0003466346,0.0003463249,0.0002490463,0.00046982104,0.00012702099,0.00026124463,0.0017469283],"category_scores_gemma":[0.0015935784,0.00015384013,0.00046747547,0.000374489,0.00023947578,0.0002077034,0.00033542063,0.00040327178,0.00028173145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016972711,0.00092459953,0.84999555,0.0004884931,0.0015211046,0.0011531984,0.0019213386,0.00026499468,0.051014807,0.0007787543,0.0011234538,0.07384092],"study_design_scores_gemma":[0.0004445573,0.0024183337,0.98739713,0.000055245935,0.000501686,0.000553156,0.00065366447,0.00040166735,0.0049111405,0.00027429656,0.0023713387,0.000017909031],"about_ca_topic_score_codex":0.003004633,"about_ca_topic_score_gemma":0.0040295315,"teacher_disagreement_score":0.003004633,"about_ca_system_score_codex":0.00019451004,"about_ca_system_score_gemma":0.0003076243,"threshold_uncertainty_score":0.00713706},"labels":[],"label_agreement":null},{"id":"W1980583128","doi":"10.1177/0091270005278808","title":"Conversion From Subcutaneous to Intravenous Erythropoietin in a Hemodialysis Population","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Manitoba","funders":"","keywords":"Medicine; Erythropoietin; Dosing; Hemodialysis; Epoetin alfa; Anemia; Subcutaneous injection; Population; Route of administration; Anesthesia; Surgery; Internal medicine","score_opus":0.035477294615036126,"score_gpt":0.4016039375321011,"score_spread":0.366126642917065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980583128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997477,0.00009665353,0.00004605226,0.000007155166,0.000002271578,0.0000036105646,0.000007956552,9.565612e-7,0.00008767558],"genre_scores_gemma":[0.99976724,0.00005485601,0.00005667148,0.000034635315,0.000009100391,0.00000500213,0.000034883236,6.945932e-7,0.000036977734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949837,0.00021343357,0.000044976987,0.00006704434,0.00011875234,0.000057402976],"domain_scores_gemma":[0.99862134,0.0004907847,0.00055564224,0.00007958028,0.00006115118,0.000191351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005822198,0.00012601555,0.00036871637,0.00023024116,0.000262683,0.0006019383,0.00010310596,0.0002652571,0.00047373513],"category_scores_gemma":[0.002650744,0.00012429823,0.00026709624,0.00023324924,0.00020853881,0.00024470667,0.00018046696,0.00060774654,0.00009203276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011127076,0.0016381671,0.94708055,0.000038370676,0.00015640917,0.0007087682,0.00038784143,0.00025032018,0.008120943,0.000089278925,0.00014893826,0.030253353],"study_design_scores_gemma":[0.0006447787,0.01785345,0.9736868,0.00001852015,0.00015337711,0.0036098754,0.00039076692,0.00093404367,0.0020270888,0.000087782566,0.0005760928,0.000017449249],"about_ca_topic_score_codex":0.0003707761,"about_ca_topic_score_gemma":0.00036183125,"teacher_disagreement_score":0.0006019383,"about_ca_system_score_codex":0.00019553369,"about_ca_system_score_gemma":0.00022076376,"threshold_uncertainty_score":0.0030791163},"labels":[],"label_agreement":null},{"id":"W1981726399","doi":"10.1177/0091270006292126","title":"The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":662,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto","funders":"National Center for Research Resources; National Institute of Nursing Research; National Institute of Mental Health; National Institute on Aging","keywords":"Anticholinergic; Delirium; Drug; Medicine; Linear regression; Internal medicine; Regression analysis; Adverse effect; Pharmacology; Psychiatry; Statistics","score_opus":0.019733009001229835,"score_gpt":0.3669907101671299,"score_spread":0.3472577011659001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981726399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993899,0.00011231159,0.00012188866,0.000020418825,0.000006730936,0.000021274134,0.000096760945,0.000004410687,0.0002263017],"genre_scores_gemma":[0.99915636,0.000059031507,0.0003644838,0.000011920139,0.000010992788,0.000026866084,0.00017556117,0.0000021031628,0.00019276199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989286,0.00045872288,0.000109916706,0.00010491887,0.00034823193,0.000049638358],"domain_scores_gemma":[0.9961636,0.0012855518,0.0013997531,0.00033225433,0.00038491105,0.00043401695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014754555,0.00059313944,0.00049132574,0.0007162113,0.00028566387,0.00050544785,0.00035246165,0.00038897202,0.001276471],"category_scores_gemma":[0.0064098616,0.00024959087,0.0005184312,0.00054662465,0.00031079655,0.00038877927,0.00053089927,0.00071236724,0.00022539916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003346928,0.00017157366,0.99541,0.000016589276,0.00013839667,0.00003688862,0.00004844989,0.000055108172,0.0008284153,0.000009838978,0.000053712673,0.0028963217],"study_design_scores_gemma":[0.00002154138,0.00043553024,0.9987612,0.0000023665564,0.000027753642,0.000112051195,0.000025783893,0.00035080226,0.00019280965,0.0000096728245,0.000057704932,0.000002757391],"about_ca_topic_score_codex":0.0022390573,"about_ca_topic_score_gemma":0.0058143535,"teacher_disagreement_score":0.0022390573,"about_ca_system_score_codex":0.0003034851,"about_ca_system_score_gemma":0.00031300262,"threshold_uncertainty_score":0.007803023},"labels":[],"label_agreement":null},{"id":"W1982887770","doi":"10.1177/0091270007305299","title":"Enzyme Replacement in Fabry Disease: Pharmacokinetics and Pharmacodynamics of Agalsidase Alfa in Children and Adolescents","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health","keywords":"Pharmacokinetics; Medicine; Dosing; Pharmacodynamics; Fabry disease; Plasma clearance; Enzyme replacement therapy; Anesthesia; Urology; Internal medicine; Disease","score_opus":0.031236489079753498,"score_gpt":0.4313814460170934,"score_spread":0.40014495693733987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982887770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985429,0.0011325178,0.00015893368,0.000021741718,0.0000042160905,0.000013892291,0.000028572027,0.0000058835108,0.00009142281],"genre_scores_gemma":[0.9986506,0.0006063696,0.00047305942,0.000055527424,0.000018045122,0.000035373287,0.00009687054,0.0000033086544,0.000060850336],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997435,0.00013107684,0.000019216097,0.00002783058,0.000050992887,0.000027351278],"domain_scores_gemma":[0.9994573,0.00013291692,0.00020564324,0.000021851489,0.000040970175,0.00014136295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006381168,0.00029736108,0.00075092306,0.00012033563,0.000121069716,0.00026735177,0.00012835018,0.00026404418,0.00024260496],"category_scores_gemma":[0.0008779287,0.000118380434,0.00021298196,0.00016201106,0.00024829045,0.00023273852,0.00010448668,0.00048093888,0.00008017481],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08747565,0.0046947203,0.66066945,0.0005006238,0.0006023327,0.001974088,0.00099494,0.0023380416,0.07899144,0.00031057443,0.0010363089,0.1604118],"study_design_scores_gemma":[0.011074677,0.22671643,0.725177,0.00007356574,0.0005476102,0.00802664,0.00044250756,0.0034992348,0.018107044,0.0001393949,0.006169234,0.000026657366],"about_ca_topic_score_codex":0.00037532713,"about_ca_topic_score_gemma":0.00032074776,"teacher_disagreement_score":0.00075092306,"about_ca_system_score_codex":0.00024759024,"about_ca_system_score_gemma":0.0003374078,"threshold_uncertainty_score":0.0033746958},"labels":[],"label_agreement":null},{"id":"W1983440297","doi":"10.1177/0091270010395940","title":"Anti‐EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab","year":2011,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Panitumumab; Cetuximab; Medicine; Bevacizumab; Colorectal cancer; Epidermal growth factor receptor; Monoclonal antibody; Clinical trial; Oncology; Internal medicine; Adjuvant; EGFR inhibitors; Pharmacology; Cancer; Antibody; Immunology; Chemotherapy","score_opus":0.26552730539843883,"score_gpt":0.5152066995027675,"score_spread":0.2496793941043287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983440297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001750344,0.9987295,0.00014770035,0.00012587059,0.00007079661,0.000008441574,0.000011476655,0.0000055250753,0.00072557695],"genre_scores_gemma":[0.000739089,0.99840814,0.00022510931,0.000110425186,0.00006369642,0.000007583063,0.000017591143,0.0000010565652,0.00042724065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997508,0.000051171264,0.000035409215,0.00003713056,0.000105858264,0.000019696998],"domain_scores_gemma":[0.9998134,0.0000754436,0.000035121688,0.0000067891074,0.000047148264,0.000022081853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007496997,0.0007696174,0.0016345303,0.0033738522,0.00022472428,0.0007112923,0.0008093728,0.00091690104,0.0030098697],"category_scores_gemma":[0.0004703554,0.00031583474,0.0006316045,0.0026171296,0.0004045559,0.0011325091,0.0006067574,0.0017123211,0.002315817],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013322654,0.0001540493,0.00012541904,0.018698178,0.0001413176,0.00035245172,0.000066251676,0.00031007102,0.0031445601,0.002493013,0.013354959,0.9610264],"study_design_scores_gemma":[0.00009887953,0.00032228188,0.0014722768,0.0041379128,0.0002313574,0.0036596893,0.00006223564,0.00014320156,0.0017249691,0.001612633,0.98650485,0.000029811928],"about_ca_topic_score_codex":0.00083956757,"about_ca_topic_score_gemma":0.0019014076,"teacher_disagreement_score":0.0033738522,"about_ca_system_score_codex":0.00048015302,"about_ca_system_score_gemma":0.0008756333,"threshold_uncertainty_score":0.010068953},"labels":[],"label_agreement":null},{"id":"W1983767665","doi":"10.1177/0091270009343697","title":"Teaching Pharmacology in an Innovative Medical Curriculum: Challenges of Integration, Technology, and Future Training","year":2009,"lang":"en","type":"editorial","venue":"The Journal of Clinical Pharmacology","topic":"Innovations in Medical Education","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Curriculum; Relevance (law); Medical education; Set (abstract data type); Subject (documents); Engineering ethics; Task (project management); Medical knowledge; Problem-based learning; Psychology; Medicine; Mathematics education; Computer science; Pedagogy; Engineering; Political science","score_opus":0.0493189278868662,"score_gpt":0.498453784632757,"score_spread":0.4491348567458908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983767665","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031453557,0.0986529,0.08031841,0.7194846,0.005865265,0.00040749717,0.000050119826,0.00035375648,0.063413896],"genre_scores_gemma":[0.5159355,0.10942857,0.24179797,0.09579914,0.012148118,0.0015948142,0.00017320379,0.00034475164,0.022777976],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.98106456,0.009332981,0.00078581047,0.0010752507,0.0064234934,0.0013179355],"domain_scores_gemma":[0.98373485,0.0082713915,0.0012224377,0.001111758,0.0018171389,0.0038424316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03632133,0.0006877168,0.0009117706,0.002213059,0.006132239,0.020335317,0.003780706,0.006651407,0.006010537],"category_scores_gemma":[0.018581772,0.00068808167,0.0006363219,0.0017878219,0.01817857,0.021461902,0.02138635,0.0130404085,0.0017721251],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006834069,0.0006497014,0.00300079,0.001798436,0.000040912873,0.0004670666,0.024300221,0.0013538814,0.001362193,0.51478004,0.025844168,0.4263343],"study_design_scores_gemma":[0.00008134146,0.00054458034,0.004527174,0.0050862613,0.000029981607,0.001687386,0.021813637,0.0033943723,0.0008989981,0.42414895,0.5376784,0.00010896852],"about_ca_topic_score_codex":0.0020877835,"about_ca_topic_score_gemma":0.0035604225,"teacher_disagreement_score":0.03632133,"about_ca_system_score_codex":0.011789665,"about_ca_system_score_gemma":0.023538413,"threshold_uncertainty_score":0.19208783},"labels":[],"label_agreement":null},{"id":"W1987148753","doi":"10.1177/0091270005284389","title":"Use of Omeprazole as a CYP3A Probe Drug: Effect of Sex and Menstrual Cycle Phase on CYP3A Activity in Healthy Caucasian Adults","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Luteal phase; Omeprazole; Follicular phase; Menstrual cycle; CYP3A; Medicine; Endocrinology; Internal medicine; Metabolism; Hormone","score_opus":0.1143286373631692,"score_gpt":0.5257836796528554,"score_spread":0.4114550422896862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987148753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988182,0.0007801536,0.00007087471,0.000018379054,0.0000051642733,0.000009187544,0.000075767755,0.000003347445,0.00021889008],"genre_scores_gemma":[0.99936813,0.00020846938,0.000118364784,0.00004498318,0.0000136570625,0.000011064415,0.0001248532,0.000002899109,0.00010750731],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993364,0.0002684274,0.000073227435,0.00013865891,0.00013435872,0.00004880586],"domain_scores_gemma":[0.9988895,0.00033014454,0.0004264442,0.00008335008,0.00010447306,0.00016613398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007387094,0.00027215254,0.0005885291,0.00030648228,0.00026172254,0.0002906246,0.0001322306,0.00042132242,0.00054264173],"category_scores_gemma":[0.0020288783,0.00021099005,0.00039838033,0.00039650867,0.00026634402,0.00025008494,0.00020041685,0.00027903717,0.00016738678],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044857254,0.0002582605,0.9777565,0.000040478106,0.000332459,0.00028915337,0.00020863971,0.0000672733,0.007146794,0.000016569556,0.00009841684,0.009299738],"study_design_scores_gemma":[0.00002339284,0.0012281755,0.9978296,0.0000020139855,0.00006161453,0.00031752684,0.0000406748,0.00010861354,0.00024440963,0.000007357529,0.00013366778,0.0000028942181],"about_ca_topic_score_codex":0.0010414068,"about_ca_topic_score_gemma":0.0015347447,"teacher_disagreement_score":0.0010414068,"about_ca_system_score_codex":0.00016660639,"about_ca_system_score_gemma":0.00013229252,"threshold_uncertainty_score":0.003906727},"labels":[],"label_agreement":null},{"id":"W1987539558","doi":"10.1002/j.1552-4604.2002.tb06009.x","title":"Adolescents Prenatally Exposed to Marijuana: Examination of Facets of Complex Behaviors and Comparisons with the Influence of In Utero Cigarettes","year":2002,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"","keywords":"Psychology; Developmental psychology; Context (archaeology); Offspring; Cognition; In utero; Pregnancy; Clinical psychology; Psychiatry; Fetus","score_opus":0.11709426686251614,"score_gpt":0.4360151626969021,"score_spread":0.318920895834386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987539558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0662055,0.9317992,0.0001703136,0.00014670556,0.0001112602,0.000016801525,0.00013558255,0.0000058788314,0.0014086923],"genre_scores_gemma":[0.047941476,0.95122254,0.0001927781,0.00007869345,0.000086701264,0.000018942399,0.00008236776,0.0000021027429,0.00037434927],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99988127,0.000025737372,0.000023984834,0.000027481761,0.000028325261,0.000013114359],"domain_scores_gemma":[0.9997491,0.00013242374,0.000059688227,0.0000051219004,0.000039046587,0.000014494988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001955227,0.00021398607,0.00046407987,0.00085891865,0.00009113776,0.00038056853,0.00021077733,0.00023413828,0.00046319244],"category_scores_gemma":[0.0005657306,0.00013622273,0.00031002707,0.0007916277,0.00015159918,0.00017931174,0.00018865151,0.0002576399,0.00008271442],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005465839,0.00023159668,0.12151948,0.029980576,0.0010073467,0.0036326488,0.0027338616,0.00042779988,0.024782242,0.001243627,0.0027416723,0.8111526],"study_design_scores_gemma":[0.000018562141,0.0013781866,0.869081,0.0060330513,0.00164373,0.0067628245,0.0020446943,0.00014015309,0.004862243,0.0003197281,0.107674055,0.00004177259],"about_ca_topic_score_codex":0.0038595377,"about_ca_topic_score_gemma":0.005306423,"teacher_disagreement_score":0.0038595377,"about_ca_system_score_codex":0.0001858949,"about_ca_system_score_gemma":0.0004548808,"threshold_uncertainty_score":0.0076741576},"labels":[],"label_agreement":null},{"id":"W1991334257","doi":"10.1177/0091270004272670","title":"Differential Toxicity of Reactive Metabolites of Clindamycin and Sulfonamides in HIV‐Infected Cells: Influence of HIV Infection on Clindamycin Toxicity In Vitro","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Clindamycin; Toxicity; Microsome; Pharmacology; Population; Metabolite; Chemistry; Medicine; In vitro; Antibiotics; Immunology; Microbiology; Biology; Internal medicine; Biochemistry","score_opus":0.03873251600058317,"score_gpt":0.396321656709676,"score_spread":0.35758914070909287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991334257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935654,0.0036556819,0.0011448289,0.00004527553,0.000019064537,0.00004297805,0.00044690527,0.000017746104,0.0010620636],"genre_scores_gemma":[0.9928762,0.002420926,0.0026640426,0.000046856458,0.000015291862,0.00006789811,0.0008620841,0.00000901825,0.0010376672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99959344,0.00017363361,0.000057277677,0.00004012363,0.00009141607,0.000044073953],"domain_scores_gemma":[0.9996221,0.0001755283,0.00005913556,0.000037935144,0.00007204196,0.000033165874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003559688,0.00041350056,0.00037007264,0.00018195237,0.00018576343,0.00033897316,0.00019543697,0.00035951758,0.0008763415],"category_scores_gemma":[0.00032326602,0.0002404853,0.0002654947,0.00032738107,0.00015034332,0.00024471182,0.000234948,0.0002856778,0.00027793873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004901012,0.00007161937,0.0016458684,0.00011853914,0.000027770837,0.0001410653,0.00011858041,0.000286953,0.99468094,0.000052164556,0.000042581883,0.0023237462],"study_design_scores_gemma":[0.000030086887,0.0020876017,0.014891163,0.00001475914,0.00003635871,0.00038657442,0.00008756355,0.001414471,0.98007274,0.000041665357,0.00092590257,0.000011203475],"about_ca_topic_score_codex":0.0010440443,"about_ca_topic_score_gemma":0.0014422835,"teacher_disagreement_score":0.0010440443,"about_ca_system_score_codex":0.00023439314,"about_ca_system_score_gemma":0.00016952693,"threshold_uncertainty_score":0.0029316545},"labels":[],"label_agreement":null},{"id":"W1991774560","doi":"10.1177/0091270010382420","title":"Increased Risk of Myocardial Infarction Associated With Angiotensin-Converting Enzyme Gene Polymorphism Is Age Dependent","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Myocardial infarction; Angiotensin-converting enzyme; Genotype; Medicine; Internal medicine; Allele; Young adult; Coronary artery disease; Polymorphism (computer science); Gene polymorphism; Locus (genetics); Endocrinology; Genetics; Gene; Biology; Blood pressure","score_opus":0.03792610348517438,"score_gpt":0.3600109217731067,"score_spread":0.3220848182879323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991774560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992845,0.0043794024,0.00033557313,0.00013210543,0.00001868021,0.000008066611,0.00008419569,0.0000074200716,0.0021894318],"genre_scores_gemma":[0.9978271,0.0011763269,0.00014609213,0.00006671029,0.000041647218,0.0000027594745,0.0000686361,0.0000012290101,0.00066948717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999887,0.000032444794,0.00000761694,0.000022096034,0.00003175372,0.000019164258],"domain_scores_gemma":[0.9995395,0.00012526991,0.00016069398,0.00002661558,0.00006186579,0.00008611383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003031884,0.00017009332,0.0002359956,0.00031155956,0.00015074296,0.00025822668,0.00011859907,0.00025990503,0.0014492562],"category_scores_gemma":[0.0006697269,0.00009278477,0.00013329006,0.0003010368,0.00020044723,0.00012499127,0.000110659385,0.00024026507,0.00016825281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063327624,0.00010252047,0.9809966,0.00005227148,0.00013699483,0.0005533683,0.00011323636,0.00004352207,0.005838745,0.000070796996,0.00016818753,0.011290575],"study_design_scores_gemma":[0.0000033835795,0.00007857427,0.99925774,0.000003921702,0.00002289155,0.00024499994,0.000016532207,0.000030560266,0.00010309882,0.000026826692,0.00021028507,0.0000011550363],"about_ca_topic_score_codex":0.004210215,"about_ca_topic_score_gemma":0.005777512,"teacher_disagreement_score":0.004210215,"about_ca_system_score_codex":0.00014059644,"about_ca_system_score_gemma":0.00019394705,"threshold_uncertainty_score":0.008371413},"labels":[],"label_agreement":null},{"id":"W1994093013","doi":"10.1177/00912700122010177","title":"Effect of Alosetron on the Pharmacokinetics of Fluoxetine","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Fluoxetine; Medicine; Pharmacokinetics; Pharmacology; CYP2C9; Active metabolite; CYP2D6; CYP3A4; Metabolite; Irritable bowel syndrome; Crossover study; Drug interaction; Internal medicine; Cytochrome P450; Placebo; Serotonin; Metabolism; Receptor","score_opus":0.07725395056796786,"score_gpt":0.47573142917853245,"score_spread":0.3984774786105646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994093013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900985,0.00022556032,0.00011065581,0.000041636737,0.000019401476,0.000056773253,0.00006601898,0.000016567448,0.00045346605],"genre_scores_gemma":[0.99853015,0.0002919166,0.000325191,0.0000675623,0.000038562568,0.00004502281,0.00011634785,0.0000073668803,0.0005778772],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995621,0.00025481122,0.0000289539,0.000052792697,0.00004985487,0.000051567444],"domain_scores_gemma":[0.9991704,0.00042051636,0.00012304053,0.00006831622,0.00004576136,0.0001720263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034807707,0.00039884486,0.0006995138,0.00013140628,0.00018866014,0.00031143957,0.00017109973,0.00054819626,0.0022038259],"category_scores_gemma":[0.0021309676,0.00031034971,0.00030226598,0.00012816269,0.0003680131,0.00044446447,0.00013584501,0.0006698454,0.0003095829],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60529995,0.017903332,0.009525765,0.0002500075,0.0005258417,0.00049835286,0.00034848964,0.00071183033,0.28381896,0.00015022146,0.00056196115,0.080405325],"study_design_scores_gemma":[0.049782608,0.68767965,0.15389107,0.0000502155,0.0008500106,0.001217216,0.0002891438,0.0042811,0.09788979,0.00022377686,0.0037559315,0.00008946206],"about_ca_topic_score_codex":0.00059869105,"about_ca_topic_score_gemma":0.0011897632,"teacher_disagreement_score":0.0022038259,"about_ca_system_score_codex":0.00022602626,"about_ca_system_score_gemma":0.0002925829,"threshold_uncertainty_score":0.0073724985},"labels":[],"label_agreement":null},{"id":"W1995558772","doi":"10.1177/00912700222011436","title":"Effects of Azimilide on Heart Rate and ECG Conduction Intervals during Sinus Rhythm in Patients with a History of Atrial Fibrillation","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atrial fibrillation; Cardiology; Atrial flutter; QT interval; Internal medicine; Placebo; Sinus rhythm; Anesthesia; Torsades de pointes; Heart rate; Population; Blood pressure","score_opus":0.027511190880355193,"score_gpt":0.33170404422967287,"score_spread":0.30419285334931767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995558772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949109,0.0032903412,0.00011938211,0.000117240415,0.00004500497,0.000027012604,0.000050641873,0.000011818603,0.0014277298],"genre_scores_gemma":[0.99803036,0.0010889346,0.00017140398,0.00021530906,0.00008831253,0.000021550184,0.00009602466,0.0000022417546,0.00028594985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999635,0.0001730693,0.000043058877,0.00003433074,0.00007637804,0.000038201168],"domain_scores_gemma":[0.99878496,0.00056174817,0.00033022746,0.000050978404,0.000060905724,0.000211036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005404101,0.000397415,0.00078841054,0.00022667089,0.00023311251,0.0002852369,0.00011454037,0.00031536233,0.0009159031],"category_scores_gemma":[0.0021363054,0.00012998335,0.00048274663,0.00019459389,0.00017443103,0.00022717632,0.00013272377,0.0005845981,0.00017171589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06937591,0.0043003955,0.67031187,0.0007210957,0.0016408903,0.0020722626,0.00058241386,0.0008783869,0.03745634,0.00012041092,0.0010074525,0.21153253],"study_design_scores_gemma":[0.0036723781,0.06259641,0.92419875,0.00007446029,0.0008139489,0.0026956764,0.00018962346,0.0005946711,0.0029747158,0.000060565693,0.0020970257,0.000031837266],"about_ca_topic_score_codex":0.00025305405,"about_ca_topic_score_gemma":0.00075348705,"teacher_disagreement_score":0.0009159031,"about_ca_system_score_codex":0.00013921755,"about_ca_system_score_gemma":0.00014754244,"threshold_uncertainty_score":0.0030640364},"labels":[],"label_agreement":null},{"id":"W1995726799","doi":"10.1177/0091270010378858","title":"Incidence and Contributors to Potential Drug‐Drug Interactions in Hospitalized Patients","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Drug; Incidence (geometry); Medicine; Intensive care medicine; Pharmacology","score_opus":0.07025344659038651,"score_gpt":0.5034002863795165,"score_spread":0.43314683978913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995726799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985102,0.00059122,0.0001074187,0.00015360364,0.000004847522,0.0000076204656,0.00019378803,0.000004563625,0.00042672278],"genre_scores_gemma":[0.9994035,0.00026508726,0.00009260545,0.000020762982,0.000016352567,0.000004714375,0.00015059672,0.0000015017577,0.000044979537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984079,0.0004029808,0.000372321,0.00022059532,0.00039514725,0.0002010682],"domain_scores_gemma":[0.9919817,0.0022434886,0.0043196213,0.0004127761,0.00045087832,0.0005914194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008320383,0.00019425093,0.000486672,0.0009887621,0.00047924308,0.00079685025,0.00041678007,0.00050837477,0.0018541473],"category_scores_gemma":[0.011536836,0.00044763403,0.0006821137,0.0013950691,0.00024808882,0.0006982104,0.00068607205,0.001081503,0.00018208356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003835971,0.000017198377,0.998582,0.0000055973146,0.000024322671,0.00006441631,0.000031208478,0.000036133206,0.000020267462,0.00002300945,0.00005045194,0.0011069897],"study_design_scores_gemma":[0.000007177973,0.000064460706,0.9978218,0.000015024708,0.00003408848,0.0009759665,0.00019576758,0.0005941056,0.000056280976,0.00008938498,0.00013921894,0.00000677539],"about_ca_topic_score_codex":0.003751892,"about_ca_topic_score_gemma":0.0032330654,"teacher_disagreement_score":0.003751892,"about_ca_system_score_codex":0.0006194265,"about_ca_system_score_gemma":0.0004960518,"threshold_uncertainty_score":0.0074601173},"labels":[],"label_agreement":null},{"id":"W1996277995","doi":"10.1177/0091270009347871","title":"Does Therapeutic Equivalence Follow Bioequivalence? A Randomized Trial to Assess Clinical Effects After Switching From Clozaril to Generic Clozapine (Gen‐Clozapine)","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Initiatives Ontario North; Northeast Cancer Centre; University of Calgary","funders":"","keywords":"Clozapine; Bioequivalence; Medicine; Randomized controlled trial; Clinical trial; Rating scale; Brief Psychiatric Rating Scale; Internal medicine; Psychology; Schizophrenia (object-oriented programming); Psychosis; Psychiatry; Pharmacokinetics","score_opus":0.12305645854272743,"score_gpt":0.4881997655925069,"score_spread":0.3651433070497795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996277995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913304,0.0012309339,0.0012033898,0.0008973483,0.0005966679,0.0033151028,0.00023817475,0.000047066562,0.0011409891],"genre_scores_gemma":[0.99511933,0.00039239746,0.0011716515,0.0006856984,0.00041418461,0.0015764665,0.00016006683,0.000008600674,0.00047163127],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98839986,0.008949064,0.0007548224,0.0007773364,0.0005158053,0.00060303236],"domain_scores_gemma":[0.99157894,0.004335176,0.0019061075,0.0009808633,0.0003465435,0.00085244817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010637791,0.00088274427,0.0033904198,0.0005771132,0.000672839,0.0010661184,0.00074188336,0.0038405713,0.004839582],"category_scores_gemma":[0.015879722,0.00064317696,0.0023647568,0.0004864944,0.0026174793,0.0020690972,0.00071694906,0.003110114,0.0005832815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9762374,0.009691521,0.00095138996,0.00013407871,0.000674733,0.00003281031,0.00006361457,0.00016381797,0.0012226868,0.00020926337,0.00015892461,0.010459827],"study_design_scores_gemma":[0.78341156,0.21126416,0.0028247158,0.000017642002,0.00049920287,0.00003122883,0.000025891388,0.000646198,0.00044778714,0.0004909191,0.00032175356,0.00001896228],"about_ca_topic_score_codex":0.0004685587,"about_ca_topic_score_gemma":0.0005519202,"teacher_disagreement_score":0.010637791,"about_ca_system_score_codex":0.0006877777,"about_ca_system_score_gemma":0.0010836641,"threshold_uncertainty_score":0.05625868},"labels":[],"label_agreement":null},{"id":"W2000782600","doi":"10.1177/0091270004269521","title":"Pharmacokinetics of Dextromethorphan After Single or Multiple Dosing in Combination With Quinidine in Extensive and Poor Metabolizers","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Dextromethorphan; Dextrorphan; Dosing; Pharmacokinetics; Quinidine; Pharmacology; CYP2D6; Medicine; Urine; Oral administration; Debrisoquine; Bioequivalence; Internal medicine; Metabolism; Cytochrome P450","score_opus":0.09137928177373802,"score_gpt":0.44312241836992794,"score_spread":0.35174313659618994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000782600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991066,0.00048241596,0.00015814122,0.000019241197,0.000004996518,0.000023353452,0.00007336416,0.0000075935945,0.00012422996],"genre_scores_gemma":[0.9991586,0.00019454479,0.0002571687,0.000039405993,0.0000158734,0.000016005099,0.00010518581,0.0000037691843,0.00020953179],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996215,0.00016713371,0.000031735148,0.00007724975,0.000063496904,0.000038904232],"domain_scores_gemma":[0.99934727,0.00017898221,0.00019798399,0.00006783882,0.000040315324,0.00016763373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006066212,0.00041601752,0.0010124987,0.00026475,0.00020526725,0.00031562222,0.00015564747,0.0005223709,0.00071767264],"category_scores_gemma":[0.0015772772,0.0003696351,0.0004560552,0.00024273315,0.000384762,0.00044403548,0.00015390645,0.0006583651,0.0001352288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33904535,0.0042864727,0.147564,0.00022792115,0.0014251057,0.0010338678,0.0005818877,0.003000167,0.42424133,0.00016324634,0.0006385343,0.077792056],"study_design_scores_gemma":[0.008973053,0.2310032,0.69292575,0.000024387573,0.0012230753,0.0019441467,0.00023326358,0.0055460036,0.055554505,0.00028634653,0.0021960144,0.000090247755],"about_ca_topic_score_codex":0.0007827705,"about_ca_topic_score_gemma":0.0010662779,"teacher_disagreement_score":0.0010124987,"about_ca_system_score_codex":0.0003073074,"about_ca_system_score_gemma":0.00018080212,"threshold_uncertainty_score":0.0032081604},"labels":[],"label_agreement":null},{"id":"W2002629531","doi":"10.1177/0091270006288953","title":"Pharmacokinetics and Urinary Excretion of Vincristine Sulfate Liposomes Injection in Metastatic Melanoma Patients","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Pharmacokinetics; Vincristine; Chemistry; Volume of distribution; Pharmacology; Urology; Distribution (mathematics); Medicine; Chemotherapy; Internal medicine","score_opus":0.10486971386985322,"score_gpt":0.4804081156616854,"score_spread":0.3755384017918322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002629531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874914,0.0006042143,0.00020154283,0.000024672769,0.000002483996,0.000017731922,0.00008692645,0.000019344428,0.00029386627],"genre_scores_gemma":[0.99919814,0.00013360548,0.0001723669,0.000039249906,0.000006766248,0.000018030325,0.00013975507,0.0000044442495,0.0002876325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998536,0.00004496895,0.000008215503,0.000033260258,0.000033232453,0.00002668556],"domain_scores_gemma":[0.99971765,0.000060218244,0.00008794879,0.000019692026,0.00003599741,0.00007851393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023198726,0.00021965915,0.0006040386,0.00016443174,0.00021280252,0.0002711324,0.000082467035,0.00027346995,0.000497222],"category_scores_gemma":[0.00071757013,0.00017526044,0.00024735005,0.00016306587,0.0001398322,0.00015856407,0.000101951504,0.0003556401,0.00014018171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018933687,0.0010854219,0.7777477,0.00013487626,0.0002730113,0.0017621599,0.00053965324,0.002076793,0.12148825,0.00007599412,0.00087263196,0.075009786],"study_design_scores_gemma":[0.0005476262,0.025594994,0.94670933,0.00002035794,0.00021372439,0.002816972,0.00009592664,0.003471249,0.01831688,0.00006140733,0.0021235303,0.000027936616],"about_ca_topic_score_codex":0.0008085223,"about_ca_topic_score_gemma":0.00095300906,"teacher_disagreement_score":0.0008085223,"about_ca_system_score_codex":0.0003982655,"about_ca_system_score_gemma":0.00021444276,"threshold_uncertainty_score":0.0028896332},"labels":[],"label_agreement":null},{"id":"W2004250367","doi":"10.1002/jcph.435","title":"The use of antidepressants and the risk of chronic atrial fibrillation","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cohort; Depression (economics); Internal medicine; Atrial fibrillation; Confidence interval; Logistic regression; Incidence (geometry); Cohort study; Anxiety; Relative risk; Psychiatry","score_opus":0.15135383200253413,"score_gpt":0.45432407537447794,"score_spread":0.3029702433719438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004250367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522346,0.003542257,0.00012814566,0.000109023844,0.000011560717,0.000009134856,0.0002867592,0.000004027496,0.0006857286],"genre_scores_gemma":[0.998743,0.0008121441,0.00012751414,0.000024297586,0.000024142899,0.0000055293667,0.0001338463,0.0000010185743,0.00012861687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989532,0.00039218497,0.00016702087,0.00017050096,0.00021355388,0.000103529725],"domain_scores_gemma":[0.99408567,0.0014699108,0.0035647643,0.00029698125,0.0002610715,0.0003216383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010514872,0.00013856965,0.00031517688,0.00073725893,0.00022893911,0.0006333563,0.0002583141,0.00054803427,0.0012836526],"category_scores_gemma":[0.0069292183,0.0002434131,0.0005517882,0.0007840191,0.00022207943,0.0002498802,0.0002930223,0.00046333045,0.00013096209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003240722,0.000031329007,0.99613637,0.00003320601,0.00019478732,0.00007075846,0.000030009403,0.00004581319,0.00018546189,0.000031412448,0.00005703094,0.0028597855],"study_design_scores_gemma":[0.00002045063,0.000118467295,0.9988715,0.000016099746,0.000095853786,0.0003488118,0.000019658553,0.0002754471,0.000042539163,0.000043180382,0.00014466839,0.0000032846035],"about_ca_topic_score_codex":0.00480907,"about_ca_topic_score_gemma":0.0038549826,"teacher_disagreement_score":0.00480907,"about_ca_system_score_codex":0.00029235787,"about_ca_system_score_gemma":0.00022323134,"threshold_uncertainty_score":0.009562194},"labels":[],"label_agreement":null},{"id":"W2006239204","doi":"10.1177/0091270007303767","title":"Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Lawson Health Research Institute","funders":"Canadian Institutes of Health Research; Lawson Health Research Institute","keywords":"Homocysteine; Plasma homocysteine; Medicine; Internal medicine","score_opus":0.10692436997708163,"score_gpt":0.5071067901197855,"score_spread":0.4001824201427039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006239204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94973594,0.04210918,0.0020307018,0.001769108,0.00018869765,0.00025696773,0.00013066678,0.00007844371,0.0037002824],"genre_scores_gemma":[0.9828972,0.010349829,0.0044647665,0.00052785006,0.00013467256,0.00015789235,0.000050429007,0.000004764522,0.001412608],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996319,0.00028776177,0.00001465858,0.000019920046,0.000036266254,0.000009517983],"domain_scores_gemma":[0.9996123,0.00021735164,0.00007400322,0.000018790108,0.00002167031,0.00005591498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060280465,0.00030852863,0.00058763876,0.0002273605,0.00015955734,0.00032936363,0.00027119444,0.0007083525,0.0026362487],"category_scores_gemma":[0.0010142177,0.0000857908,0.00018424251,0.00013651661,0.0003971546,0.00024195448,0.00014686953,0.0003632606,0.00013800725],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22006446,0.01356246,0.025395803,0.0031029999,0.0006296253,0.0011626655,0.00023968088,0.0006625243,0.1671209,0.0025451137,0.0018985913,0.5636151],"study_design_scores_gemma":[0.059651848,0.4643152,0.33360234,0.0013955756,0.001996151,0.0036527396,0.0011358962,0.00862534,0.09096324,0.007717695,0.02673138,0.00021267394],"about_ca_topic_score_codex":0.00024952544,"about_ca_topic_score_gemma":0.001207972,"teacher_disagreement_score":0.0026362487,"about_ca_system_score_codex":0.00016604828,"about_ca_system_score_gemma":0.00040102776,"threshold_uncertainty_score":0.008819163},"labels":[],"label_agreement":null},{"id":"W2008330092","doi":"10.1177/0091270004268320","title":"Population Pharmacokinetics of Ibuprofen Enantiomers in Very Premature Neonates","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiovascular Conditions and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Ibuprofen; Pharmacokinetics; Medicine; Gestational age; NONMEM; Population; Anesthesia; Placebo; Pharmacodynamics; Pharmacology; Pregnancy","score_opus":0.03818168804833455,"score_gpt":0.423713679316355,"score_spread":0.38553199126802046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008330092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814546,0.00074091833,0.0009502245,0.0000144396445,0.0000037155014,0.000010202094,0.0000537699,0.0000051902466,0.000075996184],"genre_scores_gemma":[0.9986136,0.00037399092,0.0007435265,0.000028751945,0.000005966767,0.000037283156,0.0001228954,0.0000030938297,0.00007090088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999199,0.0004611099,0.000049495964,0.00012074105,0.00012701916,0.000042712523],"domain_scores_gemma":[0.99875605,0.00055358396,0.0003535368,0.00013506105,0.000087981665,0.00011384621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001356416,0.00018027106,0.000994966,0.00018054561,0.0001018055,0.0003913299,0.0002166438,0.0004343139,0.0002715766],"category_scores_gemma":[0.004288436,0.00016871838,0.00035275036,0.00018546397,0.00019965754,0.00020734269,0.00019364769,0.00045772042,0.00006695981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044460174,0.0006787155,0.6419063,0.0004171293,0.0014720693,0.0027692176,0.0008838251,0.015388665,0.17830004,0.000840084,0.00049577246,0.11238794],"study_design_scores_gemma":[0.00048769274,0.026196888,0.92079264,0.000056605328,0.0006596111,0.0037820074,0.00056622707,0.024488835,0.020154808,0.0007371554,0.0019828181,0.00009465966],"about_ca_topic_score_codex":0.000773578,"about_ca_topic_score_gemma":0.0003251068,"teacher_disagreement_score":0.001356416,"about_ca_system_score_codex":0.0003076055,"about_ca_system_score_gemma":0.0003800633,"threshold_uncertainty_score":0.007173538},"labels":[],"label_agreement":null},{"id":"W2008423993","doi":"10.1177/0091270003261078","title":"Effects of St. John's Wort (<i>Hypericum perforatum</i>) on Tacrolimus Pharmacokinetics in Healthy Volunteers","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Pharmacokinetics; Hypericum perforatum; Tacrolimus; Pharmacology; CYP3A; Volume of distribution; Medicine; Pharmacokinetic interaction; Oral administration; Dosing; Drug interaction; Chemistry; Transplantation; Metabolism; Internal medicine; Cytochrome P450","score_opus":0.09962250996604795,"score_gpt":0.4859302468162513,"score_spread":0.38630773685020336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008423993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825174,0.0008773692,0.00015072602,0.00003410027,0.000023237073,0.00003390367,0.0000743307,0.000021614536,0.00053296617],"genre_scores_gemma":[0.9986369,0.0003716643,0.00026970546,0.000095824325,0.000036644502,0.000026696513,0.00011728008,0.0000060538237,0.0004391149],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99975413,0.000098825636,0.000015003497,0.000059639136,0.000035903136,0.000036507085],"domain_scores_gemma":[0.9997316,0.00007416517,0.00005049384,0.000017978364,0.00002557991,0.000100089426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024946383,0.00038117435,0.00043993333,0.000097377466,0.00022093812,0.00028910933,0.00009412409,0.00037790296,0.00090898067],"category_scores_gemma":[0.0006324388,0.00017781294,0.00024610892,0.000105465275,0.00028849256,0.00018052082,0.00013614807,0.0003352312,0.00030940818],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19098379,0.011799263,0.07984664,0.00063353206,0.000772419,0.0020745457,0.0006232398,0.00064247486,0.5531252,0.00011691626,0.002063356,0.15731862],"study_design_scores_gemma":[0.0052725193,0.36226144,0.5471344,0.000049970502,0.00087197364,0.0047219372,0.00035183242,0.0023038893,0.071304336,0.00014777022,0.005516412,0.000063533065],"about_ca_topic_score_codex":0.0007594418,"about_ca_topic_score_gemma":0.0008396215,"teacher_disagreement_score":0.00090898067,"about_ca_system_score_codex":0.00015508985,"about_ca_system_score_gemma":0.00018015869,"threshold_uncertainty_score":0.0030407906},"labels":[],"label_agreement":null},{"id":"W2008486886","doi":"10.1177/0091270009337946","title":"Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health","keywords":"Escitalopram; Body mass index; CYP2C19; Population; Internal medicine; Volume of distribution; Demography; Medicine; Pharmacokinetics; Antidepressant","score_opus":0.03755929623619485,"score_gpt":0.4499459992483756,"score_spread":0.4123867030121807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008486886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790764,0.0010930237,0.0002827117,0.00005480862,0.000012682566,0.000020278301,0.00016893823,0.0000060259567,0.0004538712],"genre_scores_gemma":[0.998936,0.00028659825,0.00025373237,0.000048862763,0.000020095278,0.00001786227,0.00023800698,0.0000055849423,0.00019332104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991504,0.00041624313,0.00007815541,0.0001363113,0.00014388448,0.00007499278],"domain_scores_gemma":[0.99715555,0.001417906,0.00084994803,0.00020743099,0.00013100762,0.00023815306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016508383,0.00036667238,0.0006254802,0.00023430621,0.00017283091,0.0004448875,0.00016705338,0.0002885049,0.0013021915],"category_scores_gemma":[0.005114479,0.0001492909,0.0007520438,0.00037438728,0.0001473067,0.00031228818,0.00020871905,0.00045207597,0.00017506003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011128062,0.0002409252,0.97032374,0.000052108247,0.0007719928,0.00030188367,0.00006186644,0.00053824444,0.0025690943,0.000043398282,0.00018645098,0.013782256],"study_design_scores_gemma":[0.00017600045,0.0024673652,0.9944465,0.0000068022714,0.00050548895,0.00034259193,0.000033633103,0.0011282011,0.00042859314,0.000041581712,0.00041589423,0.0000073215156],"about_ca_topic_score_codex":0.0011412803,"about_ca_topic_score_gemma":0.0015981179,"teacher_disagreement_score":0.0016508383,"about_ca_system_score_codex":0.0002270622,"about_ca_system_score_gemma":0.00032035235,"threshold_uncertainty_score":0.00873059},"labels":[],"label_agreement":null},{"id":"W2008793637","doi":"10.1177/0091270010376973","title":"Risperidone‐Induced QT Prolongation Following Overdose Correlates With Serum Drug Concentration and Resolves Rapidly With No Evidence of Altered Pharmacokinetics","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation; Centre for Addiction and Mental Health; University of Calgary","funders":"","keywords":"Medicine","score_opus":0.02700299677982943,"score_gpt":0.37827359297261937,"score_spread":0.35127059619278994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008793637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864443,0.0038146086,0.0036663956,0.00038783284,0.00008549688,0.00011332493,0.00028859964,0.0003765445,0.0048228],"genre_scores_gemma":[0.9974412,0.0006694855,0.00078589754,0.00023428322,0.00009116227,0.000015754275,0.00019575506,0.000027501317,0.0005388722],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9994455,0.00017495386,0.00007171872,0.00006334826,0.00019360032,0.000050878993],"domain_scores_gemma":[0.99474347,0.0016265537,0.0024887207,0.00041401573,0.0003519862,0.00037532146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053039426,0.0005049497,0.0012102368,0.00027698535,0.00016950673,0.0005735764,0.00020456736,0.00063325424,0.00088028493],"category_scores_gemma":[0.006139358,0.00023256373,0.0004580404,0.00026684118,0.0003818996,0.00050770526,0.00023723616,0.0017575835,0.0005245941],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021759965,0.0012811752,0.38405967,0.0007595154,0.0014061204,0.021500295,0.0007752071,0.001599149,0.34354115,0.0010972448,0.0036680265,0.21855253],"study_design_scores_gemma":[0.00032392613,0.007392168,0.90248626,0.000087875465,0.00033380606,0.036910135,0.00011211577,0.00308189,0.04499511,0.00049567205,0.0037226188,0.000058431084],"about_ca_topic_score_codex":0.00041290026,"about_ca_topic_score_gemma":0.00090942415,"teacher_disagreement_score":0.0012102368,"about_ca_system_score_codex":0.00037000314,"about_ca_system_score_gemma":0.00034673506,"threshold_uncertainty_score":0.002944827},"labels":[],"label_agreement":null},{"id":"W2009236753","doi":"10.1177/00912700222011418","title":"Limited Sampling Strategy to Predict AUC of the CYP3A Phenotyping Probe Midazolam in Adults: Application to Various Assay Techniques","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North","funders":"","keywords":"Midazolam; Reproducibility; Mean squared error; CYP3A; Sampling (signal processing); Linear regression; Pharmacokinetics; Mathematics; Statistics; Medicine; Anesthesia; Pharmacology; Internal medicine; Computer science","score_opus":0.17446470495559757,"score_gpt":0.48976398802201493,"score_spread":0.31529928306641736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009236753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.652538,0.001351004,0.34395605,0.00025914586,0.000034618035,0.0002891677,0.0003552156,0.0007389292,0.0004777528],"genre_scores_gemma":[0.91878814,0.00034085306,0.079688124,0.00011522865,0.00001636211,0.00024962603,0.00047125772,0.00003653529,0.00029392412],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971986,0.0016869663,0.000201788,0.00036042568,0.000495492,0.00005687742],"domain_scores_gemma":[0.9926771,0.00493712,0.0008455209,0.000617301,0.0007979822,0.0001250137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005636983,0.0009052951,0.0010803677,0.0007284529,0.00020140877,0.00049595296,0.00069673377,0.0006444987,0.00046623347],"category_scores_gemma":[0.017268354,0.00044774075,0.0008124138,0.00044875682,0.0002327434,0.00041327058,0.00048237244,0.000628548,0.00025221054],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060927407,0.0011861508,0.33316958,0.00038171836,0.0010469168,0.00040646532,0.0003531294,0.26507458,0.057827387,0.0007115063,0.0012639022,0.33248585],"study_design_scores_gemma":[0.0001784596,0.0022989637,0.06647864,0.000039784154,0.0002652903,0.00042407142,0.000035060842,0.9146444,0.014402472,0.0005125904,0.0006666078,0.00005373835],"about_ca_topic_score_codex":0.0036186066,"about_ca_topic_score_gemma":0.0030522398,"teacher_disagreement_score":0.005636983,"about_ca_system_score_codex":0.00045127512,"about_ca_system_score_gemma":0.0007463863,"threshold_uncertainty_score":0.02981162},"labels":[],"label_agreement":null},{"id":"W2010278974","doi":"10.1177/0091270010382915","title":"Pharmacogenetics of Intravenous and Oral Busulfan in Hematopoietic Cell Transplant Recipients","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Busulfan; Medicine; Dosing; Pharmacology; Population; Hematopoietic stem cell transplantation; Pharmacokinetics; Pharmacogenetics; Internal medicine; Gastroenterology; Oncology; Transplantation; Genotype; Chemistry","score_opus":0.04259470473159469,"score_gpt":0.3938264752781396,"score_spread":0.35123177054654486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010278974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883765,0.00040382688,0.00032756585,0.00004069578,0.0000029045395,0.000006475149,0.00003432918,0.0000062969666,0.00034029834],"genre_scores_gemma":[0.99960464,0.00007867414,0.00014917915,0.00002888227,0.0000044502062,0.0000035464443,0.000048132366,0.0000036697422,0.00007888127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999385,0.00025769914,0.000056841116,0.00010166003,0.00012959841,0.000069119546],"domain_scores_gemma":[0.9989153,0.00039685983,0.00045953205,0.00007058122,0.00005175206,0.000105878404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009274013,0.00019680204,0.0003881688,0.00035376407,0.00015760312,0.0004987676,0.00015509443,0.00033446794,0.00046275285],"category_scores_gemma":[0.0019478665,0.0001397016,0.0003443517,0.00039399095,0.0002313992,0.00014396236,0.00017723827,0.00042495952,0.000158007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017453892,0.00008331067,0.9703311,0.000020199,0.00017800592,0.0002935401,0.000093258604,0.0005747422,0.01169149,0.00015522058,0.00011428626,0.014719591],"study_design_scores_gemma":[0.000033165827,0.0009259285,0.9912723,0.000007113436,0.000112448455,0.0010425869,0.0000564519,0.0019040067,0.0040908796,0.00015196267,0.0003970768,0.0000060770913],"about_ca_topic_score_codex":0.00062911795,"about_ca_topic_score_gemma":0.0005026787,"teacher_disagreement_score":0.0009274013,"about_ca_system_score_codex":0.0003795593,"about_ca_system_score_gemma":0.00018868802,"threshold_uncertainty_score":0.004904628},"labels":[],"label_agreement":null},{"id":"W2011296465","doi":"10.1177/0091270005284388","title":"The Effect of AST‐120 on the Single‐Dose Pharmacokinetics of Losartan and Losartan Acid (E‐3174) in Healthy Subjects","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Losartan; Pharmacokinetics; Pharmacology; Medicine; Internal medicine; Angiotensin II; Receptor","score_opus":0.07835730691922209,"score_gpt":0.4704475623508394,"score_spread":0.3920902554316173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011296465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992354,0.00022920017,0.000161864,0.000025678028,0.00002814505,0.000057544446,0.00008288233,0.00002135862,0.00015800858],"genre_scores_gemma":[0.9985904,0.00015634968,0.00036432513,0.00008186448,0.00005193063,0.00007460068,0.00016931327,0.000009693831,0.00050153903],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99939156,0.00025467205,0.000045688146,0.000114614006,0.00009344866,0.000100094614],"domain_scores_gemma":[0.99911743,0.00021698253,0.00015122561,0.00008790194,0.0000623437,0.00036407894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000976804,0.0007832966,0.0016056363,0.00029419435,0.00036031567,0.0004927654,0.00026302232,0.0011038997,0.0015034633],"category_scores_gemma":[0.0012694389,0.00053419283,0.0006984623,0.00020581146,0.00070898805,0.0006295326,0.000230878,0.0012784025,0.00041013534],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83280057,0.015232174,0.0037677453,0.000109979774,0.00042872023,0.0001175239,0.00008709539,0.00028107053,0.13186099,0.00003475087,0.00023638475,0.015042994],"study_design_scores_gemma":[0.061837643,0.808776,0.07611887,0.000010670299,0.00087967573,0.0002997881,0.00007988473,0.0022623432,0.048615675,0.00014649509,0.0009164907,0.000056502155],"about_ca_topic_score_codex":0.0006759723,"about_ca_topic_score_gemma":0.00071001035,"teacher_disagreement_score":0.0016056363,"about_ca_system_score_codex":0.00028675536,"about_ca_system_score_gemma":0.00045704315,"threshold_uncertainty_score":0.005165875},"labels":[],"label_agreement":null},{"id":"W2011560794","doi":"10.1177/0091270011400414","title":"In Vitro and In Vivo Assessment of Renal Drug Transporters in the Disposition of Mesna and Dimesna","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Disposition; Mesna; Pharmacology; In vivo; In vitro; Drug; Transporter; Medicine; Chemistry; Pharmacokinetics; Internal medicine; Biology; Biochemistry; Psychology; Biotechnology","score_opus":0.0446273170396223,"score_gpt":0.40099197996210395,"score_spread":0.35636466292248165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011560794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98957527,0.0037012843,0.004800404,0.000099273784,0.000047495636,0.00005972738,0.00043874935,0.00006331807,0.001214452],"genre_scores_gemma":[0.9929467,0.0013135468,0.0026436185,0.00006525859,0.000023847266,0.00007993065,0.00048619826,0.00001859616,0.0024223938],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99960154,0.0001594415,0.000020121674,0.0000930722,0.00006943298,0.00005629996],"domain_scores_gemma":[0.9998023,0.000045609384,0.000036092588,0.00002911733,0.00003662728,0.000050253646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005117608,0.00030629858,0.0004678379,0.00019074642,0.00016291572,0.00034894855,0.00023526566,0.00045155702,0.0017847007],"category_scores_gemma":[0.00041442298,0.00027394385,0.00036028356,0.00025023686,0.00021286056,0.00031887024,0.00016092054,0.00074088183,0.00049280503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035813055,0.00038817537,0.00096447323,0.00008918001,0.00006471546,0.00006124957,0.000045573805,0.00044883406,0.9903228,0.00009140628,0.000121973564,0.0038201883],"study_design_scores_gemma":[0.00017737417,0.010460692,0.008212469,0.0000068747236,0.00015946277,0.00038029754,0.00007001433,0.0048026918,0.97316223,0.00008414694,0.0024642355,0.000019415984],"about_ca_topic_score_codex":0.0007590099,"about_ca_topic_score_gemma":0.0009585068,"teacher_disagreement_score":0.0017847007,"about_ca_system_score_codex":0.00023279266,"about_ca_system_score_gemma":0.00031320052,"threshold_uncertainty_score":0.005970478},"labels":[],"label_agreement":null},{"id":"W2012919964","doi":"10.1177/0091270008328099","title":"Influence of Controlled Rheumatoid Arthritis on the Action and Disposition of Verapamil: Focus on Infliximab","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Rheumatoid arthritis; Infliximab; Verapamil; Medicine; Disposition; Pharmacology; Internal medicine; Tumor necrosis factor alpha; Psychology; Calcium","score_opus":0.0576005643334588,"score_gpt":0.43407641104862316,"score_spread":0.3764758467151644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012919964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802005,0.0012619938,0.000056931603,0.000034539426,0.000011367821,0.000008226019,0.000021166732,0.0000033941103,0.0005823445],"genre_scores_gemma":[0.99943966,0.00026542597,0.000042881722,0.000034050845,0.00004519194,0.0000037570144,0.00004356453,0.000002325351,0.0001230441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995154,0.00019326758,0.000056696932,0.00007184328,0.00009189508,0.00007084305],"domain_scores_gemma":[0.9983902,0.0007438793,0.00033418174,0.00012428006,0.00007511946,0.00033236376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004039016,0.00024076106,0.00051808415,0.0003384939,0.0002079733,0.00052960083,0.0001239707,0.0002795255,0.0014471544],"category_scores_gemma":[0.0017998737,0.00015565607,0.0003382505,0.00022891226,0.00038854676,0.00023145195,0.00016748448,0.00037036807,0.00020753058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.095900156,0.0030731217,0.6938219,0.0003723135,0.0010525351,0.006476987,0.0007269418,0.000424724,0.12041102,0.0002725018,0.00041097013,0.07705688],"study_design_scores_gemma":[0.00080492866,0.01467893,0.9765919,0.00001152465,0.00039227481,0.0027415259,0.00010147299,0.0002812714,0.0034734868,0.00006427087,0.0008438665,0.000014408629],"about_ca_topic_score_codex":0.00056871225,"about_ca_topic_score_gemma":0.00078966655,"teacher_disagreement_score":0.0014471544,"about_ca_system_score_codex":0.00021713825,"about_ca_system_score_gemma":0.00014537839,"threshold_uncertainty_score":0.004841149},"labels":[],"label_agreement":null},{"id":"W2013594289","doi":"10.1177/0091270009347673","title":"Comparative Pharmacokinetics of a Once‐Daily Tramadol Extended‐Release Tablet and an Immediate‐Release Reference Product Following Single‐Dose and Multiple‐Dose Administration","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Tramadol; Pharmacokinetics; Bioequivalence; Medicine; Dosing; Anesthesia; Analgesic; Pharmacology; Plasma concentration","score_opus":0.17478328394214743,"score_gpt":0.4708381661928176,"score_spread":0.29605488225067017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013594289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830294,0.0006397981,0.0006452745,0.000018451039,0.000017789838,0.000060184433,0.00007679316,0.000034689994,0.0002042014],"genre_scores_gemma":[0.9977938,0.0005321852,0.0010896544,0.000024062721,0.000025293337,0.000053054617,0.00015929861,0.000011988073,0.00031068508],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99943715,0.00019696914,0.00003477829,0.00010370125,0.00017845935,0.00004890462],"domain_scores_gemma":[0.99892706,0.00034798754,0.00032264582,0.00013152893,0.00013246383,0.00013841716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000850417,0.000398927,0.0009510932,0.00032138324,0.00015526355,0.0006171874,0.00045650604,0.00056833425,0.0010517807],"category_scores_gemma":[0.0031760656,0.000362386,0.000534947,0.00039420172,0.00053291867,0.0007468093,0.000096631804,0.0008660066,0.00022246917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13639891,0.0059475875,0.005855172,0.0005431244,0.00059924234,0.00038187546,0.0007904897,0.0027415224,0.7563645,0.0003765036,0.00044338542,0.08955769],"study_design_scores_gemma":[0.009484814,0.51963776,0.0997355,0.00005096871,0.0013779656,0.0025534627,0.00023566477,0.014152965,0.3492833,0.00016572629,0.003164624,0.00015737093],"about_ca_topic_score_codex":0.00086969015,"about_ca_topic_score_gemma":0.000712664,"teacher_disagreement_score":0.0010517807,"about_ca_system_score_codex":0.0004180697,"about_ca_system_score_gemma":0.00054336997,"threshold_uncertainty_score":0.004497528},"labels":[],"label_agreement":null},{"id":"W2014643868","doi":"10.1177/0091270011399574","title":"Combined Administration of Quinidine and Propafenone for Atrial Fibrillation: The CAQ‐PAF Study","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université Laval; Centre Hospitalier de l’Université de Montréal; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Propafenone; Quinidine; Atrial fibrillation; Medicine; Cardiology; Internal medicine; Disposition; Anesthesia; Psychology","score_opus":0.11092955567430206,"score_gpt":0.44046418615151484,"score_spread":0.32953463047721276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014643868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453014,0.0036678438,0.0003298968,0.00029330858,0.00008645275,0.0002917995,0.00009958776,0.000018671379,0.0006823044],"genre_scores_gemma":[0.9950724,0.0021593391,0.00075749884,0.00038521332,0.00059390743,0.0003350122,0.00022788858,0.000010438152,0.00045829013],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9980597,0.0010055987,0.00011270218,0.0002667097,0.0003338402,0.00022144226],"domain_scores_gemma":[0.9978108,0.00061761885,0.00041057914,0.00020066279,0.00011157718,0.00084878795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021259228,0.001400813,0.0031621964,0.000616494,0.00047774252,0.0010260263,0.0009136312,0.0020333913,0.0018344398],"category_scores_gemma":[0.0027190645,0.00071295304,0.00142987,0.0007016179,0.0014942439,0.0011399981,0.00042247667,0.002715839,0.00048729268],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64994156,0.072079465,0.035014957,0.00081977586,0.0061273924,0.0024150982,0.00043900553,0.0008559691,0.10806658,0.00036998428,0.0012670488,0.12260326],"study_design_scores_gemma":[0.183303,0.77155703,0.03174921,0.00004192862,0.001826371,0.0016547554,0.0000626524,0.00074596127,0.0060056713,0.00007834643,0.0029131835,0.0000618697],"about_ca_topic_score_codex":0.00090348814,"about_ca_topic_score_gemma":0.0016551804,"teacher_disagreement_score":0.0031621964,"about_ca_system_score_codex":0.0011160923,"about_ca_system_score_gemma":0.0012069414,"threshold_uncertainty_score":0.011243045},"labels":[],"label_agreement":null},{"id":"W2019890777","doi":"10.1002/j.1552-4604.2000.tb05982.x","title":"Drug Labeling and Risk Perceptions of Teratogenicity: A Survey of Pregnant Canadian Women and Their Health Professionals","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pregnancy; Health professionals; Perception; Nausea; Vomiting; Risk perception; Family medicine; Drug; Drugs in pregnancy; Obstetrics; Pediatrics; Health care; Psychiatry; Fetus; Psychology; Anesthesia","score_opus":0.06532141854844371,"score_gpt":0.44941326886651645,"score_spread":0.38409185031807275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019890777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950492,0.0004266146,0.00005319408,0.0009903202,0.000015165299,0.000054593074,0.00012917776,0.0000033901795,0.0032783458],"genre_scores_gemma":[0.99741805,0.00095538446,0.00019287638,0.0005347963,0.000009462126,0.00002201744,0.0000777749,0.0000031286868,0.00078651775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997433,0.00048125963,0.00016595882,0.00014848048,0.0013393852,0.00043196089],"domain_scores_gemma":[0.99384475,0.001319052,0.0014783568,0.00012487377,0.0018978893,0.0013351828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027566247,0.00020067114,0.00038358895,0.0011831102,0.0038309984,0.0014930242,0.00062898087,0.00079403474,0.0019360865],"category_scores_gemma":[0.010055771,0.0004862839,0.00038208332,0.0018711291,0.001511782,0.0005472364,0.000988731,0.0011007031,0.00016866706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018118799,0.0002316029,0.8261358,0.00021521593,0.00004504147,0.0008239114,0.14711107,0.0000620805,0.001041609,0.0002259013,0.0021873023,0.02173927],"study_design_scores_gemma":[0.000021434746,0.00026738693,0.8041808,0.00022608589,0.000034696863,0.0005542735,0.18776448,0.00034143616,0.00020441838,0.000065734035,0.00628265,0.000056533605],"about_ca_topic_score_codex":0.91933537,"about_ca_topic_score_gemma":0.91363347,"teacher_disagreement_score":0.080664635,"about_ca_system_score_codex":0.011471603,"about_ca_system_score_gemma":0.013442799,"threshold_uncertainty_score":0.16227931},"labels":[],"label_agreement":null},{"id":"W2020477779","doi":"10.1177/009127000104100908","title":"Evaluating Possible Pharmacokinetic Interactions between Tobramycin, Piperacillin, and a Combination of Piperacillin and Tazobactam in Patients with Various Degrees of Renal Impairment","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Piperacillin; Tobramycin; Piperacillin/tazobactam; Medicine; Pharmacokinetics; Tazobactam; Renal function; Crossover study; Pharmacology; Antibacterial agent; Anesthesia; Internal medicine; Antibiotics; Chemistry; Gentamicin; Pathology","score_opus":0.07063823566904713,"score_gpt":0.4405121916659936,"score_spread":0.36987395599694645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020477779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899215,0.0004603989,0.0002621007,0.00003112539,0.0000045754346,0.000029571995,0.000024897605,0.0000048661605,0.00019025509],"genre_scores_gemma":[0.99926263,0.00016596811,0.0002987688,0.00005828229,0.00002120483,0.000020846814,0.00004901177,0.0000018803762,0.00012140552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993338,0.00031847865,0.00004199412,0.0000727521,0.00015451964,0.00007839312],"domain_scores_gemma":[0.99880755,0.000515222,0.0003246132,0.000054845856,0.00007634029,0.00022145208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000742435,0.00043648997,0.0010073386,0.0003028986,0.0004387675,0.00043753022,0.00013309739,0.00046257052,0.0008629334],"category_scores_gemma":[0.002976746,0.00023127215,0.0003713941,0.0003059434,0.00028246085,0.00034112978,0.00017414238,0.0005034339,0.00019129754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03875144,0.0027934152,0.8562358,0.00029669903,0.0007311541,0.0027477478,0.0007054735,0.0010861285,0.04627087,0.00008995533,0.0002731816,0.050018143],"study_design_scores_gemma":[0.001443941,0.10589212,0.8672741,0.000021439282,0.0008633158,0.0062849927,0.00045281043,0.002877385,0.012547996,0.00014430964,0.0021581259,0.00003945266],"about_ca_topic_score_codex":0.0005900391,"about_ca_topic_score_gemma":0.0009090521,"teacher_disagreement_score":0.0010073386,"about_ca_system_score_codex":0.0003033992,"about_ca_system_score_gemma":0.00032995167,"threshold_uncertainty_score":0.0039263964},"labels":[],"label_agreement":null},{"id":"W2022326153","doi":"10.1177/0091270003261496","title":"Effect of St. John's Wort on the Pharmacokinetics of Theophylline in Healthy Volunteers","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Natural Compound Pharmacology Studies","field":"Agricultural and Biological Sciences","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Theophylline; Pharmacokinetics; Urine; Crossover study; Hypericum perforatum; Pharmacology; Medicine; Oral administration; Plasma concentration; Internal medicine","score_opus":0.052939215698079654,"score_gpt":0.4047689388473475,"score_spread":0.35182972314926786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022326153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986596,0.00071313203,0.00010907471,0.000037493577,0.000022382565,0.00004334693,0.000050192146,0.000009386016,0.00035534296],"genre_scores_gemma":[0.9984426,0.00040417933,0.00029905533,0.0001338844,0.00006140335,0.000037710208,0.0001131895,0.000005775216,0.0005021408],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99963653,0.00016324536,0.00002858881,0.000067045374,0.00005789701,0.00004659664],"domain_scores_gemma":[0.9993352,0.00023012262,0.00012217328,0.00005455747,0.00005424023,0.0002036531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000528395,0.0004651166,0.0008866396,0.00017521567,0.00040062523,0.000273604,0.00009391984,0.0005544194,0.0014929916],"category_scores_gemma":[0.0013883534,0.00028724846,0.00031825947,0.00011352109,0.0003678479,0.00028125025,0.00016083325,0.00040753096,0.000313366],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30664122,0.016102705,0.14190124,0.0010375284,0.0010779548,0.002071225,0.0011012994,0.00048588222,0.37737808,0.00014355785,0.0011706847,0.15088874],"study_design_scores_gemma":[0.0073068035,0.33265758,0.6331949,0.00002900296,0.0006475183,0.001756248,0.00029191226,0.00081429415,0.020350913,0.00012825013,0.0027769546,0.00004561127],"about_ca_topic_score_codex":0.0005285207,"about_ca_topic_score_gemma":0.00093608885,"teacher_disagreement_score":0.0014929916,"about_ca_system_score_codex":0.00012066045,"about_ca_system_score_gemma":0.0002006811,"threshold_uncertainty_score":0.0049945116},"labels":[],"label_agreement":null},{"id":"W2022811284","doi":"10.1177/0091270004268910","title":"Lack of Weight‐Based Dose Dependency and Intraindividual Variability of Omeprazole for CYP2C19 Phenotyping","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Omeprazole; CYP2C19; Proton-pump inhibitor; Medicine; Interquartile range; Coefficient of variation; Pharmacology; Internal medicine; Chemistry; Metabolism; Chromatography","score_opus":0.34318280028713016,"score_gpt":0.5652223211458592,"score_spread":0.22203952085872908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022811284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96282387,0.0009988936,0.03236621,0.00018652492,0.00008052223,0.0003224116,0.000603159,0.00016767139,0.0024506445],"genre_scores_gemma":[0.9906557,0.000110871464,0.0073608146,0.00021541526,0.00003938173,0.00018303949,0.000620028,0.00013488495,0.00067982037],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99243873,0.0032011648,0.00033979028,0.0011713144,0.0026635902,0.00018542042],"domain_scores_gemma":[0.990987,0.0030817203,0.0018911313,0.0030604207,0.00077449874,0.00020520527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054912586,0.0005633281,0.0007161658,0.00061570626,0.00036474565,0.0006006025,0.00042525292,0.0007515817,0.00073296804],"category_scores_gemma":[0.011683623,0.00049297704,0.0006147871,0.00054915063,0.0006048474,0.00045106804,0.00040401443,0.0009885451,0.00041104405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033701025,0.00060614944,0.29287896,0.00013985635,0.00085502694,0.00040996092,0.0005524851,0.0014636712,0.6576877,0.00044276222,0.0007522128,0.040841065],"study_design_scores_gemma":[0.000074167605,0.005074855,0.87509245,0.000012591387,0.00026200432,0.0018694762,0.00005406177,0.0062545543,0.10898553,0.00027712388,0.002012196,0.00003106135],"about_ca_topic_score_codex":0.0006968786,"about_ca_topic_score_gemma":0.0014884803,"teacher_disagreement_score":0.0054912586,"about_ca_system_score_codex":0.00024336252,"about_ca_system_score_gemma":0.00020700964,"threshold_uncertainty_score":0.029040873},"labels":[],"label_agreement":null},{"id":"W2023040232","doi":"10.1177/0091270010390806","title":"Bias Toward the Null Hypothesis in Pregnancy Drug Studies That Do Not Include Data on Medical Terminations of Pregnancy: The Folic Acid Antagonists","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pregnancy; Odds ratio; Medicine; Confidence interval; Obstetrics; Neural tube; Internal medicine; Biology","score_opus":0.48740391772190744,"score_gpt":0.4917224524585324,"score_spread":0.004318534736624968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023040232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5164725,0.13863781,0.22912803,0.037647627,0.01757996,0.013775014,0.0076803355,0.00071963604,0.038358983],"genre_scores_gemma":[0.9155497,0.0047804327,0.050913636,0.014718495,0.0033786385,0.0070357197,0.0014535057,0.00019607139,0.0019738518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.4041807,0.44949177,0.06700269,0.033790603,0.041446295,0.00408787],"domain_scores_gemma":[0.1940896,0.6729264,0.06609006,0.051161468,0.013011458,0.002720977],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4510202,0.001681498,0.0060786484,0.0053475304,0.0021633725,0.0060033565,0.0052045956,0.007409022,0.0042440346],"category_scores_gemma":[0.65921116,0.0014200149,0.0059213974,0.0056668227,0.009531705,0.0061756964,0.004326066,0.0047388375,0.00078217883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027648197,0.0007373963,0.6422134,0.031159475,0.06398299,0.004557915,0.01652519,0.0022692622,0.0026966692,0.047642797,0.013835105,0.14673172],"study_design_scores_gemma":[0.013608424,0.01087153,0.50734574,0.024996065,0.068552576,0.012237748,0.010814619,0.019773465,0.0145410765,0.22479251,0.09146111,0.0010051831],"about_ca_topic_score_codex":0.002064583,"about_ca_topic_score_gemma":0.0019097897,"teacher_disagreement_score":0.54897976,"about_ca_system_score_codex":0.0018561487,"about_ca_system_score_gemma":0.0029077565,"threshold_uncertainty_score":0.6769898},"labels":[],"label_agreement":null},{"id":"W2030694526","doi":"10.1177/0091270007301799","title":"Pharmacological Risk Factors for Amphotericin B Nephrotoxicity in Children","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of British Columbia; University of Toronto; BC Children's Hospital","funders":"","keywords":"Emergency department; Medicine; Pediatric emergency medicine; Sick child; Columbia university; Family medicine; Pediatrics; Emergency physician; Psychiatry; Media studies","score_opus":0.07610468210957791,"score_gpt":0.4671582270183429,"score_spread":0.391053544908765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030694526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976063,0.0009594012,0.00007644455,0.0002136621,0.000009766042,0.0000063541393,0.0001267699,0.000007729813,0.00099363],"genre_scores_gemma":[0.999126,0.00050665083,0.000116625866,0.000038371243,0.000021093587,0.000006910832,0.00009103575,0.0000035186906,0.000089706205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996238,0.00007517141,0.0000570301,0.000043095737,0.000096323645,0.00010458776],"domain_scores_gemma":[0.9975478,0.0007452116,0.0010698604,0.000048921967,0.000105750194,0.00048249593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028573032,0.0003388804,0.0005505332,0.00096098665,0.00049449597,0.0005766637,0.00030053698,0.0006093906,0.0019177491],"category_scores_gemma":[0.0029983148,0.0003029116,0.0005778472,0.0010192532,0.00051766384,0.0005140809,0.0003843234,0.0010340075,0.00019066002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001573928,0.000056367888,0.994898,0.000024672721,0.000026677979,0.0026644303,0.00006445241,0.00006605363,0.00032908574,0.00007880902,0.00014011947,0.0014939394],"study_design_scores_gemma":[0.000021044998,0.00022091754,0.9797906,0.000036171954,0.00006596169,0.01856219,0.00034747887,0.00023095417,0.0002701846,0.00008028483,0.00036496983,0.000009129198],"about_ca_topic_score_codex":0.0035315962,"about_ca_topic_score_gemma":0.002973261,"teacher_disagreement_score":0.0035315962,"about_ca_system_score_codex":0.0004674263,"about_ca_system_score_gemma":0.0011346877,"threshold_uncertainty_score":0.007022083},"labels":[],"label_agreement":null},{"id":"W2032322018","doi":"10.1177/0091270008319708","title":"Acyclovir Bioavailability in Patients With Acute Myelogenous Leukemia Treated With Daunorubicin and Cytarabine","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Wellcome Trust","keywords":"Medicine; Gerontology; Library science; Family medicine","score_opus":0.030747347746441875,"score_gpt":0.353929433316853,"score_spread":0.3231820855704111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032322018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945023,0.0041489173,0.00010906605,0.000111305046,0.000023122502,0.000021001859,0.000082121616,0.000012209338,0.0009898818],"genre_scores_gemma":[0.9991652,0.00043763535,0.00007650139,0.000051547508,0.000027742448,0.000008556028,0.00006242522,0.000002962145,0.00016747936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965966,0.00016317054,0.000033451714,0.00004346505,0.000051954667,0.000048272832],"domain_scores_gemma":[0.9993542,0.0002806229,0.00016588092,0.000028252556,0.000044417975,0.00012667883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038364183,0.0002535252,0.0010402813,0.00022188663,0.000273854,0.0005143316,0.00014147745,0.00035089493,0.0009787985],"category_scores_gemma":[0.00215545,0.00015457238,0.00030953242,0.00024684824,0.00019798816,0.00036140965,0.00014428861,0.0007594241,0.00014134085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32191172,0.0026244954,0.4111728,0.0007194032,0.0017407592,0.004455349,0.00074135105,0.0019845848,0.065236084,0.0005446081,0.0019777091,0.1868911],"study_design_scores_gemma":[0.015188426,0.04935489,0.8957824,0.0001179169,0.0019563264,0.008118452,0.00048199904,0.004737052,0.016091285,0.00047351772,0.007630661,0.000067010995],"about_ca_topic_score_codex":0.0011894737,"about_ca_topic_score_gemma":0.0011188367,"teacher_disagreement_score":0.0011894737,"about_ca_system_score_codex":0.0005121883,"about_ca_system_score_gemma":0.00039063682,"threshold_uncertainty_score":0.0037161708},"labels":[],"label_agreement":null},{"id":"W2032426985","doi":"10.1177/0091270003254800","title":"From Bench to Bedside: Utilization of an In Vitro Model to Predict Potential Drug‐Drug Interactions in the Kidney: The Digoxin‐Mifepristone Example","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mifepristone; Digoxin; Pharmacology; P-glycoprotein; Drug; Medicine; Kidney; Drug interaction; Internal medicine; Biology; Drug resistance; Multiple drug resistance; Pregnancy","score_opus":0.08950686802518415,"score_gpt":0.4324385615157118,"score_spread":0.34293169349052766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032426985","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.472634,0.02939371,0.48038864,0.003849476,0.0007500694,0.0004044558,0.0018119571,0.002158075,0.008609678],"genre_scores_gemma":[0.83054733,0.016193846,0.14952819,0.0004223872,0.00014296951,0.00020148075,0.0010710971,0.000090596324,0.0018021003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99945086,0.00024432974,0.000032471246,0.000076963624,0.00015525242,0.00004005437],"domain_scores_gemma":[0.9989588,0.00065741275,0.00009302815,0.00012553214,0.00011028734,0.000054951608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008810469,0.0011538254,0.0016111817,0.0004650366,0.00040907736,0.0012403617,0.000756399,0.001789987,0.0013129752],"category_scores_gemma":[0.0013516292,0.0006506165,0.0009865556,0.00038618597,0.00042394196,0.0007922506,0.00052788935,0.0013935122,0.0007737671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00191897,0.001161601,0.01494555,0.0012325279,0.00037493132,0.0008821632,0.00016187134,0.1398241,0.74364495,0.0030431803,0.0023022844,0.09050796],"study_design_scores_gemma":[0.00017540644,0.0061946963,0.008260691,0.00009306069,0.0005252597,0.0014525246,0.00016344596,0.54284215,0.4228219,0.003826736,0.013463031,0.00018116232],"about_ca_topic_score_codex":0.0027539688,"about_ca_topic_score_gemma":0.004316743,"teacher_disagreement_score":0.0027539688,"about_ca_system_score_codex":0.00077403296,"about_ca_system_score_gemma":0.0005695259,"threshold_uncertainty_score":0.0056159496},"labels":[],"label_agreement":null},{"id":"W2037103488","doi":"10.1177/00912700222011526","title":"Valuing Knowledge and the Knowledge of Values: Understanding Guideline‐ Incongruent Prescribing","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Guideline; Medicine; Psychology; Pathology","score_opus":0.7244596182812622,"score_gpt":0.6264683863405677,"score_spread":0.09799123194069448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037103488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85287344,0.0019361784,0.013993358,0.071359456,0.00010360533,0.000103353195,0.00006631639,0.000018677089,0.059545662],"genre_scores_gemma":[0.9969585,0.00030061608,0.0015206337,0.0010456896,0.000019821124,0.000015992655,0.000013866293,0.0000030298913,0.00012178569],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9814254,0.012644511,0.0007805826,0.00080086355,0.003146009,0.001202633],"domain_scores_gemma":[0.86372715,0.10927914,0.014514369,0.0035816384,0.0052641355,0.0036335632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021803392,0.00039426488,0.00055077247,0.0024297338,0.0026718979,0.0085363,0.0019312515,0.005646632,0.0018700343],"category_scores_gemma":[0.09293782,0.00057731976,0.00050396763,0.0015125868,0.02090048,0.013618248,0.0044845277,0.0059531964,0.00012457803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046734285,0.0016618647,0.19991778,0.00082518574,0.0002692669,0.0028409634,0.34897128,0.0029632426,0.00133924,0.31565818,0.004221811,0.12086385],"study_design_scores_gemma":[0.00014277273,0.00027700188,0.06372011,0.001035429,0.00017855341,0.0017734444,0.1472923,0.008894935,0.00096867594,0.76454574,0.011011856,0.0001593196],"about_ca_topic_score_codex":0.008883274,"about_ca_topic_score_gemma":0.00903425,"teacher_disagreement_score":0.021803392,"about_ca_system_score_codex":0.007067813,"about_ca_system_score_gemma":0.009217754,"threshold_uncertainty_score":0.11530876},"labels":[],"label_agreement":null},{"id":"W2037155442","doi":"10.1177/0091270010387604","title":"Population Pharmacokinetic Modeling of Ziprasidone in Patients With Schizophrenia From the CATIE Study","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Centre for Addiction and Mental Health; University of Toronto","funders":"National Institute of Mental Health; Canadian Institutes of Health Research","keywords":"Ziprasidone; Medicine; Population; Pollock; Family medicine; Library science; Psychiatry; Schizophrenia (object-oriented programming); Antipsychotic; Art; Art history","score_opus":0.10473143568896107,"score_gpt":0.4085082857155987,"score_spread":0.3037768500266377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037155442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966607,0.00017720858,0.0015696211,0.00014115412,0.000005911416,0.00002745397,0.00095212366,0.00003013366,0.0004356515],"genre_scores_gemma":[0.9967001,0.0001512086,0.00077499356,0.00005795426,0.0000074932786,0.000035903548,0.001848375,0.000016733587,0.00040724713],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99958366,0.00023881858,0.000021248086,0.00007037845,0.00004568847,0.00004034151],"domain_scores_gemma":[0.99889755,0.0006009212,0.00016673496,0.00016192565,0.000100578174,0.00007228625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019004145,0.0005692488,0.0009391332,0.00020529563,0.00020341319,0.00069759483,0.00055104267,0.00051612075,0.0013049975],"category_scores_gemma":[0.0029636123,0.00035345106,0.0015093546,0.00026742136,0.00015036023,0.0003302739,0.00041135153,0.0007472513,0.00024768375],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031030651,0.0014223945,0.71230245,0.00028957924,0.010454007,0.002012353,0.0012206667,0.1820037,0.00904182,0.0036519754,0.008894652,0.03767579],"study_design_scores_gemma":[0.0029746415,0.0031074006,0.46617728,0.00005044882,0.005362411,0.0015243292,0.0006221989,0.5087273,0.002041175,0.002854978,0.006346592,0.00021130203],"about_ca_topic_score_codex":0.02064192,"about_ca_topic_score_gemma":0.015215047,"teacher_disagreement_score":0.02064192,"about_ca_system_score_codex":0.0006546526,"about_ca_system_score_gemma":0.00085329486,"threshold_uncertainty_score":0.04104352},"labels":[],"label_agreement":null},{"id":"W2037845030","doi":"10.1177/0091270005280851","title":"Effect of a Triphasic Oral Contraceptive on Drug‐Metabolizing Enzyme Activity as Measured by the Validated Cooperstown 5+1 Cocktail","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Pharmacology; CYP2C19; Dextromethorphan; Medicine; CYP3A; CYP1A2; Drug; CYP2C9; Bioequivalence; Pharmacokinetics; Crossover study; Drug metabolism; Dextrorphan; Mephenytoin; Paraxanthine; Active metabolite; Oral administration; Internal medicine; Cytochrome P450; Metabolism; Placebo","score_opus":0.14238138566770764,"score_gpt":0.5159168353209036,"score_spread":0.37353544965319596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037845030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785584,0.0009964682,0.0003178136,0.00004561794,0.000022411054,0.000078351724,0.00017001962,0.000015358051,0.00049815426],"genre_scores_gemma":[0.9937494,0.0014372389,0.0024832515,0.00012379244,0.0000444022,0.00012134101,0.0005637827,0.000012108675,0.001464686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99887484,0.00053486635,0.00008217662,0.00016691588,0.0002546331,0.00008662992],"domain_scores_gemma":[0.9985973,0.00033903262,0.0006500534,0.00012676846,0.00010189494,0.00018488412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008490979,0.00044290294,0.00067122345,0.00035730636,0.00015488679,0.00027814417,0.0002877517,0.0003650723,0.0027551306],"category_scores_gemma":[0.0018698855,0.00030810357,0.00044378728,0.00032229238,0.00032835914,0.00020931633,0.00026493004,0.00049535814,0.00023047836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1997185,0.010055617,0.021402221,0.0006842536,0.0012590234,0.0002971753,0.00030115555,0.0011532423,0.5510014,0.00023466146,0.001186443,0.21270633],"study_design_scores_gemma":[0.01236725,0.5638212,0.13632844,0.00012143221,0.0018845279,0.0013188792,0.0002069728,0.0024017717,0.26778942,0.00012046148,0.013491996,0.00014769443],"about_ca_topic_score_codex":0.0011278518,"about_ca_topic_score_gemma":0.0037361977,"teacher_disagreement_score":0.0027551306,"about_ca_system_score_codex":0.0003881723,"about_ca_system_score_gemma":0.0006229197,"threshold_uncertainty_score":0.009216845},"labels":[],"label_agreement":null},{"id":"W2038572124","doi":"10.1177/0091270011422815","title":"Disposition of Atorvastatin, Rosuvastatin, and Simvastatin in Oatp1b2‐/‐ Mice and Intraindividual Variability in Human Subjects","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Lawson Health Research Institute; London Health Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Rosuvastatin; Simvastatin; Atorvastatin; Statin; Context (archaeology); Medicine; Pharmacokinetics; Pharmacology; Crossover study; Internal medicine; HMG-CoA reductase; Bioavailability; Endocrinology; Chemistry; Placebo; Biology; Biochemistry; Pathology; Reductase; Enzyme","score_opus":0.06669206091737347,"score_gpt":0.3963727576278466,"score_spread":0.3296806967104731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038572124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938021,0.0005445118,0.0042214408,0.00012290964,0.000028533954,0.0000715172,0.0006467884,0.00018102853,0.00038127325],"genre_scores_gemma":[0.9911088,0.00052068435,0.0044315225,0.0001844875,0.000026187683,0.00025008645,0.0011844507,0.00013270823,0.002161092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99888426,0.00032569031,0.00009435911,0.00035231092,0.00023342614,0.00011004378],"domain_scores_gemma":[0.99943465,0.000055067096,0.00018783088,0.00014478502,0.00004928369,0.00012829015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011624326,0.00065322977,0.0010124911,0.0009944689,0.00029726216,0.0006805413,0.00026484014,0.00083254976,0.0011166767],"category_scores_gemma":[0.00053377706,0.0006823461,0.00053892017,0.00050310104,0.00058451534,0.00043574703,0.0002466123,0.0010642897,0.00042889046],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013954559,0.0011942623,0.010305882,0.000051052393,0.00018126074,0.00018246874,0.00011905363,0.00032329033,0.96716213,0.00017811781,0.0003366376,0.0060112593],"study_design_scores_gemma":[0.0023975247,0.031521916,0.19484082,0.00003441213,0.0011064131,0.0036284719,0.0002789724,0.010894534,0.7464071,0.00088981,0.007833733,0.0001662123],"about_ca_topic_score_codex":0.0008102329,"about_ca_topic_score_gemma":0.0006751306,"teacher_disagreement_score":0.0011624326,"about_ca_system_score_codex":0.00038020735,"about_ca_system_score_gemma":0.00028441162,"threshold_uncertainty_score":0.006147623},"labels":[],"label_agreement":null},{"id":"W2039223287","doi":"10.1177/00912700122012751","title":"Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody‐Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Calicheamicin; Pharmacokinetics; CD33; Medicine; Pharmacology; Myeloid leukemia; Radioimmunotherapy; Chemotherapy; Antibody; Internal medicine; Monoclonal antibody; Immunology; Stem cell; CD34","score_opus":0.05835483957096098,"score_gpt":0.43984683313773504,"score_spread":0.38149199356677405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039223287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977847,0.0014838659,0.0002607556,0.00007515342,0.0000054336906,0.000025080531,0.000040979154,0.000024757668,0.0002992921],"genre_scores_gemma":[0.99866366,0.00044446863,0.00035616918,0.0000999397,0.000018212057,0.000023165992,0.0001578012,0.000007332033,0.00022924977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998367,0.00005395987,0.000008367425,0.000028220544,0.00004115866,0.000031705404],"domain_scores_gemma":[0.99968934,0.00006125249,0.00012449591,0.00001665405,0.000019553216,0.000088711335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035517948,0.00023970287,0.00075139414,0.00015991056,0.00020506965,0.00047790646,0.00015830257,0.00031335434,0.00049934915],"category_scores_gemma":[0.00087562826,0.00019373487,0.00025135593,0.00015081972,0.0001683462,0.00024477878,0.00012083466,0.0006169183,0.00019211243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033691566,0.0025560572,0.3683079,0.0003614713,0.00057759066,0.0012673641,0.0009281324,0.005443894,0.27589294,0.0003137455,0.003525388,0.30713388],"study_design_scores_gemma":[0.004912172,0.056197386,0.8469293,0.00006676703,0.00089323753,0.0076272856,0.00024447788,0.009541939,0.06166273,0.00019836391,0.011667716,0.00005861233],"about_ca_topic_score_codex":0.0007655892,"about_ca_topic_score_gemma":0.0015388986,"teacher_disagreement_score":0.0007880086,"about_ca_system_score_codex":0.0007880086,"about_ca_system_score_gemma":0.00037191887,"threshold_uncertainty_score":0.0057173967},"labels":[],"label_agreement":null},{"id":"W2040768488","doi":"10.1177/0091270005282628","title":"A Comparative Study of Sirolimus Tablet Versus Oral Solution for Prophylaxis of Acute Renal Allograft Rejection","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Sirolimus; Pharmacokinetics; Medicine; Pharmacology; Urology; Antibacterial agent; Internal medicine; Antibiotics; Chemistry","score_opus":0.13577547502566623,"score_gpt":0.4886153690682973,"score_spread":0.35283989404263105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040768488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734914,0.0015944121,0.00032215548,0.000077970035,0.000076731725,0.00028296522,0.00007111307,0.00001680978,0.00020868471],"genre_scores_gemma":[0.99680495,0.0011646284,0.00087029714,0.00016162093,0.0002852944,0.00022727156,0.00015756025,0.0000070602487,0.0003213294],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99887294,0.0006722286,0.0001060291,0.00014096388,0.00011873599,0.00008917314],"domain_scores_gemma":[0.9983082,0.00065286766,0.00046346162,0.00013570294,0.00008034936,0.00035952815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014431778,0.0006753947,0.002463723,0.0005148204,0.00023592878,0.0006092193,0.0005313782,0.000800405,0.0028007673],"category_scores_gemma":[0.002001517,0.00035827386,0.00081293617,0.00039319962,0.0008079885,0.00092662807,0.00024103852,0.0012221355,0.00041438523],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8530343,0.035856836,0.0021451064,0.00047325995,0.0007443075,0.00009490037,0.00008637003,0.00033263103,0.032498598,0.00013546098,0.00021275302,0.07438553],"study_design_scores_gemma":[0.11364983,0.87859875,0.0032043878,0.000017733755,0.000377599,0.00009352945,0.000027576289,0.00049517676,0.0030485261,0.00006017163,0.00041154333,0.000015024113],"about_ca_topic_score_codex":0.0001860254,"about_ca_topic_score_gemma":0.00025449344,"teacher_disagreement_score":0.0028007673,"about_ca_system_score_codex":0.00025014428,"about_ca_system_score_gemma":0.0004657029,"threshold_uncertainty_score":0.0093694925},"labels":[],"label_agreement":null},{"id":"W2041832372","doi":"10.1177/0091270010397730","title":"Estimation of Onset of Analgesia From Simulated Data","year":2011,"lang":"en","type":"letter","venue":"The Journal of Clinical Pharmacology","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pharmacokinetics; Acetaminophen; Analgesic; Clinical trial; Covariate; Clinical pharmacology; Pain relief; Anesthesia; Pharmacology; Internal medicine; Statistics","score_opus":0.4859159350533638,"score_gpt":0.5559504315765739,"score_spread":0.07003449652321009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041832372","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36953518,0.007853277,0.60421175,0.008097715,0.0009775141,0.0006140002,0.0038663864,0.0010917819,0.0037524316],"genre_scores_gemma":[0.93947303,0.0017990797,0.053720605,0.0010082547,0.00025542243,0.00048367967,0.002132575,0.00008985791,0.0010375594],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978642,0.0014342824,0.00012673774,0.00020377012,0.00028775522,0.00008334086],"domain_scores_gemma":[0.9524464,0.043542847,0.0014709701,0.0008600102,0.001251092,0.0004286566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005423277,0.0008097116,0.0011179487,0.00075075525,0.00018833538,0.0008964498,0.0010027402,0.0017211952,0.001608978],"category_scores_gemma":[0.048125062,0.00060212566,0.0014143472,0.0005221193,0.0004361959,0.0006793604,0.00071925326,0.0020728852,0.00043642154],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011739646,0.00015762003,0.01062425,0.0004242789,0.0002870385,0.00024091829,0.0000762773,0.95148253,0.0010263247,0.0031276478,0.0035195218,0.027859636],"study_design_scores_gemma":[0.00010008239,0.0003562551,0.002631734,0.000078022334,0.000046571804,0.00013411458,0.00002310371,0.9898134,0.0011459013,0.003827799,0.0018053132,0.000037780188],"about_ca_topic_score_codex":0.003430406,"about_ca_topic_score_gemma":0.0018670238,"teacher_disagreement_score":0.005423277,"about_ca_system_score_codex":0.0012429861,"about_ca_system_score_gemma":0.0008528799,"threshold_uncertainty_score":0.028681397},"labels":[],"label_agreement":null},{"id":"W2042687713","doi":"10.1177/0091270007304777","title":"Lack of Effect of Antacids on Single‐Dose Pharmacokinetics of Etoricoxib","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Library science; Philosophy; Medicine; Computer science","score_opus":0.09905219942831701,"score_gpt":0.4897158995093864,"score_spread":0.3906637000810694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042687713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584264,0.0009949837,0.0008223414,0.00016922686,0.0000763753,0.000080358644,0.00044108284,0.00010343101,0.001469562],"genre_scores_gemma":[0.99707365,0.00037209282,0.000658077,0.00013923878,0.000051767955,0.000035040244,0.00050198584,0.000055594024,0.0011125609],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99930966,0.0002655003,0.000054851927,0.00010297898,0.00018942718,0.00007768704],"domain_scores_gemma":[0.9969976,0.0013345875,0.0004768867,0.0006251704,0.0001858091,0.0003800907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081638334,0.00043398695,0.0019402658,0.00017853141,0.00017978887,0.00058722135,0.00045698104,0.000599585,0.0024437634],"category_scores_gemma":[0.003760473,0.00053293846,0.00063863886,0.00019082063,0.0004273083,0.0008704077,0.00018385347,0.0017804363,0.00056060794],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22657003,0.0033064247,0.012010023,0.00044665497,0.001183567,0.0008140699,0.00028824835,0.002715698,0.5974315,0.00049277185,0.0023390844,0.1524019],"study_design_scores_gemma":[0.009739182,0.13130094,0.41282594,0.000096230884,0.0011314028,0.0071008503,0.00027435573,0.020113409,0.40201238,0.0005583427,0.014721442,0.00012563293],"about_ca_topic_score_codex":0.0014664151,"about_ca_topic_score_gemma":0.0018059778,"teacher_disagreement_score":0.0024437634,"about_ca_system_score_codex":0.0005062379,"about_ca_system_score_gemma":0.0008083555,"threshold_uncertainty_score":0.008175194},"labels":[],"label_agreement":null},{"id":"W2044991833","doi":"10.1177/0091270007307572","title":"Pharmacokinetics of Lamivudine, Zidovudine, and Nevirapine Administered as a Fixed‐Dose Combination Formulation Versus Coadministration of the Individual Products","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nuvo Pharmaceuticals (Canada); Patheon (Canada); BioPhage Pharma (Canada); Quebec Rehabilitation Research Network","funders":"","keywords":"Nevirapine; Fixed-dose combination; Lamivudine; Zidovudine; Pharmacokinetics; Bioequivalence; Pharmacology; Medicine; Crossover study; Viral load; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Viral disease","score_opus":0.11958774544962152,"score_gpt":0.4448748509857567,"score_spread":0.32528710553613516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044991833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990902,0.00043575704,0.00018358053,0.000012539327,0.000013375365,0.000056809182,0.000035311452,0.000014234947,0.00015811164],"genre_scores_gemma":[0.99784243,0.00037549026,0.0011083775,0.000031593798,0.000051142168,0.00008968618,0.000097472905,0.000006678792,0.0003971465],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990345,0.0004123043,0.000049460974,0.00020247055,0.00022506781,0.00007620851],"domain_scores_gemma":[0.99930394,0.00019808814,0.0002173874,0.00006810943,0.00004657416,0.00016591197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007844174,0.00047495702,0.0014042953,0.00032399446,0.00016349807,0.00046416748,0.00047036976,0.00053811667,0.0011669836],"category_scores_gemma":[0.0018522888,0.00057519914,0.00050482963,0.00038080063,0.00048003817,0.0004315891,0.00013735949,0.0009279404,0.00021050137],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4567382,0.01814964,0.012816906,0.00034147152,0.0015883915,0.00020588783,0.0004063584,0.0013958863,0.38472968,0.00013743741,0.0005443256,0.122945875],"study_design_scores_gemma":[0.03802341,0.80756724,0.08066356,0.000023699153,0.0014925417,0.0006875936,0.000110624766,0.003931272,0.0658835,0.000119608645,0.0014248827,0.000072183306],"about_ca_topic_score_codex":0.0010867692,"about_ca_topic_score_gemma":0.0014863684,"teacher_disagreement_score":0.0014042953,"about_ca_system_score_codex":0.00043506242,"about_ca_system_score_gemma":0.0004181291,"threshold_uncertainty_score":0.0041484237},"labels":[],"label_agreement":null},{"id":"W2045228294","doi":"10.1177/0091270009343694","title":"Population Pharmacokinetics of Perphenazine in Schizophrenia Patients From CATIE: Impact of Race and Smoking","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; University of Toronto","funders":"National Institute of Mental Health; National Institute on Aging","keywords":"Perphenazine; Pharmacokinetics; Population; Antipsychotic; Medicine; Internal medicine; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.04552524627873902,"score_gpt":0.45026336011851115,"score_spread":0.4047381138397721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045228294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956876,0.00011021269,0.00015043758,0.000017770013,0.000001151729,0.0000060284624,0.000048050657,0.0000033586614,0.00009417251],"genre_scores_gemma":[0.99946374,0.00008028939,0.00016792801,0.000028203882,0.0000035401933,0.000010009911,0.0001707582,0.000002433063,0.00007303792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994758,0.0002537954,0.000041229272,0.000075897064,0.00010183024,0.00005142843],"domain_scores_gemma":[0.9989813,0.00036702704,0.0003594088,0.00011077302,0.00008061999,0.00010081056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001002767,0.00024244218,0.0006396527,0.00023791935,0.0002599256,0.0004970848,0.00016694207,0.00032511362,0.000686612],"category_scores_gemma":[0.0033539317,0.00028996644,0.00043123012,0.00022359495,0.00020655378,0.00048747918,0.00024915437,0.00050645653,0.00016952954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057077445,0.00026056843,0.9633011,0.000044883778,0.00039757224,0.00037559425,0.00046649607,0.0011112016,0.0089876475,0.000086926455,0.00015976271,0.019100605],"study_design_scores_gemma":[0.0001339209,0.0018975133,0.9927361,0.000007069864,0.00016874674,0.00086396636,0.00016290147,0.0027512468,0.00082396274,0.00012677044,0.00030957078,0.00001819011],"about_ca_topic_score_codex":0.002291677,"about_ca_topic_score_gemma":0.0029576116,"teacher_disagreement_score":0.002291677,"about_ca_system_score_codex":0.00042527425,"about_ca_system_score_gemma":0.000345971,"threshold_uncertainty_score":0.0053032637},"labels":[],"label_agreement":null},{"id":"W2046257359","doi":"10.1177/0091270005280297","title":"Aging and Clinical Pharmacology: Implications for Antidepressants","year":2005,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital","funders":"National Institute of Mental Health","keywords":"Antidepressant; Medicine; Clinical trial; Depression (economics); Polypharmacy; Adverse effect; Clinical pharmacology; Pharmacokinetics; Intensive care medicine; Psychiatry; Pharmacology; Internal medicine; Anxiety","score_opus":0.32260002734407256,"score_gpt":0.6227360357906193,"score_spread":0.30013600844654675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046257359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004901882,0.99795866,0.00005590501,0.0010493007,0.0002959158,0.0000029024568,0.000003872595,0.0000033844312,0.0005810358],"genre_scores_gemma":[0.00046232104,0.997335,0.00016313675,0.00097115233,0.00048428518,0.000006282483,0.000006502416,7.1569053e-7,0.0005706399],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99944264,0.00018442965,0.0000945691,0.000059640344,0.00018560566,0.000033012377],"domain_scores_gemma":[0.9987344,0.00059169746,0.00021726724,0.000035796602,0.0003245981,0.00009624612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013944296,0.001016232,0.0025381397,0.002074779,0.0003891534,0.0015244053,0.0008527836,0.0021921583,0.0048164744],"category_scores_gemma":[0.0018942549,0.00037294743,0.0008086355,0.0036702608,0.0008325593,0.0028778964,0.00085894566,0.0023153068,0.0023279053],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011609723,0.00011960438,0.00029140062,0.021058518,0.00016322946,0.00038670673,0.0001767065,0.00041787614,0.00086476066,0.005020172,0.07835386,0.89303106],"study_design_scores_gemma":[0.00008297696,0.00018087264,0.002660729,0.012902861,0.0002010385,0.0022865883,0.00026829776,0.00013837297,0.00012833462,0.0069998903,0.97411525,0.000034873607],"about_ca_topic_score_codex":0.0021621243,"about_ca_topic_score_gemma":0.006082262,"teacher_disagreement_score":0.0048164744,"about_ca_system_score_codex":0.0012243621,"about_ca_system_score_gemma":0.0021011683,"threshold_uncertainty_score":0.016112685},"labels":[],"label_agreement":null},{"id":"W2046814818","doi":"10.1177/0091270006288733","title":"Time‐Dependent Interaction Between Lopinavir/Ritonavir and Fexofenadine","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Genome Canada; Ottawa Hospital","funders":"","keywords":"Lopinavir; Ritonavir; Fexofenadine; Lopinavir/ritonavir; Pharmacology; Pharmacokinetics; Medicine; Bioavailability; Chemistry; Internal medicine; Immunology; Viral load; Human immunodeficiency virus (HIV); Coronavirus disease 2019 (COVID-19)","score_opus":0.07987383447987405,"score_gpt":0.4649334033480723,"score_spread":0.38505956886819825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046814818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988642,0.00052453805,0.00027805,0.00001724713,0.000010118374,0.000012237047,0.000040171824,0.000012983754,0.00024053609],"genre_scores_gemma":[0.99903107,0.00016528637,0.00025863043,0.000028261988,0.000015901718,0.000009527434,0.00008185438,0.000004721183,0.00040463838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997261,0.000110052104,0.000009250235,0.0000536608,0.00005820393,0.000042655578],"domain_scores_gemma":[0.99963975,0.00018061163,0.000077684315,0.000034426703,0.000023482326,0.00004404721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032428713,0.00026117315,0.0006303849,0.00010215071,0.00011652144,0.00034553476,0.00012288977,0.00029705337,0.001466638],"category_scores_gemma":[0.0010604534,0.00019593757,0.00032162076,0.00008426898,0.00014561535,0.000248818,0.00013319476,0.00039343623,0.00027551464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03224405,0.0009833842,0.028036442,0.00016925893,0.00033962878,0.00064681005,0.00019238905,0.0011114948,0.88460964,0.000104213585,0.00023141815,0.051331304],"study_design_scores_gemma":[0.0015920673,0.053338975,0.55958164,0.000030454545,0.0007227945,0.004369778,0.00016834828,0.02017692,0.35513085,0.00029531735,0.0044931252,0.000099677454],"about_ca_topic_score_codex":0.00048500067,"about_ca_topic_score_gemma":0.00056653895,"teacher_disagreement_score":0.001466638,"about_ca_system_score_codex":0.00018358842,"about_ca_system_score_gemma":0.000114739334,"threshold_uncertainty_score":0.0049063563},"labels":[],"label_agreement":null},{"id":"W2048164325","doi":"10.1177/0091270006293752","title":"NXY‐059 Does Not Affect Bleeding Time in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled, 3‐Period Crossover Phase I Study","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Placebo; Crossover study; Medicine; Hemostasis; Anesthesia; Modified Rankin Scale; Double blind; Bleeding time; Stroke (engine); Randomized controlled trial; Platelet; Platelet aggregation; Cardiology; Internal medicine; Ischemia; Ischemic stroke; Pathology","score_opus":0.060906010070268454,"score_gpt":0.47021777025445977,"score_spread":0.4093117601841913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048164325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126947,0.0026222097,0.00086508505,0.0002918586,0.00031978003,0.0029355863,0.0005877959,0.00013259248,0.0009755605],"genre_scores_gemma":[0.9878193,0.0023449878,0.0019559704,0.0008793981,0.0005324554,0.003697249,0.00081037555,0.000037556292,0.0019226],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99914825,0.00037906514,0.000084096355,0.00016085982,0.00009634755,0.0001313498],"domain_scores_gemma":[0.9989103,0.0002865887,0.00027310805,0.00012408209,0.00008025917,0.00032571124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002060242,0.0015161826,0.0033762467,0.00043951182,0.00069547334,0.00081246614,0.0009820182,0.0023903172,0.0060136258],"category_scores_gemma":[0.0018449753,0.0007153875,0.0013410853,0.00042043973,0.001490114,0.00093401567,0.00027763654,0.0021611792,0.0010404692],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9641789,0.014720616,0.00035110232,0.000453503,0.00052393274,0.00004723753,0.000047090314,0.000085918895,0.008734067,0.000052663712,0.00041558582,0.010389393],"study_design_scores_gemma":[0.7303477,0.2644821,0.0028993348,0.000018865267,0.00036666964,0.000042882453,0.000020490048,0.00018268748,0.0010989504,0.00006832817,0.0004546614,0.00001736169],"about_ca_topic_score_codex":0.0006069234,"about_ca_topic_score_gemma":0.0010065228,"teacher_disagreement_score":0.0060136258,"about_ca_system_score_codex":0.0004183434,"about_ca_system_score_gemma":0.0010797436,"threshold_uncertainty_score":0.02011758},"labels":[],"label_agreement":null},{"id":"W2050102690","doi":"10.1177/0091270007299930","title":"Nuclear Receptors and the Regulation of Drug‐Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs","year":2007,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Institute of General Medical Sciences","keywords":"Drug; Pharmacology; Transporter; Drug response; Drug metabolism; Receptor; ATP-binding cassette transporter; Pharmacogenetics; Medicine; Biology; Internal medicine; Biochemistry; Gene","score_opus":0.0861631247075621,"score_gpt":0.4553976741284672,"score_spread":0.3692345494209051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050102690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013848897,0.973566,0.0034286499,0.005104675,0.00039747762,0.000014583744,0.00013903245,0.00004273629,0.0034579015],"genre_scores_gemma":[0.12730977,0.8615145,0.0027924567,0.001794998,0.0010999476,0.00006601372,0.00030898946,0.000024595387,0.0050887726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994918,0.00017063765,0.000050831397,0.000116470575,0.00011393475,0.00005629523],"domain_scores_gemma":[0.99939156,0.00027386914,0.00014393569,0.000029847797,0.00011971693,0.000041045772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009324552,0.0003442488,0.0006677407,0.0004105561,0.00022104557,0.0012274992,0.0003608674,0.0007579622,0.0018167641],"category_scores_gemma":[0.00095993525,0.00015600868,0.00059072254,0.00065301225,0.00072590687,0.0006863143,0.00042345322,0.0010969219,0.00045518155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016707967,0.0002437159,0.032534927,0.007878895,0.0011790103,0.0039027783,0.002080151,0.0028735367,0.108588494,0.055514663,0.03175792,0.7517751],"study_design_scores_gemma":[0.00018704335,0.0014612136,0.11957576,0.0024626735,0.0011306053,0.01678263,0.0020557519,0.002219051,0.024973849,0.049876787,0.77900153,0.00027306497],"about_ca_topic_score_codex":0.0012869628,"about_ca_topic_score_gemma":0.0015019028,"teacher_disagreement_score":0.0018167641,"about_ca_system_score_codex":0.0009038394,"about_ca_system_score_gemma":0.0006551563,"threshold_uncertainty_score":0.006557882},"labels":[],"label_agreement":null},{"id":"W2050487849","doi":"10.1177/0091270004264164","title":"Absence of a Pharmacokinetic Interaction between Etanercept and Warfarin","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Etanercept; Medicine; Pharmacokinetics; Warfarin; Pharmacodynamics; Rheumatoid arthritis; Pharmacology; Arthritis; Internal medicine","score_opus":0.08921902864956445,"score_gpt":0.47234528397580794,"score_spread":0.3831262553262435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050487849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985592,0.00039395178,0.0004959012,0.00002466462,0.000013073433,0.00004529372,0.000037457572,0.000009045897,0.00042139468],"genre_scores_gemma":[0.9990638,0.00008191905,0.00035806038,0.000038772363,0.00002328889,0.000031639647,0.000056306602,0.0000040738023,0.00034220476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829596,0.00091039314,0.00012490913,0.00020767376,0.00036639944,0.000094568495],"domain_scores_gemma":[0.99796283,0.00093454716,0.0004580489,0.0002878701,0.00015332761,0.0002033905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012759543,0.0002663062,0.0010734939,0.00016372115,0.00022906445,0.0003924458,0.00022967417,0.00048532768,0.00094167294],"category_scores_gemma":[0.0031149625,0.000339707,0.00037065663,0.00016682639,0.0004403235,0.00033958122,0.00014100876,0.00064391113,0.00020713797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19616653,0.0056700497,0.14578898,0.0003001475,0.0010102117,0.0012744109,0.00027684114,0.0014278735,0.59507793,0.00022570608,0.0003417663,0.05243947],"study_design_scores_gemma":[0.005499294,0.1892178,0.6730376,0.000022649416,0.0011123053,0.008215411,0.00014873817,0.007426667,0.11162871,0.00030480768,0.003331015,0.00005499682],"about_ca_topic_score_codex":0.00043142235,"about_ca_topic_score_gemma":0.00057469006,"teacher_disagreement_score":0.0012759543,"about_ca_system_score_codex":0.00028766034,"about_ca_system_score_gemma":0.0003199659,"threshold_uncertainty_score":0.006747961},"labels":[],"label_agreement":null},{"id":"W2051140296","doi":"10.1177/0091270005277937","title":"An Evaluation of an Optimal Sampling Strategy for Meropenem in Febrile Neutropenics","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Sampling (signal processing); Meropenem; Nonparametric statistics; Population; Sampling design; Statistics; Computer science; Mathematics; Medicine; Biology","score_opus":0.2952749834255073,"score_gpt":0.5682998057018513,"score_spread":0.27302482227634406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051140296","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3498955,0.000230859,0.64861435,0.00014591677,0.000016326956,0.00055509474,0.00004336984,0.00008100313,0.00041753202],"genre_scores_gemma":[0.7648633,0.00012481077,0.2341696,0.00008105962,0.000009784106,0.0005407493,0.000076450655,0.000011792446,0.00012244658],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.990681,0.007992987,0.00029797436,0.000357881,0.00054279726,0.00012736762],"domain_scores_gemma":[0.9773626,0.019388376,0.0010372015,0.00078627095,0.0011882209,0.00023739954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015376751,0.00046169077,0.000984308,0.0004822844,0.00021060216,0.0004887301,0.0006644866,0.0006184095,0.0004021897],"category_scores_gemma":[0.03447508,0.00041382943,0.000509999,0.00030582177,0.00054075744,0.0005506292,0.0008255497,0.0005609016,0.000049282582],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010967719,0.0015847551,0.023676114,0.0004907527,0.0003543509,0.00013793964,0.00041243192,0.631107,0.015511586,0.014364255,0.00040682612,0.3009863],"study_design_scores_gemma":[0.000630661,0.005548441,0.004058205,0.000025590543,0.00010013829,0.000075416625,0.000050660678,0.9800182,0.0051879645,0.0037472087,0.0005267633,0.00003067461],"about_ca_topic_score_codex":0.0013692369,"about_ca_topic_score_gemma":0.00082678726,"teacher_disagreement_score":0.015376751,"about_ca_system_score_codex":0.00057510514,"about_ca_system_score_gemma":0.0015465948,"threshold_uncertainty_score":0.081321},"labels":[],"label_agreement":null},{"id":"W2056298376","doi":"10.1177/0091270004273320","title":"CYP3A and P‐Glycoprotein Activity Induction With St. John's Wort in Healthy Volunteers From 6 Ethnic Populations","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical pharmacology; Family medicine; Library science; Traditional medicine; Pharmacology","score_opus":0.11155049814062448,"score_gpt":0.4478634263768943,"score_spread":0.3363129282362698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056298376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945384,0.0001243112,0.00004606613,0.00002328632,0.00000730846,0.000008577611,0.00005140901,0.0000023646453,0.00028285934],"genre_scores_gemma":[0.9993468,0.000082230195,0.000041016898,0.00004448993,0.00001732865,0.000008287826,0.000115902134,0.0000019618628,0.00034198046],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997559,0.00009089867,0.000021982798,0.000052742544,0.00003692484,0.000041533654],"domain_scores_gemma":[0.9997625,0.00006604503,0.000039179562,0.000019662544,0.000038953083,0.00007359829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031296353,0.00031401106,0.0004127814,0.00026193497,0.00046329733,0.00037309786,0.0001087646,0.00040268805,0.0013840939],"category_scores_gemma":[0.0009926457,0.00020794099,0.00027390808,0.00023036434,0.0002687469,0.00021221755,0.00018517525,0.000360333,0.00030647643],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019808268,0.0014835496,0.9126555,0.0001356345,0.00043606255,0.0025665483,0.0023059822,0.00012912918,0.036915302,0.0001493255,0.00078924967,0.022625513],"study_design_scores_gemma":[0.0002125663,0.003709549,0.99246806,0.000004426465,0.00013306638,0.0012930477,0.00040311978,0.00015612817,0.0011979408,0.00006776297,0.00034561503,0.000008716281],"about_ca_topic_score_codex":0.0017145502,"about_ca_topic_score_gemma":0.0018503722,"teacher_disagreement_score":0.0017145502,"about_ca_system_score_codex":0.00015038418,"about_ca_system_score_gemma":0.00013487852,"threshold_uncertainty_score":0.004630208},"labels":[],"label_agreement":null},{"id":"W2056389297","doi":"10.1177/0091270008319794","title":"Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Dosing; Medicine; Drug; Pharmacology","score_opus":0.207105375854416,"score_gpt":0.4668571482132321,"score_spread":0.2597517723588161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056389297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835734,0.005853928,0.003473493,0.00077098724,0.000044014505,0.000054518285,0.00019948561,0.000012390567,0.006017792],"genre_scores_gemma":[0.99625826,0.000979254,0.0017808396,0.0004711372,0.000026393933,0.000014003921,0.00012656565,0.000013894598,0.00032969753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931331,0.0036830967,0.001314726,0.00061548874,0.001053511,0.00020000552],"domain_scores_gemma":[0.9814368,0.008903936,0.0061886744,0.0012286205,0.0019077926,0.00033425936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069615073,0.000108298984,0.00033517307,0.00060585537,0.00030746008,0.0010107553,0.0002645116,0.00037489212,0.0011494538],"category_scores_gemma":[0.022880767,0.0001550103,0.0004248437,0.0013606217,0.00058693934,0.0010846872,0.0004798984,0.0006050818,0.00025829094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029116133,0.00016274124,0.8700676,0.00024012887,0.0005730481,0.000252508,0.0037195683,0.00034196847,0.004889625,0.001730325,0.0007850879,0.114325754],"study_design_scores_gemma":[0.00003400448,0.00039622272,0.9928894,0.000053283773,0.00016190343,0.00046903876,0.0012442063,0.00033615093,0.0011569121,0.00080273004,0.00243983,0.000016239168],"about_ca_topic_score_codex":0.0017337293,"about_ca_topic_score_gemma":0.003562211,"teacher_disagreement_score":0.0069615073,"about_ca_system_score_codex":0.00059671566,"about_ca_system_score_gemma":0.0004195389,"threshold_uncertainty_score":0.03681642},"labels":[],"label_agreement":null},{"id":"W2057686207","doi":"10.1177/0091270009350483","title":"The Safety of H<sub>2</sub>‐Blockers Use During Pregnancy","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Odds ratio; Confidence interval; Apgar score; Obstetrics; Confounding; Pediatrics; Birth weight; Internal medicine","score_opus":0.06089951179241699,"score_gpt":0.4245510688326612,"score_spread":0.3636515570402442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057686207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98989785,0.0050690593,0.00015865354,0.0002997868,0.000015393081,0.000012339081,0.0030193443,0.0000069573475,0.0015206893],"genre_scores_gemma":[0.993693,0.003527854,0.0001228903,0.00014718286,0.000042408108,0.000015285816,0.0022555771,0.0000032129667,0.00019257542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975146,0.001152346,0.00037131392,0.00024589748,0.0005835262,0.00013234014],"domain_scores_gemma":[0.9875924,0.0052796686,0.005800509,0.00049626874,0.000539017,0.00029214573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018373398,0.00011792403,0.00038953553,0.0007305281,0.00013993664,0.00087650097,0.00032222323,0.00036660617,0.0008765582],"category_scores_gemma":[0.0090292,0.00015904682,0.00023884348,0.0014714838,0.00022065746,0.00035710013,0.00024827174,0.00034770544,0.0001836038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052687526,0.000029585028,0.9820711,0.00009923546,0.0001951121,0.00012545819,0.00008988351,0.00013158466,0.0002921149,0.00004445849,0.00023012942,0.01616443],"study_design_scores_gemma":[0.000018657787,0.00033654072,0.99766064,0.00008004059,0.0000930336,0.0003670634,0.000089941605,0.00023722503,0.00030857293,0.000057866942,0.00074408465,0.000006435163],"about_ca_topic_score_codex":0.0047672135,"about_ca_topic_score_gemma":0.0037704776,"teacher_disagreement_score":0.0047672135,"about_ca_system_score_codex":0.00047705835,"about_ca_system_score_gemma":0.0005623499,"threshold_uncertainty_score":0.009716928},"labels":[],"label_agreement":null},{"id":"W2061293585","doi":"10.1177/0091270003262951","title":"Rheumatoid Arthritis Does Not Reduce the Pharmacodynamic Response to Valsartan","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Rheumatoid arthritis; Valsartan; Medicine; Pharmacodynamics; Inflammation; Pharmacology; Internal medicine; Arthritis; Pharmacokinetics; Tumor necrosis factor alpha; Endocrinology; Blood pressure","score_opus":0.02884002884328935,"score_gpt":0.38890449552481066,"score_spread":0.3600644666815213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061293585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742895,0.0013378217,0.0001532136,0.00010928347,0.000020456531,0.0000065144436,0.00003538744,0.0000161929,0.00089219294],"genre_scores_gemma":[0.9991702,0.00024050057,0.00008158208,0.0000670316,0.000029993771,0.0000028984962,0.000047086312,0.0000027838169,0.0003578766],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99973077,0.00008655009,0.000021571712,0.000030123403,0.000075787524,0.000055137538],"domain_scores_gemma":[0.9995461,0.000094676805,0.0001184029,0.000050470513,0.000034157547,0.00015602453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017403481,0.00019756536,0.0003692114,0.00011232232,0.00010400813,0.00017696404,0.00008243684,0.00019285316,0.0012670489],"category_scores_gemma":[0.00061643636,0.00009170337,0.00017091792,0.00005238478,0.00018016435,0.000103683225,0.00008853057,0.000381283,0.00031774255],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0172217,0.0013453481,0.029847598,0.00016573073,0.00023642677,0.0008930604,0.000120460536,0.00022365914,0.8894309,0.00012425153,0.00057113206,0.0598198],"study_design_scores_gemma":[0.0019842077,0.06423912,0.79039145,0.00003470537,0.00040667292,0.0064123897,0.00016840144,0.0011554415,0.12902227,0.00033408214,0.0058235717,0.000027663966],"about_ca_topic_score_codex":0.000250536,"about_ca_topic_score_gemma":0.0004471053,"teacher_disagreement_score":0.0012670489,"about_ca_system_score_codex":0.00008859331,"about_ca_system_score_gemma":0.000091087546,"threshold_uncertainty_score":0.004238665},"labels":[],"label_agreement":null},{"id":"W2062442341","doi":"10.1177/0091270011420253","title":"The Seduction of Biomarkers in the Practice of Medicine and the Tyranny of Power in the Drug Approval Process: Lessons From Niacin","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Psychological intervention; Diligence; Medicine; Due diligence; Intensive care medicine; Psychology; Psychiatry; Business; Social psychology","score_opus":0.08051743857832007,"score_gpt":0.4551217575855924,"score_spread":0.37460431900727237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062442341","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017354691,0.17581017,0.0046369587,0.8046063,0.0056217965,0.00002221181,0.000034935347,0.000070512484,0.0074616615],"genre_scores_gemma":[0.1085107,0.40411234,0.016158424,0.41560924,0.047079355,0.00020860975,0.000071287126,0.0002869948,0.00796301],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97285795,0.01871041,0.0012350619,0.0015624738,0.004489926,0.0011441697],"domain_scores_gemma":[0.87341404,0.096540876,0.0038874021,0.0060245963,0.012974163,0.0071589374],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.050397765,0.0014275265,0.0032444657,0.0026737815,0.003380805,0.012042689,0.0029063302,0.014428318,0.005409085],"category_scores_gemma":[0.060196538,0.0008012032,0.002365335,0.0018951369,0.03381787,0.02485743,0.007234969,0.034135398,0.002492321],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010024959,0.0004991985,0.004009691,0.004023711,0.0003535239,0.0022674035,0.010884418,0.0019091029,0.0009175674,0.29249787,0.24126163,0.44037342],"study_design_scores_gemma":[0.00034977583,0.00060475105,0.0025591855,0.0073794527,0.00012363645,0.0017713794,0.00645707,0.0012658271,0.0007460443,0.40098202,0.5774848,0.00027605932],"about_ca_topic_score_codex":0.006732338,"about_ca_topic_score_gemma":0.010266771,"teacher_disagreement_score":0.9966192,"about_ca_system_score_codex":0.0075377496,"about_ca_system_score_gemma":0.015107674,"threshold_uncertainty_score":0.26653206},"labels":[],"label_agreement":null},{"id":"W2064041298","doi":"10.1177/0091270005281350","title":"Pharmacokinetics of Sirolimus (Rapamycin) in Subjects With Mild to Moderate Hepatic Impairment","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Sirolimus; Medicine; Pharmacokinetics; Trough level; Renal transplant; Internal medicine; Urology; Gastroenterology; Oral administration; Kidney; Transplantation","score_opus":0.06198061023468587,"score_gpt":0.4355212086474842,"score_spread":0.37354059841279835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064041298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940014,0.00027545754,0.00006549832,0.000013655925,0.0000030290157,0.000009464434,0.000035571004,0.000005372293,0.0001918845],"genre_scores_gemma":[0.999632,0.00008019721,0.00006603831,0.000025466079,0.0000089398945,0.000008597233,0.000056220495,0.0000011976744,0.00012128766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999874,0.000037444814,0.000013370292,0.000026334437,0.000024178353,0.000024717525],"domain_scores_gemma":[0.99965537,0.00007443742,0.00010897489,0.000021238995,0.000037627327,0.0001023334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002406548,0.00033372262,0.00060314516,0.00027961985,0.00035387638,0.00026404267,0.00007994067,0.00023607323,0.00057151995],"category_scores_gemma":[0.00089663686,0.00020363541,0.00017505803,0.000225855,0.0002277821,0.00021655644,0.0001555322,0.00028822452,0.0001435462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0148422215,0.0008715054,0.9500735,0.00009145806,0.00018585006,0.0011546292,0.0007078093,0.00036861078,0.015209882,0.000081631944,0.0003740351,0.016038818],"study_design_scores_gemma":[0.00022352871,0.0064490195,0.98992586,0.0000041731396,0.000103058075,0.0012734613,0.0001351871,0.0004601521,0.00087160536,0.000045139204,0.0005000891,0.0000086389255],"about_ca_topic_score_codex":0.0021876653,"about_ca_topic_score_gemma":0.0019677822,"teacher_disagreement_score":0.0021876653,"about_ca_system_score_codex":0.00023566709,"about_ca_system_score_gemma":0.00014493505,"threshold_uncertainty_score":0.0043498874},"labels":[],"label_agreement":null},{"id":"W2065604666","doi":"10.1177/0091270004265643","title":"Influence of Omeprazole on Bioavailability of Bismuth following Administration of a Triple Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; BioPhage Pharma (Canada)","funders":"","keywords":"Omeprazole; Cmax; Metronidazole; Bioavailability; Capsule; Tetracycline; Toxicity; Pharmacology; Bismuth; Chemistry; Pharmacokinetics; Medicine; Gastroenterology; Internal medicine; Antibiotics; Biochemistry; Biology","score_opus":0.04307213297367731,"score_gpt":0.4060488820230471,"score_spread":0.36297674904936983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065604666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994116,0.0003498318,0.00010400026,0.000015420022,0.000007079474,0.000017694541,0.000012814957,0.0000042378374,0.00007742099],"genre_scores_gemma":[0.9993754,0.00013311647,0.00019437463,0.000029000164,0.000020201905,0.00001357547,0.000030857595,0.0000031383595,0.00020028652],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994758,0.00021615619,0.000030055582,0.000074498465,0.00014008832,0.00006341189],"domain_scores_gemma":[0.9991516,0.0003788207,0.00023630039,0.00005872509,0.000037047765,0.00013749408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005652296,0.00022465656,0.00070815074,0.00010244452,0.0001302306,0.00025671793,0.00014458982,0.00033446855,0.0009986354],"category_scores_gemma":[0.0015595269,0.00019374207,0.00033391136,0.000072547766,0.0002212134,0.00019863957,0.0001439286,0.0004718139,0.00014594925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30045745,0.00362234,0.02175777,0.00036654025,0.000414856,0.0006296146,0.00023404631,0.00062846096,0.58953464,0.000049527265,0.00017698869,0.08212782],"study_design_scores_gemma":[0.009191408,0.45268545,0.39608428,0.000038938117,0.00055483665,0.0014860828,0.00021116238,0.004817768,0.13313131,0.00009118283,0.0016574428,0.000050179526],"about_ca_topic_score_codex":0.0005400551,"about_ca_topic_score_gemma":0.0007099115,"teacher_disagreement_score":0.0009986354,"about_ca_system_score_codex":0.00015133776,"about_ca_system_score_gemma":0.00013405086,"threshold_uncertainty_score":0.0033407807},"labels":[],"label_agreement":null},{"id":"W2067571642","doi":"10.1177/0091270008326716","title":"The Effects of Desvenlafaxine and Paroxetine on the Pharmacokinetics of the Cytochrome P450 2D6 Substrate Desipramine in Healthy Adults","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Desipramine; Paroxetine; Pharmacokinetics; CYP2D6; Pharmacology; Medicine; Cytochrome P450; Internal medicine; Antidepressant","score_opus":0.1405376604974933,"score_gpt":0.4776603833222849,"score_spread":0.3371227228247916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067571642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979479,0.0013141716,0.00010840825,0.000053840886,0.000020418434,0.000051946437,0.00012423485,0.000009125334,0.0003699165],"genre_scores_gemma":[0.9983304,0.0005319289,0.00032954905,0.00013203344,0.000048337457,0.00005451202,0.00018400492,0.000002890354,0.00038642355],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992126,0.0004448771,0.000055959084,0.00012608638,0.00010006828,0.000060326085],"domain_scores_gemma":[0.99918944,0.00030009728,0.00018719297,0.000045606823,0.00005435752,0.00022330259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009949052,0.00042557126,0.0008705242,0.00017408808,0.00018800255,0.00025076134,0.00015434717,0.0007392643,0.0010634952],"category_scores_gemma":[0.0020579405,0.00032898985,0.00046053654,0.00014610603,0.00029953237,0.00034334618,0.00015934829,0.0005345418,0.00022692347],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66143715,0.011532548,0.13647613,0.00043675082,0.0021653732,0.00065754016,0.0006531917,0.00058395416,0.06182968,0.00014696119,0.001024462,0.12305629],"study_design_scores_gemma":[0.028555254,0.33146653,0.6283804,0.000021110181,0.00087512785,0.0010318845,0.00016049712,0.0009302278,0.0061957226,0.00016195101,0.0021886148,0.00003261894],"about_ca_topic_score_codex":0.0006738363,"about_ca_topic_score_gemma":0.0010248657,"teacher_disagreement_score":0.0010634952,"about_ca_system_score_codex":0.0002698262,"about_ca_system_score_gemma":0.00016644648,"threshold_uncertainty_score":0.0052616},"labels":[],"label_agreement":null},{"id":"W2067746663","doi":"10.1177/0091270004271403","title":"Paradoxical Cyclosporine A Requirements in Pediatric Renal Transplants Receiving High‐Dose Steroids","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre; Queen's University; Capital District Health Authority","funders":"","keywords":"Medicine; Pharmacology; Intensive care medicine","score_opus":0.08958645473415587,"score_gpt":0.4495713655283556,"score_spread":0.3599849107941997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067746663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890506,0.0003715568,0.00017556992,0.00006241956,0.000004329368,0.000009049195,0.00009593063,0.000008892076,0.00036728717],"genre_scores_gemma":[0.9994573,0.00021299924,0.00014130848,0.000035274737,0.000008038322,0.000004154642,0.00010634418,0.000002463775,0.000032161908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935967,0.00011753567,0.00011438039,0.000092142254,0.00021174828,0.00010464432],"domain_scores_gemma":[0.9956435,0.0013790426,0.002117384,0.00009376164,0.00023010644,0.00053608505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041713062,0.00016320244,0.00048609762,0.0007783923,0.00035077453,0.00047405311,0.00022981613,0.00028570637,0.0009584558],"category_scores_gemma":[0.0047071213,0.00015511765,0.0002140124,0.0009688419,0.00023570731,0.0004871415,0.00028147936,0.0005049666,0.00010400584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020783117,0.00006988105,0.9814995,0.00004654389,0.000019638936,0.008170612,0.00015762767,0.00019925361,0.0007545736,0.00009803421,0.00025049268,0.008526133],"study_design_scores_gemma":[0.00002763165,0.0005340616,0.9470131,0.000035160854,0.000066760746,0.048363086,0.0003970503,0.0008814538,0.0014930728,0.0001816645,0.0009947238,0.000012244831],"about_ca_topic_score_codex":0.001229793,"about_ca_topic_score_gemma":0.0016515236,"teacher_disagreement_score":0.001229793,"about_ca_system_score_codex":0.00056717725,"about_ca_system_score_gemma":0.00060901494,"threshold_uncertainty_score":0.004115224},"labels":[],"label_agreement":null},{"id":"W2067858710","doi":"10.1002/jcph.480","title":"Comparing pyridoxine and doxylamine succinate‐pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Pyridoxine; Medicine; Vomiting; Metoclopramide; Nausea; Internal medicine; Anesthesia; Gastroenterology; Pharmacology","score_opus":0.14887125824406683,"score_gpt":0.4708826012822895,"score_spread":0.32201134303822265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067858710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965354,0.0015842426,0.00028527222,0.000046779995,0.00012374046,0.00059008057,0.0005054965,0.000010455632,0.00031835373],"genre_scores_gemma":[0.9966618,0.0006985794,0.0004019815,0.0002121249,0.00011299914,0.0007125588,0.000629866,0.00000764093,0.00056249305],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99807787,0.0007268388,0.00017250894,0.00054914824,0.00022608544,0.0002474961],"domain_scores_gemma":[0.99766964,0.00057760946,0.0005862566,0.00048350933,0.00027871353,0.00040434446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029773416,0.0010830541,0.0017359301,0.00049521297,0.00094806013,0.0010421631,0.00080346665,0.001852704,0.002852031],"category_scores_gemma":[0.004542889,0.0009385894,0.0022903092,0.0006267067,0.0007430642,0.0006952341,0.00053474866,0.0012981546,0.00053196505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72210246,0.023163343,0.20975439,0.0010913047,0.020720059,0.00053372217,0.00051808334,0.0002536578,0.008255009,0.00019043559,0.0013622869,0.012055193],"study_design_scores_gemma":[0.19044586,0.23463607,0.5495476,0.00016824061,0.016967572,0.0006842005,0.00072854717,0.0011067555,0.001571796,0.00035486682,0.0036239815,0.00016448271],"about_ca_topic_score_codex":0.005346544,"about_ca_topic_score_gemma":0.0051916456,"teacher_disagreement_score":0.005346544,"about_ca_system_score_codex":0.0007352049,"about_ca_system_score_gemma":0.0010299379,"threshold_uncertainty_score":0.015745878},"labels":[],"label_agreement":null},{"id":"W2069942679","doi":"10.1177/0091270008327538","title":"The Effect of Reporting Methods for Dosing Times on the Estimation of Pharmacokinetic Parameters of Escitalopram","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Mental Health","keywords":"NONMEM; Dosing; Escitalopram; Pharmacokinetics; Population; Medicine; Volume of distribution; Elimination rate constant; Anesthesia; Pharmacology; Internal medicine","score_opus":0.12579272282585838,"score_gpt":0.5792357211528095,"score_spread":0.4534429983269511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069942679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49818918,0.027030095,0.45805752,0.0040343176,0.0021445982,0.0014589846,0.0025337413,0.0025340614,0.004017538],"genre_scores_gemma":[0.7826261,0.003977811,0.205177,0.0019390924,0.0008179739,0.0013875512,0.001957937,0.0009884806,0.0011281593],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.6680476,0.28619257,0.021713888,0.00816327,0.015078046,0.00080461084],"domain_scores_gemma":[0.21171266,0.69945216,0.053195275,0.025031516,0.010166113,0.00044231184],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21764277,0.0016240668,0.0013383338,0.0011405933,0.0005872373,0.0030092716,0.0016832559,0.0018271715,0.0010136347],"category_scores_gemma":[0.5199633,0.0010177792,0.0034336105,0.0019345897,0.0011608596,0.0028738258,0.0013962255,0.0022182558,0.00046703743],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03225084,0.0011290963,0.31807742,0.0037598603,0.010946066,0.00038056934,0.00372897,0.05921635,0.012225859,0.0044774017,0.005199105,0.5486085],"study_design_scores_gemma":[0.004296891,0.021053564,0.42519093,0.0037108592,0.0099654645,0.0032346724,0.0013617992,0.44485748,0.046628192,0.008042006,0.030540165,0.0011179693],"about_ca_topic_score_codex":0.0018767741,"about_ca_topic_score_gemma":0.001143941,"teacher_disagreement_score":0.7823572,"about_ca_system_score_codex":0.0013889029,"about_ca_system_score_gemma":0.0013153413,"threshold_uncertainty_score":0.96478575},"labels":[],"label_agreement":null},{"id":"W2071271954","doi":"10.1177/00912700122010005","title":"The Influence of Food on the Bioavailability of a Twice‐Daily Controlled Release Carbamazepine Formulation","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada","funders":"","keywords":"Bioavailability; Crossover study; Carbamazepine; Bioequivalence; Meal; Pharmacology; Medicine; Absorption (acoustics); Capsule; Internal medicine; Biology; Placebo","score_opus":0.07858251866896701,"score_gpt":0.4285742120667621,"score_spread":0.3499916933977951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071271954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99913377,0.00035641162,0.00022053937,0.000033977663,0.000029779572,0.000038886956,0.000031438984,0.000010745314,0.00014452761],"genre_scores_gemma":[0.99799013,0.00045829584,0.00091283716,0.00005147152,0.000042026662,0.000052321135,0.00007848545,0.000013577665,0.00040078227],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999464,0.0002460387,0.000036420486,0.00008789621,0.0001088645,0.000056764675],"domain_scores_gemma":[0.99888724,0.0006125374,0.00022628627,0.000074426054,0.0000742416,0.000125359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006673908,0.00037044875,0.000690453,0.0002025481,0.00021051902,0.00036134385,0.00026469398,0.0005311086,0.0011766988],"category_scores_gemma":[0.0021384046,0.00036505086,0.00031650238,0.00013675453,0.0005558162,0.00045362784,0.00017311033,0.00071318814,0.00012097913],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17178613,0.005525866,0.0027209022,0.00040986147,0.00020939586,0.00034860376,0.0002636188,0.00040596724,0.77825207,0.00014091999,0.00019127647,0.03974542],"study_design_scores_gemma":[0.017335968,0.54276866,0.053789698,0.000043274144,0.00082947494,0.0007891691,0.00018647156,0.003051737,0.37837207,0.00014264633,0.0026212928,0.000069419766],"about_ca_topic_score_codex":0.0006777456,"about_ca_topic_score_gemma":0.0007453493,"teacher_disagreement_score":0.0011766988,"about_ca_system_score_codex":0.00025020656,"about_ca_system_score_gemma":0.0003037135,"threshold_uncertainty_score":0.00393641},"labels":[],"label_agreement":null},{"id":"W2072077675","doi":"10.1177/00912700222011283","title":"Serum Concentrations, Efficacy, and Safety of a New, Intravenously Administered Varicella Zoster Immune Globulin in Pregnant Women","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Université de Montréal; B.C. Women's Hospital & Health Centre; British Columbia Centre of Excellence for Women's Health; University of Winnipeg; SickKids Foundation; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Chickenpox; Varicella zoster virus; Antibody; Virus; Immunology; Internal medicine","score_opus":0.06420611288494987,"score_gpt":0.39132936446859873,"score_spread":0.32712325158364886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072077675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841833,0.0010170796,0.000119740725,0.00006294789,0.000022019141,0.00008150374,0.00002425675,0.0000047362846,0.00024932917],"genre_scores_gemma":[0.9985886,0.0005992622,0.00036176518,0.00010936943,0.000048945512,0.000094805386,0.000045900488,0.0000022218062,0.00014904658],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998698,0.0008170197,0.00009016238,0.00012201703,0.00019740114,0.00007539702],"domain_scores_gemma":[0.9984824,0.00080701587,0.00034338888,0.00009839363,0.000078807825,0.0001900293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001723293,0.00029875123,0.000775619,0.00023461136,0.0002120238,0.00027876114,0.00021221391,0.0008061262,0.0007070309],"category_scores_gemma":[0.005824685,0.00039998812,0.00037679446,0.00017861517,0.0006632203,0.00033763226,0.0001423975,0.00074687804,0.00015653946],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54436743,0.033668842,0.106027,0.0007806742,0.0012517081,0.0011671332,0.00082028186,0.0014007521,0.13176374,0.00034858036,0.00068607833,0.17771776],"study_design_scores_gemma":[0.038804732,0.84812117,0.08469609,0.000054118365,0.0008676961,0.001018001,0.00016658395,0.0010236021,0.023555879,0.00019840774,0.0014624863,0.00003127803],"about_ca_topic_score_codex":0.00035161723,"about_ca_topic_score_gemma":0.00040962294,"teacher_disagreement_score":0.001723293,"about_ca_system_score_codex":0.00042715375,"about_ca_system_score_gemma":0.00035778098,"threshold_uncertainty_score":0.009113729},"labels":[],"label_agreement":null},{"id":"W2076382338","doi":"10.1177/0091270011413588","title":"Current Understanding of Drug Disposition in Kidney Disease","year":2012,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Kidney disease; Drug; Pharmacology; Disposition; Drug metabolism; Renal function; Population; Kidney; Pharmacokinetics; Parathyroid hormone; Disease; Internal medicine; Calcium","score_opus":0.33834513803193345,"score_gpt":0.5491011623739794,"score_spread":0.210756024342046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076382338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010532281,0.9981584,0.0002158997,0.0003110367,0.00010136382,0.0000067106193,0.000025978141,0.000009538186,0.0010658175],"genre_scores_gemma":[0.0005252805,0.9986915,0.00021649059,0.00012731244,0.00009996708,0.0000061993974,0.000024468196,8.275162e-7,0.0003080034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996551,0.00006126639,0.000062687235,0.00005464915,0.00014546585,0.00002075045],"domain_scores_gemma":[0.9994599,0.00025468777,0.00009097737,0.000018535071,0.0001449293,0.000030956206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081588124,0.0010219553,0.0021840078,0.0020017389,0.00029591905,0.0012783769,0.0011785806,0.0012321966,0.005088706],"category_scores_gemma":[0.0007312197,0.0003228173,0.0007217292,0.0026868915,0.0005669484,0.0016731533,0.00074913766,0.0016829515,0.0028226946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069818714,0.000092603856,0.0002614014,0.024348706,0.000118401935,0.00017891837,0.00006175811,0.0003372864,0.0010798313,0.0026247345,0.018028993,0.9527975],"study_design_scores_gemma":[0.000024969888,0.0001675898,0.0015894588,0.0063106352,0.00026786493,0.0019798174,0.000085048225,0.00018734527,0.0005135065,0.0035623293,0.98528117,0.000030237838],"about_ca_topic_score_codex":0.0013923927,"about_ca_topic_score_gemma":0.0018889308,"teacher_disagreement_score":0.005088706,"about_ca_system_score_codex":0.0006465846,"about_ca_system_score_gemma":0.0016749757,"threshold_uncertainty_score":0.017023444},"labels":[],"label_agreement":null},{"id":"W2076424992","doi":"10.1177/009127002401102614","title":"Trends of Medication Errors in Hospitalized Children","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medication error; Medicine; Emergency medicine; Patient safety; Pediatrics; Medical emergency; Health care","score_opus":0.16890927089005242,"score_gpt":0.5417259858060803,"score_spread":0.3728167149160279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076424992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944577,0.0009124585,0.00008312634,0.0003904089,0.0000094305615,0.000009637146,0.0029429279,0.000027886033,0.0011663251],"genre_scores_gemma":[0.9959198,0.0011612811,0.00020669714,0.000069945105,0.00001679395,0.000014339279,0.0021218383,0.0000045371894,0.00048475075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993223,0.000060075545,0.00011282119,0.000101538244,0.00026843205,0.00013494791],"domain_scores_gemma":[0.9948325,0.00037415687,0.0027870724,0.00008359292,0.001457044,0.00046561466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037772037,0.00014390046,0.0002520627,0.0017056884,0.00034935435,0.0006202177,0.00041726805,0.00045433128,0.0014742379],"category_scores_gemma":[0.003701083,0.0001694148,0.00027178953,0.0022612303,0.0002847372,0.0005988189,0.00029228625,0.00061341637,0.0002889021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003500029,0.000011634666,0.9958748,0.00003561278,0.000015562908,0.000048286118,0.00029770337,0.00007222135,0.00011117966,0.00003045126,0.00047881142,0.0029888123],"study_design_scores_gemma":[9.713397e-7,0.000029352666,0.99919885,0.0000085925,0.000004672463,0.00009762012,0.00019364338,0.00006209043,0.00004979993,0.0000033447343,0.00034894457,0.0000021258984],"about_ca_topic_score_codex":0.19178894,"about_ca_topic_score_gemma":0.20933655,"teacher_disagreement_score":0.19178894,"about_ca_system_score_codex":0.0021751567,"about_ca_system_score_gemma":0.0018285651,"threshold_uncertainty_score":0.3813452},"labels":[],"label_agreement":null},{"id":"W2077031675","doi":"10.1177/0091270006296763","title":"Pharmacokinetics of Saquinavir With Atazanavir or Low‐Dose Ritonavir Administered Once Daily (ASPIRE I) or Twice Daily (ASPIRE II) in Seronegative Volunteers","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity Western University","funders":"","keywords":"Saquinavir; Cmin; Pharmacokinetics; Ritonavir; Atazanavir; Cmax; Dosing; Pharmacology; Medicine; Crossover study; Adverse effect; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy; Virology","score_opus":0.07292333696626545,"score_gpt":0.4390793595960441,"score_spread":0.36615602262977864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077031675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866104,0.0005200143,0.0002593874,0.000027207776,0.000012780993,0.000088948356,0.00009252783,0.000029918396,0.0003081768],"genre_scores_gemma":[0.9986773,0.00016515223,0.0003775591,0.00007235128,0.00002778844,0.00006864887,0.0001989665,0.00000734658,0.00040491985],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99940753,0.00027572765,0.00003702963,0.000120276614,0.000081052494,0.000078411394],"domain_scores_gemma":[0.99937683,0.00011862414,0.000112477326,0.00007092185,0.000054412223,0.00026678244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009897759,0.00064493984,0.000900267,0.00026323507,0.00029651236,0.00045526508,0.0002664507,0.0008621636,0.0013122045],"category_scores_gemma":[0.0014415166,0.00073011784,0.00060445815,0.00022079762,0.00061048,0.00060301006,0.00017469018,0.0009976213,0.0005493234],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4598047,0.017825553,0.030167889,0.00031538276,0.000878513,0.00043770278,0.0008321589,0.0013558139,0.40971562,0.00019436664,0.0010435883,0.07742879],"study_design_scores_gemma":[0.046469573,0.7714224,0.13549711,0.000029203253,0.00069761317,0.0010890916,0.00016544848,0.0028294562,0.03979632,0.00022517778,0.0016941795,0.00008441365],"about_ca_topic_score_codex":0.0005049329,"about_ca_topic_score_gemma":0.00068031735,"teacher_disagreement_score":0.0013122045,"about_ca_system_score_codex":0.00025731,"about_ca_system_score_gemma":0.00032790707,"threshold_uncertainty_score":0.0052345395},"labels":[],"label_agreement":null},{"id":"W2077165819","doi":"10.1177/0091270011402500","title":"Optimizing Drug Development and Use in Patients With Kidney Disease","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Kidney disease; Intensive care medicine; Population; Public health; Disease; Dosing; Drug development; Health care; Clearance; Drug; Internal medicine; Environmental health; Pharmacology; Pathology; Economic growth","score_opus":0.15558054303457677,"score_gpt":0.35719692523095314,"score_spread":0.20161638219637637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077165819","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20863369,0.48315609,0.02865899,0.14491269,0.0030911278,0.0013178219,0.0022591657,0.0010814944,0.12688899],"genre_scores_gemma":[0.64000994,0.24893121,0.051737204,0.035670307,0.005207942,0.0007951211,0.0018382814,0.00026957062,0.015540401],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9965366,0.0017272921,0.00048473492,0.00021343036,0.00084763253,0.00019040493],"domain_scores_gemma":[0.99544024,0.0012813369,0.0014908039,0.00016691642,0.00088347716,0.0007372076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041805366,0.00029007014,0.00071749353,0.00057056715,0.0005379774,0.001653765,0.0007021165,0.000937542,0.006072642],"category_scores_gemma":[0.01616843,0.00013252471,0.0006017456,0.00082165434,0.00033270608,0.0018204829,0.001199241,0.0014814333,0.0019270803],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010031144,0.0011679278,0.034507662,0.0015976687,0.0002324247,0.00033582468,0.00029058772,0.00076451903,0.0015099557,0.0031716218,0.061713964,0.8937048],"study_design_scores_gemma":[0.0011528626,0.0075188377,0.093913265,0.005346976,0.0012289392,0.0041093784,0.0009841443,0.0055878456,0.008538749,0.014894549,0.85660046,0.00012392772],"about_ca_topic_score_codex":0.0011632163,"about_ca_topic_score_gemma":0.0033638745,"teacher_disagreement_score":0.006072642,"about_ca_system_score_codex":0.0009840211,"about_ca_system_score_gemma":0.002898937,"threshold_uncertainty_score":0.022109032},"labels":[],"label_agreement":null},{"id":"W2077817920","doi":"10.1177/0091270008319792","title":"Pharmacokinetic Interaction Between Efavirenz and Carbamazepine After Multiple‐Dose Administration in Healthy Subjects","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Carbamazepine; Efavirenz; Pharmacokinetics; Crossover study; Pharmacology; Confidence interval; Dosing; Pharmacokinetic interaction; Drug interaction; Active metabolite; Metabolite; Medicine; Chemistry; Internal medicine; Antiretroviral therapy; Epilepsy; Viral load; Human immunodeficiency virus (HIV); Immunology","score_opus":0.0899044327554101,"score_gpt":0.4442458723768858,"score_spread":0.3543414396214757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077817920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856806,0.0006947871,0.00027409897,0.000026097538,0.000020672078,0.00008749007,0.00007453386,0.000020796811,0.00023329438],"genre_scores_gemma":[0.9986473,0.0002329736,0.00047587976,0.000111976144,0.000048446822,0.000079304446,0.00011314449,0.0000051216543,0.00028583693],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99898297,0.0004940301,0.00004593395,0.00022843489,0.00016123448,0.00008731799],"domain_scores_gemma":[0.99927,0.000251065,0.00015163883,0.000073285446,0.0000488626,0.00020519255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012726433,0.000544304,0.0018258422,0.00023265954,0.00035396515,0.00059431564,0.00025507013,0.00086486194,0.001140488],"category_scores_gemma":[0.0021689,0.000552525,0.0005436471,0.0002579201,0.0005342657,0.00045297126,0.000177314,0.0009051011,0.00023764615],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55652404,0.01638062,0.1406671,0.00044535525,0.0023954958,0.0011825734,0.0008566716,0.0015081281,0.1671432,0.00029373117,0.0012141737,0.11138883],"study_design_scores_gemma":[0.043994993,0.31604254,0.6151174,0.000027374232,0.0012391326,0.0020222124,0.00020097377,0.004946313,0.013168066,0.00033659564,0.0027987808,0.00010559732],"about_ca_topic_score_codex":0.001825552,"about_ca_topic_score_gemma":0.0017693882,"teacher_disagreement_score":0.0018258422,"about_ca_system_score_codex":0.000529562,"about_ca_system_score_gemma":0.0005143336,"threshold_uncertainty_score":0.006730497},"labels":[],"label_agreement":null},{"id":"W2078570464","doi":"10.1177/0091270010393344","title":"A Review of Psychophysiological Stressors on Pharmacokinetics","year":2011,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Defence Research and Development Canada","funders":"","keywords":"Pharmacokinetics; Stressor; Drug; Medicine; Pharmacology; Clinical psychology","score_opus":0.34768733622085984,"score_gpt":0.580390445315223,"score_spread":0.23270310909436315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078570464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012314292,0.9992384,0.0000852647,0.00011429411,0.000077568,0.000004840041,0.00002455951,0.0000045251336,0.00032746702],"genre_scores_gemma":[0.00049006945,0.99902606,0.00015452363,0.0000713155,0.00009319443,0.0000056990966,0.000022248634,9.018107e-7,0.00013597612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963415,0.000072388284,0.0000960817,0.00006375024,0.00011090515,0.000022752842],"domain_scores_gemma":[0.999008,0.0005838364,0.00016194231,0.000020520909,0.0001860998,0.00003955705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075714145,0.0013504847,0.0022738618,0.0035619605,0.0003425742,0.000929636,0.0011186656,0.0010824797,0.0049598627],"category_scores_gemma":[0.0015391345,0.00047424494,0.001237467,0.0036790872,0.00036151058,0.0015771977,0.0006278322,0.0010477813,0.0014716687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013226549,0.0001265463,0.00046629074,0.07728121,0.00031766505,0.00035336666,0.00010276473,0.00044643943,0.0012018185,0.0010103725,0.020093404,0.89846796],"study_design_scores_gemma":[0.000056993886,0.00045434135,0.005616735,0.039991938,0.0014716225,0.004142534,0.00022536358,0.0003101106,0.0013908726,0.0023316136,0.9439152,0.00009261216],"about_ca_topic_score_codex":0.002052081,"about_ca_topic_score_gemma":0.0026513303,"teacher_disagreement_score":0.0049598627,"about_ca_system_score_codex":0.0006504581,"about_ca_system_score_gemma":0.001672489,"threshold_uncertainty_score":0.016592383},"labels":[],"label_agreement":null},{"id":"W2079912339","doi":"10.1177/00912700122010735","title":"The Safety of Higher Than Standard Dose of Doxylamine‐Pyridoxine (Diclectin®) for Nausea and Vomiting of Pregnancy","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Nausea; Vomiting; Pregnancy; Adverse effect; Incidence (geometry); Metoclopramide; Antiemetic; Birth weight; Obstetrics; Gestational age; Population; Hyperemesis gravidarum; Anesthesia; Internal medicine","score_opus":0.08021228769728539,"score_gpt":0.4714493809293559,"score_spread":0.3912370932320705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079912339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990583,0.00060597097,0.00008203275,0.000024000132,0.0000027546994,0.000006376461,0.000036248384,0.0000015074454,0.000182837],"genre_scores_gemma":[0.9995603,0.00028364835,0.000061610364,0.000017471075,0.0000028525885,0.0000029057592,0.00002894057,4.273518e-7,0.000041766292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940395,0.00022513063,0.00006927026,0.000070523674,0.00020077493,0.00003045394],"domain_scores_gemma":[0.9978447,0.0010423561,0.00080204563,0.00010490813,0.00011059002,0.00009534693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069737015,0.00009201468,0.00020303013,0.00015122423,0.00015076868,0.00021526364,0.00015084606,0.00027038067,0.0004582871],"category_scores_gemma":[0.0033077002,0.00011352467,0.00022794613,0.00018163584,0.00017744777,0.00015676665,0.0001037486,0.00033222747,0.00006348083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003401522,0.00022000626,0.94819015,0.00011108788,0.00013380933,0.0004840789,0.0002082598,0.0001455268,0.0062184054,0.000050763796,0.00011932023,0.04071708],"study_design_scores_gemma":[0.00014591705,0.008800675,0.9840455,0.000024163042,0.00010948523,0.0032061562,0.000108568995,0.00034106092,0.002719989,0.000029106694,0.0004608076,0.000008588486],"about_ca_topic_score_codex":0.0021460003,"about_ca_topic_score_gemma":0.0029603466,"teacher_disagreement_score":0.0021460003,"about_ca_system_score_codex":0.00032731085,"about_ca_system_score_gemma":0.00026701117,"threshold_uncertainty_score":0.004267037},"labels":[],"label_agreement":null},{"id":"W2081057141","doi":"10.1177/0091270009340417","title":"Toward Optimal Treatment in Women: The Effect of Sex on Metoprolol‐Diphenhydramine Interaction","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Metoprolol; Diphenhydramine; Medicine; Placebo; Pharmacokinetics; CYP2D6; Internal medicine; Chronotropic; Pharmacology; Anesthesia; Blood pressure; Heart rate","score_opus":0.15756673208901237,"score_gpt":0.5327479104422379,"score_spread":0.3751811783532255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081057141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97246,0.021398861,0.0007545988,0.0013985584,0.00016406277,0.000050845072,0.00015383151,0.0000103833745,0.0036088924],"genre_scores_gemma":[0.9964851,0.0018623857,0.0004080553,0.00065692444,0.00013583261,0.000021583695,0.00004194916,0.0000071067216,0.0003810217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987923,0.0007835434,0.000092497816,0.00012193574,0.00013577109,0.00007398308],"domain_scores_gemma":[0.9974637,0.0017094772,0.00046673795,0.00012477893,0.000080341524,0.00015492304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002148848,0.00017426646,0.000627942,0.00016049501,0.00018971307,0.00051832595,0.000153175,0.0004167469,0.0024905554],"category_scores_gemma":[0.0056322464,0.00011035265,0.0004108838,0.00020643763,0.00026095833,0.00033929403,0.00023967908,0.00040403387,0.00024140236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03919859,0.00049670984,0.77505267,0.0006687474,0.001324375,0.0011036975,0.00095800223,0.00019290531,0.013070048,0.000850607,0.0011092321,0.16597438],"study_design_scores_gemma":[0.0009583212,0.007942693,0.9777819,0.00016882071,0.0011487068,0.0015396411,0.00060342427,0.00034513662,0.0017197637,0.00064862764,0.007124159,0.000018696954],"about_ca_topic_score_codex":0.00019373062,"about_ca_topic_score_gemma":0.00047036598,"teacher_disagreement_score":0.0024905554,"about_ca_system_score_codex":0.00011429445,"about_ca_system_score_gemma":0.0002179869,"threshold_uncertainty_score":0.011364341},"labels":[],"label_agreement":null},{"id":"W2081854990","doi":"10.1177/0091270010391790","title":"N‐acetylcysteine as a Novel Prophylactic Treatment for Ifosfamide‐Induced Nephrotoxicity in Children: Translational Pharmacokinetics","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Children's Hospital of Western Ontario; London Health Sciences Centre; McMaster University; Royal College of Physicians and Surgeons of Canada; Hospital for Sick Children; Lawson Health Research Institute; University of Waterloo; Western University","funders":"Canadian Institutes of Health Research","keywords":"Nephrotoxicity; Acetylcysteine; Medicine; Ifosfamide; Antidote; Pharmacokinetics; Acetaminophen; acetaminophen overdose; Pharmacology; Chemotherapy; Cisplatin; Toxicity; Internal medicine; Chemistry","score_opus":0.15785577206162577,"score_gpt":0.43801656532004907,"score_spread":0.2801607932584233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081854990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8847857,0.10091491,0.004822905,0.0019682003,0.00014105458,0.00019211671,0.00015148225,0.00009041563,0.0069333035],"genre_scores_gemma":[0.9440167,0.04677605,0.0071921716,0.00034407023,0.00010117045,0.000068178066,0.00014229082,0.000015087619,0.0013442616],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99990666,0.000034232955,0.000008027845,0.000014629799,0.000022913584,0.000013621863],"domain_scores_gemma":[0.9998776,0.000018132041,0.000054715863,0.0000086049895,0.000020210227,0.000020691807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027025232,0.00021554192,0.00031307037,0.00020343628,0.00012322314,0.00033013854,0.00019446535,0.00019219762,0.0006791251],"category_scores_gemma":[0.00024535944,0.00007402335,0.0001760557,0.00022325157,0.00023901115,0.00030943827,0.00013533677,0.0005025594,0.00011123036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054033757,0.0029197927,0.022331523,0.0016578239,0.00023002288,0.001448214,0.0003526558,0.0015487672,0.37023526,0.0035476661,0.0026928855,0.587632],"study_design_scores_gemma":[0.0030134423,0.07655557,0.20997724,0.0006935433,0.0009167527,0.01947507,0.00078775216,0.007562669,0.41453376,0.0020238415,0.26435626,0.00010412384],"about_ca_topic_score_codex":0.0009142712,"about_ca_topic_score_gemma":0.0027318385,"teacher_disagreement_score":0.0009142712,"about_ca_system_score_codex":0.00052052696,"about_ca_system_score_gemma":0.00065734534,"threshold_uncertainty_score":0.003776729},"labels":[],"label_agreement":null},{"id":"W2082095891","doi":"10.1002/jcph.235","title":"Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse‐deterrent controlled‐release tablets in recreational opioid users","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"Purdue Pharma; Purdue University","keywords":"Oxycodone; Nasal administration; Medicine; Pharmacodynamics; Pharmacokinetics; Pharmacology; Placebo; Tolerability; Opioid; Cmax; Anesthesia; Crossover study; Adverse effect; Internal medicine","score_opus":0.026369272544800797,"score_gpt":0.366351148035836,"score_spread":0.3399818754910352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082095891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941075,0.00043079755,0.000046207228,0.0000085037345,0.0000029104078,0.000022766899,0.00002024424,0.0000018474625,0.000056007928],"genre_scores_gemma":[0.9987006,0.0006564285,0.00033796072,0.000034466404,0.000016261567,0.000025352785,0.00006382278,0.0000020695052,0.00016287089],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99973816,0.00010465789,0.000022709075,0.000034479122,0.000076716045,0.000023237455],"domain_scores_gemma":[0.99939466,0.00020327869,0.00024993,0.000038967173,0.000045520672,0.00006764447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004104109,0.00023002239,0.0005022106,0.00014025098,0.00014984769,0.00024402823,0.00015661829,0.0002597569,0.00083722523],"category_scores_gemma":[0.0011466825,0.00022499613,0.00030284692,0.00014789683,0.0002998904,0.00030243056,0.000098823955,0.00038521507,0.00010819431],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22328626,0.013738532,0.10945765,0.0012864304,0.0008570512,0.0009033222,0.00087911525,0.00097335724,0.45388976,0.0001420996,0.000333734,0.19425271],"study_design_scores_gemma":[0.010542127,0.46847662,0.46502584,0.00006957298,0.00081036164,0.0025183011,0.0005137738,0.002166692,0.048359293,0.00006636459,0.0014061362,0.000044836663],"about_ca_topic_score_codex":0.0006666747,"about_ca_topic_score_gemma":0.0014074469,"teacher_disagreement_score":0.00083722523,"about_ca_system_score_codex":0.00017592934,"about_ca_system_score_gemma":0.00019646999,"threshold_uncertainty_score":0.0028008223},"labels":[],"label_agreement":null},{"id":"W2085955843","doi":"10.1177/0091270008325148","title":"Pharmacokinetics of Novel Atrial‐Selective Antiarrhythmic Agent Vernakalant Hydrochloride Injection (RSD1235): Influence of CYP2D6 Expression and Other Factors","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"Pharmacology; Pharmacokinetics; CYP2D6; Antiarrhythmic agent; Medicine; Hydrochloride; Cardiology; Internal medicine; Chemistry; Heart disease; Cytochrome P450; Metabolism","score_opus":0.14086357352761503,"score_gpt":0.4407561802247087,"score_spread":0.29989260669709367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085955843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771416,0.00088153355,0.00070653314,0.00004066641,0.000010331924,0.000028175005,0.00013883018,0.000018798335,0.000460931],"genre_scores_gemma":[0.9986707,0.00028750396,0.0004118002,0.0000382741,0.000016881871,0.0000290441,0.00020665875,0.000013142651,0.0003259637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997569,0.0000996755,0.000018331424,0.00005418064,0.00004871533,0.00002221587],"domain_scores_gemma":[0.9996449,0.00014038809,0.00009751525,0.000033654283,0.000031457916,0.000052194657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033214892,0.00018820273,0.000477868,0.000104437066,0.000098356606,0.00037564122,0.00009486205,0.00025159784,0.0009292942],"category_scores_gemma":[0.0010398489,0.00017369876,0.0002665676,0.00019752863,0.00020254905,0.0003138587,0.00007787541,0.00044748752,0.00019574242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057986267,0.0014409343,0.06572589,0.00021573043,0.00057880254,0.000865489,0.00039703975,0.0023979766,0.7854457,0.0002192117,0.00086079416,0.08386614],"study_design_scores_gemma":[0.0035032956,0.06674123,0.63020855,0.000025103149,0.0010733653,0.005283211,0.00024398576,0.023795173,0.2617657,0.00034322328,0.0069157486,0.0001014629],"about_ca_topic_score_codex":0.0004526357,"about_ca_topic_score_gemma":0.000495179,"teacher_disagreement_score":0.0009292942,"about_ca_system_score_codex":0.00024623354,"about_ca_system_score_gemma":0.00017405987,"threshold_uncertainty_score":0.0031087995},"labels":[],"label_agreement":null},{"id":"W2086227412","doi":"10.1177/0091270009360979","title":"Dose Proportionality of Once‐Daily Trazodone Extended‐Release Caplets Under Fasting Conditions","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Bioequivalence; Confidence interval; Trazodone; Pharmacokinetics; Crossover study; Chemistry; Pharmacology; Medicine; Internal medicine; Placebo","score_opus":0.09624446245214258,"score_gpt":0.4861058692314061,"score_spread":0.3898614067792635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086227412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993765,0.0012921315,0.0031587519,0.00006468203,0.00011381015,0.00061506947,0.00030299346,0.00011045122,0.0005772243],"genre_scores_gemma":[0.99250925,0.0010327131,0.0038606273,0.00008773467,0.00009947605,0.0005869925,0.00045437235,0.0000337863,0.0013349397],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9983329,0.00072769023,0.00010434636,0.00034727927,0.0003528272,0.00013490421],"domain_scores_gemma":[0.99834585,0.000434253,0.0005377315,0.00032741454,0.00019300959,0.00016179362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017756706,0.00067291886,0.0012694189,0.0005177712,0.00015973393,0.00066567666,0.00081576814,0.0007458115,0.0014298563],"category_scores_gemma":[0.0036096124,0.00045468094,0.00057729776,0.00043307815,0.00048660522,0.0007804095,0.00024758128,0.0014872341,0.00029827878],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.101515725,0.0075638173,0.0016645819,0.0004972147,0.00036787137,0.00010814316,0.000336148,0.0017705387,0.785594,0.00034207987,0.00072208873,0.09951781],"study_design_scores_gemma":[0.011266202,0.51441896,0.03850573,0.000064053005,0.00071727554,0.0005893821,0.00014628151,0.012299809,0.41543937,0.00021182607,0.0062194043,0.000121760786],"about_ca_topic_score_codex":0.0007573254,"about_ca_topic_score_gemma":0.00084392604,"teacher_disagreement_score":0.0017756706,"about_ca_system_score_codex":0.00058543973,"about_ca_system_score_gemma":0.00062013854,"threshold_uncertainty_score":0.009390712},"labels":[],"label_agreement":null},{"id":"W2086291342","doi":"10.1002/jcph.510","title":"Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Exelixis","keywords":"Cabozantinib; Pharmacology; Ketoconazole; CYP3A4; Pharmacokinetics; CYP3A; Drug interaction; Tyrosine-kinase inhibitor; Chemistry; Medicine; Cytochrome P450; Internal medicine; Cancer; Metabolism","score_opus":0.09779140068654354,"score_gpt":0.4436915727444264,"score_spread":0.3459001720578828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086291342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330986,0.0037793852,0.0013789285,0.000099018944,0.000019769595,0.00010186386,0.00033512694,0.00007229177,0.0009037824],"genre_scores_gemma":[0.99762315,0.00070796115,0.0008015411,0.000037915943,0.000019103809,0.000039012597,0.00028509105,0.000011592062,0.00047458633],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995542,0.00017345915,0.00003373754,0.0000695395,0.000116294366,0.000052697113],"domain_scores_gemma":[0.99969006,0.00008064296,0.00008795207,0.000026402688,0.000045135417,0.000069805166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047529174,0.00044214175,0.0009069507,0.00024788693,0.000257078,0.0004306989,0.00018821367,0.00033095694,0.001242805],"category_scores_gemma":[0.00090149743,0.00022405654,0.00063806365,0.0004424415,0.0002830283,0.0003227422,0.0001290252,0.0006854887,0.00022458033],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06524626,0.0019625793,0.025227396,0.0005986551,0.0007953106,0.0009962809,0.00057755713,0.0044447533,0.8411952,0.00026563433,0.0009880202,0.057702355],"study_design_scores_gemma":[0.004322703,0.068649895,0.32341933,0.00005027922,0.0020454545,0.005865385,0.00041704313,0.02491266,0.5547731,0.00029459206,0.015122192,0.00012730359],"about_ca_topic_score_codex":0.0037581692,"about_ca_topic_score_gemma":0.0042756437,"teacher_disagreement_score":0.0037581692,"about_ca_system_score_codex":0.0006800146,"about_ca_system_score_gemma":0.0005395393,"threshold_uncertainty_score":0.0074725747},"labels":[],"label_agreement":null},{"id":"W2088345106","doi":"10.1177/0091270011408425","title":"Population Pharmacokinetics of Vernakalant Hydrochloride Injection (RSD1235) in Patients With Atrial Fibrillation or Atrial Flutter","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"Atrial fibrillation; Atrial flutter; Medicine; Pharmacokinetics; Cardiology; Internal medicine; Anesthesia; Population pharmacokinetics; Population; Pharmacology","score_opus":0.11597592399445847,"score_gpt":0.4155165467127693,"score_spread":0.29954062271831083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088345106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995378,0.00059332716,0.002804488,0.000082934464,0.000008105769,0.000050788138,0.0001835579,0.000065162596,0.0008336637],"genre_scores_gemma":[0.9986706,0.00015389314,0.0006799473,0.00006160627,0.000012978661,0.000034804456,0.00025651194,0.0000068490913,0.00012287791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947935,0.00025681392,0.000036546822,0.000100470286,0.000088935456,0.000037871607],"domain_scores_gemma":[0.99923277,0.00038974817,0.00016994018,0.000082048806,0.000051205465,0.000074202435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010349408,0.0002989655,0.0008788895,0.00027949538,0.0001601141,0.00064410444,0.0001513317,0.00049015164,0.0005573478],"category_scores_gemma":[0.0026537268,0.00023487836,0.00041681065,0.00030349524,0.00019308554,0.00041108046,0.00019667036,0.00080461556,0.00018987432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024792181,0.0014730573,0.79809505,0.00018470209,0.0021911575,0.001972832,0.0008682108,0.02061067,0.028048161,0.0006512982,0.0019812656,0.11913141],"study_design_scores_gemma":[0.0012795602,0.02153728,0.9221167,0.000020512116,0.0010029082,0.003575811,0.00018015191,0.042664394,0.0037083433,0.0010347716,0.002795452,0.00008405869],"about_ca_topic_score_codex":0.0004229546,"about_ca_topic_score_gemma":0.00031589885,"teacher_disagreement_score":0.0010349408,"about_ca_system_score_codex":0.00023340608,"about_ca_system_score_gemma":0.00028895115,"threshold_uncertainty_score":0.0054733753},"labels":[],"label_agreement":null},{"id":"W2088355176","doi":"10.1177/0091270011407195","title":"Semagacestat Pharmacokinetics Are Not Significantly Affected by Formulation, Food, or Time of Dosing in Healthy Participants","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Pharmacokinetics; Bioavailability; Dosing; Confidence interval; Morning; Medicine; Evening; Crossover study; Pharmacodynamics; Bioequivalence; Cmax; Half-life; Area under the curve; Pharmacology; Internal medicine; Animal science; Placebo","score_opus":0.2351494950380212,"score_gpt":0.48090644255593323,"score_spread":0.24575694751791202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088355176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982495,0.00077741063,0.00027862695,0.000026360065,0.000013618014,0.0000754414,0.00022294407,0.000021889951,0.00033429687],"genre_scores_gemma":[0.99851674,0.00023553331,0.0003621656,0.00009776564,0.00001680343,0.00008414304,0.00032651197,0.000010325956,0.0003499882],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993544,0.00025915643,0.000044447774,0.00015853006,0.00012100031,0.0000624455],"domain_scores_gemma":[0.99879634,0.0004275454,0.00033027877,0.00016087308,0.0001317506,0.000153072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017412747,0.000562255,0.0011683968,0.00022240214,0.00029155178,0.0004184513,0.00022223787,0.00078783935,0.0019366726],"category_scores_gemma":[0.003512236,0.00038142808,0.00062061095,0.00023187978,0.00042376982,0.00055305846,0.00022405549,0.0006627688,0.0003861589],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46440834,0.005942413,0.23817444,0.00083758513,0.0041495673,0.0014383899,0.0014875605,0.0007652129,0.1823045,0.00021000333,0.0020907442,0.09819117],"study_design_scores_gemma":[0.017314022,0.14468181,0.81012183,0.00004268284,0.002360735,0.0024051256,0.00036014421,0.0015290234,0.017300347,0.00045489776,0.0033468872,0.000082538325],"about_ca_topic_score_codex":0.0006114825,"about_ca_topic_score_gemma":0.0007434265,"teacher_disagreement_score":0.0019366726,"about_ca_system_score_codex":0.0002356026,"about_ca_system_score_gemma":0.00026862035,"threshold_uncertainty_score":0.009208858},"labels":[],"label_agreement":null},{"id":"W2090079955","doi":"10.1177/009127002401102830","title":"Efficacy and Tolerability of Nonprescription Ibuprofen versus Celecoxib for Dental Pain","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Ibuprofen; Medicine; Analgesic; Celecoxib; Tolerability; Placebo; Anesthesia; Etodolac; Cancer pain; Adverse effect; Internal medicine; Pharmacology; Cancer","score_opus":0.11944502214446621,"score_gpt":0.43596552186026,"score_spread":0.31652049971579377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090079955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993036,0.0055689337,0.00013830289,0.000108018474,0.00007065119,0.0001380034,0.00009648966,0.0000136315575,0.0008299206],"genre_scores_gemma":[0.9968251,0.0019742337,0.00023951636,0.000098285134,0.00022073426,0.000087991975,0.0001034768,0.0000034388602,0.0004472767],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99898416,0.00055704004,0.00010049571,0.000085799154,0.00016799876,0.00010445347],"domain_scores_gemma":[0.99838006,0.0007848647,0.00046125494,0.00009815188,0.000062898485,0.00021278042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014850193,0.00049692753,0.0012257501,0.00037623543,0.00024170984,0.0005039503,0.0003806712,0.00063688465,0.0031336213],"category_scores_gemma":[0.0026948636,0.0003001072,0.0010345727,0.00031435286,0.0006515212,0.00062683725,0.00022206716,0.0009520874,0.0003553126],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77988404,0.01819066,0.014205878,0.0012385411,0.0011049539,0.0001851893,0.00024090344,0.00044811136,0.030227395,0.00014976162,0.00034512137,0.15377948],"study_design_scores_gemma":[0.11188872,0.78037244,0.08999378,0.00010069273,0.0015288655,0.0004211654,0.00028038773,0.0012257191,0.012579355,0.00017852885,0.0013797199,0.000050700724],"about_ca_topic_score_codex":0.00033932604,"about_ca_topic_score_gemma":0.000954703,"teacher_disagreement_score":0.0031336213,"about_ca_system_score_codex":0.00031209202,"about_ca_system_score_gemma":0.0003504685,"threshold_uncertainty_score":0.0104830265},"labels":[],"label_agreement":null},{"id":"W2092729209","doi":"10.1177/0091270007306957","title":"Pharmacokinetic Profile of Temsirolimus With Concomitant Administration of Cytochrome P450‐Inducing Medications<sup>1</sup>","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Temsirolimus; Pharmacology; Sirolimus; CYP3A4; Pharmacokinetics; CYP3A; Concomitant; Medicine; Cytochrome P450; Internal medicine; Chemistry; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Biochemistry; Metabolism","score_opus":0.03752277635510766,"score_gpt":0.40245016355153684,"score_spread":0.3649273871964292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092729209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99620026,0.0015290509,0.0011755503,0.00007255691,0.000019729136,0.000037395926,0.00012574547,0.00006396948,0.00077571376],"genre_scores_gemma":[0.9969772,0.0004832212,0.001208838,0.000099540564,0.000043004024,0.000032350625,0.0004145183,0.000022286375,0.0007190828],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996232,0.00015161981,0.000018351466,0.000066232045,0.00010125315,0.000039252416],"domain_scores_gemma":[0.9995906,0.00010587543,0.00012623865,0.000037022783,0.00003923807,0.00010117562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032372956,0.00027157893,0.00068158895,0.0001558071,0.0001260688,0.00037922888,0.0001620523,0.0003593524,0.00073009415],"category_scores_gemma":[0.0011624353,0.00021074456,0.0002998584,0.00024523944,0.00017758911,0.00025945294,0.00011753112,0.0007071799,0.0003383726],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.089736626,0.0024525258,0.03335489,0.0002642904,0.0007633317,0.0011038092,0.0003549348,0.002903216,0.68241733,0.00042058784,0.0017310751,0.18449748],"study_design_scores_gemma":[0.005728013,0.18133815,0.34576786,0.000068614914,0.0016539161,0.012116952,0.00019447364,0.03212803,0.39119256,0.00042394028,0.029254703,0.00013276844],"about_ca_topic_score_codex":0.00068424275,"about_ca_topic_score_gemma":0.00081281574,"teacher_disagreement_score":0.00073009415,"about_ca_system_score_codex":0.00030199348,"about_ca_system_score_gemma":0.0003986136,"threshold_uncertainty_score":0.0024424195},"labels":[],"label_agreement":null},{"id":"W2093981065","doi":"10.1177/0091270001417011","title":"Monitoring Disease Progression in Parkinson's Disease","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pavilion; Library science; Medicine; Glioblastoma; Neurology; Family medicine; History; Psychiatry; Computer science","score_opus":0.10340023488546343,"score_gpt":0.486644437889344,"score_spread":0.3832442030038805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093981065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557711,0.033366185,0.0028320178,0.0004703027,0.00015568084,0.00014992055,0.0008176771,0.00028914044,0.0061479006],"genre_scores_gemma":[0.9897016,0.004776862,0.0028412968,0.00021487332,0.000084725936,0.00007325743,0.0005226299,0.000023206228,0.001761557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926084,0.00024026792,0.000094477895,0.000117978954,0.00023946157,0.000046995294],"domain_scores_gemma":[0.99813867,0.00058943353,0.00046894397,0.000060544546,0.0005112133,0.00023126771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012076487,0.00060890237,0.0019537534,0.0014035907,0.0005195321,0.0009955453,0.00036508119,0.0009822086,0.00062095386],"category_scores_gemma":[0.0027150912,0.00024325606,0.00033381043,0.00091642287,0.00024976704,0.0007444935,0.00032812316,0.0012198153,0.00034360436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015695691,0.0009471803,0.618619,0.000818063,0.0005735168,0.0008895696,0.00038438095,0.0015616758,0.025896622,0.00020842381,0.0028643112,0.3315415],"study_design_scores_gemma":[0.0009654124,0.019723002,0.9057962,0.0003103646,0.0016574055,0.0072122375,0.0004359964,0.012013136,0.040487178,0.0011304616,0.0101533625,0.000115256655],"about_ca_topic_score_codex":0.0021814043,"about_ca_topic_score_gemma":0.0037936175,"teacher_disagreement_score":0.0021814043,"about_ca_system_score_codex":0.0005074868,"about_ca_system_score_gemma":0.000448481,"threshold_uncertainty_score":0.006386757},"labels":[],"label_agreement":null},{"id":"W2094323797","doi":"10.1002/jcph.339","title":"Biosimilar monoclonal antibodies: A Canadian regulatory perspective on the assessment of clinically relevant differences and indication extrapolation","year":2014,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Biosimilar; Monoclonal antibody; Perspective (graphical); Medicine; Extrapolation; Pharmacology; Antibody; Internal medicine; Immunology; Computer science; Mathematics; Statistics; Artificial intelligence","score_opus":0.1412695353166486,"score_gpt":0.5070305994950575,"score_spread":0.36576106417840887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094323797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022064561,0.9790261,0.0007805408,0.009915152,0.0008411266,0.000031464926,0.000057793495,0.000019952964,0.009107185],"genre_scores_gemma":[0.0037226484,0.98684466,0.0015913502,0.005276655,0.00050872256,0.000028837701,0.00007027181,0.000009357179,0.001947492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942906,0.0010115342,0.00047626637,0.0003714419,0.0034721307,0.00037805884],"domain_scores_gemma":[0.98888993,0.0036321555,0.0008013014,0.0001916978,0.0060003884,0.00048459854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011722838,0.0010838592,0.002074106,0.0052180956,0.0012852565,0.004276393,0.0030859562,0.0051292763,0.003296714],"category_scores_gemma":[0.011015992,0.00045646925,0.0010424521,0.0054722866,0.0039201025,0.0032223219,0.0016055652,0.0060830177,0.0011453136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099310164,0.00006522081,0.0004392807,0.011233747,0.000083584244,0.0006442394,0.0005678311,0.00074099115,0.0019195102,0.06637321,0.09577572,0.82205737],"study_design_scores_gemma":[0.000013647766,0.00003745018,0.0005385489,0.0048664254,0.000058529247,0.0005246606,0.00014273447,0.0000965612,0.0003276067,0.004082271,0.9892853,0.000026293012],"about_ca_topic_score_codex":0.14760561,"about_ca_topic_score_gemma":0.18396112,"teacher_disagreement_score":0.9868849,"about_ca_system_score_codex":0.013115093,"about_ca_system_score_gemma":0.04516722,"threshold_uncertainty_score":0.29349285},"labels":[],"label_agreement":null},{"id":"W2094409037","doi":"10.1177/0091270005283285","title":"Challenges and Opportunities for Pharmacoepidemiology in Drug‐Therapy Decision Making","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University; Centre for Advancing Health Outcomes; Royal Victoria Hospital","funders":"","keywords":"Pharmacoepidemiology; Medicine; Adverse effect; Drug; Intensive care medicine; Population; Drug reaction; MEDLINE; Alternative medicine; Randomized controlled trial; Clinical study design; Adverse drug reaction; Clinical trial; Pharmacology; Internal medicine; Pathology; Environmental health","score_opus":0.5675048479289339,"score_gpt":0.5966121160322262,"score_spread":0.02910726810329234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094409037","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011115726,0.024916997,0.014581711,0.9531541,0.0029968473,0.00012354387,0.000042670956,0.000057355464,0.003015202],"genre_scores_gemma":[0.2433124,0.08997658,0.19290659,0.4092492,0.059515443,0.0025985674,0.00022413721,0.0002571496,0.0019600214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6286149,0.32080024,0.014431663,0.007273151,0.025092503,0.00378748],"domain_scores_gemma":[0.25486612,0.6738004,0.015339829,0.009643279,0.029960135,0.016390314],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.5048445,0.002075168,0.0076322677,0.009047634,0.0073760827,0.028020907,0.011972819,0.027463863,0.00754718],"category_scores_gemma":[0.5005136,0.0025388796,0.0036501673,0.004723762,0.041407786,0.038583737,0.020073162,0.047277186,0.002330374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093178486,0.00078061305,0.011462449,0.00490805,0.0012515747,0.00198938,0.009066395,0.008886344,0.00029782602,0.329189,0.1748352,0.45640147],"study_design_scores_gemma":[0.000613325,0.00028079867,0.0029150308,0.009587574,0.0001998868,0.001158198,0.008998343,0.01008921,0.00013828743,0.86305916,0.10254743,0.00041279293],"about_ca_topic_score_codex":0.007883723,"about_ca_topic_score_gemma":0.0082963165,"teacher_disagreement_score":0.5048445,"about_ca_system_score_codex":0.014677391,"about_ca_system_score_gemma":0.044010904,"threshold_uncertainty_score":0.6106149},"labels":[],"label_agreement":null},{"id":"W2094518494","doi":"10.1177/0091270003251388","title":"Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Lawson Health Research Institute; Western University","funders":"","keywords":"Cmax; Pharmacokinetics; 4-Aminopyridine; Spinal cord injury; High-performance liquid chromatography; Oral administration; Medicine; Plasma concentration; Spinal cord; Anesthesia; Chemistry; Pharmacology; Chromatography; Internal medicine; Potassium channel","score_opus":0.056258487578764935,"score_gpt":0.42508783929785565,"score_spread":0.3688293517190907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094518494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99906856,0.00048645056,0.00011990958,0.00002062756,0.0000072229677,0.000018858984,0.000053823835,0.0000112372145,0.00021329011],"genre_scores_gemma":[0.9988225,0.0003072528,0.00023781385,0.00007418881,0.000025296726,0.000041190142,0.00021624597,0.0000033532297,0.0002721411],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997968,0.000080245714,0.000017452674,0.00004113767,0.00003609632,0.000028281085],"domain_scores_gemma":[0.9995009,0.00020314465,0.00008822725,0.000029279301,0.00004527689,0.00013327507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035914467,0.0003588945,0.0006239708,0.0002360046,0.00022217516,0.00026309205,0.00012283494,0.00048464115,0.0007077529],"category_scores_gemma":[0.0017433272,0.00027993086,0.00018179316,0.00017122556,0.00036326025,0.00023651369,0.000110988054,0.0005287111,0.00023568392],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2253139,0.008675102,0.31593707,0.0006254426,0.00091443956,0.0041275416,0.002514336,0.0018046825,0.32710108,0.0002582554,0.0016336261,0.11109454],"study_design_scores_gemma":[0.0060482384,0.18168026,0.7743603,0.000028465229,0.0005220771,0.0056323386,0.00046229284,0.0026999062,0.026422583,0.00012768697,0.0019535006,0.00006241855],"about_ca_topic_score_codex":0.0009508836,"about_ca_topic_score_gemma":0.00088664464,"teacher_disagreement_score":0.0009508836,"about_ca_system_score_codex":0.00030963894,"about_ca_system_score_gemma":0.00021527697,"threshold_uncertainty_score":0.0023676157},"labels":[],"label_agreement":null},{"id":"W2095984197","doi":"10.1177/0091270009341182","title":"Acute Hemodynamic Effects of Single‐Dose Sildenafil When Added to Established Bosentan Therapy in Patients With Pulmonary Arterial Hypertension: Results of the COMPASS‐1 Study","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"Actelion Pharmaceuticals; Universität Leipzig; Universität zu Köln","keywords":"Sildenafil; Bosentan; Medicine; Pulmonary hypertension; Ambrisentan; Hemodynamics; Internal medicine; Vascular resistance; Cardiology; Pharmacodynamics; Confidence interval; Anesthesia; Pharmacokinetics; Endothelin receptor","score_opus":0.03882880036594852,"score_gpt":0.3676106898940989,"score_spread":0.32878188952815035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095984197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982855,0.0011148346,0.00014744402,0.00006467001,0.000019154011,0.00006612139,0.00006181239,0.000010096487,0.0002304303],"genre_scores_gemma":[0.99820817,0.00049642095,0.0004066855,0.00017291674,0.00014796265,0.000099244615,0.00029073496,0.0000042562206,0.00017359121],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9984565,0.0008858445,0.00010157497,0.00017997305,0.00025455706,0.0001215721],"domain_scores_gemma":[0.997738,0.0005650357,0.00067991903,0.00013244554,0.00010782985,0.0007765993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021806827,0.00094356126,0.0023367994,0.00021799207,0.00027392007,0.0009473658,0.00047456648,0.00070400035,0.0007891742],"category_scores_gemma":[0.0021522637,0.0003258801,0.0014733388,0.00033034384,0.00073475385,0.0005745627,0.00034847253,0.0013725361,0.0002227073],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.617761,0.024434503,0.19457473,0.00055660045,0.0050848857,0.00084398175,0.0004989865,0.0020337496,0.04726502,0.00014391095,0.0007641839,0.10603845],"study_design_scores_gemma":[0.09353598,0.5707922,0.32149312,0.00005009814,0.0021378368,0.0010542066,0.00015289005,0.0023365468,0.0062915734,0.000086829044,0.0019905765,0.00007811616],"about_ca_topic_score_codex":0.00032014534,"about_ca_topic_score_gemma":0.0005034251,"teacher_disagreement_score":0.0023367994,"about_ca_system_score_codex":0.00057646615,"about_ca_system_score_gemma":0.00077311596,"threshold_uncertainty_score":0.011532664},"labels":[],"label_agreement":null},{"id":"W2099178340","doi":"10.1177/0091270002239824","title":"The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function","year":2003,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Bone health and treatments","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Pharmacokinetics; Pharmacodynamics; Zoledronic acid; Medicine; Cancer; Renal function; Pharmacology; Impaired renal function; Oncology; Internal medicine","score_opus":0.045790833849402864,"score_gpt":0.41797851588960183,"score_spread":0.372187682040199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099178340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992489,0.0004842329,0.00010258017,0.000011841564,0.0000021387682,0.000008866257,0.000037325455,0.000004531677,0.00009956103],"genre_scores_gemma":[0.9995419,0.00012536773,0.00015034863,0.000025543342,0.000008057032,0.000008619739,0.00009504424,0.000001200639,0.000043965345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968195,0.000114579765,0.000029453524,0.000054291144,0.00007017452,0.000049608236],"domain_scores_gemma":[0.9993432,0.00022817103,0.00019030253,0.000038232763,0.000047210346,0.00015295905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035661127,0.0003127321,0.0008120342,0.00030549307,0.0002879935,0.00038944345,0.00012340034,0.0003473993,0.00032137372],"category_scores_gemma":[0.0016704004,0.00019914591,0.00033175998,0.0003757399,0.000287209,0.00028103075,0.00015554659,0.000326405,0.000104039274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044152897,0.0010587679,0.8546678,0.00016383058,0.00061686896,0.0013152261,0.0005050459,0.002128128,0.05814365,0.00009432678,0.00023168705,0.036921848],"study_design_scores_gemma":[0.0013524907,0.024648886,0.9637481,0.00000859738,0.00032302283,0.0023753447,0.000115879826,0.0019973263,0.0042580646,0.0000729544,0.0010678124,0.000031444342],"about_ca_topic_score_codex":0.0009633386,"about_ca_topic_score_gemma":0.0011389587,"teacher_disagreement_score":0.0009633386,"about_ca_system_score_codex":0.00034726932,"about_ca_system_score_gemma":0.00024011507,"threshold_uncertainty_score":0.0025196671},"labels":[],"label_agreement":null},{"id":"W2099744961","doi":"10.1177/00912700122010663","title":"Population Pharmacokinetics of Fentanyl in Healthy Volunteers","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Pharmacokinetics; Fentanyl; Volume of distribution; Population pharmacokinetics; Population; Medicine; Distribution (mathematics); Anesthesia; Nonparametric statistics; Pharmacology; Mathematics; Statistics","score_opus":0.23344573158738122,"score_gpt":0.5612801435504464,"score_spread":0.3278344119630652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099744961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992964,0.00025088096,0.0062477477,0.000026869471,0.000006484336,0.000051024173,0.00007627547,0.000052799318,0.00032373192],"genre_scores_gemma":[0.99717724,0.00010410954,0.0023247031,0.000040283296,0.000011474586,0.00005999412,0.0001297791,0.000006270739,0.00014614186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969053,0.0001391227,0.000014109937,0.00007412889,0.00006315915,0.000018981638],"domain_scores_gemma":[0.9995529,0.00021883851,0.000080932965,0.000045354493,0.00006826518,0.000033738877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007818506,0.00028116527,0.00040028946,0.00015983495,0.00011242025,0.0002397497,0.00009927146,0.00029708396,0.00037786298],"category_scores_gemma":[0.0029436832,0.0001445107,0.0001619383,0.000106992295,0.00020148385,0.00021370714,0.00016261652,0.00023994363,0.00013406045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031338718,0.0020258396,0.63504547,0.00029815728,0.001027201,0.0018027293,0.0014802603,0.028357467,0.09865296,0.0012697388,0.0016564118,0.19704512],"study_design_scores_gemma":[0.0015855347,0.06924828,0.75803405,0.00003350363,0.0007855219,0.0066554295,0.00050848396,0.13125727,0.024980715,0.002775818,0.004024136,0.00011123223],"about_ca_topic_score_codex":0.00048149913,"about_ca_topic_score_gemma":0.00031306918,"teacher_disagreement_score":0.0007818506,"about_ca_system_score_codex":0.0001536853,"about_ca_system_score_gemma":0.00016984406,"threshold_uncertainty_score":0.004134834},"labels":[],"label_agreement":null},{"id":"W2102128538","doi":"10.1177/0091270008329550","title":"Lopinavir/Ritonavir Pharmacokinetics in a Substitution of High‐Dose Soft‐Gelatin Capsule to Tablet Formulation","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; HIV Legal Network; AIDS Vancouver","funders":"","keywords":"Pharmacokinetics; Lopinavir; Ritonavir; Capsule; Lopinavir/ritonavir; Pharmacology; Gelatin; Medicine; Bioequivalence; Chemistry; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral load","score_opus":0.05661761758653071,"score_gpt":0.43117385757911747,"score_spread":0.37455623999258675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102128538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940528,0.0019373375,0.0012745636,0.00011856838,0.00003736535,0.00022133203,0.00030539537,0.00009447004,0.0019582377],"genre_scores_gemma":[0.9952532,0.00058907236,0.0024424454,0.00015748054,0.00001575533,0.000059337526,0.00046520244,0.000028678132,0.0009888957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992581,0.00025207613,0.00007336149,0.00014765553,0.00020620468,0.00006255344],"domain_scores_gemma":[0.9995714,0.000096252756,0.0001511298,0.00007299063,0.00004129299,0.000066883644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008567309,0.00026432757,0.0005449462,0.00022427818,0.00014311582,0.0006985961,0.00033210331,0.0003811213,0.0028586208],"category_scores_gemma":[0.0014200473,0.00019815133,0.0006240701,0.00027641526,0.00026540182,0.00037579652,0.00019526355,0.0006654762,0.0007259979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049669586,0.0025788154,0.031891976,0.0005821384,0.0010992232,0.00064128096,0.000292456,0.0018523034,0.5505415,0.00022528389,0.0027980711,0.35782728],"study_design_scores_gemma":[0.012130844,0.12201431,0.56997067,0.00030496094,0.0016460166,0.004680614,0.00035289253,0.013249446,0.24757148,0.00030530227,0.027531995,0.0002415165],"about_ca_topic_score_codex":0.0009863953,"about_ca_topic_score_gemma":0.0012152022,"teacher_disagreement_score":0.0028586208,"about_ca_system_score_codex":0.0003307406,"about_ca_system_score_gemma":0.0002480179,"threshold_uncertainty_score":0.009563029},"labels":[],"label_agreement":null},{"id":"W2103407911","doi":"10.1002/jcph.564","title":"Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Astellas Pharma; Pfizer","keywords":"Abiraterone acetate; Pharmacokinetics; Prostate cancer; Medicine; Meal; Prednisone; Endocrinology; Internal medicine; Adverse effect; Cancer; Androgen deprivation therapy","score_opus":0.09995530838740403,"score_gpt":0.4608467841323652,"score_spread":0.36089147574496117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103407911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915624,0.00054144347,0.00004124747,0.000015891384,0.0000076491115,0.00002756695,0.00007963111,0.000005322267,0.00012508308],"genre_scores_gemma":[0.99924135,0.00021865933,0.000111489135,0.00005182981,0.00001691228,0.00004132119,0.00014616364,0.0000023290531,0.00016995217],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99957556,0.00018204011,0.0000346363,0.00007423695,0.00008339174,0.000050085335],"domain_scores_gemma":[0.99928916,0.00020568512,0.00015663375,0.00004721072,0.000047701127,0.0002536164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057382113,0.00034607522,0.00090052944,0.00022852999,0.0003204797,0.0003602449,0.00013797724,0.000367752,0.0010165336],"category_scores_gemma":[0.0012365009,0.00033023424,0.000450251,0.00032651547,0.00048636735,0.00028313708,0.00021535724,0.00058080064,0.00020657979],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6538089,0.0063356846,0.1931991,0.00036525936,0.0012080921,0.00079347176,0.0008962307,0.0010190274,0.08371279,0.00013903495,0.0006738829,0.057848554],"study_design_scores_gemma":[0.020429114,0.22657555,0.7414803,0.000022169454,0.00067714974,0.0010032876,0.0004108743,0.0012932932,0.0063113356,0.00015321378,0.0015809834,0.000062793835],"about_ca_topic_score_codex":0.0017956371,"about_ca_topic_score_gemma":0.002501579,"teacher_disagreement_score":0.0017956371,"about_ca_system_score_codex":0.00044042675,"about_ca_system_score_gemma":0.0004446007,"threshold_uncertainty_score":0.0035703778},"labels":[],"label_agreement":null},{"id":"W2105461052","doi":"10.1177/00912700022009549","title":"The Future of Clinical Trials in Chronic Renal Disease: Outcome of an NIH/FDA/Physician Specialist Conference","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Renal function; Dialysis; Kidney disease; Proteinuria; Transplantation; Internal medicine; Clinical trial; Disease; Creatinine; End stage renal disease; Intensive care medicine; Urology; Kidney","score_opus":0.1717190249127503,"score_gpt":0.5421633479599028,"score_spread":0.3704443230471526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105461052","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010027589,0.23368178,0.0011339792,0.70177656,0.03658385,0.0005809634,0.00066856673,0.00020069689,0.02437083],"genre_scores_gemma":[0.03580945,0.28765026,0.012097891,0.5303499,0.10449228,0.002921405,0.0023127105,0.00041379087,0.02395227],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.79906625,0.1296519,0.015675385,0.0038645656,0.046366688,0.005375262],"domain_scores_gemma":[0.5253606,0.19648701,0.03590148,0.013841643,0.15477915,0.073630184],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.315557,0.0021217482,0.0039944425,0.0052606524,0.004002481,0.026091084,0.004827559,0.032192,0.017187627],"category_scores_gemma":[0.29615787,0.0011971695,0.0036518758,0.0062081604,0.005939436,0.016431846,0.0080876155,0.016725566,0.0052627367],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015867976,0.00030088014,0.0014058079,0.002668247,0.00027644998,0.00009444239,0.00016139948,0.00033154406,0.00014599663,0.020888248,0.7755755,0.1965646],"study_design_scores_gemma":[0.0018326268,0.0012211438,0.0069719986,0.015910435,0.00033505622,0.00019386887,0.00028716904,0.0010526961,0.00016178482,0.016074458,0.9558132,0.00014562502],"about_ca_topic_score_codex":0.0051133386,"about_ca_topic_score_gemma":0.01049996,"teacher_disagreement_score":0.315557,"about_ca_system_score_codex":0.019557523,"about_ca_system_score_gemma":0.0480112,"threshold_uncertainty_score":0.8440401},"labels":[],"label_agreement":null},{"id":"W2107017366","doi":"10.1177/0091270009333017","title":"Trigeminal Neuralgia Treated With Pregabalin in Family Medicine Settings: Its Effect on Pain Alleviation and Cost Reduction","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Trigeminal Neuralgia and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pregabalin; Trigeminal neuralgia; Observational study; Neuropathic pain; Health care; Neuralgia; Physical therapy; Emergency medicine; Anesthesia; Internal medicine","score_opus":0.05855088445694896,"score_gpt":0.43263845140783014,"score_spread":0.3740875669508812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107017366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315566,0.005763043,0.00004654857,0.00017880941,0.000014601759,0.00004468245,0.000042342475,0.0000035728217,0.0007507287],"genre_scores_gemma":[0.9970727,0.0023348704,0.00024832127,0.00008531732,0.000058773443,0.000027390352,0.000044776145,7.640614e-7,0.0001271673],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99960667,0.00024115283,0.000025255047,0.000031979,0.000057476627,0.000037526806],"domain_scores_gemma":[0.9993863,0.00023716151,0.00019843914,0.0000233583,0.000030337138,0.00012432747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004628338,0.00023459346,0.00063885615,0.00023541688,0.00029368963,0.0003082487,0.00018095027,0.00027617373,0.0017294348],"category_scores_gemma":[0.0019286814,0.00009207648,0.0004901572,0.00035725746,0.0002566668,0.00025869315,0.0002683774,0.0003761275,0.00011317307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13680503,0.017510833,0.18479119,0.0028611152,0.0020187462,0.0011876388,0.0006774946,0.0016827746,0.012818423,0.00021690488,0.0011823956,0.6382475],"study_design_scores_gemma":[0.00926227,0.08817065,0.8957089,0.00019680323,0.0011805785,0.0012520048,0.00040186144,0.0008271136,0.0011493969,0.00014883623,0.00167401,0.000027437805],"about_ca_topic_score_codex":0.0017110369,"about_ca_topic_score_gemma":0.0050895507,"teacher_disagreement_score":0.0017294348,"about_ca_system_score_codex":0.0005017818,"about_ca_system_score_gemma":0.00048104476,"threshold_uncertainty_score":0.005785525},"labels":[],"label_agreement":null},{"id":"W2108043165","doi":"10.1177/0091270007310385","title":"Sex, Race, and Smoking Impact Olanzapine Exposure","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Mental Health; National Institutes of Health","keywords":"Olanzapine; Antipsychotic; Clearance; Medicine; Population; Pharmacokinetics; Volume of distribution; Internal medicine; Atypical antipsychotic; Schizophrenia (object-oriented programming); Psychiatry; Urology; Environmental health","score_opus":0.10352528642345275,"score_gpt":0.47661050049044423,"score_spread":0.37308521406699147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108043165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965551,0.0010242288,0.0003144248,0.0002398725,0.000027126824,0.000009272162,0.00022248161,0.000008474837,0.0015991981],"genre_scores_gemma":[0.99910873,0.00019899361,0.000120690434,0.00006206482,0.000013316238,0.00000396525,0.000090215464,0.000006665085,0.00039530286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931157,0.00028369972,0.00005918669,0.000116542884,0.00013712807,0.00009185531],"domain_scores_gemma":[0.9982895,0.0006959207,0.0005784643,0.00011338799,0.00015528957,0.00016731248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008633499,0.00019286197,0.00029075984,0.00022860758,0.0003053204,0.00063968933,0.00020136365,0.0003504765,0.0028576534],"category_scores_gemma":[0.004259183,0.00014586493,0.0006801595,0.00031988538,0.00018191125,0.00034435894,0.00025235701,0.00039236087,0.0003675121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038885948,0.00005551162,0.9899435,0.000012100345,0.00014352157,0.00011170811,0.000111456655,0.00005837397,0.00069917616,0.000063695144,0.00014779781,0.008264422],"study_design_scores_gemma":[0.000006939378,0.000088257795,0.99813205,0.000009283187,0.00009692603,0.0003211741,0.00012415556,0.0004509345,0.00018979385,0.00011835973,0.00045627652,0.000005939291],"about_ca_topic_score_codex":0.0047826064,"about_ca_topic_score_gemma":0.008468122,"teacher_disagreement_score":0.0047826064,"about_ca_system_score_codex":0.00021940209,"about_ca_system_score_gemma":0.00042225886,"threshold_uncertainty_score":0.00955981},"labels":[],"label_agreement":null},{"id":"W2109748368","doi":"10.1002/jcph.139","title":"Exposure to Nitrofurantoin During the First Trimester of Pregnancy and the Risk for Major Malformations","year":2013,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Nitrofurantoin; Pregnancy; Medicine; Obstetrics; Congenital malformations; First trimester; Retrospective cohort study; Gestation; Cohort study; Medical record; Pediatrics; Gynecology; Antibiotics; Surgery; Internal medicine","score_opus":0.03719027354448589,"score_gpt":0.3958296222977215,"score_spread":0.3586393487532356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109748368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972364,0.0014998383,0.0001294517,0.00012875751,0.000008927994,0.0000067989736,0.000274623,0.0000052960104,0.00071000407],"genre_scores_gemma":[0.9984876,0.00099535,0.00018887884,0.000025674404,0.000014415501,0.0000047682665,0.00010880152,0.0000019460686,0.00017255112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992692,0.00024766484,0.00006623713,0.00012868317,0.00016621123,0.00012211349],"domain_scores_gemma":[0.9961134,0.001279757,0.001985792,0.00020798632,0.000140553,0.00027244337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005731589,0.00018234662,0.0002616946,0.0007981509,0.00020529698,0.00042687877,0.0002444357,0.0003571373,0.0016436105],"category_scores_gemma":[0.0052240766,0.0002652174,0.00038744492,0.0007542712,0.0002045145,0.0001759196,0.0002844176,0.00056794385,0.00012085829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008996913,0.000014686846,0.99674183,0.000010872294,0.00003486651,0.00015254067,0.00003628487,0.000019529132,0.00023376154,0.000016454087,0.000040295858,0.0026089528],"study_design_scores_gemma":[0.0000026939292,0.000073469535,0.99880385,0.000012387904,0.000028507411,0.00069739076,0.00003192825,0.0000737706,0.000101134654,0.000020247639,0.00015304892,0.0000016548802],"about_ca_topic_score_codex":0.006670615,"about_ca_topic_score_gemma":0.007139476,"teacher_disagreement_score":0.006670615,"about_ca_system_score_codex":0.00031977257,"about_ca_system_score_gemma":0.00040644853,"threshold_uncertainty_score":0.013263583},"labels":[],"label_agreement":null},{"id":"W2109918996","doi":"10.1002/j.1552-4604.2002.tb05998.x","title":"Cannabidiol: An Overview of Some Pharmacological Aspects","year":2002,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":506,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University","funders":"","keywords":"Cannabidiol; Cannabinoid; Pharmacology; Cannabis; Endocannabinoid system; Cannabinoid receptor; Antipsychotic; Anandamide; Mechanism of action; Chemistry; Tetrahydrocannabinol; Mechanism (biology); Medicine; Receptor; Schizophrenia (object-oriented programming); Psychiatry; Biochemistry","score_opus":0.43935877927221867,"score_gpt":0.5887265220845699,"score_spread":0.1493677428123512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109918996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026933782,0.9963174,0.00024451094,0.00018359063,0.00021865833,0.000008622089,0.000023739132,0.000011090405,0.0027229874],"genre_scores_gemma":[0.00093640236,0.9960849,0.00047747407,0.00018774971,0.00030759766,0.000014050737,0.000040487757,0.0000020918524,0.0019492406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983704,0.000017689721,0.000028428303,0.000038396644,0.00006445737,0.000013932985],"domain_scores_gemma":[0.9998677,0.000046374687,0.000016451379,0.000006667566,0.000041041756,0.000021761514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032355523,0.001028424,0.0013967096,0.003939344,0.0005335209,0.0010250928,0.0009915767,0.0011291772,0.0045740334],"category_scores_gemma":[0.0002825317,0.00043561932,0.000511956,0.0034438465,0.00044093948,0.0015295269,0.0006090057,0.001713828,0.0042991773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013247895,0.00019780196,0.00020557738,0.00921372,0.000052276624,0.0007702219,0.000083809115,0.0003959693,0.0064659882,0.0034577232,0.013514766,0.9655097],"study_design_scores_gemma":[0.000021277072,0.00014524967,0.0010964118,0.0014722898,0.000062685765,0.0030701547,0.00007880731,0.00011895113,0.0015274988,0.0020194007,0.99036,0.000027075499],"about_ca_topic_score_codex":0.001862236,"about_ca_topic_score_gemma":0.0028583657,"teacher_disagreement_score":0.0045740334,"about_ca_system_score_codex":0.0008027561,"about_ca_system_score_gemma":0.000848956,"threshold_uncertainty_score":0.015301645},"labels":[],"label_agreement":null},{"id":"W2112914725","doi":"10.1177/0091270006297226","title":"Pharmacokinetics and Pharmacodynamics of Once‐Daily Controlled‐Release Oxybutynin and Immediate‐Release Oxybutynin","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Oxybutynin; Pharmacokinetics; Pharmacodynamics; Crossover study; Medicine; Anesthesia; Pharmacology; Urology; Chemistry; Overactive bladder","score_opus":0.05100878752085448,"score_gpt":0.45186913944050794,"score_spread":0.40086035191965347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112914725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896073,0.0005098339,0.0002815652,0.00001112959,0.000017492895,0.000039952265,0.000051879342,0.000013359481,0.00011405811],"genre_scores_gemma":[0.9986809,0.00028245978,0.00051229575,0.000044415785,0.000029840345,0.000093355586,0.000121014855,0.000007665804,0.00022800892],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996501,0.0001444915,0.000019359351,0.00006307504,0.00008683047,0.00003617227],"domain_scores_gemma":[0.9991602,0.00027073867,0.00024347863,0.000075031065,0.000054367956,0.00019624771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005568163,0.00036762792,0.00089443114,0.00013290702,0.00010911634,0.00040293342,0.00022769002,0.00044363842,0.0007267943],"category_scores_gemma":[0.001544658,0.00031254964,0.00043305193,0.00014039254,0.00035689186,0.00039610968,0.000100844314,0.0005876589,0.00015813437],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42047465,0.011203778,0.03133244,0.00061725854,0.0013703788,0.0004234058,0.0005728355,0.00250564,0.3857366,0.00015702946,0.00064953894,0.14495638],"study_design_scores_gemma":[0.037269577,0.5966324,0.2935856,0.000046725283,0.0010069592,0.0012317937,0.0002410678,0.008694532,0.058610827,0.00016031187,0.002400166,0.00011994798],"about_ca_topic_score_codex":0.00030259063,"about_ca_topic_score_gemma":0.0002877679,"teacher_disagreement_score":0.00089443114,"about_ca_system_score_codex":0.0001984387,"about_ca_system_score_gemma":0.00016144602,"threshold_uncertainty_score":0.0029447079},"labels":[],"label_agreement":null},{"id":"W2114457800","doi":"10.1177/00912700222011193","title":"Multiple‐Dose, Safety, Pharmacokinetics, and Pharmacodynamics of a New Selective Estrogen Receptor Modulator, ERA‐923, in Healthy Postmenopausal Women","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacokinetics; Medicine; Pharmacodynamics; Tolerability; Placebo; Adverse effect; Selective estrogen receptor modulator; Internal medicine; Estrogen; Tamoxifen; Pharmacology; Breast cancer; Oncology; Cancer","score_opus":0.022099064252359652,"score_gpt":0.3476892674425801,"score_spread":0.3255902031902205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114457800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99845374,0.0010310624,0.00017487846,0.000040141567,0.000006966976,0.000034655583,0.00006810069,0.000016878785,0.0001735811],"genre_scores_gemma":[0.9979778,0.0008815777,0.00036837455,0.00008540967,0.00003551286,0.0000486445,0.00014182038,0.0000075622784,0.0004532612],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998036,0.00008568744,0.000011713273,0.0000343515,0.000045704106,0.000019076886],"domain_scores_gemma":[0.9997255,0.00006837667,0.00009581185,0.000020992324,0.000022143491,0.00006712939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042165746,0.00043096667,0.0006384608,0.0001862547,0.0002401423,0.0001932443,0.00016553719,0.00041668036,0.00078519253],"category_scores_gemma":[0.0008118945,0.00029964861,0.0002792908,0.0001563105,0.00035699908,0.00023183491,0.00011781894,0.00074152957,0.00020247568],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21669047,0.009952991,0.055276606,0.0006233045,0.0011616955,0.0010087924,0.0007815278,0.0011706448,0.5373512,0.00009838324,0.00086109183,0.17502338],"study_design_scores_gemma":[0.02940586,0.58143735,0.3237156,0.000041235893,0.0016562856,0.0027677251,0.00034018865,0.0020917174,0.054854214,0.00021087613,0.003406552,0.00007247968],"about_ca_topic_score_codex":0.00057044753,"about_ca_topic_score_gemma":0.0010838897,"teacher_disagreement_score":0.00078519253,"about_ca_system_score_codex":0.0001775207,"about_ca_system_score_gemma":0.00021594077,"threshold_uncertainty_score":0.0026267767},"labels":[],"label_agreement":null},{"id":"W2115198007","doi":"10.1002/jcph.335","title":"An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Capital District Health Authority; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Dabigatran; Medicine; Hemodialysis; Cmax; Pharmacokinetics; Pharmacodynamics; Direct thrombin inhibitor; Warfarin; Anesthesia; Pharmacology; Atrial fibrillation; Anticoagulant; Internal medicine","score_opus":0.20264000342271588,"score_gpt":0.5325608484467391,"score_spread":0.32992084502402325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115198007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918145,0.00034974003,0.00022859711,0.0000134360125,0.0000028413197,0.00001408759,0.000021642592,0.000005183533,0.00018295285],"genre_scores_gemma":[0.9989286,0.00030625126,0.00044235666,0.00003422038,0.000011674975,0.000016977368,0.00006347498,0.0000020790665,0.00019437577],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998437,0.000047546604,0.00001101009,0.00002533015,0.000056208974,0.000016184786],"domain_scores_gemma":[0.99972075,0.00011151029,0.00006225547,0.000018854944,0.000025885995,0.00006084523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002222103,0.00023276737,0.00049202004,0.00013183364,0.00014160835,0.0003287823,0.00009193645,0.00020559083,0.000546825],"category_scores_gemma":[0.0008505248,0.00010333638,0.00014021754,0.00013387676,0.00020969246,0.00017554694,0.0001097576,0.0004112496,0.000082079314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043694083,0.003626549,0.25963584,0.0002885193,0.00037360395,0.0012879844,0.0007791214,0.001828149,0.4961053,0.00023480043,0.0003812641,0.19176479],"study_design_scores_gemma":[0.0012640534,0.11370693,0.7485686,0.000024489842,0.0004204456,0.0039698966,0.0003578738,0.004590261,0.123088345,0.00019447523,0.0037709083,0.00004376554],"about_ca_topic_score_codex":0.000392227,"about_ca_topic_score_gemma":0.00036316662,"teacher_disagreement_score":0.000546825,"about_ca_system_score_codex":0.00017670673,"about_ca_system_score_gemma":0.0002560367,"threshold_uncertainty_score":0.0018292665},"labels":[],"label_agreement":null},{"id":"W2117179744","doi":"10.1177/0091270006296421","title":"Potential Interactions Between Pharmaceuticals and Natural Health Products in Canada","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Population; Environmental health; Drug; Family medicine; Pharmacology","score_opus":0.15330381352389033,"score_gpt":0.5394708613179644,"score_spread":0.38616704779407407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117179744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529434,0.016030543,0.00049157627,0.0034422313,0.000055544726,0.00021178939,0.004271041,0.000041008017,0.022512808],"genre_scores_gemma":[0.9924527,0.0043361173,0.00068125135,0.0005538993,0.000016371429,0.000018109824,0.0006921177,0.0000038096614,0.0012456919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960801,0.00042697473,0.00025846722,0.00025382554,0.0026151668,0.00036545613],"domain_scores_gemma":[0.9965078,0.00050324225,0.0012794832,0.000058372752,0.0011631622,0.00048786058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011658758,0.00021060837,0.00036149696,0.0012588737,0.0018424656,0.0010915997,0.0006338562,0.000368732,0.0026018708],"category_scores_gemma":[0.004284319,0.00023657749,0.00054115185,0.0034530982,0.00056931446,0.0003549696,0.0006771894,0.0005881806,0.0001536702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023775494,0.000095389136,0.95145404,0.00031741455,0.00014678785,0.0006120572,0.00077653804,0.00018723743,0.00040843058,0.0002907855,0.0029297704,0.04254381],"study_design_scores_gemma":[0.000022872906,0.000094741656,0.98977953,0.000120761106,0.00010398947,0.00065166486,0.0009104593,0.0005270842,0.000254406,0.000095878095,0.007414314,0.000024416606],"about_ca_topic_score_codex":0.9708302,"about_ca_topic_score_gemma":0.9826806,"teacher_disagreement_score":0.029169798,"about_ca_system_score_codex":0.01557624,"about_ca_system_score_gemma":0.024934253,"threshold_uncertainty_score":0.1130141},"labels":[],"label_agreement":null},{"id":"W2118216302","doi":"10.1177/0091270011403740","title":"Effects of Alcohol on the Pharmacokinetics of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Naltrexone; Pharmacokinetics; Pharmacology; Morphine; Bioavailability; Crossover study; Alcohol; Opioid; Narcotic antagonist; Drug; Medicine; Anesthesia; Chemistry; Internal medicine; Biochemistry","score_opus":0.07106933015080256,"score_gpt":0.38791553595837497,"score_spread":0.3168462058075724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118216302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925894,0.00027439432,0.00014808845,0.000015563222,0.000010428524,0.00003054157,0.00005860864,0.0000068208246,0.0001965655],"genre_scores_gemma":[0.9984654,0.00032221168,0.00037030905,0.00002913366,0.000017619219,0.000029445751,0.00008846148,0.000005822027,0.0006716974],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996486,0.00013159255,0.000022637636,0.000054670683,0.00008791177,0.000054597636],"domain_scores_gemma":[0.99941003,0.00023161243,0.00016086281,0.00004416368,0.000048700284,0.000104656174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003557651,0.00024874063,0.0004019153,0.00011272781,0.00011043381,0.00021361791,0.000134682,0.00019425483,0.0017610942],"category_scores_gemma":[0.001186189,0.00028266155,0.0002825387,0.00008620337,0.00027960358,0.0003098173,0.00015790608,0.00042145033,0.0002061878],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32548913,0.0045918375,0.018658115,0.00023541976,0.00040156543,0.00036303364,0.00034678448,0.0010136509,0.58213943,0.0001268526,0.00035167407,0.066282585],"study_design_scores_gemma":[0.0058390703,0.43530023,0.33196065,0.00003078908,0.00064702396,0.0012874175,0.00030438346,0.008032661,0.21259992,0.00019036188,0.003715181,0.00009238517],"about_ca_topic_score_codex":0.0009773513,"about_ca_topic_score_gemma":0.0012755449,"teacher_disagreement_score":0.0017610942,"about_ca_system_score_codex":0.0002547175,"about_ca_system_score_gemma":0.00026786258,"threshold_uncertainty_score":0.005891502},"labels":[],"label_agreement":null},{"id":"W2118693119","doi":"10.1177/0091270006292163","title":"Drug‐Disease Interactions: Losartan Effect Is Not Downregulated by Rheumatoid Arthritis","year":2006,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Losartan; Rheumatoid arthritis; Active metabolite; Pharmacology; Metabolite; Medicine; Arthritis; Inflammation; Pharmacokinetics; Internal medicine; Endocrinology; Angiotensin II; Chemistry; Receptor","score_opus":0.012671496766233704,"score_gpt":0.3470690022118119,"score_spread":0.3343975054455782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118693119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98383015,0.005615063,0.00092312647,0.0005891906,0.00015039448,0.000070097434,0.00040626377,0.000111379886,0.008304356],"genre_scores_gemma":[0.9970982,0.0006123918,0.0002683329,0.00019778006,0.000058472317,0.000020916,0.00020986664,0.000008879032,0.001525098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994512,0.00017828665,0.00005214122,0.000080208796,0.0001649096,0.000073229916],"domain_scores_gemma":[0.9994758,0.00016753524,0.000099060584,0.000056174144,0.00006225079,0.00013929591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038958061,0.00021514625,0.0009377617,0.00018657483,0.0002470957,0.00032448134,0.00012436083,0.00026665832,0.006138461],"category_scores_gemma":[0.0011461672,0.00008272128,0.000261616,0.00017896447,0.0002524001,0.00020822052,0.00019766559,0.0005250301,0.00087073736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031764485,0.0019633472,0.04158027,0.0009370175,0.001003167,0.0028426384,0.0001664879,0.00033778453,0.7548859,0.0006512377,0.004144741,0.15972283],"study_design_scores_gemma":[0.00281918,0.037833497,0.61939543,0.00009098524,0.0018970612,0.012587136,0.00015140603,0.002616372,0.26166758,0.0014303855,0.059454806,0.000056200184],"about_ca_topic_score_codex":0.00027864822,"about_ca_topic_score_gemma":0.00065387384,"teacher_disagreement_score":0.006138461,"about_ca_system_score_codex":0.00024723334,"about_ca_system_score_gemma":0.00026162848,"threshold_uncertainty_score":0.02053523},"labels":[],"label_agreement":null},{"id":"W2120703255","doi":"10.1002/jcph.436","title":"Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: In vitro and in vivo correlation","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"CYP3A; CYP2B6; CYP2C9; Pharmacology; Midazolam; CYP3A4; In vivo; Pharmacokinetics; In vitro; CYP2D6; Protease inhibitor (pharmacology); Chemistry; Cytochrome P450; Biology; Virology; Microsome; Enzyme; Virus; Biochemistry; Viral load","score_opus":0.04768740136658928,"score_gpt":0.4200101933250173,"score_spread":0.37232279195842805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120703255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96697503,0.020183127,0.008390778,0.00020746341,0.000087204404,0.00014575188,0.0008652235,0.000115986084,0.0030293448],"genre_scores_gemma":[0.9903668,0.004505646,0.0029549608,0.000098108445,0.000051605188,0.00006035174,0.0009728288,0.00001814831,0.0009715276],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985776,0.0008235346,0.00007518833,0.00015727995,0.0002534849,0.00011297637],"domain_scores_gemma":[0.9987483,0.00064782763,0.00024890903,0.000099891,0.00016527253,0.00008977995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010888869,0.00075995334,0.00072654185,0.00045528836,0.00024986325,0.0007263872,0.0004285703,0.00050863164,0.0015198367],"category_scores_gemma":[0.0017666741,0.00038250443,0.0005199857,0.00045655805,0.000231352,0.00039474454,0.0002267113,0.00087101123,0.0005825765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007538807,0.001824207,0.030501919,0.00068619865,0.0008524712,0.00034242493,0.00013914949,0.007597678,0.88467884,0.0003602054,0.0011984671,0.06427971],"study_design_scores_gemma":[0.00020315146,0.014472437,0.06533342,0.00005032352,0.00047631067,0.002032748,0.00011602474,0.033946246,0.8765881,0.00022905151,0.006486028,0.0000662206],"about_ca_topic_score_codex":0.0016153296,"about_ca_topic_score_gemma":0.0015395604,"teacher_disagreement_score":0.0016153296,"about_ca_system_score_codex":0.0006105949,"about_ca_system_score_gemma":0.0003323824,"threshold_uncertainty_score":0.005758643},"labels":[],"label_agreement":null},{"id":"W2123329990","doi":"10.1002/jcph.281","title":"Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Dosing; Renal function; Creatinine; Vancomycin; Pharmacokinetics; Urology; Medicine; Chemistry; Pharmacology; Internal medicine","score_opus":0.06810537494621932,"score_gpt":0.4423548053465175,"score_spread":0.3742494304002982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123329990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97722137,0.0149411075,0.0019700485,0.0026399696,0.00010559007,0.000026720325,0.0006941296,0.000046733214,0.0023542927],"genre_scores_gemma":[0.99702054,0.0013748013,0.0010967052,0.000177406,0.000034758883,0.0000068049612,0.00018007038,0.000009278033,0.00009973037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754494,0.0008815378,0.00027078504,0.00023990133,0.00089287036,0.00016998724],"domain_scores_gemma":[0.99097556,0.004326613,0.00302246,0.00021692338,0.0011674188,0.00029107672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003298827,0.00036125878,0.00043543853,0.0005298147,0.00025636476,0.0006670674,0.0004400291,0.0005363945,0.00042532146],"category_scores_gemma":[0.021643572,0.00015027623,0.00032459208,0.0008334523,0.00050700427,0.00046591225,0.00036499297,0.0007770023,0.0001277392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014634669,0.0000105207955,0.986641,0.000038312715,0.00003238514,0.00017742622,0.00010732235,0.00030813317,0.00024511453,0.00004991948,0.0003728394,0.011870764],"study_design_scores_gemma":[0.000007136666,0.00011962415,0.9961611,0.000090534515,0.00006126807,0.0010438575,0.00016068753,0.0007411348,0.00063083024,0.00005971174,0.0009177454,0.0000064397655],"about_ca_topic_score_codex":0.07094377,"about_ca_topic_score_gemma":0.059414294,"teacher_disagreement_score":0.07094377,"about_ca_system_score_codex":0.0019424104,"about_ca_system_score_gemma":0.001675719,"threshold_uncertainty_score":0.14106166},"labels":[],"label_agreement":null},{"id":"W2126315888","doi":"10.1177/0091270009335766","title":"Iatrogenic Severe Depression of High‐Density Lipoprotein Cholesterol","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Fibrate; Fenofibrate; Medicine; Cholesterol; Internal medicine; Drug; Depression (economics); Statin; Endocrinology; Pharmacology","score_opus":0.035605492307966544,"score_gpt":0.3924006890397838,"score_spread":0.35679519673181725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126315888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807376,0.010684866,0.0022290158,0.00062971766,0.00013336896,0.0000475208,0.00006610344,0.00008214609,0.005389585],"genre_scores_gemma":[0.99775296,0.001298465,0.00023281493,0.0002697614,0.00012871013,0.0000058507785,0.000034706478,0.0000040773093,0.00027271724],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99924123,0.00018247729,0.00015008368,0.00009022897,0.0001304349,0.00020550037],"domain_scores_gemma":[0.9972,0.0010261463,0.0010708135,0.0003041318,0.00018653006,0.0002123887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036313923,0.00061487645,0.00044507923,0.0013161327,0.00087563164,0.0004911506,0.0008519056,0.00091340014,0.0023639502],"category_scores_gemma":[0.0047233296,0.00046803977,0.00066726643,0.0011644252,0.0007814264,0.0003896809,0.0007765042,0.00072038546,0.00061424094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019669667,0.0000661772,0.16472667,0.00023770834,0.000095251096,0.81131595,0.0006839559,0.00017580917,0.0013309557,0.00037516005,0.0009719142,0.01982376],"study_design_scores_gemma":[0.000021355729,0.00012316617,0.037455373,0.00004963651,0.00004967364,0.9591004,0.00019944998,0.00022477862,0.0008501409,0.00014866429,0.0017644616,0.0000128423635],"about_ca_topic_score_codex":0.0009286538,"about_ca_topic_score_gemma":0.0010876242,"teacher_disagreement_score":0.0023639502,"about_ca_system_score_codex":0.00031248023,"about_ca_system_score_gemma":0.00030356526,"threshold_uncertainty_score":0.007908225},"labels":[],"label_agreement":null},{"id":"W2126980140","doi":"10.1177/0091270007299759","title":"Single‐Dose Pharmacokinetics of Multilayer‐Release Methylphenidate and Immediate‐Release Methylphenidate in Children With Attention‐Deficit/Hyperactivity Disorder","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada); Royal University Hospital","funders":"","keywords":"Methylphenidate; Pharmacokinetics; Attention deficit hyperactivity disorder; Controlled release; Medicine; Immediate release; Attention deficit disorder; Pharmacology; Anesthesia; Pediatrics; Psychiatry","score_opus":0.05213842800743826,"score_gpt":0.4118467299516465,"score_spread":0.3597083019442082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126980140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882525,0.000765836,0.00014984404,0.000027048523,0.000011361401,0.00004110687,0.000060648683,0.000008618966,0.00011030025],"genre_scores_gemma":[0.99833953,0.0005074387,0.0007246658,0.000051987445,0.000021519045,0.00006665396,0.00013033224,0.000005301531,0.00015252137],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99963963,0.00015295365,0.000030969157,0.000049592323,0.00009048387,0.000036349327],"domain_scores_gemma":[0.99922514,0.00026803915,0.00027613912,0.00004309293,0.000039081726,0.00014853958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045754178,0.0002889947,0.0013389221,0.00012312096,0.00013323147,0.00028086948,0.00027984442,0.00037848073,0.001138237],"category_scores_gemma":[0.0018028078,0.00029213916,0.00035910925,0.00015888827,0.0003328555,0.0004218352,0.00016493125,0.00069127337,0.00021406873],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45178604,0.012842683,0.12132605,0.0011359679,0.002122463,0.000703203,0.0006710909,0.004117473,0.11912988,0.0001871419,0.001465385,0.28451255],"study_design_scores_gemma":[0.06725788,0.52674574,0.35974932,0.00009137145,0.0013745378,0.003007656,0.00048238417,0.005561092,0.032011703,0.00019814554,0.0034343526,0.00008580057],"about_ca_topic_score_codex":0.00065233296,"about_ca_topic_score_gemma":0.0011750931,"teacher_disagreement_score":0.0013389221,"about_ca_system_score_codex":0.00040990885,"about_ca_system_score_gemma":0.0003610482,"threshold_uncertainty_score":0.0038077831},"labels":[],"label_agreement":null},{"id":"W2128897405","doi":"10.1177/0091270011415528","title":"Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation","year":2012,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Physiologically based pharmacokinetic modelling; Pharmacokinetics; Pharmacology; Telithromycin; Repaglinide; Renal function; Bioavailability; Medicine; Bioequivalence; In vivo; Chemistry; Internal medicine; Antibacterial agent; Antibiotics; Biology","score_opus":0.16298244757660132,"score_gpt":0.45662863504824647,"score_spread":0.29364618747164517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128897405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90011543,0.0005437169,0.09543603,0.00034431557,0.00002426498,0.00013843244,0.0004967617,0.00019923552,0.0027017791],"genre_scores_gemma":[0.99184567,0.00019811509,0.007316525,0.00004388031,0.0000045053926,0.00010181746,0.00013363616,0.000009002767,0.00034693832],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997694,0.00011258763,0.000013837115,0.000039996507,0.00004051172,0.000023714509],"domain_scores_gemma":[0.99930525,0.00048079397,0.00009482367,0.000026777407,0.0000707023,0.000021570018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006266933,0.0004453235,0.0006065785,0.00025372833,0.00017297022,0.00070301205,0.00039479067,0.00076159684,0.0005805367],"category_scores_gemma":[0.0017001979,0.00023745498,0.0008253916,0.0002581644,0.00022089429,0.0002875559,0.00029381874,0.0004956961,0.00010011402],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017123835,0.000074346135,0.0082941605,0.000045193345,0.00005380731,0.00010756963,0.000044084554,0.9836723,0.0029348726,0.0006148104,0.00011758169,0.003870055],"study_design_scores_gemma":[0.00001791559,0.00016157726,0.0020751948,0.000004959669,0.000024883013,0.000053470565,0.000016963806,0.99588376,0.0011354723,0.00035194785,0.0002645154,0.000009335883],"about_ca_topic_score_codex":0.009092913,"about_ca_topic_score_gemma":0.003031757,"teacher_disagreement_score":0.009092913,"about_ca_system_score_codex":0.0006723227,"about_ca_system_score_gemma":0.00088674354,"threshold_uncertainty_score":0.018079996},"labels":[],"label_agreement":null},{"id":"W2131499894","doi":"10.1177/00912700122012706","title":"Pharmacokinetics and Tolerability of GW420867X, a Nonnucleoside Reverse Transcriptase Inhibitor, following Single Escalating Doses in Healthy Male Volunteers","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Pharmacokinetics; Cmax; Pharmacology; Dosing; Tolerability; Medicine; Reverse-transcriptase inhibitor; Adverse effect; Placebo; Human immunodeficiency virus (HIV); Viral load; Immunology; Antiretroviral therapy","score_opus":0.06472534940166322,"score_gpt":0.4050944900719915,"score_spread":0.3403691406703283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131499894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984425,0.00028958966,0.0005406672,0.000018218498,0.0000063560456,0.00019000792,0.00012369512,0.000025945914,0.00036315335],"genre_scores_gemma":[0.99725515,0.0002762926,0.0009847817,0.0000930981,0.00003129977,0.00022401332,0.0002735742,0.000016398883,0.0008455392],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996904,0.00013577167,0.000016171476,0.000060093895,0.0000654592,0.00003208463],"domain_scores_gemma":[0.99976987,0.000056592726,0.00006695686,0.000028704753,0.00002600991,0.000051922005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046267017,0.0004254899,0.00053942716,0.00016121988,0.00023121703,0.00028536745,0.00013584955,0.0004114839,0.0011112742],"category_scores_gemma":[0.00074662245,0.0002969905,0.00019579526,0.0001441614,0.00028344497,0.00030714629,0.00013511111,0.0005139712,0.00041006773],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08207775,0.007893736,0.048371676,0.00030571118,0.00025034483,0.0006599269,0.0007678757,0.0012228913,0.71628594,0.000106811596,0.001029038,0.14102824],"study_design_scores_gemma":[0.00731486,0.43925542,0.45932925,0.000023029635,0.00046097898,0.002856738,0.0003377021,0.0030041866,0.08419496,0.00022547842,0.0029226353,0.00007478807],"about_ca_topic_score_codex":0.00037560615,"about_ca_topic_score_gemma":0.0005101203,"teacher_disagreement_score":0.0011112742,"about_ca_system_score_codex":0.00012094106,"about_ca_system_score_gemma":0.00017846723,"threshold_uncertainty_score":0.0037175417},"labels":[],"label_agreement":null},{"id":"W2134568577","doi":"10.1177/0091270003262106","title":"Teaching Application of Clinical Pharmacology Skills Using Unusual Observations from Clozapine Overdoses","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Clozapine; Medicine; Pharmacokinetics; Dosing; Drug; Pharmacology; Absorption (acoustics); Clinical pharmacology; Toxicity; Intensive care medicine; Schizophrenia (object-oriented programming); Psychiatry; Internal medicine","score_opus":0.3675259103323184,"score_gpt":0.5928112687652362,"score_spread":0.22528535843291775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134568577","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21027155,0.010705083,0.42823255,0.122716196,0.01646269,0.004544627,0.0013316732,0.009767211,0.19596846],"genre_scores_gemma":[0.37898552,0.013404237,0.50065273,0.026251443,0.00669003,0.002371488,0.0010063922,0.0012050441,0.06943315],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99715257,0.0012633692,0.00020813064,0.00038874187,0.000686182,0.0003008929],"domain_scores_gemma":[0.9874215,0.005954291,0.0009819545,0.0009652867,0.0020460822,0.0026308696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005021967,0.0023628045,0.0010701184,0.0018512362,0.001604963,0.0035370188,0.002761705,0.0034822212,0.016512845],"category_scores_gemma":[0.021105027,0.0006100885,0.0015812833,0.00050714763,0.002979847,0.0037199832,0.006216038,0.007312121,0.0064348457],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006675951,0.004234915,0.01137517,0.002664801,0.00015292474,0.013498786,0.04300776,0.011101041,0.028457254,0.026085705,0.32527232,0.5334818],"study_design_scores_gemma":[0.00030739245,0.002858792,0.010762948,0.0027508757,0.00012963613,0.024942188,0.027847765,0.015372953,0.014681555,0.156972,0.74304336,0.0003305009],"about_ca_topic_score_codex":0.00048764976,"about_ca_topic_score_gemma":0.001226122,"teacher_disagreement_score":0.016512845,"about_ca_system_score_codex":0.0018920063,"about_ca_system_score_gemma":0.0028786887,"threshold_uncertainty_score":0.05524093},"labels":[],"label_agreement":null},{"id":"W2135186116","doi":"10.1177/00912700122010168","title":"Effect of Alosetron on the Pharmacokinetics of Alprazolam","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Alprazolam; Medicine; Pharmacokinetics; CYP3A4; Pharmacology; Crossover study; Irritable bowel syndrome; Internal medicine; Gastroenterology; Placebo; Cytochrome P450; Anxiety","score_opus":0.07925662576691779,"score_gpt":0.47852998843760375,"score_spread":0.39927336267068597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135186116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885917,0.00031001767,0.0001659671,0.000052572257,0.000032714815,0.00009353205,0.000077132856,0.000024215047,0.0003846604],"genre_scores_gemma":[0.99811697,0.0003167027,0.00054359256,0.000087238055,0.00006510106,0.000089489724,0.00013683632,0.000011932907,0.0006321264],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99935335,0.00039171882,0.00004540303,0.000081098675,0.00006710568,0.00006141519],"domain_scores_gemma":[0.9986908,0.00062862795,0.00021789582,0.000113690134,0.00007074999,0.00027829033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004904245,0.0005308555,0.0011370038,0.00016159817,0.00022870916,0.0004749009,0.00026739866,0.0007610215,0.0024901074],"category_scores_gemma":[0.0028727425,0.00041622936,0.00042756888,0.00017461408,0.000511665,0.00073924917,0.00016474373,0.0010884098,0.00036649188],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76917696,0.016967745,0.0036429795,0.00025267905,0.00048259908,0.0002807674,0.0002159513,0.0005902125,0.15546352,0.0000934238,0.00037593747,0.052457266],"study_design_scores_gemma":[0.097723454,0.7860865,0.052735306,0.000043383377,0.0007457291,0.00064630655,0.00017010956,0.0040849745,0.05526845,0.00015853127,0.002263797,0.000073488525],"about_ca_topic_score_codex":0.00042007878,"about_ca_topic_score_gemma":0.00074356643,"teacher_disagreement_score":0.0024901074,"about_ca_system_score_codex":0.00019843229,"about_ca_system_score_gemma":0.00032972274,"threshold_uncertainty_score":0.008330226},"labels":[],"label_agreement":null},{"id":"W2138758167","doi":"10.1177/00912700222011210","title":"Multiple‐Dose, Linear, Dose‐Proportional Pharmacokinetics of Retigabine in Healthy Volunteers","year":2002,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pharmacokinetics; Medicine; Evening; Placebo; Population; Morning; Volume of distribution; Pharmacology; Oral administration; Anesthesia; Internal medicine","score_opus":0.13995706701739158,"score_gpt":0.478575900618726,"score_spread":0.33861883360133443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138758167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977549,0.000501799,0.000775665,0.0000277983,0.000020552498,0.00041018648,0.00014201824,0.00005235422,0.0003148187],"genre_scores_gemma":[0.9974421,0.00022277502,0.0010630566,0.00013046617,0.000050347466,0.00033401346,0.00015769403,0.000012414649,0.00058719347],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99917763,0.00036753248,0.000039466988,0.00019483479,0.00012348282,0.00009706504],"domain_scores_gemma":[0.999574,0.000102207734,0.0001033588,0.00007649612,0.000044029992,0.000099857236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014028844,0.0005670992,0.0010516389,0.0002431051,0.0003373684,0.0003864563,0.0003051394,0.00059978734,0.0012657449],"category_scores_gemma":[0.0013160212,0.000513969,0.00034215022,0.00017313061,0.00053881336,0.0005117179,0.00023542633,0.0007130315,0.0005157524],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57390183,0.028966982,0.017090226,0.0003319552,0.00058600307,0.00023692647,0.000616208,0.0012004662,0.28223655,0.00014081414,0.001166872,0.093525305],"study_design_scores_gemma":[0.050044794,0.77999705,0.11996856,0.000019047899,0.0005786181,0.0006383132,0.00014696024,0.0045686364,0.040948972,0.00022702677,0.0027954644,0.000066453904],"about_ca_topic_score_codex":0.0005641104,"about_ca_topic_score_gemma":0.00061172846,"teacher_disagreement_score":0.0014028844,"about_ca_system_score_codex":0.00023168908,"about_ca_system_score_gemma":0.00034488327,"threshold_uncertainty_score":0.0074192286},"labels":[],"label_agreement":null},{"id":"W2138799068","doi":"10.1177/0091270007307571","title":"A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q<sub>10</sub> (Ubiquinone)","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Coenzyme Q10 studies and effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Biostatistics; Medicine; Library science; Family medicine; Internal medicine; Computer science","score_opus":0.041513446203637554,"score_gpt":0.3941344114753074,"score_spread":0.35262096527166986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138799068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934562,0.0009523494,0.0011689512,0.00036819218,0.00059312186,0.0019007819,0.00056605984,0.000108316664,0.000886125],"genre_scores_gemma":[0.9888678,0.0007684501,0.0026419582,0.00089588994,0.00059489964,0.0020360027,0.0005308311,0.000059704777,0.0036043744],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961832,0.0020179076,0.00023820144,0.00077322,0.00033362242,0.00045379112],"domain_scores_gemma":[0.99192643,0.0036145973,0.0015667261,0.0010492161,0.00042530498,0.0014176752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004924531,0.002238638,0.005687597,0.0007211379,0.0008450014,0.0015632816,0.0016047431,0.0034917553,0.00873184],"category_scores_gemma":[0.005450399,0.0014641645,0.0022983109,0.00070906064,0.004456276,0.0020270331,0.0007659789,0.005084411,0.0013316929],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9833332,0.0108429175,0.00010971514,0.00008643045,0.00019183024,0.000012048845,0.000019629184,0.00007869831,0.002108042,0.000066123575,0.00010917782,0.0030422898],"study_design_scores_gemma":[0.75252676,0.24391666,0.0009257476,0.000011588962,0.00034153566,0.000017332657,0.00002221971,0.00035278153,0.0014340167,0.00013319067,0.0002920489,0.000026083002],"about_ca_topic_score_codex":0.0017353551,"about_ca_topic_score_gemma":0.0017396607,"teacher_disagreement_score":0.00873184,"about_ca_system_score_codex":0.0013617359,"about_ca_system_score_gemma":0.0020360993,"threshold_uncertainty_score":0.029210925},"labels":[],"label_agreement":null},{"id":"W2138869278","doi":"10.1177/0091270005279799","title":"FTY720, a Novel Immunomodulator in de Novo Kidney Transplant Patients: Pharmacokinetics and Exposure‐Response Relationship","year":2005,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Pharmacokinetics; Volume of distribution; Medicine; Population; Pharmacology; Urology; Renal function; Distribution (mathematics); Internal medicine","score_opus":0.029964187003614383,"score_gpt":0.35836579525568396,"score_spread":0.3284016082520696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138869278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990276,0.0003545562,0.0004411532,0.000026839525,0.0000018844573,0.000008732494,0.00002300032,0.000007451986,0.000108792796],"genre_scores_gemma":[0.99941874,0.00012073467,0.00028899065,0.000019157551,0.00000740875,0.000006782319,0.000046439352,0.0000015080957,0.00009033395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997377,0.00009385755,0.000023295801,0.000057555473,0.000055561843,0.00003206761],"domain_scores_gemma":[0.9991536,0.00037817893,0.0002664973,0.000055301025,0.000040757255,0.00010573129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076156494,0.00022058532,0.0006320721,0.00019650502,0.00013294238,0.00034857585,0.00011650833,0.00024870862,0.00047172914],"category_scores_gemma":[0.0022145503,0.000102165126,0.00018800651,0.000168125,0.00016297027,0.0002842395,0.00016003959,0.00047492122,0.00008827068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03330193,0.0016558531,0.65300584,0.00018648549,0.0005164102,0.0012840505,0.0004978341,0.0037807024,0.13800317,0.00026522492,0.00030586563,0.16719669],"study_design_scores_gemma":[0.0008979164,0.037925098,0.90549815,0.000013600687,0.00037815355,0.004513316,0.00014286352,0.009682449,0.03890617,0.000334807,0.0016753951,0.000032058833],"about_ca_topic_score_codex":0.0003331663,"about_ca_topic_score_gemma":0.00037745255,"teacher_disagreement_score":0.00076156494,"about_ca_system_score_codex":0.0004261317,"about_ca_system_score_gemma":0.000231819,"threshold_uncertainty_score":0.004027605},"labels":[],"label_agreement":null},{"id":"W2139025099","doi":"10.1177/0091270010365554","title":"The In Vitro Platelet Toxicity Assay (iPTA): A Novel Approach for Assessment of Drug Hypersensitivity Syndrome","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Drug; Toxicity; In vitro; Medicine; Pharmacology; Platelet; Hypersensitivity reaction; Immunology; Chemistry; Internal medicine","score_opus":0.08553915562320197,"score_gpt":0.44641309873995777,"score_spread":0.3608739431167558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139025099","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41506782,0.03562844,0.5026133,0.0023660532,0.0026763189,0.003612014,0.0029485433,0.0038004583,0.031287055],"genre_scores_gemma":[0.8558401,0.010154612,0.11799486,0.0017496794,0.0014006877,0.0018954836,0.0015035929,0.00017587443,0.009285157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9935905,0.002981152,0.00042176028,0.00037743538,0.002434624,0.00019448674],"domain_scores_gemma":[0.99651057,0.0013459498,0.00082472194,0.00033167566,0.0007557536,0.0002313282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027632457,0.0020894601,0.0020657,0.0034254228,0.0005955696,0.0011403358,0.0012422949,0.0017877674,0.001585168],"category_scores_gemma":[0.0044336957,0.0006634175,0.0016094,0.0014849055,0.0007381869,0.0011182554,0.0010044005,0.002841107,0.0010615345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021500913,0.0012098607,0.024520643,0.00075963885,0.00035918696,0.0021302586,0.00032920545,0.0008322724,0.90487367,0.0015732084,0.0022911003,0.058970932],"study_design_scores_gemma":[0.00030374006,0.02225608,0.06614106,0.00015552602,0.00089412037,0.017501723,0.00034037879,0.015917785,0.85768914,0.0019225818,0.016718237,0.00015964008],"about_ca_topic_score_codex":0.00074347015,"about_ca_topic_score_gemma":0.0012159843,"teacher_disagreement_score":0.0034254228,"about_ca_system_score_codex":0.00048018256,"about_ca_system_score_gemma":0.0009346157,"threshold_uncertainty_score":0.014613569},"labels":[],"label_agreement":null},{"id":"W2139517640","doi":"10.1177/00912700122009953","title":"Pharmacodynamic Modeling of Pantoprazole's Irreversible Effect on Gastric Acid Secretion in Humans and Rats","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Pantoprazole; Gastric acid; Pharmacodynamics; Pharmacokinetics; Pentagastrin; Proton-pump inhibitor; Oral administration; Secretion; Chemistry; Stimulation; Internal medicine; Pharmacology; Placebo; Dose–response relationship; Endocrinology; Medicine; Omeprazole","score_opus":0.0560408509565002,"score_gpt":0.4287510628516842,"score_spread":0.372710211895184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139517640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8775573,0.002025572,0.11463644,0.0003098005,0.0000306229,0.00019545434,0.0006769234,0.00041912126,0.0041486067],"genre_scores_gemma":[0.992816,0.00073532056,0.0047630984,0.00006852581,0.000009338713,0.00011179957,0.00018808969,0.000029024151,0.0012788048],"study_design_codex":"simulation_or_modeling","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998233,0.0000802855,0.0000071150544,0.000029497187,0.000030591505,0.000029172807],"domain_scores_gemma":[0.99978834,0.000107484426,0.000056482586,0.000015237614,0.000022756914,0.000009708218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033629796,0.0006937,0.0004307739,0.00024683552,0.00009677752,0.00034379505,0.00043730874,0.0005369848,0.0006810871],"category_scores_gemma":[0.0009957431,0.0002250989,0.0008433801,0.00014459534,0.00020016494,0.00016920008,0.00020485312,0.0004328664,0.0002736867],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023041356,0.00040142567,0.014452126,0.00043318,0.000545477,0.0012351876,0.00020731821,0.8242116,0.09681626,0.0026377821,0.0012668197,0.05548867],"study_design_scores_gemma":[0.00012590898,0.0024000402,0.012489145,0.000019541982,0.00028171105,0.00085388887,0.00004289164,0.9623022,0.018163884,0.0009395783,0.002333346,0.000047740643],"about_ca_topic_score_codex":0.006540885,"about_ca_topic_score_gemma":0.0025846201,"teacher_disagreement_score":0.006540885,"about_ca_system_score_codex":0.00039018632,"about_ca_system_score_gemma":0.00048220027,"threshold_uncertainty_score":0.013005674},"labels":[],"label_agreement":null},{"id":"W2140742930","doi":"10.1002/jcph.479","title":"Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of General Medical Sciences","keywords":"Medicine; Cardiac arrhythmia; Hypomagnesemia; Internal medicine; Cardiology; Proton-pump inhibitor; Critically ill; Sudden cardiac death; Cohort; Cohort study; Heart failure; Atrial fibrillation","score_opus":0.09731841499499422,"score_gpt":0.4276299999289619,"score_spread":0.3303115849339677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140742930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798393,0.0007721781,0.00005745988,0.00016098541,0.00001918879,0.0000064218452,0.00018302749,0.0000037855154,0.00081297464],"genre_scores_gemma":[0.9995635,0.00014935195,0.00003421954,0.000054056265,0.000022375174,0.0000027904427,0.00011535721,0.0000011516067,0.000057240468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994332,0.00014657897,0.00009248641,0.00009715962,0.00014811372,0.00008247639],"domain_scores_gemma":[0.99630547,0.0007557671,0.0019328411,0.00020150578,0.00027652326,0.0005279485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038137683,0.00016775221,0.00048305135,0.00036980145,0.00034864497,0.0006547637,0.00025749378,0.00046745478,0.0018784826],"category_scores_gemma":[0.004838622,0.00019573272,0.00045236805,0.00060339674,0.00019957799,0.00038993603,0.00030615987,0.0007053283,0.00019180421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026970866,0.000028469927,0.9979215,0.000016791299,0.0000692524,0.0001341488,0.000027418246,0.000016053616,0.00020494967,0.000012493726,0.000119358,0.0011799472],"study_design_scores_gemma":[0.000023295486,0.0002086101,0.99879694,0.000013041526,0.000068725625,0.0004232359,0.00007771303,0.00012881852,0.000046053683,0.00003057316,0.00017905638,0.0000038269864],"about_ca_topic_score_codex":0.0021188445,"about_ca_topic_score_gemma":0.0027984655,"teacher_disagreement_score":0.0021188445,"about_ca_system_score_codex":0.0002451623,"about_ca_system_score_gemma":0.00041776238,"threshold_uncertainty_score":0.0062841177},"labels":[],"label_agreement":null},{"id":"W2141387431","doi":"10.1002/jcph.582","title":"Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Tolerability; Medicine; Pharmacodynamics; Adverse effect; Methylprednisolone; Rheumatoid arthritis; Crossover study; Adrenocorticotropic hormone; Anesthesia; Hydrocortisone; Internal medicine; Pharmacology; Pharmacokinetics; Hormone; Placebo","score_opus":0.16443226951735881,"score_gpt":0.4961834245506466,"score_spread":0.3317511550332878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141387431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980533,0.0010937728,0.00024977315,0.000030507194,0.000038018487,0.00017053643,0.00009301743,0.000013200139,0.00025779422],"genre_scores_gemma":[0.9984308,0.00049503194,0.00030172715,0.00011050291,0.00011968011,0.00015437162,0.00016242612,0.0000052139344,0.00022017265],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99905425,0.00054614246,0.000067283705,0.00014112104,0.0001226642,0.00006851713],"domain_scores_gemma":[0.9986889,0.00040969218,0.00040973653,0.00009413332,0.00007421326,0.00032339746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001251312,0.00068406505,0.001304234,0.00026973544,0.00021991941,0.00049766584,0.00025994345,0.00092291017,0.0013930843],"category_scores_gemma":[0.0021669979,0.00034842567,0.0007031166,0.00024652318,0.0007326475,0.000541295,0.00019985161,0.00080592616,0.00038696727],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8702492,0.020144852,0.018327262,0.00046859076,0.0011407479,0.00025294395,0.00022338222,0.0006068395,0.045558933,0.00007306724,0.00031277142,0.042641453],"study_design_scores_gemma":[0.067800544,0.84615517,0.07802779,0.000019518366,0.0006931011,0.00026581215,0.000091298105,0.0011664757,0.0050133364,0.000100632606,0.00062635064,0.000039949104],"about_ca_topic_score_codex":0.00035888387,"about_ca_topic_score_gemma":0.00039114585,"teacher_disagreement_score":0.0013930843,"about_ca_system_score_codex":0.00021017066,"about_ca_system_score_gemma":0.00031375882,"threshold_uncertainty_score":0.0066176653},"labels":[],"label_agreement":null},{"id":"W2143746873","doi":"10.1177/0091270009355814","title":"Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Rivaroxaban; Apixaban; Medicine; Warfarin; Atrial fibrillation; Dabigatran; Clinical trial; Stroke (engine); Pharmacodynamics; Intensive care medicine; Internal medicine; Pharmacology; Pharmacokinetics","score_opus":0.11246280484235874,"score_gpt":0.46424650051919475,"score_spread":0.351783695676836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143746873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030329898,0.9709971,0.0012833476,0.01990976,0.0007086828,0.000018078184,0.000016553664,0.000024174888,0.0040092836],"genre_scores_gemma":[0.025502067,0.95391476,0.0033903734,0.0065722386,0.009032175,0.00004501957,0.000038136553,0.000030314923,0.0014749782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986609,0.00062265585,0.00014992329,0.00020049924,0.00027080064,0.00009515429],"domain_scores_gemma":[0.9952324,0.003053881,0.0004973281,0.00019369385,0.0007578533,0.0002648087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062259547,0.00067138986,0.0020874625,0.00082311034,0.0003341932,0.0025676885,0.00086396176,0.001969701,0.002960421],"category_scores_gemma":[0.0038299905,0.00028091957,0.00072753197,0.00068751595,0.0017684049,0.0035677706,0.0009475085,0.005116753,0.00078030204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067648944,0.0006378075,0.0010057314,0.0027810624,0.00011404132,0.00042115233,0.00016214259,0.00077457965,0.0053415494,0.013086131,0.013940093,0.9610592],"study_design_scores_gemma":[0.0013776991,0.007636149,0.009327599,0.0059941793,0.00054098724,0.0058521675,0.00051719917,0.0027892035,0.0059082,0.022791537,0.937125,0.0001400684],"about_ca_topic_score_codex":0.0005468782,"about_ca_topic_score_gemma":0.0010991693,"teacher_disagreement_score":0.0062259547,"about_ca_system_score_codex":0.0008694362,"about_ca_system_score_gemma":0.0013756644,"threshold_uncertainty_score":0.03292638},"labels":[],"label_agreement":null},{"id":"W2146447716","doi":"10.1177/0091270008317589","title":"Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment‐Failure Gout","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Hyperuricemia; Gout; Pharmacodynamics; Medicine; Pharmacokinetics; Uric acid; Dosing; Pharmacology; Population; Internal medicine; Volume of distribution","score_opus":0.04565843014041542,"score_gpt":0.3927535771106155,"score_spread":0.34709514697020005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146447716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902415,0.00016950785,0.00051349855,0.000022023176,0.0000016759374,0.000011008507,0.000051157385,0.000012732598,0.00019426405],"genre_scores_gemma":[0.9995741,0.000051045547,0.00015753019,0.000019164969,0.000004007786,0.000010694117,0.00010592136,0.0000022992665,0.000075129836],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996617,0.00017691049,0.000014727215,0.00005454662,0.00005257878,0.00003947854],"domain_scores_gemma":[0.99919313,0.0004543428,0.00016335715,0.000073569354,0.00004067891,0.000074894495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009928042,0.0003192797,0.0006922497,0.00026294435,0.00019587089,0.0005319871,0.00016340688,0.0004913346,0.00060816057],"category_scores_gemma":[0.0023784745,0.00024006696,0.00048637035,0.0003194499,0.00022319025,0.00033388907,0.00016381031,0.0005866102,0.00011551559],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027625902,0.0019661912,0.8865231,0.00010715477,0.0018241169,0.0015315384,0.0006754755,0.02448085,0.018126095,0.00040048815,0.0005922783,0.0361468],"study_design_scores_gemma":[0.00072973815,0.0123238135,0.9371343,0.00000944226,0.00075358205,0.0013623731,0.000227901,0.0432487,0.0023736055,0.0006877113,0.0011072841,0.00004148668],"about_ca_topic_score_codex":0.0015917213,"about_ca_topic_score_gemma":0.0008128618,"teacher_disagreement_score":0.0015917213,"about_ca_system_score_codex":0.000397372,"about_ca_system_score_gemma":0.0003424439,"threshold_uncertainty_score":0.0052505136},"labels":[],"label_agreement":null},{"id":"W2150253814","doi":"10.1002/jcph.418","title":"Effect of faldaprevir on raltegravir pharmacokinetics in healthy volunteers","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Raltegravir; Pharmacology; Pharmacokinetics; Medicine; Integrase inhibitor; Adverse effect; Virology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","score_opus":0.07340238251602631,"score_gpt":0.5299250640556625,"score_spread":0.4565226815396362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150253814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874556,0.0004167617,0.00010900558,0.00003225953,0.000027669774,0.000114534676,0.00013048836,0.00003296655,0.0003906953],"genre_scores_gemma":[0.9983613,0.00020777392,0.00022382764,0.000104322564,0.000037655424,0.00010862406,0.00021854677,0.00001025236,0.0007278094],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99949527,0.00021181337,0.000024650122,0.00012963485,0.00005107702,0.00008751295],"domain_scores_gemma":[0.999527,0.00010523553,0.000061139595,0.000055124565,0.000057101257,0.00019445676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007182717,0.0005930196,0.0009888028,0.00017935174,0.00028109504,0.00041680687,0.00020611999,0.00059666706,0.0020626865],"category_scores_gemma":[0.0012176991,0.00040902727,0.00041082915,0.00013962317,0.00034593538,0.0003851275,0.00025126943,0.00069935416,0.0006749198],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65675324,0.02806874,0.026728421,0.00024216225,0.0003786354,0.0008336249,0.00048981747,0.00072230026,0.1979187,0.000072053015,0.0012752544,0.0865171],"study_design_scores_gemma":[0.026519604,0.73825717,0.19373947,0.000037029113,0.0004690072,0.00096870214,0.00035950326,0.0033081416,0.03260911,0.0001726596,0.0034692045,0.00009035485],"about_ca_topic_score_codex":0.0012711429,"about_ca_topic_score_gemma":0.0012437197,"teacher_disagreement_score":0.0020626865,"about_ca_system_score_codex":0.00026038894,"about_ca_system_score_gemma":0.0003929111,"threshold_uncertainty_score":0.00690037},"labels":[],"label_agreement":null},{"id":"W2150276412","doi":"10.1177/0091270004265642","title":"The Influence of St. John's Wort on CYP2C19 Activity with Respect to Genotype","year":2004,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genotype; CYP2C19; Medicine; Traditional medicine; Pharmacology; Genetics; Biology; Gene","score_opus":0.14819380871095922,"score_gpt":0.5163174603508064,"score_spread":0.36812365163984717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150276412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814653,0.001230434,0.00013116706,0.000033653898,0.000014595748,0.000015669364,0.00005300787,0.0000051388474,0.0003696676],"genre_scores_gemma":[0.9989642,0.00038466087,0.00017209187,0.00004127397,0.000029192668,0.000012073161,0.00006147153,0.0000030693293,0.00033201862],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99958366,0.00021197033,0.00003175287,0.000070199014,0.000066649,0.00003585141],"domain_scores_gemma":[0.9993057,0.00034037957,0.00017228078,0.000058232523,0.00003177266,0.000091626076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040704542,0.00024998884,0.00055721606,0.00014366917,0.00011536676,0.00019005997,0.00008037606,0.00026780536,0.0015950971],"category_scores_gemma":[0.0010246651,0.00014378305,0.00034951756,0.00017622617,0.00022570818,0.00012450582,0.00009458835,0.00021197143,0.00016934179],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.108657,0.0021677767,0.36276883,0.0005302098,0.0013471107,0.0014526412,0.00032305566,0.00063078315,0.37946546,0.00015820425,0.0006448005,0.14185409],"study_design_scores_gemma":[0.00089766295,0.026918303,0.9497904,0.000012712524,0.00036684383,0.0014074577,0.000056117147,0.0005132569,0.018986434,0.000043829048,0.0009938459,0.00001298699],"about_ca_topic_score_codex":0.00026986352,"about_ca_topic_score_gemma":0.0005522907,"teacher_disagreement_score":0.0015950971,"about_ca_system_score_codex":0.00010448279,"about_ca_system_score_gemma":0.00007551151,"threshold_uncertainty_score":0.0053361654},"labels":[],"label_agreement":null},{"id":"W2150283025","doi":"10.1177/0091270008319465","title":"Pharmacokinetics of High‐Dose Abetimus Sodium in Normal Subjects With Specific Assessment of Effect on Coagulation","year":2008,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital","funders":"","keywords":"Partial thromboplastin time; Pharmacokinetics; Medicine; Pharmacology; Prothrombin time; Adverse effect; Placebo; Thromboplastin; Dose; Dose–response relationship; Coagulation; Internal medicine","score_opus":0.07607168347934419,"score_gpt":0.4454504800145086,"score_spread":0.3693787965351644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150283025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998073,0.00065575645,0.000611585,0.00002386903,0.000007516578,0.000053649674,0.00005353136,0.00003735616,0.0004837747],"genre_scores_gemma":[0.99858725,0.00024007437,0.000502727,0.000054089804,0.000021956284,0.000055105942,0.00009882538,0.00000726711,0.00043285362],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997875,0.000102625374,0.0000115269595,0.000036539725,0.000042183256,0.000019545103],"domain_scores_gemma":[0.9996996,0.00010467811,0.00006119245,0.00003270854,0.000035681463,0.00006623723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003689004,0.00034697726,0.00055260875,0.00019418019,0.00020657075,0.00027879677,0.00011555205,0.00038840936,0.0007339421],"category_scores_gemma":[0.00088531256,0.0002458718,0.00015837369,0.0001592072,0.00026805367,0.00019012684,0.000092561284,0.00054817507,0.00026541724],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.112390354,0.008487025,0.12580977,0.00033017495,0.0004918002,0.0024995524,0.0010192223,0.0019069001,0.6161376,0.00027453902,0.0017924305,0.12886055],"study_design_scores_gemma":[0.006890186,0.32710776,0.5347279,0.00003864819,0.00063079165,0.010524516,0.0003204367,0.008601586,0.104487225,0.00044683827,0.0061385534,0.000085611406],"about_ca_topic_score_codex":0.00047441138,"about_ca_topic_score_gemma":0.0004107591,"teacher_disagreement_score":0.0007339421,"about_ca_system_score_codex":0.00017831278,"about_ca_system_score_gemma":0.00020202578,"threshold_uncertainty_score":0.0024552941},"labels":[],"label_agreement":null},{"id":"W2153132143","doi":"10.1002/jcph.526","title":"Evaluation of the effect of food and gastric pH on the single‐dose pharmacokinetics of cabozantinib in healthy adult subjects","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Exelixis","keywords":"Cabozantinib; Pharmacokinetics; Esomeprazole; Bioavailability; Tyrosine-kinase inhibitor; Medicine; Pharmacology; Medullary thyroid cancer; Gastroenterology; Concomitant; Drug interaction; Internal medicine; Drug; Cancer; Thyroid cancer","score_opus":0.12958508742111535,"score_gpt":0.44994349247232857,"score_spread":0.3203584050512132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153132143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974222,0.00084112276,0.00041003997,0.000036156525,0.000018886423,0.00012008314,0.0002742394,0.000021582699,0.0008556532],"genre_scores_gemma":[0.99861777,0.00021779616,0.00035614325,0.00009497811,0.000026947699,0.00006332447,0.00025283403,0.0000070271403,0.00036315736],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99909747,0.00034171744,0.000058907794,0.00021323854,0.00022816671,0.00006039062],"domain_scores_gemma":[0.9984909,0.0005465309,0.0003401656,0.0001183112,0.00021545835,0.00028859515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012297694,0.00055043085,0.0009059048,0.0002821707,0.0003673275,0.00040260647,0.00018387659,0.0006474948,0.0010558411],"category_scores_gemma":[0.003003512,0.0003112959,0.00042463074,0.00032327,0.0003358507,0.00036135383,0.00020198378,0.0004959386,0.0003378119],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10095832,0.005573847,0.78545326,0.00038430962,0.0013044674,0.0015121744,0.0007087317,0.0008531596,0.054135896,0.00013108306,0.0008590765,0.04812569],"study_design_scores_gemma":[0.000683558,0.046747062,0.94543165,0.000006383077,0.00035703255,0.0010174273,0.000112558046,0.0010603721,0.0037003737,0.00005190378,0.0008107611,0.000020764313],"about_ca_topic_score_codex":0.0012120971,"about_ca_topic_score_gemma":0.0010844573,"teacher_disagreement_score":0.0012297694,"about_ca_system_score_codex":0.0002763444,"about_ca_system_score_gemma":0.00028322078,"threshold_uncertainty_score":0.006503701},"labels":[],"label_agreement":null},{"id":"W2153400265","doi":"10.1177/0091270011405524","title":"Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Escitalopram; Medicine; Prospective cohort study; Pregnancy; Cohort study; Cohort; Obstetrics; Internal medicine; Psychiatry; Anxiety; Antidepressant","score_opus":0.2805889978629389,"score_gpt":0.49912108651699827,"score_spread":0.21853208865405938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153400265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99929583,0.00014314111,0.000057575264,0.000016113547,0.0000039052875,0.000018613859,0.00028934388,0.000001168325,0.00017422275],"genre_scores_gemma":[0.9990108,0.00022752373,0.00011068273,0.000032580192,0.0000075883354,0.000027371767,0.00043701456,0.00000190519,0.00014442566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990951,0.00025681022,0.000093191265,0.00023829815,0.00016505532,0.00015164814],"domain_scores_gemma":[0.99827576,0.0003627738,0.00058995036,0.00023993562,0.00022376001,0.0003079031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012945882,0.00032581642,0.0004262881,0.00081839354,0.0006171004,0.00059464056,0.00046133535,0.0007516136,0.0010412551],"category_scores_gemma":[0.003237586,0.0006520533,0.00082240003,0.0013409307,0.00024260959,0.0005578213,0.0004838334,0.00079629535,0.00020649195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025679194,0.000084197585,0.9983668,0.000008151575,0.0001508262,0.00017020582,0.00011556398,0.000016144535,0.00016923984,0.000012647856,0.00004318533,0.0006063027],"study_design_scores_gemma":[0.000025903615,0.00030917607,0.9989312,0.0000063222647,0.000070883674,0.00030715647,0.00017484165,0.000060757764,0.000026780177,0.000008583687,0.000073064046,0.000005223537],"about_ca_topic_score_codex":0.013006581,"about_ca_topic_score_gemma":0.010184351,"teacher_disagreement_score":0.013006581,"about_ca_system_score_codex":0.00040716672,"about_ca_system_score_gemma":0.0004659844,"threshold_uncertainty_score":0.02586174},"labels":[],"label_agreement":null},{"id":"W2153778965","doi":"10.1002/jcph.570","title":"Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shriners Hospitals for Children - Canada","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Kyowa Hakko Kirin; University of California, San Francisco; Shriners Hospitals for Children; Yale University","keywords":"Pharmacokinetics; Pharmacodynamics; Hypophosphatemia; Medicine; Pharmacology; Monoclonal antibody; Antibody; Internal medicine; Immunology","score_opus":0.08344190394491893,"score_gpt":0.4537382079247536,"score_spread":0.3702963039798347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153778965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790645,0.0009204794,0.00021492744,0.00009250095,0.000022779246,0.00019349567,0.000110754976,0.000025641895,0.0005130769],"genre_scores_gemma":[0.9976412,0.00046083712,0.00058485003,0.00014102038,0.000036787893,0.00028036506,0.00018304403,0.000008638834,0.0006632028],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995534,0.00024714135,0.000019355815,0.00007114508,0.00005541694,0.000053618227],"domain_scores_gemma":[0.99954104,0.00013788429,0.000080735896,0.000027275104,0.000033308577,0.00017972424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093875977,0.00072882033,0.0012976787,0.00021133212,0.00021603281,0.00058047887,0.00034840027,0.0007879707,0.0008528384],"category_scores_gemma":[0.0015392782,0.0003383958,0.00053785666,0.00014705479,0.0004415479,0.0004737789,0.00019809484,0.0016018554,0.00023108457],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7938336,0.019143706,0.008947361,0.0003724231,0.0010483679,0.00040184104,0.00038257442,0.0040386594,0.04973481,0.00024232049,0.0015065103,0.12034787],"study_design_scores_gemma":[0.20962074,0.73811406,0.035066415,0.00004321143,0.0006041453,0.0006051298,0.00007549155,0.0040336144,0.0083210245,0.00020468759,0.0032556478,0.000055927427],"about_ca_topic_score_codex":0.0009171619,"about_ca_topic_score_gemma":0.0014724398,"teacher_disagreement_score":0.0012976787,"about_ca_system_score_codex":0.0005449597,"about_ca_system_score_gemma":0.0005894363,"threshold_uncertainty_score":0.0049647093},"labels":[],"label_agreement":null},{"id":"W2155235311","doi":"10.1177/0091270009355155","title":"Operating Characteristics of a Partial‐Block Randomized Crossover Bioequivalence Study for Dutasteride, a Drug with a Long Half‐Life: Investigation Through Simulation and Comparison with Final Results","year":2010,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Bioequivalence; Crossover study; Dutasteride; Crossover; Medicine; Randomized controlled trial; Block (permutation group theory); Sample size determination; Mathematics; Computer science; Pharmacology; Statistics; Pharmacokinetics; Surgery; Internal medicine; Machine learning; Placebo","score_opus":0.5556653165397538,"score_gpt":0.6166235713161934,"score_spread":0.06095825477643957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155235311","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8598682,0.00094879925,0.13569003,0.00023948037,0.000031797677,0.00074548635,0.00036672293,0.0002548298,0.0018547545],"genre_scores_gemma":[0.97502816,0.00024632344,0.023426348,0.00004659347,0.000005702927,0.00048894994,0.00022476634,0.000014742637,0.0005183722],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9967018,0.0024694176,0.00012256588,0.00024723148,0.00030855904,0.00015035327],"domain_scores_gemma":[0.96088296,0.035203453,0.0019672527,0.0006828436,0.0009777542,0.00028582072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012221095,0.00067040895,0.0014327884,0.00046546326,0.00024689885,0.000649295,0.00064086093,0.0010105156,0.0015769078],"category_scores_gemma":[0.019042052,0.00046735498,0.0013772071,0.0003031271,0.00042079418,0.00055405044,0.00038801265,0.001033519,0.0001982738],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017023642,0.0007732294,0.010102105,0.00039622563,0.0005474138,0.00017275398,0.000231013,0.93066525,0.009263925,0.003236573,0.00046287145,0.027124975],"study_design_scores_gemma":[0.0008390738,0.008095987,0.0043980638,0.000027494963,0.00022741416,0.00014298828,0.000030500252,0.98156595,0.0030651034,0.0011508496,0.0004080379,0.000048417194],"about_ca_topic_score_codex":0.0025595922,"about_ca_topic_score_gemma":0.0007788308,"teacher_disagreement_score":0.012221095,"about_ca_system_score_codex":0.00083446025,"about_ca_system_score_gemma":0.0014567717,"threshold_uncertainty_score":0.06463212},"labels":[],"label_agreement":null},{"id":"W2157210369","doi":"10.1002/jcph.387","title":"Pregnancy-induced changes in the long-term pharmacokinetics of 1.1 mg vs. 5 mg folic acid: A randomized clinical trial","year":2014,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Canadian Nutrition Society; University of Toronto; Hospital for Sick Children","funders":"Duchesnay","keywords":"Pharmacokinetics; Medicine; Pregnancy; Randomized controlled trial; Folic acid; Gestation; Gestational age; Internal medicine; Folic acid supplementation; Gastroenterology; Endocrinology; Biology","score_opus":0.18560481331910206,"score_gpt":0.5281143321011844,"score_spread":0.34250951878208236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157210369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908903,0.0029691672,0.00052453385,0.00069523754,0.0005842258,0.0030291453,0.00036050103,0.00007598932,0.00087093824],"genre_scores_gemma":[0.9849043,0.0023658662,0.0025438294,0.0011905396,0.00064890756,0.005894259,0.0004062375,0.000022659557,0.002023477],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99785835,0.0014393433,0.00012783094,0.00026540057,0.00012725756,0.00018177625],"domain_scores_gemma":[0.99756855,0.0009994571,0.0006326739,0.000198509,0.00010150274,0.0004992677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003235251,0.0013151447,0.0033169547,0.00041560846,0.0004459388,0.0009936312,0.0010632231,0.002767697,0.0045149378],"category_scores_gemma":[0.0047838367,0.00076741923,0.0013176699,0.00035685004,0.001361634,0.0009865152,0.00045484956,0.0024309244,0.0006461691],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9888467,0.004355257,0.00015737445,0.00016461086,0.00019944791,0.000018801633,0.0000180043,0.00008343838,0.0012853934,0.000045516856,0.00010479621,0.0047206418],"study_design_scores_gemma":[0.8798621,0.11826385,0.00068405835,0.000020229201,0.00024077347,0.000020402973,0.000012560069,0.00024372317,0.00031669505,0.00008820405,0.00023503767,0.000012433848],"about_ca_topic_score_codex":0.0005894467,"about_ca_topic_score_gemma":0.0010995154,"teacher_disagreement_score":0.0045149378,"about_ca_system_score_codex":0.00076437613,"about_ca_system_score_gemma":0.001470546,"threshold_uncertainty_score":0.01710987},"labels":[],"label_agreement":null},{"id":"W2157932545","doi":"10.1177/00912700022009558","title":"Who Needs Individual Bioequivalence Studies for Narrow Therapeutic Index Drugs? A Case for Warfarin","year":2000,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Sainte Foy","funders":"","keywords":"Bioequivalence; Warfarin; Medicine; Pharmacokinetics; Crossover study; Pharmacology; Therapeutic index; Replicate; CYP2C9; Internal medicine; Drug; Statistics; Mathematics; Placebo","score_opus":0.421124098491936,"score_gpt":0.5880239667940168,"score_spread":0.1668998683020808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157932545","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037481066,0.09648057,0.06676552,0.78139514,0.0041073593,0.00064705056,0.00017548572,0.0003642361,0.012583619],"genre_scores_gemma":[0.44027263,0.04866009,0.22385173,0.2646632,0.016606279,0.0019293388,0.0002476187,0.00044523322,0.0033238556],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8584155,0.09531488,0.011521415,0.0067906175,0.025919564,0.0020379645],"domain_scores_gemma":[0.68871415,0.2358036,0.0150881875,0.028481731,0.025731008,0.0061812634],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.26738182,0.0008919906,0.0070125023,0.0023213173,0.0020764265,0.00637444,0.004801951,0.022100838,0.0025708827],"category_scores_gemma":[0.3001836,0.000988311,0.0034700788,0.0023067587,0.013752464,0.020724429,0.003239846,0.016202545,0.0008176496],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044942037,0.00096715335,0.02304313,0.0023343398,0.00090799003,0.0042808335,0.0028975487,0.0017195509,0.0031763632,0.07401786,0.04896589,0.83319515],"study_design_scores_gemma":[0.004149545,0.010624705,0.037854712,0.008150579,0.0016781371,0.029430322,0.007291748,0.01819642,0.0061957072,0.5793167,0.29628935,0.00082210574],"about_ca_topic_score_codex":0.001645582,"about_ca_topic_score_gemma":0.002816782,"teacher_disagreement_score":0.26738182,"about_ca_system_score_codex":0.0031283202,"about_ca_system_score_gemma":0.0058891787,"threshold_uncertainty_score":0.90344864},"labels":[],"label_agreement":null},{"id":"W2160527274","doi":"10.1177/0091270010377503","title":"Response to “Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban”","year":2011,"lang":"en","type":"letter","venue":"The Journal of Clinical Pharmacology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dosing; Rivaroxaban; Medicine; Regimen; Knee replacement; Surgery; Anesthesia; Internal medicine; Arthroplasty; Warfarin; Atrial fibrillation","score_opus":0.08548956022768175,"score_gpt":0.4107141093005324,"score_spread":0.3252245490728507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160527274","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005284402,0.0020224282,0.000299293,0.87792045,0.11379941,0.00018495061,0.00069917156,0.0002942136,0.0042516636],"genre_scores_gemma":[0.0015277597,0.0013247716,0.00029194157,0.9234979,0.0660379,0.00014337664,0.00018191557,0.00008175583,0.006912653],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958002,0.0007586868,0.0008880371,0.00073883985,0.0012918202,0.0005224047],"domain_scores_gemma":[0.9894748,0.0041414998,0.00095583906,0.00038232008,0.003809849,0.0012357745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004762124,0.0021737888,0.002879042,0.0011718951,0.003253071,0.0035096798,0.0038013184,0.037121255,0.018121196],"category_scores_gemma":[0.02081475,0.0011033671,0.002836039,0.0012976225,0.00278131,0.0032320188,0.0018085275,0.033395495,0.018638624],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013110864,0.000034409975,0.00020078654,0.00018838959,0.000019168168,0.00024932087,0.000042764477,0.000042243213,0.00014686637,0.0004043367,0.99397707,0.004563433],"study_design_scores_gemma":[0.00032025075,0.00014641846,0.0027339559,0.00084256916,0.000064014486,0.00054942176,0.00035850974,0.0003421213,0.00049811025,0.0014708267,0.9925857,0.00008818031],"about_ca_topic_score_codex":0.005844267,"about_ca_topic_score_gemma":0.00690967,"teacher_disagreement_score":0.037121255,"about_ca_system_score_codex":0.005023092,"about_ca_system_score_gemma":0.00347624,"threshold_uncertainty_score":0.06062138},"labels":[],"label_agreement":null},{"id":"W2162908443","doi":"10.1177/0091270007308615","title":"Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic‐Controlled Extended‐Release Methylphenidate Formulation in Humans","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Methylphenidate; Placebo; Stimulant; Crossover study; Pharmacodynamics; Pharmacokinetics; Pharmacology; Anesthesia; Controlled release; Medicine; Attention deficit hyperactivity disorder; Psychiatry","score_opus":0.03448215947735757,"score_gpt":0.4752178458980692,"score_spread":0.44073568642071165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162908443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758625,0.0009491942,0.00070959143,0.000039620354,0.000028938062,0.00024549075,0.00012739307,0.000016724474,0.00029680994],"genre_scores_gemma":[0.997182,0.0009584524,0.0009998934,0.00009883183,0.000051853036,0.00019370901,0.00017564288,0.0000073218393,0.00033238443],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9996767,0.00014243784,0.000021195257,0.000056629342,0.00007258001,0.000030506064],"domain_scores_gemma":[0.9996575,0.000091001086,0.00011711155,0.00003610492,0.000026082542,0.000072109266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006421755,0.00044894664,0.0006913369,0.00016191837,0.00023229847,0.00033208495,0.00021167113,0.0004554279,0.0010378357],"category_scores_gemma":[0.00091644336,0.00041494594,0.00031119058,0.00012978927,0.0004793354,0.0004807193,0.00014836564,0.0005810451,0.00019348896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33269235,0.019625608,0.0320261,0.00090291875,0.0009942891,0.0008376072,0.0007017103,0.0016254397,0.44186187,0.00027293895,0.000972529,0.16748662],"study_design_scores_gemma":[0.03472909,0.6991103,0.19499125,0.00004610435,0.0009276565,0.0026550975,0.00029167716,0.0046854573,0.057427496,0.00023923742,0.0047970023,0.000099701036],"about_ca_topic_score_codex":0.00037861842,"about_ca_topic_score_gemma":0.0006291236,"teacher_disagreement_score":0.0010378357,"about_ca_system_score_codex":0.00018207282,"about_ca_system_score_gemma":0.00033529004,"threshold_uncertainty_score":0.003471911},"labels":[],"label_agreement":null},{"id":"W2164900475","doi":"10.1177/0091270007305504","title":"Ciprofloxacin Prolonged‐Release Tablets Do Not Affect Warfarin Pharmacokinetics and Pharmacodynamics","year":2007,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Pharmacokinetics; Warfarin; Pharmacodynamics; Ciprofloxacin; Crossover study; Medicine; Pharmacology; Prothrombin time; Drug interaction; Partial thromboplastin time; Anticoagulant; Antibiotics; Internal medicine; Chemistry; Atrial fibrillation; Coagulation; Placebo","score_opus":0.16523373510749947,"score_gpt":0.5281118326839626,"score_spread":0.36287809757646305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164900475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983688,0.0009796132,0.00029363923,0.00004691091,0.00001448337,0.000020252974,0.000033347653,0.000012363781,0.00023061287],"genre_scores_gemma":[0.9987525,0.00036145878,0.00036975535,0.00005162912,0.000033319582,0.000008215767,0.000072506344,0.0000053045433,0.0003452394],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995377,0.00017435818,0.000034555153,0.00007373277,0.00013154595,0.000048130976],"domain_scores_gemma":[0.9990355,0.00028367896,0.00043182573,0.00007396116,0.000056220873,0.00011886941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002692475,0.00020301735,0.000638812,0.00009518127,0.00015768551,0.0002951515,0.00014041182,0.00040992742,0.0016203307],"category_scores_gemma":[0.001686534,0.00020336162,0.0003059603,0.00010095554,0.00023738798,0.00030464988,0.0001028576,0.0005695929,0.0002743011],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08793614,0.00221002,0.042245965,0.00043600565,0.00056560274,0.0017574496,0.00032027336,0.00037927245,0.71494704,0.00009942216,0.0005455898,0.14855728],"study_design_scores_gemma":[0.007858407,0.29978445,0.54818875,0.00004238304,0.0008800142,0.013404865,0.00026449718,0.0020951754,0.120001175,0.0001440947,0.007269055,0.00006709172],"about_ca_topic_score_codex":0.0003602248,"about_ca_topic_score_gemma":0.0005922447,"teacher_disagreement_score":0.0016203307,"about_ca_system_score_codex":0.00013709295,"about_ca_system_score_gemma":0.00016144663,"threshold_uncertainty_score":0.005420506},"labels":[],"label_agreement":null},{"id":"W2172198715","doi":"10.1177/0091270011407196","title":"Low‐Density Lipoprotein Cholesterol and High‐Sensitivity C‐Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; Université Laval; Canadian Respiratory Research Network; McMaster University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atorvastatin; Internal medicine; Body mass index; Medicine; Cholesterol; C-reactive protein; Simvastatin; Endocrinology; Gastroenterology; Inflammation","score_opus":0.03404934312411262,"score_gpt":0.3015063388714265,"score_spread":0.2674569957473139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172198715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987465,0.0007435496,0.000066944296,0.00006119711,0.000009875328,0.000008651258,0.00005395576,8.224674e-7,0.00030845046],"genre_scores_gemma":[0.99915624,0.0003960135,0.00010979402,0.000111727626,0.000022788816,0.000011058927,0.00011836689,0.0000014763091,0.000072590046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953413,0.00021683695,0.000058707814,0.00007440965,0.0000573729,0.000058476253],"domain_scores_gemma":[0.99904174,0.0002212477,0.00034489308,0.00008821674,0.00009611153,0.0002077229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001501983,0.00038865182,0.000689418,0.0004095464,0.00027546263,0.0005731087,0.00018852636,0.00038208056,0.0011843296],"category_scores_gemma":[0.0015557552,0.00017724671,0.0014008898,0.0007330683,0.00030320053,0.00031180857,0.0004186656,0.00042129308,0.00016830223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014702471,0.00024674975,0.97205913,0.00018001348,0.0014501687,0.0003131731,0.00041066838,0.00007136465,0.0028066405,0.000089663234,0.00012535964,0.0075446004],"study_design_scores_gemma":[0.0007146028,0.0011371574,0.99561214,0.00003052582,0.0008425155,0.00035908693,0.0004600606,0.0001891869,0.00023618028,0.00007986542,0.00032667065,0.000012019724],"about_ca_topic_score_codex":0.0015303734,"about_ca_topic_score_gemma":0.0026996417,"teacher_disagreement_score":0.0015303734,"about_ca_system_score_codex":0.00023025674,"about_ca_system_score_gemma":0.00037084715,"threshold_uncertainty_score":0.007943332},"labels":[],"label_agreement":null},{"id":"W2172262068","doi":"10.1002/jcph.552","title":"Intranasal administration of crushed ALO‐02 (extended‐release oxycodone with sequestered naltrexone): A randomized, controlled abuse‐potential study in nondependent recreational opioid users","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vale (Canada)","funders":"Pfizer","keywords":"Oxycodone; Naltrexone; Medicine; Opioid; Nasal administration; Anesthesia; Randomized controlled trial; Pharmacology; Surgery; Internal medicine","score_opus":0.04970508110535511,"score_gpt":0.40881595491288547,"score_spread":0.3591108738075304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172262068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779594,0.0003607164,0.00024211465,0.000056530025,0.00007131475,0.0011033949,0.00015269805,0.00002261918,0.00019476346],"genre_scores_gemma":[0.9933106,0.000982872,0.0013111298,0.00024205526,0.0001987264,0.002068575,0.00030333415,0.000015274627,0.0015675722],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991405,0.00038242183,0.00008013714,0.00016603759,0.00009835075,0.00013251399],"domain_scores_gemma":[0.99850994,0.0003501564,0.00035315086,0.0001802847,0.00012980319,0.00047668134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001476727,0.0012129904,0.0024015366,0.0006286513,0.0005244454,0.00076611934,0.0012322535,0.0015299938,0.0035643375],"category_scores_gemma":[0.001574155,0.0010176033,0.0012441884,0.00047006583,0.0015841939,0.0011534975,0.0005033368,0.0016506464,0.0005438918],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87555677,0.08212478,0.0011819772,0.0004669105,0.00043059306,0.00007389792,0.000120098346,0.00018724696,0.026704606,0.000069767055,0.00017637007,0.012907005],"study_design_scores_gemma":[0.407538,0.58331966,0.0047786464,0.00001697738,0.00033937843,0.00006158497,0.00007592686,0.00036654936,0.0030402807,0.00005824557,0.000375774,0.000028913502],"about_ca_topic_score_codex":0.0014455339,"about_ca_topic_score_gemma":0.0030522803,"teacher_disagreement_score":0.0035643375,"about_ca_system_score_codex":0.00057520374,"about_ca_system_score_gemma":0.0012333591,"threshold_uncertainty_score":0.01192385},"labels":[],"label_agreement":null},{"id":"W2188542029","doi":"10.1002/jcph.688","title":"Increased Risk of Adverse Renal Outcome Following Polyethylene Glycol Bowel Preparation Compared to Sodium Picosulfate","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Medicine; Bowel preparation; Polyethylene glycol; Adverse effect; Sodium; Bisacodyl; Gastroenterology; Internal medicine; Urology; Colonoscopy; Colorectal cancer; Chemistry; Cancer","score_opus":0.08141559703530282,"score_gpt":0.44902245659959833,"score_spread":0.3676068595642955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188542029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985446,0.0007682044,0.00012052741,0.00004992786,0.00001743351,0.00000804996,0.000044931494,0.0000049286477,0.00044156102],"genre_scores_gemma":[0.9993625,0.00032069566,0.000065747554,0.000030815434,0.000015182629,0.0000030069132,0.000043672317,0.0000016150877,0.00015690361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999716,0.00009350172,0.000029343724,0.000035364043,0.00006544821,0.000060436938],"domain_scores_gemma":[0.9988668,0.00024812412,0.0005654266,0.00006159699,0.000070463124,0.00018758941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035977524,0.00015767454,0.00049044745,0.00016953891,0.00021409465,0.00038918958,0.00012936942,0.00023371362,0.0014622672],"category_scores_gemma":[0.0015997149,0.00008286023,0.0007029427,0.00028946402,0.00013307911,0.00019351703,0.00025795918,0.0005476294,0.000114622315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08193876,0.0010311733,0.8491011,0.00061742694,0.0015700035,0.002293464,0.00017901478,0.00035179357,0.014952154,0.0002113669,0.000448562,0.047305007],"study_design_scores_gemma":[0.000468043,0.014340362,0.9766757,0.00008021709,0.0010538588,0.001837661,0.00024429781,0.0007490334,0.0035221197,0.0002156558,0.0007932524,0.000019825418],"about_ca_topic_score_codex":0.0006274314,"about_ca_topic_score_gemma":0.00055807765,"teacher_disagreement_score":0.0014622672,"about_ca_system_score_codex":0.00017087995,"about_ca_system_score_gemma":0.00043317475,"threshold_uncertainty_score":0.004891813},"labels":[],"label_agreement":null},{"id":"W2260994960","doi":"10.1002/jcph.710","title":"Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated With Mirtazapine","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Japan Society for the Promotion of Science; Astellas Pharma; Meiji Seika Pharma; Kyowa Hakko Kirin; Dainippon Sumitomo Pharma","keywords":"Mirtazapine; Major depressive disorder; Placebo; Hamilton Rating Scale for Depression; Internal medicine; Depressive symptoms; Insomnia; Psychology; Depression (economics); Logistic regression; Rating scale; Psychiatry; Antidepressant; Medicine; Anxiety; Cognition","score_opus":0.034127921085280365,"score_gpt":0.3922577559557528,"score_spread":0.35812983487047245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2260994960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984382,0.0009389239,0.00014017249,0.000042724227,0.000009227734,0.00003277505,0.000109081004,0.00001371016,0.00027521682],"genre_scores_gemma":[0.9989643,0.00027435346,0.00025959435,0.000041218194,0.000014442245,0.000019756988,0.00024465885,0.0000030063,0.00017872093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946696,0.00025095025,0.000074680196,0.00007313343,0.000086438085,0.000047889218],"domain_scores_gemma":[0.9973968,0.0009687385,0.0011728709,0.0001231752,0.0001073881,0.00023104757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015087309,0.00042832294,0.0011619001,0.00045523624,0.00017520864,0.00046065002,0.00026698317,0.00048835843,0.00096662855],"category_scores_gemma":[0.0037424306,0.0003457397,0.00087411905,0.0002908849,0.00017927651,0.000316669,0.00029704798,0.0009381451,0.00016778211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028756814,0.0008028538,0.9209565,0.00018971336,0.0010572448,0.0001618022,0.00016761746,0.0006885476,0.005879807,0.00002876633,0.00020517013,0.041105185],"study_design_scores_gemma":[0.00050953886,0.002592977,0.9955356,0.000015242443,0.00021934985,0.00013386214,0.0000214529,0.00046346945,0.00035348994,0.00003250298,0.00011340089,0.0000090227395],"about_ca_topic_score_codex":0.0007343139,"about_ca_topic_score_gemma":0.0020697678,"teacher_disagreement_score":0.0015087309,"about_ca_system_score_codex":0.00019905648,"about_ca_system_score_gemma":0.00020366181,"threshold_uncertainty_score":0.007979035},"labels":[],"label_agreement":null},{"id":"W2280682835","doi":"10.1002/jcph.714","title":"Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"Exelixis","keywords":"Cabozantinib; Pharmacokinetics; Medicine; Tyrosine-kinase inhibitor; Internal medicine; Adverse effect; Renal function; Gastroenterology; Dosing; Body mass index; Toxicity; Urology; Oncology; Cancer; Pharmacology","score_opus":0.06468027082223873,"score_gpt":0.4890645115591757,"score_spread":0.4243842407369369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280682835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981589,0.00093346974,0.000116704694,0.000049066824,0.0000066586726,0.000016320602,0.000054379245,0.000005540534,0.0006590081],"genre_scores_gemma":[0.99952006,0.00013857543,0.000059407503,0.0000485879,0.000008370417,0.0000046645114,0.000051984087,0.0000020224427,0.0001662845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993591,0.00033246772,0.000042645206,0.000053837484,0.00009159864,0.00012039541],"domain_scores_gemma":[0.9984548,0.0005676883,0.00031325454,0.0001673226,0.000136832,0.00036003735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011525396,0.00028770397,0.0005655077,0.00018342533,0.00020960292,0.00035937826,0.00016440148,0.00028537968,0.000986013],"category_scores_gemma":[0.001900335,0.00014977112,0.00035442758,0.00018811786,0.0003573307,0.0002851961,0.00028222665,0.00043166484,0.00014390431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2745569,0.0048099426,0.4425158,0.0004478133,0.0014151774,0.0023601817,0.00034870396,0.0021318246,0.1890692,0.00030837648,0.0007539426,0.08128222],"study_design_scores_gemma":[0.0008697913,0.026301231,0.9446793,0.000018660041,0.0005536653,0.0014062121,0.00011109448,0.0014984738,0.023096288,0.00011991826,0.001319844,0.000025385763],"about_ca_topic_score_codex":0.0016066846,"about_ca_topic_score_gemma":0.0020914585,"teacher_disagreement_score":0.0016066846,"about_ca_system_score_codex":0.00031792134,"about_ca_system_score_gemma":0.00043449257,"threshold_uncertainty_score":0.00609529},"labels":[],"label_agreement":null},{"id":"W2474151176","doi":"10.1002/jcph.797","title":"Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute of Mental Health; National Institute of Child Health and Human Development; Canadian Institutes of Health Research; U.S. Food and Drug Administration; Biomedical Advanced Research and Development Authority; National Institutes of Health","keywords":"Clinical pharmacology; Medicine; Pharmacy; Library science; Family medicine; Gerontology; Pharmacology","score_opus":0.07831174594227665,"score_gpt":0.4836225283893333,"score_spread":0.40531078244705665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474151176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968689,0.0016984328,0.0002521627,0.000113920585,0.000013566137,0.000004598572,0.00027027886,0.0000066740067,0.0007715409],"genre_scores_gemma":[0.9972566,0.0014300052,0.00039448723,0.00003160447,0.000009416632,0.000013409119,0.0001691013,0.000013620709,0.00068175845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994179,0.00018792055,0.000040401967,0.0001551789,0.00012120156,0.000077410405],"domain_scores_gemma":[0.99889755,0.00040038896,0.00039278707,0.000080349586,0.00009992727,0.000128964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005903302,0.00027617082,0.00036735396,0.0009642715,0.00030195576,0.00083773833,0.00035894994,0.0005742588,0.001438282],"category_scores_gemma":[0.0024321529,0.0002488595,0.00031813842,0.0008219551,0.00061276427,0.00038402787,0.000769499,0.0005303839,0.00018561754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036530737,0.00031130557,0.8162581,0.00016305482,0.0003072691,0.004041352,0.002091948,0.00087970676,0.113330394,0.001873092,0.0004596588,0.056631062],"study_design_scores_gemma":[0.000006227509,0.0002088339,0.9942526,0.00003065626,0.000039877177,0.0012050722,0.0004016055,0.00022450805,0.002595839,0.0003116935,0.0007063931,0.000016691922],"about_ca_topic_score_codex":0.0029854905,"about_ca_topic_score_gemma":0.0023565835,"teacher_disagreement_score":0.0029854905,"about_ca_system_score_codex":0.00056908635,"about_ca_system_score_gemma":0.00062323676,"threshold_uncertainty_score":0.0059362054},"labels":[],"label_agreement":null},{"id":"W2476580486","doi":"10.1002/jcph.805","title":"Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of General Medical Sciences","keywords":"Medicine; Acute kidney injury; Internal medicine; Kidney disease; Hypomagnesemia; Proton-pump inhibitor; Demographics; Cohort; Nephrology; Intensive care medicine","score_opus":0.05646454235980046,"score_gpt":0.4564304335668288,"score_spread":0.3999658912070283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476580486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947541,0.002229565,0.0003226684,0.00044780064,0.000085856904,0.000016688049,0.0008018699,0.000014084466,0.0013274516],"genre_scores_gemma":[0.99918884,0.0001941144,0.00009043219,0.00006339157,0.00005483034,0.0000043990767,0.00027857945,0.000003197004,0.00012221854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872005,0.00044295445,0.00012651904,0.00023640611,0.00025230568,0.00022172723],"domain_scores_gemma":[0.99314064,0.0013751554,0.0034213453,0.00038938384,0.00049301283,0.001180426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010954234,0.00039805938,0.00048356043,0.00044493563,0.00040217416,0.0011204525,0.00058666023,0.00081362086,0.0036702866],"category_scores_gemma":[0.006634265,0.00033948704,0.0012345744,0.0008184937,0.00039477015,0.0005583937,0.00081332744,0.0014544118,0.0002780776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004414686,0.000037696493,0.99749714,0.000036763468,0.0002801239,0.0001452255,0.000015636904,0.000057180347,0.00021284255,0.000041266412,0.0002751471,0.00095949846],"study_design_scores_gemma":[0.000025922216,0.00012466253,0.9983576,0.000023431681,0.00017719164,0.00027866723,0.000059135997,0.0005302056,0.00006808135,0.00008228397,0.00026729048,0.000005423238],"about_ca_topic_score_codex":0.0038955368,"about_ca_topic_score_gemma":0.0036488685,"teacher_disagreement_score":0.0038955368,"about_ca_system_score_codex":0.0002985425,"about_ca_system_score_gemma":0.0007870132,"threshold_uncertainty_score":0.012278318},"labels":[],"label_agreement":null},{"id":"W2496244196","doi":"10.1002/jcph.691","title":"Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?","year":2016,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Transporter; Drug; Drug development; Pharmacology; Efflux; Computational biology; ATP-binding cassette transporter; Personalized medicine; Drug discovery; Biology; Medicine; Bioinformatics; Genetics; Gene","score_opus":0.1425352898254683,"score_gpt":0.5002124890627286,"score_spread":0.3576771992372604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496244196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022603793,0.99806505,0.000105929816,0.0009343893,0.000104347215,0.0000022905379,0.0000107625,0.0000031064387,0.00054808694],"genre_scores_gemma":[0.0026345116,0.99629945,0.00018906943,0.00040179724,0.00022711363,0.000005313816,0.000015932505,0.00000161746,0.00022517373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923587,0.00027452147,0.00012231735,0.00010447461,0.00021794924,0.00004484595],"domain_scores_gemma":[0.997017,0.002264122,0.00027943368,0.000049139115,0.00032828606,0.00006199173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016546431,0.00047291367,0.0017461476,0.0007779844,0.00015024572,0.0011967631,0.0007990645,0.0012825717,0.0031617905],"category_scores_gemma":[0.0037077654,0.0002154361,0.0007758859,0.001061086,0.00064567296,0.0012629511,0.0004425065,0.0018639526,0.0009745553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015237591,0.00005370247,0.0008327261,0.015534777,0.00023672373,0.0003733705,0.00005656646,0.00037436132,0.000924718,0.00391213,0.012634419,0.9649141],"study_design_scores_gemma":[0.0001056678,0.0005549686,0.005770174,0.017436992,0.0011336689,0.0059685633,0.0001799528,0.00042338143,0.0016784912,0.007519008,0.95917016,0.0000590076],"about_ca_topic_score_codex":0.00078877946,"about_ca_topic_score_gemma":0.0014893919,"teacher_disagreement_score":0.0031617905,"about_ca_system_score_codex":0.00060877757,"about_ca_system_score_gemma":0.0013828955,"threshold_uncertainty_score":0.010577261},"labels":[],"label_agreement":null},{"id":"W2520297993","doi":"10.1002/jcph.828","title":"Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Bayer","keywords":"Tolerability; Medicine; Placebo; Agonist; Ejection fraction; Partial agonist; Heart failure; Adenosine; Anesthesia; Cardiology; Heart rate; Internal medicine; Blood pressure; Adverse effect; Receptor","score_opus":0.024958583913106833,"score_gpt":0.3546411885409498,"score_spread":0.32968260462784293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520297993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772006,0.001602252,0.00013803321,0.000058140457,0.000012820162,0.000041180956,0.00008276817,0.0000070382534,0.00033771474],"genre_scores_gemma":[0.9987386,0.00050627504,0.00019106054,0.00013494577,0.00007806435,0.000050595932,0.00015670953,0.0000025244437,0.00014123692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996424,0.0001499991,0.000046931887,0.000054249707,0.000071587565,0.000034852044],"domain_scores_gemma":[0.9988248,0.00042099794,0.00032714484,0.00007107254,0.00010992521,0.000245993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008631776,0.0004494894,0.00096040824,0.00019137819,0.00030369437,0.00034084113,0.00015228882,0.0004706965,0.00074153877],"category_scores_gemma":[0.00152083,0.00019322387,0.0005584075,0.00016554572,0.0003461696,0.00032629698,0.00016552441,0.0006721251,0.00016684056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2978324,0.012162,0.31664118,0.0012778363,0.0018389474,0.00201699,0.0015708827,0.0015861928,0.1326592,0.00014136435,0.0010266621,0.23124631],"study_design_scores_gemma":[0.029964937,0.38390794,0.572148,0.00007545773,0.0010312059,0.0018810645,0.00035624404,0.001489664,0.006545539,0.00008703289,0.0024495975,0.00006330382],"about_ca_topic_score_codex":0.00038354014,"about_ca_topic_score_gemma":0.0005918621,"teacher_disagreement_score":0.00096040824,"about_ca_system_score_codex":0.00018675833,"about_ca_system_score_gemma":0.00025366643,"threshold_uncertainty_score":0.0045650005},"labels":[],"label_agreement":null},{"id":"W2526766920","doi":"10.1002/jcph.833","title":"Oral Human Abuse Potential of Oxycodone DETERx<sup>®</sup>(Xtampza<sup>®</sup>ER)","year":2016,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; University of Toronto","funders":"","keywords":"Oxycodone; Oxymorphone; Medicine; Morphine; Placebo; Pharmacology; Anesthesia; Pharmacokinetics; Opioid; Internal medicine","score_opus":0.05726826766494194,"score_gpt":0.41920358808748787,"score_spread":0.36193532042254595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526766920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987362,0.0007464855,0.00012433891,0.000018952327,0.000012435819,0.000058621128,0.0000846369,0.000005034891,0.00021333185],"genre_scores_gemma":[0.99809057,0.00072567794,0.00030045013,0.000053065232,0.000026895614,0.000052797743,0.00013348782,0.00000260652,0.0006143728],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997942,0.00009501041,0.000014940814,0.000029246166,0.00004226327,0.000024373736],"domain_scores_gemma":[0.99966526,0.00011008445,0.00009647299,0.000030056235,0.000030281428,0.000067855355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045021254,0.0002757643,0.00041353286,0.00009514534,0.0001140396,0.00024053117,0.0001414595,0.00022598963,0.0026358264],"category_scores_gemma":[0.00045735648,0.00015503542,0.00025092278,0.00007894945,0.00029111127,0.0002251706,0.00011287775,0.00040502517,0.00021631047],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33201537,0.016088048,0.016802413,0.00088840746,0.00059111876,0.00053020933,0.00029711175,0.0006205329,0.49667805,0.00034945874,0.0008082106,0.134331],"study_design_scores_gemma":[0.01761951,0.8162458,0.07856324,0.0000626665,0.00054293184,0.0010940635,0.00022479416,0.001235538,0.08102632,0.000088514455,0.0032695537,0.000026990287],"about_ca_topic_score_codex":0.0004390012,"about_ca_topic_score_gemma":0.0006817192,"teacher_disagreement_score":0.0026358264,"about_ca_system_score_codex":0.00013209789,"about_ca_system_score_gemma":0.00026261888,"threshold_uncertainty_score":0.008817732},"labels":[],"label_agreement":null},{"id":"W2582949731","doi":"10.1002/jcph.868","title":"Preliminary Evidence for the Off-Label Treatment of Bulimia Nervosa With Psychostimulants: Six Case Reports","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Bulimia nervosa; Binge eating; Psychiatry; Anorexia nervosa; Body mass index; Psychology; Eating disorders; Appetite; Binge-eating disorder; Medicine; Internal medicine","score_opus":0.2813980952795472,"score_gpt":0.5564495400787205,"score_spread":0.2750514447991733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582949731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.945176,0.03317329,0.0040367176,0.0019491009,0.00033226257,0.00023746562,0.00020441807,0.00019641884,0.01469435],"genre_scores_gemma":[0.9834358,0.010596733,0.0018959545,0.00101426,0.00054746744,0.00009007728,0.00029914096,0.00003493643,0.0020856312],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9985103,0.00037101202,0.00047288492,0.00013216356,0.0003510883,0.00016247004],"domain_scores_gemma":[0.98622,0.008032689,0.0030642003,0.001232545,0.0008859741,0.0005644972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013879726,0.00072788494,0.00043660233,0.0011607226,0.0010407259,0.0012577598,0.0008676296,0.0027470735,0.0036155994],"category_scores_gemma":[0.011729025,0.0004539343,0.0013376283,0.00070686487,0.0017453989,0.00083889696,0.00066626817,0.0014772295,0.0013623207],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036214145,0.0017091226,0.41944918,0.0021633673,0.000628609,0.3970065,0.004371131,0.0004458309,0.011484062,0.0017440275,0.0031369962,0.1542397],"study_design_scores_gemma":[0.0002870461,0.0041351616,0.09848338,0.00047655412,0.00086650834,0.8619906,0.0016003094,0.0005740197,0.008554276,0.00057577086,0.02237451,0.0000818651],"about_ca_topic_score_codex":0.0012868403,"about_ca_topic_score_gemma":0.001789971,"teacher_disagreement_score":0.0036155994,"about_ca_system_score_codex":0.0005205505,"about_ca_system_score_gemma":0.00063689036,"threshold_uncertainty_score":0.012095332},"labels":[],"label_agreement":null},{"id":"W2614817248","doi":"10.1002/jcph.931","title":"Effect of Steady‐State Faldaprevir on Pharmacokinetics of Atorvastatin or Rosuvastatin in Healthy Volunteers: A Prospective Open‐Label, Fixed‐Sequence Crossover Study","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Rosuvastatin; Atorvastatin; Crossover study; Pharmacokinetics; Crossover; Pharmacology; Medicine; Mathematics; Computer science; Artificial intelligence","score_opus":0.25938220810295654,"score_gpt":0.6031953930390901,"score_spread":0.34381318493613355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614817248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813193,0.0003676103,0.00047361184,0.0000327259,0.00007755494,0.00046459225,0.00021302026,0.00004226509,0.0001966363],"genre_scores_gemma":[0.9969393,0.00019105001,0.00095531845,0.0001354626,0.00013548238,0.00065049954,0.00037295034,0.000021274574,0.0005986591],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9975446,0.0012393708,0.0001681932,0.000484054,0.00025074175,0.00031306836],"domain_scores_gemma":[0.9977082,0.000550361,0.00045202175,0.00038741992,0.00020074418,0.00070119346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003406813,0.0015425215,0.0030987214,0.00048907934,0.000701273,0.0009767886,0.0006738391,0.0016709237,0.002806864],"category_scores_gemma":[0.0028215179,0.0011127277,0.0018976117,0.00043760904,0.001375515,0.001240777,0.0004399304,0.0020503572,0.0007477094],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9427668,0.023475152,0.0035776766,0.00010032109,0.0005847408,0.000044506814,0.000084647785,0.00024375295,0.020505305,0.00002781919,0.00018173896,0.008407556],"study_design_scores_gemma":[0.16652592,0.7918831,0.032716084,0.000011964289,0.0007372757,0.00009241201,0.000058098503,0.001177135,0.006099801,0.0000979837,0.0005403936,0.00005981518],"about_ca_topic_score_codex":0.00070282683,"about_ca_topic_score_gemma":0.0007154949,"teacher_disagreement_score":0.003406813,"about_ca_system_score_codex":0.0005030866,"about_ca_system_score_gemma":0.0008501852,"threshold_uncertainty_score":0.018017113},"labels":[],"label_agreement":null},{"id":"W2740384019","doi":"10.1002/jcph.979","title":"Pharmacokinetics and Safety of Brexpiprazole Following Multiple‐Dose Administration to Japanese Patients With Schizophrenia","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Otsuka Pharmaceutical","keywords":"Pharmacokinetics; Medicine; Pharmacology; Adverse effect; CYP2D6; Internal medicine; Cytochrome P450","score_opus":0.04972760625445495,"score_gpt":0.4251193734943682,"score_spread":0.37539176723991324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740384019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992255,0.00044280646,0.00009623597,0.000027842592,0.00000397766,0.000017804803,0.000034757104,0.0000053929125,0.00014562899],"genre_scores_gemma":[0.9992556,0.00025063154,0.00020150893,0.00004191042,0.0000061399196,0.000013360889,0.000056410514,0.0000015196903,0.00017282668],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99990404,0.000031647964,0.000009824598,0.00001737637,0.000022733107,0.000014334842],"domain_scores_gemma":[0.9997714,0.000033509867,0.00008501504,0.000015371195,0.000039076367,0.000055631906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032812753,0.00021031179,0.0005437303,0.00012261423,0.00022411872,0.00019991146,0.00010590445,0.00021248887,0.00060544815],"category_scores_gemma":[0.00052732887,0.00013240395,0.00032455713,0.0001500872,0.00015482653,0.00021446854,0.000122019155,0.00049416145,0.00013139151],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09429834,0.004594543,0.30051693,0.00072800746,0.001345446,0.001431817,0.0014896111,0.0018571008,0.37719977,0.00014046568,0.0017527251,0.21464531],"study_design_scores_gemma":[0.0044105044,0.10499976,0.86352587,0.000067398934,0.0010303328,0.0023741026,0.00069376506,0.0035136787,0.01539669,0.00007666554,0.0038502428,0.000061022693],"about_ca_topic_score_codex":0.0015863185,"about_ca_topic_score_gemma":0.002997284,"teacher_disagreement_score":0.0015863185,"about_ca_system_score_codex":0.0002717294,"about_ca_system_score_gemma":0.00026140656,"threshold_uncertainty_score":0.0031541586},"labels":[],"label_agreement":null},{"id":"W2761037621","doi":"10.1002/jcph.1024","title":"Improving Therapeutics to Better Care for Older Adults and the Young: Report From the American College of Clinical Pharmacology Workshop","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Baby boom; Life expectancy; Context (archaeology); Medicine; Population; Pediatrics; Population ageing; Gerontology; Environmental health; Geography","score_opus":0.15446826702004562,"score_gpt":0.5421725688643844,"score_spread":0.38770430184433874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761037621","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010854707,0.100560725,0.00065290334,0.82096887,0.055459563,0.00026122297,0.00047875335,0.0001864937,0.020346045],"genre_scores_gemma":[0.013093779,0.2596438,0.003932515,0.61178935,0.06888873,0.0008900186,0.001592255,0.00020189786,0.039967798],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913863,0.0015259483,0.00068699574,0.0007260842,0.004602602,0.0010720829],"domain_scores_gemma":[0.9782639,0.0027392842,0.0010535878,0.00057672773,0.0075988076,0.009767605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016923003,0.0016213367,0.0008537926,0.0014395418,0.0028439048,0.005624859,0.0031738153,0.01229174,0.008585526],"category_scores_gemma":[0.014848771,0.0007108383,0.0014788603,0.0019182613,0.0013685282,0.0052607073,0.00515113,0.019544564,0.0058229263],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004061218,0.00017026362,0.00036142187,0.00025697125,0.000014200907,0.00012078278,0.00008701259,0.000052396874,0.00017414513,0.00090227084,0.950116,0.04770403],"study_design_scores_gemma":[0.000062562794,0.000083097664,0.0016522785,0.0010973302,0.000017357244,0.00021187802,0.00017311049,0.00008372369,0.00016957274,0.0006328598,0.9957885,0.000027726086],"about_ca_topic_score_codex":0.008282694,"about_ca_topic_score_gemma":0.014032526,"teacher_disagreement_score":0.016923003,"about_ca_system_score_codex":0.004460229,"about_ca_system_score_gemma":0.030753952,"threshold_uncertainty_score":0.0894984},"labels":[],"label_agreement":null},{"id":"W2767708353","doi":"10.1002/jcph.1029","title":"Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque Psoriasis","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"U.S. Food and Drug Administration; Wyeth; Pfizer","keywords":"Etanercept; Medicine; Psoriasis; Psoriasis Area and Severity Index; Dosing; Pharmacokinetics; Pharmacodynamics; Immunogenicity; Internal medicine; Arthritis; Body mass index; Gastroenterology; Immunology; Antibody; Rheumatoid arthritis","score_opus":0.049130363699124276,"score_gpt":0.41819186797543706,"score_spread":0.3690615042763128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767708353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884075,0.00065971026,0.0001822567,0.000021045476,0.000001939796,0.000011200547,0.000058144124,0.0000056600957,0.00021935347],"genre_scores_gemma":[0.9990237,0.0004296255,0.00026183264,0.00004042275,0.000008377422,0.000012490491,0.00013819999,0.0000037219208,0.00008173746],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997036,0.0001301732,0.000023313274,0.0000369333,0.00007120593,0.00003479357],"domain_scores_gemma":[0.99924636,0.00030107817,0.00026653477,0.00003822129,0.000061438426,0.000086354674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057302456,0.0001935541,0.00046805808,0.00014940555,0.00013526864,0.00030431114,0.00008188863,0.00016792344,0.00046586493],"category_scores_gemma":[0.0015821719,0.00015826953,0.00023362362,0.00020009643,0.00017255115,0.0002970899,0.00008853799,0.00048747152,0.00012822088],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015162906,0.0012608765,0.8515583,0.00019361818,0.0002946858,0.0019549914,0.0005550919,0.001842467,0.05503933,0.00019038169,0.0008556802,0.07109178],"study_design_scores_gemma":[0.0007840282,0.019585408,0.95711756,0.000030256946,0.0002768196,0.0072099953,0.00027599029,0.002081855,0.010184843,0.00010946187,0.0023280887,0.000015781034],"about_ca_topic_score_codex":0.00059450604,"about_ca_topic_score_gemma":0.00060967647,"teacher_disagreement_score":0.00059450604,"about_ca_system_score_codex":0.00031447512,"about_ca_system_score_gemma":0.00030576784,"threshold_uncertainty_score":0.003030479},"labels":[],"label_agreement":null},{"id":"W2778907143","doi":"10.1002/jcph.1051","title":"Population Pharmacokinetic– Pharmacodynamic Analysis to Characterize the Effect of Empagliflozin on Renal Glucose Threshold in Patients With Type 1 Diabetes Mellitus","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Empagliflozin; Medicine; Pharmacodynamics; Renal glucose reabsorption; Placebo; Internal medicine; Diabetes mellitus; Population; Endocrinology; Renal function; Type 2 Diabetes Mellitus; Pharmacokinetics; Type 2 diabetes; Pharmacology; Urology","score_opus":0.026713679420603053,"score_gpt":0.3810745709882775,"score_spread":0.3543608915676745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778907143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554812,0.0008605683,0.041329347,0.00022262533,0.000020513637,0.00016909296,0.00050568563,0.00016237769,0.0012486309],"genre_scores_gemma":[0.9972499,0.0000742321,0.002219915,0.00006612662,0.000007196472,0.0000490292,0.00021366279,0.000006364063,0.00011343985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987644,0.000815011,0.000050078204,0.00018052697,0.00013958148,0.000050391813],"domain_scores_gemma":[0.9959655,0.0030468968,0.00048645388,0.0002738958,0.00012781424,0.00009937243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004137688,0.0005834058,0.0013167207,0.00044838613,0.00012832276,0.0007831995,0.00040181607,0.00060632156,0.00090477336],"category_scores_gemma":[0.008042312,0.00030898754,0.0018389261,0.00032080067,0.0002040379,0.0004759595,0.0003892614,0.0010517626,0.00012994728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024586437,0.0022248055,0.53428835,0.00031558503,0.008271936,0.00089599023,0.00030884036,0.34725034,0.01084988,0.0019337734,0.0013632505,0.067710854],"study_design_scores_gemma":[0.00068554276,0.0070423703,0.19391955,0.00002563041,0.0015652131,0.0006640587,0.000077509925,0.7901111,0.0026037993,0.0021319422,0.0011171947,0.000056094086],"about_ca_topic_score_codex":0.001227702,"about_ca_topic_score_gemma":0.000452665,"teacher_disagreement_score":0.004137688,"about_ca_system_score_codex":0.0004866556,"about_ca_system_score_gemma":0.00046995922,"threshold_uncertainty_score":0.021882474},"labels":[],"label_agreement":null},{"id":"W2790919647","doi":"10.1002/jcph.1094","title":"Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"Merck","keywords":"Posaconazole; Voriconazole; Tolerability; Medicine; Pharmacokinetics; Pharmacology; Azole; Internal medicine; Antifungal; Adverse effect; Dermatology","score_opus":0.13227700090648814,"score_gpt":0.48705294376907643,"score_spread":0.3547759428625883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790919647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756074,0.001449529,0.00016586788,0.000032983135,0.000016812015,0.00006899259,0.00012862375,0.0000130978815,0.0005634513],"genre_scores_gemma":[0.99841595,0.0004411157,0.00019068687,0.00013000192,0.000048085443,0.000047097048,0.00015381312,0.000005217787,0.0005680767],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995777,0.00017613439,0.000029588906,0.00010101476,0.00006518943,0.0000503828],"domain_scores_gemma":[0.9995485,0.00014227815,0.00010111657,0.000030941243,0.000045898585,0.00013120445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071146525,0.00029343914,0.000924945,0.00013943012,0.00025556915,0.00050701905,0.0001174303,0.00044984237,0.0010373712],"category_scores_gemma":[0.0012912103,0.0003056466,0.0004233275,0.00021342633,0.0003416041,0.00040626992,0.00013216758,0.0005302282,0.00029458784],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4421366,0.0140895,0.22901197,0.0007561229,0.0024264413,0.0026393726,0.0015034934,0.0027385547,0.17373161,0.00026567714,0.0020964274,0.12860426],"study_design_scores_gemma":[0.012800468,0.39215264,0.572258,0.00005351925,0.0018758917,0.0022368222,0.00045672045,0.003406158,0.011208479,0.00021927788,0.003237923,0.00009413691],"about_ca_topic_score_codex":0.0014820413,"about_ca_topic_score_gemma":0.0013175268,"teacher_disagreement_score":0.0014820413,"about_ca_system_score_codex":0.00027571697,"about_ca_system_score_gemma":0.00028441625,"threshold_uncertainty_score":0.0037626624},"labels":[],"label_agreement":null},{"id":"W2791625572","doi":"10.1002/jcph.1073","title":"The Drug–Drug Interaction Profile of Presatovir","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Respiratory viral infections research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"Gilead Sciences","keywords":"CYP3A; Pharmacology; Organic anion-transporting polypeptide; CYP3A4; Pharmacokinetics; Abcg2; P-glycoprotein; Chemistry; Drug interaction; Cobicistat; Medicine; ATP-binding cassette transporter; Transporter; Cytochrome P450; Internal medicine; Multiple drug resistance; Metabolism; Antibiotics; Immunology; Viral load; Biochemistry; Virus","score_opus":0.14830321942755476,"score_gpt":0.5645011660159464,"score_spread":0.4161979465883916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791625572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912032,0.005238253,0.00041932348,0.000118850694,0.00002415948,0.00007296888,0.00053261325,0.000030243364,0.0023604443],"genre_scores_gemma":[0.99816567,0.00059147243,0.000274696,0.000079865036,0.000015370997,0.000020910198,0.00028999153,0.0000037583925,0.00055831054],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993387,0.0002452903,0.00007383713,0.000106604486,0.00019363538,0.000041942698],"domain_scores_gemma":[0.99947673,0.00021153632,0.00014607488,0.00002738751,0.000078196295,0.000060097893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058871676,0.00023767672,0.0004792054,0.0002614006,0.00015273251,0.00042090288,0.00010766306,0.00023338896,0.002523572],"category_scores_gemma":[0.0015475139,0.00009009093,0.00034947606,0.000298565,0.00010996609,0.00029651972,0.000179935,0.00036261807,0.00026981876],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0515869,0.0024123117,0.2473898,0.0012855348,0.003983672,0.0016733779,0.00030095808,0.004082159,0.19128865,0.00071719696,0.003377758,0.4919017],"study_design_scores_gemma":[0.0018657013,0.03655922,0.79854864,0.000099237375,0.0033131933,0.0071860496,0.0002362668,0.01579919,0.1037471,0.00059826946,0.031949036,0.00009809134],"about_ca_topic_score_codex":0.0004614266,"about_ca_topic_score_gemma":0.0008518054,"teacher_disagreement_score":0.002523572,"about_ca_system_score_codex":0.00030465395,"about_ca_system_score_gemma":0.00023544338,"threshold_uncertainty_score":0.0084421635},"labels":[],"label_agreement":null},{"id":"W2800224917","doi":"10.1002/jcph.1103","title":"Multiple Doses of Rifabutin Reduce Exposure of Doravirine in Healthy Subjects","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"Merck","keywords":"Rifabutin; Pharmacokinetics; Pharmacology; Drug interaction; Rifamycin; Reverse-transcriptase inhibitor; Antibacterial agent; Medicine; Chemistry; Antibiotics; Sida; Human immunodeficiency virus (HIV); Immunology; Clarithromycin","score_opus":0.08523358754433018,"score_gpt":0.4618648557188534,"score_spread":0.3766312681745232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800224917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854314,0.0005177348,0.00020212602,0.000049901606,0.000023969373,0.00008566286,0.000073958494,0.000034226854,0.00046932732],"genre_scores_gemma":[0.9988201,0.00015586437,0.00021561407,0.00010722439,0.000033100983,0.000038931474,0.00007635712,0.000005081572,0.0005476666],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995314,0.00019672545,0.000024853904,0.00010740066,0.000064668144,0.00007487863],"domain_scores_gemma":[0.9996401,0.00010329232,0.00007779689,0.000036024085,0.00003056295,0.00011229943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095744577,0.0005136453,0.0010096782,0.0002344423,0.0002710414,0.0003327216,0.00021314123,0.00049850764,0.0019057527],"category_scores_gemma":[0.0009979407,0.00030698732,0.0004867922,0.0001461233,0.00021900958,0.00029387083,0.00023363273,0.0005943898,0.00035995877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43198422,0.033831622,0.08015736,0.00048518524,0.0013622352,0.00082735193,0.0007136646,0.001011944,0.24851021,0.00015157629,0.002148191,0.19881654],"study_design_scores_gemma":[0.029221565,0.4502265,0.49495336,0.000037331683,0.0007810109,0.0006930686,0.00023706708,0.0023505383,0.018100334,0.00019601095,0.0031481136,0.000055140987],"about_ca_topic_score_codex":0.0005734073,"about_ca_topic_score_gemma":0.0008337068,"teacher_disagreement_score":0.0019057527,"about_ca_system_score_codex":0.00018526442,"about_ca_system_score_gemma":0.00023285617,"threshold_uncertainty_score":0.006375313},"labels":[],"label_agreement":null},{"id":"W2801880426","doi":"10.1002/jcph.1129","title":"Drug‐induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy","year":2018,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Proarrhythmia; Pharmacy; Drug; Medicine; Pharmacology; Business; Family medicine","score_opus":0.16029762925276814,"score_gpt":0.552479589150734,"score_spread":0.3921819598979659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801880426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008611545,0.48369622,0.0055563366,0.47824576,0.019698832,0.000121237834,0.00008163427,0.00014066194,0.011598184],"genre_scores_gemma":[0.009068697,0.562282,0.0118788155,0.35228914,0.047646016,0.0004557671,0.0001890296,0.00010794037,0.016082538],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99361116,0.003092342,0.00086022716,0.00048710717,0.0016037726,0.0003453129],"domain_scores_gemma":[0.9814508,0.011801406,0.0012218475,0.000483581,0.0028117062,0.002230676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010696043,0.0019215597,0.0023780297,0.0030934245,0.0024905128,0.008152581,0.0025185356,0.020205451,0.005722308],"category_scores_gemma":[0.01792688,0.001113471,0.001114064,0.0020490775,0.0063134995,0.023999514,0.0077043404,0.022637554,0.0048635546],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012384614,0.00046263446,0.0014996206,0.0022976284,0.000020952617,0.0011346659,0.004288496,0.00028196495,0.00084159564,0.048598334,0.55206126,0.38838902],"study_design_scores_gemma":[0.00001788567,0.00020784963,0.00060247397,0.0023997864,0.000008587288,0.0025421563,0.0016507999,0.00012892354,0.00008108387,0.017896725,0.97442925,0.000034481058],"about_ca_topic_score_codex":0.0012857695,"about_ca_topic_score_gemma":0.002659482,"teacher_disagreement_score":0.020205451,"about_ca_system_score_codex":0.002520134,"about_ca_system_score_gemma":0.0067995056,"threshold_uncertainty_score":0.056566715},"labels":[],"label_agreement":null},{"id":"W2805642491","doi":"10.1002/jcph.1133","title":"Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin‐Containing Monooxygenase 3 Maturational Changes Over Time","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Korea Health Industry Development Institute","keywords":"Ethionamide; Physiologically based pharmacokinetic modelling; Flavin-containing monooxygenase; Pharmacology; Pharmacokinetics; Population; Drug metabolism; Chemistry; Drug; Medicine; Monooxygenase; Metabolism; Biochemistry; Cytochrome P450; Antibiotics; Rifampicin","score_opus":0.061538689732225385,"score_gpt":0.40239794198755285,"score_spread":0.3408592522553275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805642491","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31691065,0.0035835544,0.6642437,0.0005555573,0.000078615994,0.00025085342,0.0033981125,0.00046430153,0.010514663],"genre_scores_gemma":[0.9391681,0.0035959214,0.048951972,0.00018688879,0.000041815616,0.0005404342,0.0015240188,0.00011489106,0.005876067],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99988854,0.00003395751,0.000006859328,0.00003215456,0.000022861374,0.000015573325],"domain_scores_gemma":[0.9998704,0.000052830543,0.000029389852,0.0000072858916,0.000031118012,0.000008941994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031964606,0.00057359115,0.00067474204,0.0002102729,0.00014283865,0.00063593575,0.0005887959,0.00075602747,0.001183994],"category_scores_gemma":[0.00060804,0.00031411587,0.00086607557,0.00022932976,0.00019963525,0.00040560588,0.00042953205,0.0007874603,0.00042516217],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002379079,0.0000864908,0.007853965,0.00026798112,0.00012208772,0.000586326,0.00013498963,0.9400513,0.024888089,0.005154758,0.0011047721,0.019511286],"study_design_scores_gemma":[0.000022854822,0.0001186512,0.0020729906,0.000016997501,0.000075316806,0.00021451074,0.000023116598,0.9907103,0.0023282846,0.0009961606,0.0034025605,0.000018246683],"about_ca_topic_score_codex":0.008488453,"about_ca_topic_score_gemma":0.0040059686,"teacher_disagreement_score":0.008488453,"about_ca_system_score_codex":0.0004864886,"about_ca_system_score_gemma":0.0011969985,"threshold_uncertainty_score":0.016878068},"labels":[],"label_agreement":null},{"id":"W2883546793","doi":"10.1002/jcph.1107","title":"Cardiovascular Safety of the β<sub>3</sub>‐Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Allergan; Astellas Pharma Global Development; Astellas Foundation for Research on Metabolic Disorders; Ipsen; Pfizer","keywords":"Mirabegron; Solifenacin; Medicine; Placebo; Overactive bladder; Combination therapy; Urology; Internal medicine; Pharmacology; Anesthesia","score_opus":0.063444621870896,"score_gpt":0.4039625429456552,"score_spread":0.3405179210747592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883546793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98185605,0.012093959,0.00038425668,0.0008839855,0.0002629849,0.00039426424,0.0007021188,0.000052101925,0.0033701798],"genre_scores_gemma":[0.9926596,0.0028785241,0.00057768467,0.0009800777,0.0003136773,0.00045494462,0.0010720262,0.000010533656,0.0010529027],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99943763,0.00034541215,0.000034285356,0.000054227483,0.000051969735,0.00007644646],"domain_scores_gemma":[0.99942774,0.00014244151,0.00015289571,0.000031421343,0.0000495251,0.00019589724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015602064,0.0006979692,0.0014352936,0.00018925453,0.00023401687,0.00079433556,0.0003096118,0.0009129259,0.004121114],"category_scores_gemma":[0.0009024539,0.00026864698,0.0013235146,0.00018024769,0.00036597307,0.00040640842,0.00031548142,0.0015929776,0.00049465697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9289775,0.003120311,0.0040403996,0.0010978944,0.0021028942,0.00012372628,0.00007175473,0.00059257296,0.00949902,0.00029487102,0.0023495462,0.047729436],"study_design_scores_gemma":[0.70021933,0.2590592,0.026072484,0.00032158286,0.0030130718,0.0004828624,0.000086686225,0.0013477303,0.0033935776,0.00063116447,0.005323957,0.00004834326],"about_ca_topic_score_codex":0.00024374522,"about_ca_topic_score_gemma":0.0006414023,"teacher_disagreement_score":0.004121114,"about_ca_system_score_codex":0.0004158062,"about_ca_system_score_gemma":0.0006601794,"threshold_uncertainty_score":0.013786554},"labels":[],"label_agreement":null},{"id":"W2884326257","doi":"10.1002/jcph.1282","title":"Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"First Quantum Minerals (Canada)","funders":"Ministry of Food and Drug Safety","keywords":"Levetiracetam; Medicine; Tolerability; Irritability; Epilepsy; Anesthesia; Pharmacokinetics; Pediatrics; Dosing; Somnolence; Adverse effect; Internal medicine","score_opus":0.08013198252937535,"score_gpt":0.4743202451600297,"score_spread":0.3941882626306543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884326257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642485,0.0019933104,0.0008338713,0.00004439074,0.0000056657977,0.000016782593,0.00021966767,0.000019022265,0.00044241006],"genre_scores_gemma":[0.9977743,0.0010650762,0.000687676,0.00003554478,0.000008723394,0.000017505294,0.00027625458,0.000006761815,0.00012828007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972767,0.0000808688,0.000033650198,0.00004348401,0.000079879326,0.000034533383],"domain_scores_gemma":[0.99950314,0.00014764696,0.00023507178,0.00001912191,0.00005863767,0.000036349178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026807384,0.00027125573,0.0005179696,0.0002487122,0.000097694996,0.0002745358,0.000121974255,0.00016679251,0.0003923394],"category_scores_gemma":[0.0013288537,0.00011233142,0.00032591925,0.00030307047,0.00016321395,0.00023241877,0.00016155736,0.000314366,0.00010549957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041024727,0.0002549063,0.878561,0.00040282006,0.00030672317,0.0022548768,0.0004188059,0.0028051988,0.025645463,0.00019449834,0.0005088882,0.084544204],"study_design_scores_gemma":[0.00015991462,0.008980602,0.95494145,0.000046911402,0.00043342798,0.008389358,0.0005515279,0.005637986,0.016609015,0.000110429784,0.004107563,0.0000317344],"about_ca_topic_score_codex":0.002439524,"about_ca_topic_score_gemma":0.0024189362,"teacher_disagreement_score":0.002439524,"about_ca_system_score_codex":0.00036016866,"about_ca_system_score_gemma":0.0004376149,"threshold_uncertainty_score":0.004850626},"labels":[],"label_agreement":null},{"id":"W2886245611","doi":"10.1002/jcph.1280","title":"Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Buprenorphine; Placebo; Medicine; Opioid; Crossover study; Anesthesia; Pharmacology; Adverse effect; Partial agonist; Opioid use disorder; Antagonist; Internal medicine; Receptor","score_opus":0.034133645984824976,"score_gpt":0.4165368754345509,"score_spread":0.38240322944972593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886245611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91081995,0.03244678,0.0031073128,0.0020610702,0.0027875935,0.03847111,0.0036090245,0.000546873,0.0061503067],"genre_scores_gemma":[0.9326221,0.015262557,0.005093286,0.0025337695,0.0016224941,0.03529896,0.0015457199,0.00006761011,0.0059534563],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99856985,0.00073641393,0.00011578883,0.00030390956,0.00013628564,0.0001376803],"domain_scores_gemma":[0.99857223,0.0004897999,0.00039083353,0.00010555737,0.00016080464,0.00028072254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025297813,0.0024144722,0.00459382,0.0006387862,0.00064745103,0.0015311642,0.0014818072,0.0027863637,0.014789792],"category_scores_gemma":[0.0028453914,0.0012059865,0.0029997162,0.00076228124,0.0012417844,0.0016085982,0.0004928403,0.003325823,0.0016813314],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9764949,0.008004217,0.00016810752,0.0019718881,0.0015059867,0.00003036442,0.00004130758,0.0001396999,0.001398242,0.00009634473,0.0006395766,0.00950935],"study_design_scores_gemma":[0.9582346,0.039948147,0.00040692603,0.00007432267,0.00052659307,0.00001504707,0.00001528569,0.00018639157,0.00012144125,0.000086859116,0.0003729179,0.000011403873],"about_ca_topic_score_codex":0.00094332756,"about_ca_topic_score_gemma":0.0022208358,"teacher_disagreement_score":0.014789792,"about_ca_system_score_codex":0.00095483364,"about_ca_system_score_gemma":0.0013514265,"threshold_uncertainty_score":0.049476802},"labels":[],"label_agreement":null},{"id":"W2893109079","doi":"10.1002/jcph.1113","title":"Opioids in Breast Milk: Pharmacokinetic Principles and Clinical Implications","year":2018,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Prenatal Substance Exposure Effects","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Oxycodone; Methadone; Breastfeeding; Opioid; Pharmacokinetics; Buprenorphine; Tramadol; Breast milk; Adverse effect; Drug; CYP2D6; Pharmacology; Anesthesia; Pediatrics; Internal medicine; Analgesic","score_opus":0.17171856197060484,"score_gpt":0.5239676029081161,"score_spread":0.3522490409375112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893109079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027682826,0.90616727,0.013224466,0.04104432,0.0006297453,0.0000704737,0.00017384235,0.00011773221,0.010889296],"genre_scores_gemma":[0.30255592,0.66591614,0.013218165,0.009759981,0.0039606844,0.0002615205,0.00013574584,0.00006159192,0.0041303136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927276,0.00026744162,0.00006363932,0.00009158069,0.00026049674,0.00004411914],"domain_scores_gemma":[0.99837637,0.0008452201,0.00033534077,0.000071278904,0.00026883374,0.00010287584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017921199,0.00067012757,0.001249866,0.0007705325,0.00035693048,0.0023428958,0.0011741739,0.0021543866,0.0015198396],"category_scores_gemma":[0.0039590104,0.00044309022,0.00056589884,0.0006487769,0.001618126,0.0018681928,0.0007590023,0.0026377863,0.0006901931],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021415628,0.00085644337,0.030856377,0.005380865,0.00025151763,0.013119188,0.0010830082,0.0057968483,0.018762544,0.069570094,0.0185018,0.8336798],"study_design_scores_gemma":[0.0005738102,0.006253933,0.08908938,0.0067312047,0.000748643,0.09320075,0.002479268,0.02995309,0.024630066,0.23609504,0.50978565,0.00045910638],"about_ca_topic_score_codex":0.00097094366,"about_ca_topic_score_gemma":0.00081820687,"teacher_disagreement_score":0.0023428958,"about_ca_system_score_codex":0.0011989882,"about_ca_system_score_gemma":0.0011657714,"threshold_uncertainty_score":0.009477735},"labels":[],"label_agreement":null},{"id":"W2893167959","doi":"10.1002/jcph.1115","title":"Adverse Drug Reactions Across the Age Continuum: Epidemiology, Diagnostic Challenges, Prevention, and Treatments","year":2018,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pharmacogenomics; Dosing; Drug reaction; Epidemiology; Drug; Intensive care medicine; Pharmacotherapy; Pediatrics; Pharmacovigilance; Adverse effect; Pharmacology; Internal medicine","score_opus":0.4827540263646637,"score_gpt":0.6264753641667427,"score_spread":0.14372133780207896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893167959","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001221898,0.99832433,0.00007944168,0.0008492924,0.00011378626,0.000005801126,0.000011368815,0.000003964488,0.0004897666],"genre_scores_gemma":[0.0011913495,0.99793446,0.0001887994,0.00029549352,0.0002234884,0.0000074257446,0.000015646252,7.781612e-7,0.00014265836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907863,0.00024351588,0.00019635954,0.00010493684,0.000319411,0.000057111414],"domain_scores_gemma":[0.99789375,0.0010390766,0.00042127274,0.00004079645,0.00048512523,0.00012002024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015198961,0.00084398716,0.001706473,0.0027708418,0.00036090956,0.0015288652,0.0008882551,0.0012180082,0.0025181116],"category_scores_gemma":[0.0036093106,0.00028898972,0.0009161893,0.002411029,0.0007735308,0.0015089206,0.0007020968,0.00243803,0.0007979426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007371255,0.00009020657,0.0015095186,0.018544579,0.00017488284,0.0002916139,0.00011188382,0.0003015803,0.00031313815,0.0028994493,0.023141477,0.95254797],"study_design_scores_gemma":[0.00007184602,0.000313818,0.011933542,0.045846123,0.00068832835,0.009907634,0.0006739423,0.00036009034,0.00048572646,0.008949939,0.9206897,0.00007934191],"about_ca_topic_score_codex":0.002384626,"about_ca_topic_score_gemma":0.0034088986,"teacher_disagreement_score":0.0027708418,"about_ca_system_score_codex":0.0009740309,"about_ca_system_score_gemma":0.0023291747,"threshold_uncertainty_score":0.008423924},"labels":[],"label_agreement":null},{"id":"W2893858554","doi":"10.1002/jcph.1316","title":"Pharmacometric Modeling and Simulation Is Essential to Pediatric Clinical Pharmacology","year":2018,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute of General Medical Sciences","keywords":"Clinical pharmacology; Medicine; Subspecialty; Pharmacology; Broad spectrum; Specialty; Drug development; Intensive care medicine; Drug; Medical physics; Family medicine","score_opus":0.44415338444241576,"score_gpt":0.6476140339209964,"score_spread":0.2034606494785806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893858554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024567891,0.64905435,0.27200833,0.034160387,0.0021824497,0.00025027315,0.00050443294,0.00085314043,0.038529832],"genre_scores_gemma":[0.04414116,0.84387296,0.09913602,0.004261933,0.003552058,0.00030780217,0.00055238995,0.00021161552,0.0039639925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954796,0.0021513503,0.00038255288,0.0003857383,0.0015025092,0.00009821108],"domain_scores_gemma":[0.98506874,0.011486383,0.00084329327,0.0006749029,0.0016628931,0.00026374878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00625682,0.0012522432,0.0023571835,0.0029355518,0.0004916131,0.0034562768,0.0014706496,0.0022456814,0.00420318],"category_scores_gemma":[0.019661514,0.0006668869,0.0016240027,0.004758629,0.0025998657,0.003544113,0.0017275927,0.0052035763,0.0025181605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052881573,0.000104422405,0.0022931562,0.008070852,0.00035700307,0.00033668947,0.00037973738,0.025678383,0.00067489425,0.18539605,0.034498185,0.7421577],"study_design_scores_gemma":[0.00002456811,0.00013633812,0.001964831,0.005104463,0.00020870466,0.0008403831,0.00026820326,0.018966345,0.0011064308,0.23445587,0.7368083,0.00011553455],"about_ca_topic_score_codex":0.0033799869,"about_ca_topic_score_gemma":0.00213384,"teacher_disagreement_score":0.00625682,"about_ca_system_score_codex":0.0017645882,"about_ca_system_score_gemma":0.0053295204,"threshold_uncertainty_score":0.033089638},"labels":[],"label_agreement":null},{"id":"W2900478530","doi":"10.1002/jcph.1336","title":"Analyses of Adverse Drug Reactions–Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"University of British Columbia; Western University; Provincial Health Services Authority; Child and Family Research Institute; Genome British Columbia; Pfizer Canada; Société Canadienne de Pédiatrie; Michael Smith Health Research BC; Canadian Institutes of Health Research; Genome Canada","keywords":"Medicine; Pharmacogenomics; Pharmacovigilance; Database; MedDRA; Drug reaction; Drug; Adverse drug reaction; Cardiotoxicity; Pharmacology; Internal medicine; Toxicity","score_opus":0.22913844339583006,"score_gpt":0.5357776064072207,"score_spread":0.30663916301139066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900478530","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026922302,0.0022579527,0.0013196691,0.0006466873,0.000050165836,0.0012501074,0.95754933,0.00032669492,0.009677071],"genre_scores_gemma":[0.10299114,0.0028246914,0.0066912207,0.00074297347,0.00007085106,0.00151273,0.8826443,0.00008104689,0.0024410957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99306595,0.000532212,0.0012683716,0.0007699295,0.003849642,0.00051387405],"domain_scores_gemma":[0.9604518,0.0023221925,0.005751465,0.0018785319,0.02784591,0.0017501736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004011103,0.0009394438,0.0012072881,0.010326817,0.0017420365,0.0015008092,0.0023678816,0.0006028891,0.005701078],"category_scores_gemma":[0.019493168,0.00045362418,0.0010104501,0.019933423,0.00032148985,0.0005956051,0.0011476672,0.0010458176,0.0012789846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009448536,0.00022236831,0.5073437,0.005144655,0.0015353924,0.00036656813,0.0005150145,0.0019771012,0.001161263,0.0023873686,0.4062529,0.072148785],"study_design_scores_gemma":[0.00020218515,0.000088995796,0.834719,0.00076982024,0.0005214252,0.00023581504,0.00026852242,0.0018004412,0.000944398,0.00037550906,0.15998302,0.00009087492],"about_ca_topic_score_codex":0.9155626,"about_ca_topic_score_gemma":0.92733413,"teacher_disagreement_score":0.08443737,"about_ca_system_score_codex":0.01721677,"about_ca_system_score_gemma":0.047919907,"threshold_uncertainty_score":0.16986924},"labels":[],"label_agreement":null},{"id":"W2902782985","doi":"10.1002/jcph.1343","title":"Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pentazocine‐, Naltrexone‐, and Placebo‐Controlled Study","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Oxycodone; Placebo; Naltrexone; Opioid; Medicine; Visual analogue scale; Anesthesia; Pharmacology; Psychology; Internal medicine","score_opus":0.06326979985406189,"score_gpt":0.47798855935209056,"score_spread":0.41471875949802867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902782985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900435,0.0018343494,0.0012047838,0.00021413936,0.00020998591,0.004486159,0.0009688672,0.0001492361,0.0008890689],"genre_scores_gemma":[0.98249465,0.003251275,0.0025740436,0.0007129343,0.00047536046,0.006184955,0.0013679601,0.000049235387,0.002889577],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990522,0.00042351367,0.00006911828,0.00017185559,0.00012301083,0.0001602992],"domain_scores_gemma":[0.9986513,0.00026862274,0.00030309983,0.00017938473,0.00014765823,0.0004499713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020345536,0.0020559416,0.0028358083,0.0006242825,0.00058216543,0.0010239942,0.0011601726,0.0016254118,0.0045121224],"category_scores_gemma":[0.0014860987,0.000983843,0.0019405243,0.00060456357,0.0013545635,0.0011496657,0.00029993674,0.0020635407,0.0008646337],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87314755,0.06023541,0.0012557954,0.0009554339,0.0012278752,0.00011560242,0.00018317398,0.0004607005,0.037746623,0.00011325765,0.00089616014,0.023662386],"study_design_scores_gemma":[0.5740927,0.4160068,0.0041349353,0.000030574007,0.00062857184,0.000098225915,0.000055343102,0.00040176106,0.0036389166,0.00006983505,0.0008087267,0.000033550004],"about_ca_topic_score_codex":0.00091360946,"about_ca_topic_score_gemma":0.001903369,"teacher_disagreement_score":0.0045121224,"about_ca_system_score_codex":0.0006249382,"about_ca_system_score_gemma":0.0015486791,"threshold_uncertainty_score":0.015094578},"labels":[],"label_agreement":null},{"id":"W2905418559","doi":"10.1002/jcph.1349","title":"Population Pharmacokinetic Study and Individual Dose Adjustments of High‐Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia or Osteosarcoma","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"Research Grants Council, University Grants Committee","keywords":"NONMEM; Medicine; Pharmacokinetics; Osteosarcoma; Population; Methotrexate; Oncology; Pharmacology; Internal medicine; Cancer research","score_opus":0.042200890842123376,"score_gpt":0.4145748417704224,"score_spread":0.37237395092829906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905418559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763,0.00009661395,0.0019549276,0.00002639672,0.0000017751308,0.00002135483,0.00010632847,0.000016893802,0.00014567487],"genre_scores_gemma":[0.99829966,0.00007103897,0.0012264688,0.000014665776,0.0000028514048,0.000027621547,0.00023257844,0.000004063329,0.000121159166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995639,0.00020153764,0.000027697068,0.00009902312,0.00007565796,0.000032300035],"domain_scores_gemma":[0.9995401,0.0001669936,0.00014401008,0.000081629565,0.000042536263,0.000024762629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010370318,0.0002464663,0.00048838754,0.00023237156,0.00020719782,0.00024234188,0.00024950807,0.0002115912,0.00051883387],"category_scores_gemma":[0.0019451354,0.00017172408,0.00052083243,0.0004510083,0.00015249226,0.00019625336,0.00022179207,0.0003194688,0.00006891517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021499852,0.0004449079,0.88137037,0.00014112597,0.0006230679,0.0006053312,0.0008377649,0.029665632,0.015389221,0.000655287,0.00063291116,0.067484386],"study_design_scores_gemma":[0.00020504526,0.0024949012,0.9023581,0.000011794589,0.00047232452,0.0008047953,0.00023884386,0.0838811,0.006058015,0.00053502596,0.0028939482,0.000046186316],"about_ca_topic_score_codex":0.007867731,"about_ca_topic_score_gemma":0.007247052,"teacher_disagreement_score":0.007867731,"about_ca_system_score_codex":0.0006569915,"about_ca_system_score_gemma":0.0010506535,"threshold_uncertainty_score":0.015643835},"labels":[],"label_agreement":null},{"id":"W2906557460","doi":"10.1002/jcph.1361","title":"Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double‐Blind, Placebo‐Controlled Single‐Ascending‐Dose Study","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Medicine; Pharmacokinetics; Pharmacodynamics; Rheumatoid arthritis; Placebo; Adverse effect; Pharmacology; Internal medicine; Potency; Gastroenterology; Pathology","score_opus":0.081837816035069,"score_gpt":0.4485786332011374,"score_spread":0.3667408171660684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906557460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741334,0.00063224457,0.00053735997,0.00006736643,0.0000548225,0.0007424897,0.00017948437,0.00003558744,0.00033731628],"genre_scores_gemma":[0.9954039,0.000699943,0.0010036906,0.0002538008,0.00017255386,0.0010189429,0.0003451566,0.00001508944,0.0010869242],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99930954,0.00031129894,0.000060908547,0.000116163494,0.00008876199,0.00011342334],"domain_scores_gemma":[0.9992374,0.00016383012,0.00019082738,0.00009034461,0.000064758104,0.0002527929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014671751,0.0010447507,0.0020465993,0.00038718624,0.0002762153,0.000609116,0.0005607856,0.001287934,0.0018457526],"category_scores_gemma":[0.0011028532,0.0006659371,0.00088228774,0.00028389797,0.0011808522,0.0009137758,0.00023507238,0.001504935,0.0004890798],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8417998,0.045403305,0.0016940398,0.0003961106,0.00045092916,0.0000835816,0.00009580814,0.0007555157,0.079255395,0.00010997266,0.00044615578,0.029509343],"study_design_scores_gemma":[0.2809834,0.69528776,0.008409949,0.0000150064225,0.0004728337,0.00012696984,0.000027458003,0.0010392237,0.01243728,0.000091297574,0.0010725656,0.00003621098],"about_ca_topic_score_codex":0.0004120535,"about_ca_topic_score_gemma":0.0005974834,"teacher_disagreement_score":0.0020465993,"about_ca_system_score_codex":0.0004283579,"about_ca_system_score_gemma":0.0007566084,"threshold_uncertainty_score":0.0077592134},"labels":[],"label_agreement":null},{"id":"W2909891606","doi":"10.1002/jcph.1372","title":"Comparison of Cognitive Impairments After Intensive Care Unit Sedation Using Dexmedetomidine and Propofol Among Older Patients","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dexmedetomidine; Propofol; Medicine; Sedation; Intensive care unit; Anesthesia; Cognition; Montreal Cognitive Assessment; Intensive care; Cognitive impairment; Intensive care medicine; Psychiatry","score_opus":0.06279359722470408,"score_gpt":0.4685922046614829,"score_spread":0.4057986074367788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909891606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99960786,0.00022899847,0.000011268325,0.000013476955,0.0000034279378,0.000005885821,0.000021654636,2.905475e-7,0.000107067695],"genre_scores_gemma":[0.9996562,0.00015121514,0.00002065519,0.000029621666,0.000008604905,0.000008830338,0.000080087186,2.2232432e-7,0.00004470333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995832,0.000079891244,0.00009280539,0.00006282834,0.00009658438,0.00008459017],"domain_scores_gemma":[0.9990609,0.00015067653,0.00041364782,0.000033316268,0.00011613537,0.00022539467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005600477,0.00020979026,0.0004906029,0.00042550862,0.0002825958,0.0003991901,0.00016398018,0.0002927436,0.00043210064],"category_scores_gemma":[0.0020203844,0.00009644778,0.00059762236,0.00041269226,0.00018992356,0.00039383155,0.000338472,0.0004042739,0.000055647004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019160423,0.00026634385,0.9912816,0.00006021768,0.0001872223,0.00014612195,0.00032427226,0.000041619896,0.00030438055,0.00001821517,0.0000669376,0.005387078],"study_design_scores_gemma":[0.000037036938,0.0007937771,0.99856704,0.000010574206,0.00006791597,0.00008502413,0.00022834762,0.00006684576,0.000041070623,0.0000148326635,0.00008362337,0.000004037806],"about_ca_topic_score_codex":0.00199619,"about_ca_topic_score_gemma":0.0036891582,"teacher_disagreement_score":0.00199619,"about_ca_system_score_codex":0.00031903505,"about_ca_system_score_gemma":0.00042433615,"threshold_uncertainty_score":0.0039691925},"labels":[],"label_agreement":null},{"id":"W2913866147","doi":"10.1002/jcph.1391","title":"4β‐Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation","year":2019,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Waterloo CFD Engineering Consulting","funders":"","keywords":"CYP3A; Biomarker; Pharmacology; Midazolam; Endogeny; Metabolite; Biology; Cholesterol; Cytochrome P450; Medicine; Endocrinology; Metabolism; Biochemistry","score_opus":0.6130139562391858,"score_gpt":0.6623758551971944,"score_spread":0.04936189895800869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913866147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013789297,0.99858737,0.00015836503,0.0006550871,0.00018389772,0.00001997801,0.00005093168,0.0000056041495,0.00020092931],"genre_scores_gemma":[0.0009324814,0.9977831,0.00030275318,0.0004933828,0.00029811967,0.000034391218,0.000067832574,0.0000023188175,0.00008567599],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981133,0.00040124592,0.0006329276,0.00025628082,0.00051419367,0.00008209251],"domain_scores_gemma":[0.9828419,0.010679575,0.0019762148,0.00028438953,0.003937269,0.00028062443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056360983,0.0014180323,0.0036020624,0.010372835,0.0006449512,0.0023684043,0.0019424048,0.0020500878,0.0053585004],"category_scores_gemma":[0.013496454,0.00077995117,0.002998802,0.009344283,0.0011440864,0.0034062348,0.0013127107,0.002071907,0.0010644662],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027666852,0.00008674227,0.0011583016,0.28360844,0.001025987,0.0004782325,0.00034431412,0.00042234553,0.00084920047,0.0032827025,0.026367273,0.68209976],"study_design_scores_gemma":[0.00010013945,0.00039100825,0.0063836495,0.3260787,0.009814206,0.0034798956,0.00061346387,0.00045449438,0.0010874021,0.00454359,0.646887,0.00016645058],"about_ca_topic_score_codex":0.003316184,"about_ca_topic_score_gemma":0.004909325,"teacher_disagreement_score":0.010372835,"about_ca_system_score_codex":0.0018148671,"about_ca_system_score_gemma":0.007603318,"threshold_uncertainty_score":0.029806852},"labels":[],"label_agreement":null},{"id":"W2920650314","doi":"10.1002/jcph.1399","title":"A Study to Evaluate Doravirine Pharmacokinetics When Coadministered With Acid‐Reducing Agents","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Pharmacokinetics; Antacid; Pharmacology; Drug interaction; Zidovudine; Chemistry; Reverse-transcriptase inhibitor; Medicine; Internal medicine; Human immunodeficiency virus (HIV); Sida; Virology","score_opus":0.11937628668729905,"score_gpt":0.47735217306619193,"score_spread":0.3579758863788929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920650314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602664,0.0009496545,0.00064492703,0.00007637448,0.00012600083,0.001459818,0.0001722227,0.000019585148,0.000524843],"genre_scores_gemma":[0.9943997,0.0004910119,0.0016673367,0.00023512992,0.00026033138,0.0018483372,0.00029678285,0.000012351843,0.00078899355],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9958437,0.0026599155,0.00025405103,0.00049081544,0.00047988122,0.00027166866],"domain_scores_gemma":[0.9955505,0.0016847034,0.00093455357,0.00051067123,0.00046485552,0.0008546317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045018597,0.0008721664,0.0026577534,0.0003637624,0.00049570034,0.0008307533,0.0005820551,0.0013811911,0.0030209064],"category_scores_gemma":[0.004708777,0.00056010904,0.0015838606,0.00045269477,0.0008012196,0.000903702,0.0003986398,0.0018462586,0.0005276989],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86679536,0.055306446,0.011038388,0.00060924253,0.0012101037,0.00020780212,0.00023847453,0.00059756415,0.02801457,0.00012847387,0.00035121784,0.035502423],"study_design_scores_gemma":[0.081826895,0.9037001,0.009477425,0.000014986286,0.0004330842,0.00011593991,0.000042129235,0.0005487585,0.0027734232,0.00003060417,0.0010213031,0.000015373002],"about_ca_topic_score_codex":0.0005836461,"about_ca_topic_score_gemma":0.0005984953,"teacher_disagreement_score":0.0045018597,"about_ca_system_score_codex":0.0006562033,"about_ca_system_score_gemma":0.001295628,"threshold_uncertainty_score":0.02380842},"labels":[],"label_agreement":null},{"id":"W2945068176","doi":"10.1002/jcph.1446","title":"Membrane‐Spanning Protein Genetic Polymorphisms Related to Methotrexate Therapeutic Outcomes in a Chinese Rheumatoid Arthritis Population","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Natural Science Foundation of China","keywords":"Odds ratio; Methotrexate; Single-nucleotide polymorphism; Rheumatoid arthritis; SNP; Medicine; Internal medicine; Pharmacology; Adverse effect; Confidence interval; Arthritis; Genotype; Bioinformatics; Genetics; Gene; Biology","score_opus":0.038734896236194846,"score_gpt":0.4362140282801865,"score_spread":0.39747913204399166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945068176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995672,0.00015571566,0.000045349563,0.00003886196,0.0000035213993,0.000004395189,0.000045268327,0.0000015954217,0.0001380908],"genre_scores_gemma":[0.9996903,0.00006328629,0.00003759521,0.00002578419,0.00000900163,0.0000048830566,0.000062707506,0.0000010316184,0.00010539696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949515,0.00009700408,0.000059560432,0.00019066756,0.00008000093,0.00007761866],"domain_scores_gemma":[0.9994555,0.0001002773,0.00017600977,0.0000752035,0.00006318761,0.00012989849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064868474,0.00048262332,0.00052006595,0.0005881582,0.0009048333,0.00039991166,0.00034498883,0.0004793244,0.0014450006],"category_scores_gemma":[0.001195749,0.00029464177,0.0006459364,0.0010767643,0.00048808343,0.0002136776,0.00028269066,0.0004706622,0.00014778602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048211555,0.00007698228,0.9913421,0.000027892887,0.0003692451,0.000621286,0.00044874876,0.00013908416,0.003318446,0.00008331807,0.00012955221,0.0029613497],"study_design_scores_gemma":[0.000033594413,0.000120044344,0.99868447,0.0000038146627,0.00015224893,0.00028073936,0.00009685258,0.00032086554,0.00010514883,0.00005415262,0.00014147621,0.000006657047],"about_ca_topic_score_codex":0.024280546,"about_ca_topic_score_gemma":0.014969998,"teacher_disagreement_score":0.024280546,"about_ca_system_score_codex":0.00051028415,"about_ca_system_score_gemma":0.0005988189,"threshold_uncertainty_score":0.04827845},"labels":[],"label_agreement":null},{"id":"W2970013275","doi":"10.1002/jcph.1508","title":"Randomized Population Pharmacokinetic Analysis and Safety of Intravenous Acetaminophen for Acute Postoperative Pain in Neonates and Infants","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Acetaminophen; Placebo; Anesthesia; Pharmacokinetics; Population; Adverse effect; Randomized controlled trial; Pharmacodynamics; Mallinckrodt; Surgery; Internal medicine","score_opus":0.02126594272878669,"score_gpt":0.4057640991048461,"score_spread":0.38449815637605944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970013275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944918,0.0006009352,0.002520693,0.000056895915,0.00003806084,0.001694063,0.00023705773,0.000048058195,0.00031236938],"genre_scores_gemma":[0.9939594,0.00034725122,0.0024348125,0.0001317386,0.00003596066,0.0023127806,0.00045162172,0.000008611058,0.00031786558],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9930468,0.0057270085,0.00020241349,0.00042652662,0.0004118946,0.00018535717],"domain_scores_gemma":[0.99567586,0.0022339541,0.00089811353,0.0006684692,0.00024897055,0.0002745266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009969201,0.0008081105,0.0024395208,0.00036743958,0.00020348866,0.00060185627,0.0008374929,0.00089095306,0.0015342246],"category_scores_gemma":[0.010916328,0.0005779215,0.0017538973,0.00025821017,0.00060158846,0.00053349143,0.00047120696,0.0012381832,0.00018138385],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92710507,0.007307568,0.018566938,0.00020942022,0.0029124059,0.00013343601,0.00008379338,0.0075850785,0.003710834,0.00042044406,0.00048482497,0.031480167],"study_design_scores_gemma":[0.34709537,0.5371756,0.050737344,0.000061356724,0.0032590076,0.00031526302,0.00008408654,0.053235576,0.004666563,0.0012548559,0.0020233474,0.00009167191],"about_ca_topic_score_codex":0.00057825487,"about_ca_topic_score_gemma":0.00046727926,"teacher_disagreement_score":0.009969201,"about_ca_system_score_codex":0.00090369047,"about_ca_system_score_gemma":0.0016179734,"threshold_uncertainty_score":0.05272281},"labels":[],"label_agreement":null},{"id":"W2972367557","doi":"10.1002/jcph.1493","title":"Characterization of the Ontogeny of Hepatic UDP‐Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"UGT2B7; Glucuronidation; Microsome; Gene isoform; Glucuronosyltransferase; Isozyme; In vivo; Enzyme; Internal medicine; Endocrinology; Pharmacokinetics; Ontogeny; In vitro; Chemistry; Pharmacology; Biology; Biochemistry; Medicine; Gene; Genetics","score_opus":0.12747881036509193,"score_gpt":0.4600267149257834,"score_spread":0.3325479045606915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972367557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827376,0.0046442994,0.008251124,0.00009821987,0.000022733575,0.00004445075,0.0017838174,0.00006791868,0.002349871],"genre_scores_gemma":[0.98616856,0.0037974757,0.0042903046,0.000069106,0.000020906542,0.00006183255,0.0022225047,0.00004603751,0.0033231948],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988663,0.000018954046,0.000009383031,0.00004363592,0.000028242657,0.000013053987],"domain_scores_gemma":[0.99975675,0.00004022828,0.000078552424,0.000029015326,0.000060318544,0.000035172354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024064815,0.00024046237,0.000176073,0.00042436586,0.00009626319,0.00031945598,0.000110980756,0.00019655543,0.0010950268],"category_scores_gemma":[0.00046587674,0.00019340302,0.00022237713,0.00027800948,0.0001790826,0.00027620056,0.00016620827,0.0003332632,0.0005059634],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071496336,0.00003553247,0.06300545,0.00010849992,0.000049769435,0.00028234947,0.00020706162,0.00015331178,0.90835446,0.00040247844,0.00022416042,0.026461909],"study_design_scores_gemma":[0.0000124442395,0.00066307845,0.6491069,0.000021184982,0.00008902768,0.0013775983,0.00013777861,0.0007177714,0.34005004,0.00018848202,0.007618577,0.000017107517],"about_ca_topic_score_codex":0.0012355138,"about_ca_topic_score_gemma":0.0010126618,"teacher_disagreement_score":0.0012355138,"about_ca_system_score_codex":0.0001842847,"about_ca_system_score_gemma":0.00023713801,"threshold_uncertainty_score":0.0036632419},"labels":[],"label_agreement":null},{"id":"W2984226240","doi":"10.1002/jcph.1540","title":"Integration of Ontogeny Into a Physiologically Based Pharmacokinetic Model for Monoclonal Antibodies in Premature Infants","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Ontogeny; Monoclonal antibody; Antibody; Pharmacokinetics; Population; Medicine; Immunology; Biology; Pharmacology; Internal medicine","score_opus":0.15478821319222888,"score_gpt":0.5134345119709951,"score_spread":0.3586462987787662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984226240","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4367009,0.000623644,0.5465265,0.000493651,0.00005047399,0.00014888168,0.0007484731,0.00026336193,0.014444178],"genre_scores_gemma":[0.963248,0.0006165588,0.028374618,0.00010826844,0.000021376487,0.0002722151,0.00030597125,0.00007280315,0.0069801304],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998486,0.00005661316,0.0000045659485,0.000029060808,0.0000409484,0.000020165495],"domain_scores_gemma":[0.99973065,0.00013068708,0.000059014088,0.000015096148,0.000048919308,0.000015661144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003807213,0.00043590245,0.00035749938,0.00024589337,0.00020747003,0.0006247379,0.00053586374,0.0006001155,0.0013868343],"category_scores_gemma":[0.0011747887,0.00024833306,0.0007215728,0.00016543479,0.00032732706,0.0003094315,0.0007035117,0.0007362626,0.00025459685],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002009692,0.00001618331,0.002045973,0.000018727353,0.000012577615,0.00014239419,0.000034141543,0.987649,0.0029908195,0.00338541,0.00017310947,0.0035115231],"study_design_scores_gemma":[0.0000024113558,0.000026837188,0.000844323,0.0000036795025,0.0000063128414,0.00003380405,0.000008657356,0.9974765,0.00043261857,0.00063490734,0.0005257304,0.0000042692095],"about_ca_topic_score_codex":0.0070443405,"about_ca_topic_score_gemma":0.0027017107,"teacher_disagreement_score":0.0070443405,"about_ca_system_score_codex":0.000633257,"about_ca_system_score_gemma":0.0010855776,"threshold_uncertainty_score":0.014006674},"labels":[],"label_agreement":null},{"id":"W2985012075","doi":"10.1002/jcph.1535","title":"Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pesticide Exposure and Toxicity","field":"Agricultural and Biological Sciences","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Oxidative stress; Chemistry; Biochemistry","score_opus":0.04869333413966463,"score_gpt":0.3626578290051098,"score_spread":0.31396449486544514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985012075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583036,0.0033956496,0.0001683573,0.000045972894,0.00001338255,0.000015678272,0.00003648559,0.000004603894,0.000489437],"genre_scores_gemma":[0.99893945,0.00072692777,0.00010306342,0.00002370662,0.000026725085,0.000005209705,0.000033374385,7.8207864e-7,0.00014080813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973017,0.00010447367,0.00003919235,0.000041726606,0.000050796796,0.000033675387],"domain_scores_gemma":[0.9994547,0.00012031361,0.0002255665,0.000025545132,0.00008269475,0.00009126897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042663957,0.00038995055,0.00040328022,0.000854112,0.00033228673,0.0005094446,0.00017265386,0.0003430121,0.0012641107],"category_scores_gemma":[0.00065701746,0.00016959662,0.0002208846,0.0003346839,0.00025704296,0.00021901834,0.00030226482,0.00025599325,0.00013210544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034469063,0.0005043854,0.8318172,0.0003759779,0.00017776681,0.0043031755,0.0009805047,0.00017305567,0.1232596,0.0002542364,0.00020020378,0.034506954],"study_design_scores_gemma":[0.0000600649,0.0025250434,0.97230726,0.000080275684,0.0001553397,0.006780871,0.00073026237,0.00043005944,0.015162236,0.0003760582,0.0013781043,0.000014453584],"about_ca_topic_score_codex":0.00031265517,"about_ca_topic_score_gemma":0.0002822369,"teacher_disagreement_score":0.0012641107,"about_ca_system_score_codex":0.00018012433,"about_ca_system_score_gemma":0.00012465408,"threshold_uncertainty_score":0.0042289495},"labels":[],"label_agreement":null},{"id":"W2990457166","doi":"10.1002/jcph.1543","title":"Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo‐ and Alprazolam‐Controlled Crossover Study","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"De Beers (Canada)","funders":"Eli Lilly and Company","keywords":"Alprazolam; Placebo; Medicine; Adverse effect; Tolerability; Anesthesia; Internal medicine; Psychiatry; Anxiety","score_opus":0.03858354255254871,"score_gpt":0.45940601735817826,"score_spread":0.42082247480562956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990457166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850152,0.0013542059,0.0014230956,0.00031086954,0.00027653764,0.009523173,0.0009457754,0.0001479958,0.0010031546],"genre_scores_gemma":[0.9743172,0.002014787,0.0041029374,0.0008709846,0.0006325772,0.013721799,0.0010652716,0.00004504906,0.0032293452],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998252,0.0009927023,0.00011572185,0.00027266037,0.00016967414,0.00019730299],"domain_scores_gemma":[0.99781203,0.00062102074,0.0005524203,0.00025572622,0.00024904707,0.0005097641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034304697,0.0020712367,0.0036167332,0.0007783882,0.00076221034,0.0010136483,0.0011875841,0.001919454,0.0072126724],"category_scores_gemma":[0.0030519627,0.0011201078,0.001717338,0.0006454884,0.0016395132,0.0015105882,0.00036933602,0.0023715082,0.00112555],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9294151,0.045328025,0.00077255827,0.000499243,0.0006156714,0.00006515098,0.00010781113,0.00024136355,0.010291189,0.00012215064,0.0005622583,0.011979474],"study_design_scores_gemma":[0.7786254,0.21746074,0.0018701395,0.000019035539,0.00031672572,0.000039406572,0.000026598676,0.00032838844,0.000746912,0.00008925927,0.00045789062,0.00001958135],"about_ca_topic_score_codex":0.0007771719,"about_ca_topic_score_gemma":0.0017094061,"teacher_disagreement_score":0.0072126724,"about_ca_system_score_codex":0.00086742453,"about_ca_system_score_gemma":0.0019038427,"threshold_uncertainty_score":0.024128795},"labels":[],"label_agreement":null},{"id":"W2998100580","doi":"10.1002/jcph.1571","title":"Coexpression of Human Hepatic Uridine Diphosphate Glucuronosyltransferase Proteins: Implications for Ontogenetic Mechanisms and Isoform Coregulation","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Gene isoform; Ontogeny; Biology; Glucuronosyltransferase; Internal medicine; Endocrinology; Western blot; Blot; Uridine; Glucuronidation; Microsome; Genetics; Biochemistry; Medicine; Gene; Enzyme; RNA","score_opus":0.1620544192543954,"score_gpt":0.5110713937836602,"score_spread":0.3490169745292648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998100580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956749,0.001957746,0.00084008015,0.000046320707,0.000012682556,0.000005523073,0.000647001,0.000013717587,0.00080207083],"genre_scores_gemma":[0.9931358,0.0018177091,0.0014778463,0.000036775782,0.000015809044,0.000017001828,0.0014469798,0.000015708532,0.0020363135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988747,0.00001214633,0.000013309243,0.000040601833,0.000021212467,0.00002526019],"domain_scores_gemma":[0.99979585,0.000033556767,0.00006883235,0.000023610068,0.000038425314,0.000039773753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017047327,0.000112851056,0.00018054234,0.0004702299,0.00015529967,0.00033306342,0.00008703871,0.00017479467,0.0010026614],"category_scores_gemma":[0.000248878,0.00012687258,0.00021599699,0.00044977095,0.00014017409,0.0002467626,0.00020614632,0.0002038697,0.00034151654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085185736,0.00004382887,0.10876364,0.00006761554,0.000043138585,0.0005079455,0.0002170886,0.00009011602,0.87621444,0.0003130467,0.00014470474,0.012742698],"study_design_scores_gemma":[0.000010591436,0.0003274077,0.872444,0.000013833875,0.000048376372,0.0020211285,0.0002031131,0.00058454636,0.1200228,0.00017684157,0.00413557,0.000011846674],"about_ca_topic_score_codex":0.0014070321,"about_ca_topic_score_gemma":0.0012569287,"teacher_disagreement_score":0.0014070321,"about_ca_system_score_codex":0.00020301773,"about_ca_system_score_gemma":0.00016017334,"threshold_uncertainty_score":0.0033542514},"labels":[],"label_agreement":null},{"id":"W3003468346","doi":"10.1002/jcph.1567","title":"Reversing the Effects of 0.5% Bupivacaine Using Phentolamine Mesylate: A Preliminary Randomized Controlled Clinical Trial","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Dental Anxiety and Anesthesia Techniques","field":"Dentistry","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Phentolamine; Medicine; Anesthesia; Mesylate; Randomized controlled trial; Saline; Bupivacaine; Surgery; Chemistry; Propranolol","score_opus":0.08814747455870142,"score_gpt":0.44690200914843603,"score_spread":0.3587545345897346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003468346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667976,0.007533617,0.0011978231,0.0005926313,0.00080932974,0.020594312,0.0007487886,0.00010253524,0.0016234356],"genre_scores_gemma":[0.9592268,0.0075564124,0.0043551363,0.001099797,0.0010498447,0.022799274,0.0007880783,0.000024052582,0.0031006262],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99806815,0.0010614924,0.00023909684,0.00022872511,0.00019297449,0.0002094976],"domain_scores_gemma":[0.99793893,0.0008468193,0.0004065192,0.00015073268,0.00022423235,0.00043268956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036256434,0.0013429674,0.0033673681,0.0005067185,0.0005576536,0.0010071372,0.0010925635,0.0021361266,0.006301596],"category_scores_gemma":[0.0030753522,0.00067009276,0.0019074469,0.0005928196,0.0012862111,0.0010339987,0.00041470808,0.001707956,0.0008916916],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96760833,0.01564489,0.00036946652,0.00094672036,0.00042402794,0.000039069444,0.00006697116,0.00008038325,0.0038896115,0.00007039177,0.00021064983,0.010649452],"study_design_scores_gemma":[0.75584906,0.24078502,0.001523739,0.00005658197,0.0004428,0.000019058163,0.000030397781,0.00018453889,0.00053192454,0.00005277179,0.0005114305,0.000012774501],"about_ca_topic_score_codex":0.0006501743,"about_ca_topic_score_gemma":0.0016035326,"teacher_disagreement_score":0.006301596,"about_ca_system_score_codex":0.0005097582,"about_ca_system_score_gemma":0.001630343,"threshold_uncertainty_score":0.021080911},"labels":[],"label_agreement":null},{"id":"W3006385761","doi":"10.1002/jcph.1575","title":"Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease—A Pilot Study","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health","keywords":"Tolerability; Ursodeoxycholic acid; Medicine; Pharmacokinetics; Internal medicine; Parkinson's disease; Gastroenterology; Adverse effect; Pharmacology; Disease","score_opus":0.05089371776168045,"score_gpt":0.36159830008939864,"score_spread":0.3107045823277182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006385761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887365,0.00043061818,0.00022477396,0.000025348423,0.000008447109,0.00011340999,0.00012839642,0.0000208156,0.000174594],"genre_scores_gemma":[0.99882835,0.00018350722,0.00035840453,0.00005767343,0.00002585312,0.000102893166,0.00021765706,0.000006639795,0.00021912371],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997348,0.000121844125,0.000021994707,0.000054559667,0.000037157915,0.000029485294],"domain_scores_gemma":[0.9993561,0.00016658401,0.00013979021,0.000070644564,0.000061083694,0.00020584647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063851924,0.00064838066,0.0012224034,0.00023188333,0.0003383118,0.00043419612,0.0002231092,0.0005211348,0.00088842097],"category_scores_gemma":[0.0010568781,0.00028001762,0.0006209476,0.0002390328,0.0004499011,0.00043524124,0.00017284608,0.0009889483,0.0002472548],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44172022,0.028558034,0.1161663,0.0005911799,0.0016524068,0.0018359174,0.0010796086,0.0025888856,0.25718468,0.0001200722,0.0012104805,0.14729226],"study_design_scores_gemma":[0.03179123,0.7409048,0.2030456,0.000031647523,0.0008551904,0.0013077258,0.00021274909,0.002540405,0.016919002,0.00009096853,0.0022519345,0.000048721584],"about_ca_topic_score_codex":0.0004723404,"about_ca_topic_score_gemma":0.0005029037,"teacher_disagreement_score":0.0012224034,"about_ca_system_score_codex":0.00026347183,"about_ca_system_score_gemma":0.00034947158,"threshold_uncertainty_score":0.0033768415},"labels":[],"label_agreement":null},{"id":"W3027201765","doi":"10.1002/jcph.1645","title":"Can Colchicine as an Old Anti‐Inflammatory Agent Be Effective in COVID‐19?","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Iran University of Medical Sciences","keywords":"Colchicine; Medicine; Pneumonia; Immunology; Tumor necrosis factor alpha; Cytokine storm; Cytokine; Inflammation; Interferon; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty)","score_opus":0.1528156422679541,"score_gpt":0.5651303726928837,"score_spread":0.4123147304249296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027201765","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06729843,0.89540875,0.0009093115,0.02159256,0.005775574,0.00021803181,0.0003283368,0.000115577044,0.008353395],"genre_scores_gemma":[0.34291932,0.6062515,0.0048782267,0.027084652,0.008490979,0.00032906208,0.00070397474,0.00006670705,0.009275685],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9998282,0.00004846897,0.000020216186,0.000027621396,0.00004427546,0.00003113169],"domain_scores_gemma":[0.9997218,0.000087018576,0.00006402637,0.000013026094,0.00004978871,0.000064333384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047119346,0.0004537946,0.00095727027,0.0005152276,0.00030332457,0.0005819039,0.00059207785,0.0015007713,0.0036020093],"category_scores_gemma":[0.00090307806,0.00009493952,0.0005707194,0.000285297,0.00043620382,0.0008560181,0.00020446129,0.0011095554,0.0010512487],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022539822,0.0034647507,0.005571689,0.013208025,0.0005775052,0.0055218358,0.00021589674,0.00026032433,0.029259086,0.002656139,0.043147635,0.8735773],"study_design_scores_gemma":[0.011831363,0.040186714,0.047880765,0.0075207595,0.0017504799,0.012796434,0.0008939519,0.0011489637,0.032538686,0.0049125296,0.8382496,0.00028969639],"about_ca_topic_score_codex":0.0010600757,"about_ca_topic_score_gemma":0.0031385452,"teacher_disagreement_score":0.0036020093,"about_ca_system_score_codex":0.00037192806,"about_ca_system_score_gemma":0.00040328217,"threshold_uncertainty_score":0.012049913},"labels":[],"label_agreement":null},{"id":"W3032901080","doi":"10.1002/jcph.1684","title":"Colchicine and COVID‐19","year":2020,"lang":"en","type":"letter","venue":"The Journal of Clinical Pharmacology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; Placebo; Family medicine; Clinical trial; Colchicine; Population; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Alternative medicine; Environmental health; Pathology","score_opus":0.25126387426054914,"score_gpt":0.5924996591163878,"score_spread":0.34123578485583866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032901080","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003877342,0.04852541,0.00016284516,0.7251243,0.2243608,0.000016786218,0.000089163725,0.000045268618,0.0012876757],"genre_scores_gemma":[0.0055848705,0.027381375,0.00030856012,0.6195059,0.3430078,0.000037227514,0.00006920597,0.00005345732,0.0040516015],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99621105,0.001053014,0.00066406105,0.0005412708,0.0011826293,0.0003480223],"domain_scores_gemma":[0.98765635,0.0067403256,0.0012403323,0.00032559645,0.0029066184,0.0011307218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050748484,0.00086325203,0.0017246866,0.00092443137,0.0019859201,0.0037190982,0.0020542606,0.015986433,0.005550917],"category_scores_gemma":[0.021466497,0.00050244253,0.0012530594,0.0007044939,0.0023002776,0.0037730287,0.0012640349,0.02040667,0.0041067787],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002618163,0.00003398334,0.0003131371,0.00057228765,0.000056409175,0.0006537376,0.00006694879,0.000026822083,0.00015962012,0.0010551817,0.969069,0.027731031],"study_design_scores_gemma":[0.00014851279,0.00016519363,0.0008002986,0.0008506008,0.00008097365,0.0018052618,0.00015434803,0.00013658006,0.00034223107,0.0019859984,0.9934924,0.000037642778],"about_ca_topic_score_codex":0.0012954972,"about_ca_topic_score_gemma":0.0021858998,"teacher_disagreement_score":0.015986433,"about_ca_system_score_codex":0.0019309977,"about_ca_system_score_gemma":0.002556783,"threshold_uncertainty_score":0.02683866},"labels":[],"label_agreement":null},{"id":"W3088185875","doi":"10.1002/jcph.1743","title":"Population Pharmacokinetics of Phenobarbital in Neonates and Infants on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institute of Neurological Disorders and Stroke; National Science Foundation","keywords":"Medicine; Extracorporeal membrane oxygenation; Pharmacokinetics; Dosing; Volume of distribution; Renal replacement therapy; Concomitant; Anesthesia; Population; Phenobarbital; Loading dose; Pharmacology; Internal medicine","score_opus":0.04983872761312437,"score_gpt":0.3892984059846899,"score_spread":0.33945967837156554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088185875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99837303,0.0005098703,0.0008090052,0.000031829946,0.0000028307184,0.000008669411,0.00006627525,0.0000064547357,0.00019198844],"genre_scores_gemma":[0.9986852,0.00033748784,0.0006856903,0.000029977497,0.0000089414325,0.000017677414,0.0001768837,0.000004096381,0.00005422656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989172,0.0005293741,0.00009376728,0.00017535452,0.00020839958,0.0000759715],"domain_scores_gemma":[0.9981042,0.00083107065,0.00062490645,0.00015255016,0.0001733923,0.00011393684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001548859,0.00022601095,0.0007341918,0.00032320037,0.00012164925,0.0005272703,0.0002318108,0.00031840577,0.00026321574],"category_scores_gemma":[0.0061645815,0.00018092612,0.00036351974,0.00030439816,0.00021483652,0.0003631024,0.00025587465,0.0004474717,0.00006947498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007544396,0.00006766282,0.9824269,0.000021554826,0.0002086345,0.0005719598,0.00017120579,0.0023952285,0.0019421678,0.00015209187,0.000119795346,0.011168301],"study_design_scores_gemma":[0.000028916524,0.0010787076,0.9863875,0.000011556956,0.0001152068,0.002243329,0.00024780325,0.008345689,0.0007954495,0.00021182682,0.00051767746,0.000016397324],"about_ca_topic_score_codex":0.0020923046,"about_ca_topic_score_gemma":0.0014240199,"teacher_disagreement_score":0.0020923046,"about_ca_system_score_codex":0.00044998346,"about_ca_system_score_gemma":0.00048719769,"threshold_uncertainty_score":0.008191228},"labels":[],"label_agreement":null},{"id":"W3100206030","doi":"10.1002/jcph.1713","title":"A Physiological Approach to Pharmacokinetics in Chronic Kidney Disease","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Kidney disease; Renal function; Pharmacokinetics; Medicine; Hematocrit; Population; Intensive care medicine; Clinical trial; Internal medicine; Pharmacology; Urology","score_opus":0.11503815945997459,"score_gpt":0.42454581783916673,"score_spread":0.30950765837919214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100206030","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028011587,0.009922283,0.93843675,0.0045581865,0.00060679566,0.00022490935,0.001029658,0.0008341022,0.016375782],"genre_scores_gemma":[0.674354,0.019282496,0.2865223,0.003414944,0.0011173751,0.00084332953,0.0011354692,0.00027581982,0.013054291],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9992034,0.00034689493,0.000041199684,0.00016366682,0.00020913231,0.000035679845],"domain_scores_gemma":[0.99942565,0.00028571076,0.00007370004,0.000057414345,0.0001277808,0.000029723627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013675393,0.00079894194,0.00080433453,0.00050135824,0.00037062433,0.0015672834,0.0012842085,0.0012889195,0.0020391382],"category_scores_gemma":[0.0026120115,0.00039893578,0.0012501962,0.000573916,0.0009364849,0.0013740623,0.0010440397,0.0023322082,0.0009765713],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020028785,0.00029509544,0.0063913674,0.0012305351,0.00030438945,0.00041140927,0.0004194986,0.6829312,0.022386817,0.16397387,0.009202502,0.11225307],"study_design_scores_gemma":[0.000051823597,0.00080777355,0.003398587,0.00023627412,0.00012933573,0.00054860016,0.000118597236,0.83020914,0.0039808666,0.09543032,0.064979546,0.000109242304],"about_ca_topic_score_codex":0.003591462,"about_ca_topic_score_gemma":0.0018993773,"teacher_disagreement_score":0.003591462,"about_ca_system_score_codex":0.00091255765,"about_ca_system_score_gemma":0.0019295618,"threshold_uncertainty_score":0.0072323084},"labels":[],"label_agreement":null},{"id":"W3118172129","doi":"10.1002/jcph.1807","title":"Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX‐02 in Patients With Nephropathic Cystinosis","year":2020,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Biomedical Research and Pathophysiology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Dosing; Medicine; Renal function; Cystinosis; Pharmacokinetics; Urology; Area under the curve; Internal medicine; Urinary system; Population; Urine; Endocrinology; Chemistry; Cystine","score_opus":0.08037499124568052,"score_gpt":0.45048855609374333,"score_spread":0.3701135648480628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118172129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972951,0.00070354633,0.0007134666,0.00019799257,0.000009444157,0.00020080099,0.000086864406,0.000044917488,0.0007478663],"genre_scores_gemma":[0.9985592,0.00014413189,0.000717995,0.00014725607,0.000016041111,0.0000724431,0.0001256951,0.0000035324588,0.00021372571],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993297,0.00043594255,0.000042977634,0.00006557977,0.000079862155,0.000045939945],"domain_scores_gemma":[0.9988175,0.0004342916,0.000409853,0.00010722226,0.00008286569,0.00014822163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021194678,0.0003194313,0.0007549749,0.00009962309,0.00017453736,0.00048742135,0.0003332454,0.00047022742,0.00069852924],"category_scores_gemma":[0.0019565197,0.00011190037,0.00042841624,0.00010985174,0.00018834669,0.00033166574,0.00020899584,0.0008879725,0.000115951625],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34097695,0.018184558,0.15662386,0.0008533636,0.0019556829,0.0005967961,0.00047950298,0.014817324,0.08578679,0.00052638847,0.002269136,0.3769297],"study_design_scores_gemma":[0.07967592,0.46100482,0.3941617,0.00012399109,0.00157294,0.0012174564,0.0001797395,0.022701442,0.03105332,0.00062620663,0.0075902017,0.00009220442],"about_ca_topic_score_codex":0.0002471294,"about_ca_topic_score_gemma":0.00063116197,"teacher_disagreement_score":0.0021194678,"about_ca_system_score_codex":0.00030600085,"about_ca_system_score_gemma":0.0004994665,"threshold_uncertainty_score":0.0112089515},"labels":[],"label_agreement":null},{"id":"W3129612282","doi":"10.1002/jcph.1839","title":"Association of Urine Platinum With Acute Kidney Injury in Children Treated With Cisplatin for Cancer","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; Western University; McGill University Health Centre; BC Children's Hospital; University of Toronto; SickKids Foundation; University of British Columbia; Hospital for Sick Children; Montreal Children's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"Acute kidney injury; Medicine; Urine; Cisplatin; Urology; Creatinine; Lipocalin; Urinary system; Interquartile range; Internal medicine; Gastroenterology; Chemotherapy","score_opus":0.024114753455638818,"score_gpt":0.4001321020540021,"score_spread":0.37601734859836333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129612282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989969,0.0003897989,0.00005197581,0.00003192023,0.000003995255,0.000012577042,0.0002344366,0.0000036789204,0.0002746475],"genre_scores_gemma":[0.9994273,0.00018750146,0.0001048911,0.000018245722,0.0000036079105,0.0000067754854,0.00017230913,0.0000018233189,0.00007758431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991091,0.00008992361,0.000081644175,0.00014598104,0.0003821573,0.00019125578],"domain_scores_gemma":[0.9976699,0.00021825009,0.0012908533,0.00006632857,0.00044487725,0.00030977762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044817507,0.00028154108,0.00048655932,0.0011197563,0.000708501,0.00059471594,0.0005125329,0.0003576098,0.0012837835],"category_scores_gemma":[0.0027856498,0.00028905694,0.0004785951,0.0017609993,0.00045852174,0.00035640446,0.0004979904,0.0006153358,0.000082658196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021744436,0.0000052835453,0.99935085,0.000009479874,0.000009810636,0.00006405506,0.00006515463,0.000008872922,0.00006037599,0.0000044466883,0.000030687712,0.00036913579],"study_design_scores_gemma":[0.0000017116935,0.00004385587,0.999089,0.000011564653,0.000018309416,0.00039537688,0.00019054193,0.00005166923,0.000057699046,0.0000044214526,0.0001331851,0.0000025888603],"about_ca_topic_score_codex":0.18796845,"about_ca_topic_score_gemma":0.29502505,"teacher_disagreement_score":0.18796845,"about_ca_system_score_codex":0.0023667668,"about_ca_system_score_gemma":0.0031801562,"threshold_uncertainty_score":0.37374866},"labels":[],"label_agreement":null},{"id":"W3139458708","doi":"10.1002/jcph.1850","title":"<i>The Journal of Clinical Pharmacology</i> Adds 2 Associate Editors","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical pharmacology; Pharmacy; Medicine; Associate editor; Family medicine; Library science; Medical education; Pharmacology","score_opus":0.17579865130730293,"score_gpt":0.5619432494937948,"score_spread":0.3861445981864919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139458708","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020399944,0.0067240554,0.0005938312,0.09097699,0.8835508,0.0000987695,0.00009897638,0.0003131491,0.01743936],"genre_scores_gemma":[0.0016718275,0.008831713,0.00086204277,0.05784891,0.8993176,0.00006961585,0.00022206755,0.00015879597,0.031017398],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9861412,0.0019938927,0.0019570345,0.0013731428,0.0073910803,0.0011436737],"domain_scores_gemma":[0.83853614,0.013296391,0.007139458,0.005470985,0.11208377,0.023473306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012670102,0.0021597194,0.0025566297,0.0061222906,0.0033410343,0.015509376,0.0036851694,0.010454721,0.054936025],"category_scores_gemma":[0.061318986,0.0016297672,0.0020703212,0.0027817793,0.0025210488,0.006969585,0.0034534498,0.011246331,0.08173434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002042186,0.000020732756,0.00021126427,0.0001583691,0.0000071290606,0.000063556145,0.000011711361,0.000013522131,0.0000867787,0.00027208068,0.9754133,0.023721151],"study_design_scores_gemma":[0.000019390389,0.000035537778,0.0004565792,0.00029755192,0.00001262769,0.00039331988,0.000054169315,0.000082000195,0.000090923706,0.0006083262,0.9979259,0.000023757215],"about_ca_topic_score_codex":0.0012765421,"about_ca_topic_score_gemma":0.0033949567,"teacher_disagreement_score":0.054936025,"about_ca_system_score_codex":0.0027377075,"about_ca_system_score_gemma":0.008644484,"threshold_uncertainty_score":0.1837793},"labels":[],"label_agreement":null},{"id":"W3157957845","doi":"10.1002/jcph.1876","title":"Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Riluzole; Medicine; Pharmacokinetics; Neuroprotection; Pharmacology; Spinal cord injury; Amyotrophic lateral sclerosis; Population; Anesthesia; Spinal cord; Internal medicine","score_opus":0.17296837871998935,"score_gpt":0.5555047025165303,"score_spread":0.3825363237965409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157957845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582267,0.001056032,0.0015059045,0.000118577,0.000017968592,0.00004424185,0.00071232626,0.00005270767,0.00066961837],"genre_scores_gemma":[0.99834013,0.00025842298,0.00024724499,0.0000685835,0.0000076975775,0.000032465552,0.00054095575,0.000009591308,0.00049484253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960905,0.00014222137,0.000023853272,0.000081764534,0.00007874557,0.00006433895],"domain_scores_gemma":[0.99830073,0.00049494475,0.0005256296,0.00021087314,0.00030361128,0.00016429898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014259048,0.00027295365,0.0005887294,0.00020585622,0.00019452136,0.0006637846,0.00018434162,0.0004194925,0.0013190127],"category_scores_gemma":[0.0042533386,0.00019374337,0.00033603644,0.0002684667,0.00025452377,0.0004398796,0.00028110523,0.00076876755,0.0004343491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06688287,0.0032247987,0.5864938,0.00043612887,0.0020138354,0.0012794201,0.0007538671,0.014640248,0.17603405,0.000760107,0.0032934193,0.1441875],"study_design_scores_gemma":[0.00043271336,0.025420459,0.90092945,0.000058862566,0.0011880302,0.0011158967,0.00018018045,0.029757679,0.036057953,0.0006150959,0.004143652,0.00009991635],"about_ca_topic_score_codex":0.002193878,"about_ca_topic_score_gemma":0.0015400551,"teacher_disagreement_score":0.002193878,"about_ca_system_score_codex":0.0005370977,"about_ca_system_score_gemma":0.0010283882,"threshold_uncertainty_score":0.007541001},"labels":[],"label_agreement":null},{"id":"W3165414811","doi":"10.1002/jcph.1914","title":"Influence of Prednisone on Inflammatory Biomarkers in Community‐Acquired Pneumonia: Secondary Analysis of a Randomized Trial","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Gottfried und Julia Bangerter-Rhyner-Stiftung; Inselspital, Universitätsspital Bern; Universität Basel; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Helmut Horten Stiftung; National Science Foundation; Nora van Meeuwen Häfliger Stiftung","keywords":"Prednisone; Medicine; Procalcitonin; Placebo; Internal medicine; Pneumonia; Community-acquired pneumonia; Gastroenterology; Randomized controlled trial; Glucocorticoid; Corticosteroid; Absolute neutrophil count; Immunology; Pathology; Chemotherapy; Neutropenia; Sepsis","score_opus":0.10357982708112005,"score_gpt":0.4627796006136836,"score_spread":0.35919977353256355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165414811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687413,0.018641144,0.0015395879,0.00093436125,0.0015248833,0.004774486,0.0017170438,0.00016060431,0.0019666583],"genre_scores_gemma":[0.9904587,0.0025746597,0.0010201284,0.00056578807,0.0008264443,0.0027665158,0.00092460983,0.000023203127,0.0008398216],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99024665,0.0072529623,0.00066209584,0.00078223523,0.0005145487,0.0005414374],"domain_scores_gemma":[0.98966706,0.005048283,0.002375504,0.0009861597,0.00075552386,0.0011675174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008020499,0.0019264184,0.006028128,0.00066967396,0.00047870024,0.0018701409,0.0009944319,0.0022800418,0.005116971],"category_scores_gemma":[0.011852087,0.00060018536,0.0063411896,0.0008798862,0.001120626,0.0011423646,0.0006869065,0.0027491131,0.00055319734],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98810834,0.00086347345,0.00084570865,0.0007354027,0.004719497,0.000031010793,0.000013642102,0.00016191,0.00051250565,0.000033035165,0.00020810305,0.003767424],"study_design_scores_gemma":[0.9446306,0.042828135,0.0055124853,0.0000918928,0.00549503,0.00003536005,0.000016618853,0.0005586959,0.00028167616,0.00016938867,0.00035996552,0.00002010749],"about_ca_topic_score_codex":0.00080429204,"about_ca_topic_score_gemma":0.001138739,"teacher_disagreement_score":0.008020499,"about_ca_system_score_codex":0.00096500537,"about_ca_system_score_gemma":0.0015779975,"threshold_uncertainty_score":0.04241699},"labels":[],"label_agreement":null},{"id":"W3175294244","doi":"10.1002/jcph.1829","title":"Pediatric Dose Selection for Therapeutic Proteins","year":2021,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Dosing; Pharmacokinetics; Medicine; Context (archaeology); Pharmacology; Population; Pharmacodynamics; Drug development; Drug; Intensive care medicine; Biology","score_opus":0.4405057188521444,"score_gpt":0.6222148885577327,"score_spread":0.18170916970558826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175294244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005947627,0.97137004,0.010300805,0.0017676646,0.00047969932,0.00015342495,0.00020718425,0.00008285572,0.009690654],"genre_scores_gemma":[0.04059336,0.939654,0.012298553,0.001907294,0.00060235965,0.00022767366,0.00041906076,0.000059411374,0.0042383014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938893,0.00024185635,0.000069818234,0.00007904534,0.00018709754,0.000033311604],"domain_scores_gemma":[0.99935883,0.00032203377,0.00015641852,0.000025936586,0.00011220703,0.00002461744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018135373,0.00046939604,0.00084101915,0.00072326435,0.00011346233,0.000813817,0.0007639377,0.00069513475,0.0033141293],"category_scores_gemma":[0.0021589377,0.00015525763,0.0005373291,0.00067293906,0.00030948693,0.0009262273,0.0004887827,0.0019952804,0.0017418815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039001944,0.00012115123,0.0006456976,0.0056527634,0.000100538906,0.0001736421,0.00007338942,0.00094732933,0.004873863,0.0072565232,0.010870226,0.96889484],"study_design_scores_gemma":[0.00021280114,0.0010416632,0.0047160746,0.0040348205,0.00025784867,0.004072047,0.000089324865,0.000817851,0.008809119,0.004608916,0.971308,0.000031538406],"about_ca_topic_score_codex":0.00047079907,"about_ca_topic_score_gemma":0.0004672984,"teacher_disagreement_score":0.0033141293,"about_ca_system_score_codex":0.0004956061,"about_ca_system_score_gemma":0.00089771947,"threshold_uncertainty_score":0.011086881},"labels":[],"label_agreement":null},{"id":"W3192943827","doi":"10.1002/jcph.1951","title":"Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6‐Mediated Drug‐Drug Interactions on Tramadol and O‐Desmethyltramadol Exposures via Allosteric and Competitive Inhibition","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Tramadol; Quinidine; Pharmacology; CYP2D6; Pharmacokinetics; Drug interaction; Active metabolite; Chemistry; Oral administration; Propoxyphene; Drug; Medicine; Analgesic; Cytochrome P450; Metabolism; Biochemistry","score_opus":0.1831215674548552,"score_gpt":0.4810299608556376,"score_spread":0.2979083934007824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192943827","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39603847,0.0040304344,0.5642352,0.0009935293,0.00018068872,0.00069918187,0.0040903687,0.0014706282,0.028261602],"genre_scores_gemma":[0.9515701,0.0021716347,0.0366706,0.00026451587,0.000039301216,0.00078134274,0.0014932617,0.00013779108,0.006871454],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99970955,0.000087085675,0.000018998351,0.000049263457,0.00010254322,0.000032625998],"domain_scores_gemma":[0.99946445,0.00031892577,0.00007724528,0.000027552425,0.00010063468,0.000011146261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050457177,0.00078503025,0.0008621567,0.000305521,0.00023836165,0.00085724454,0.00080001383,0.0009875708,0.0022952144],"category_scores_gemma":[0.0014633281,0.0003683915,0.001390746,0.0003287215,0.00020925349,0.00049757713,0.00039875307,0.001372931,0.0007973474],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018711327,0.00018420866,0.0030674026,0.00029457634,0.0001592473,0.00023838895,0.00007665497,0.9582943,0.019552793,0.0040705833,0.0011022016,0.012772552],"study_design_scores_gemma":[0.000022633247,0.00015255465,0.00082536077,0.0000092698865,0.00004933425,0.00008479851,0.000011024359,0.99281436,0.003036663,0.00059403764,0.002384335,0.000015614176],"about_ca_topic_score_codex":0.0087511195,"about_ca_topic_score_gemma":0.0036404014,"teacher_disagreement_score":0.0087511195,"about_ca_system_score_codex":0.00068063836,"about_ca_system_score_gemma":0.0012860665,"threshold_uncertainty_score":0.017400384},"labels":[],"label_agreement":null},{"id":"W3196156655","doi":"10.1002/jcph.1937","title":"The Epidemiology of Drug Abuse","year":2021,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Epidemiology; Psychosocial; Recreational Drug; Pandemic; Psychiatry; Psychological intervention; Medicine; Addiction; Substance abuse; Drug; Recreation; Substance use; Disease; Psychology; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty); Political science","score_opus":0.30052645784665954,"score_gpt":0.5699602311900364,"score_spread":0.2694337733433768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196156655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032509465,0.99497616,0.00012966985,0.0013026468,0.00024650022,0.000013291065,0.00016105543,0.0000075964927,0.0028379865],"genre_scores_gemma":[0.0035340018,0.9950787,0.0001175355,0.0004981876,0.00022428739,0.0000115984785,0.000091937516,0.000001618859,0.00044209708],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905413,0.00032067468,0.0001557052,0.000105124775,0.00029690616,0.00006748484],"domain_scores_gemma":[0.99865687,0.00062882603,0.00033489446,0.000040922725,0.00025803942,0.000080419144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000870214,0.00050386676,0.0011496531,0.002342837,0.00039512763,0.001512075,0.0004690033,0.0011163849,0.0066558477],"category_scores_gemma":[0.0029947404,0.0002697172,0.0007221761,0.0031140223,0.00065347325,0.0013114942,0.00091728376,0.0016487185,0.001241027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007027374,0.00007060169,0.005375357,0.026629958,0.00045091877,0.0002277538,0.0002504456,0.00019930907,0.00021837004,0.008077878,0.038527433,0.91990167],"study_design_scores_gemma":[0.000023499992,0.000118244694,0.025850056,0.034235835,0.0004213779,0.0035078593,0.0004182995,0.00008684022,0.00016304823,0.0045572873,0.93057996,0.000037695616],"about_ca_topic_score_codex":0.008885068,"about_ca_topic_score_gemma":0.009578999,"teacher_disagreement_score":0.008885068,"about_ca_system_score_codex":0.0010820249,"about_ca_system_score_gemma":0.0029227159,"threshold_uncertainty_score":0.02226603},"labels":[],"label_agreement":null},{"id":"W3196938042","doi":"10.1002/jcph.1961","title":"Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research","keywords":"Medicine; Cannabis; Chronic pain; Brief Pain Inventory; Visual analogue scale; Quality of life (healthcare); Adverse effect; Anxiety; McGill Pain Questionnaire; Cohort; Physical therapy; Psychiatry; Internal medicine","score_opus":0.13767218119410576,"score_gpt":0.47932767940698784,"score_spread":0.3416554982128821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196938042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761885,0.00041952153,0.00005752147,0.000020707412,0.0000037662696,0.000033625878,0.0014724204,0.000003449985,0.00037007642],"genre_scores_gemma":[0.99742377,0.00022595623,0.000059662918,0.00002991426,0.000008295213,0.000038951715,0.002075219,0.0000025473794,0.0001356941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857175,0.00030273193,0.00032078312,0.00027781515,0.00033758886,0.0001892637],"domain_scores_gemma":[0.99591464,0.00065227173,0.0020536692,0.00037891802,0.000588555,0.00041201612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070204056,0.00032952192,0.00095243985,0.0014402762,0.00053147215,0.00081127736,0.00047475856,0.0005157878,0.0021049348],"category_scores_gemma":[0.0031384274,0.0004588403,0.0005979252,0.00166701,0.00042210612,0.00049097434,0.000899099,0.0004026345,0.00072703086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022479697,0.000027741795,0.99784374,0.000035405767,0.00005579711,0.00026832568,0.00012591449,0.000022956245,0.00021317415,0.0000075123867,0.00013277044,0.0010417852],"study_design_scores_gemma":[0.000019449044,0.00012595729,0.99876946,0.000011277291,0.000028460361,0.00063590286,0.00014058642,0.000054612086,0.0000405506,0.0000032313956,0.00016485069,0.000005577178],"about_ca_topic_score_codex":0.01828181,"about_ca_topic_score_gemma":0.013813262,"teacher_disagreement_score":0.01828181,"about_ca_system_score_codex":0.00089611753,"about_ca_system_score_gemma":0.0005541531,"threshold_uncertainty_score":0.036350787},"labels":[],"label_agreement":null},{"id":"W3201455773","doi":"10.1002/jcph.1966","title":"Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study","year":2021,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Rivaroxaban; Medicine; Regimen; Dosing; Pharmacokinetics; Pharmacodynamics; Population; Pharmacology; Internal medicine; Warfarin; Atrial fibrillation","score_opus":0.04027497650451648,"score_gpt":0.3775215059186179,"score_spread":0.3372465294141014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201455773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805932,0.006185865,0.009045699,0.00070631114,0.000034675915,0.00036422908,0.0008686409,0.0000847198,0.0021166008],"genre_scores_gemma":[0.98079944,0.003538418,0.013207679,0.0005330873,0.000063632084,0.00024724443,0.001301679,0.000035478624,0.00027331212],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9981505,0.0013004331,0.00006290808,0.00012698538,0.00028970384,0.00006933067],"domain_scores_gemma":[0.99666864,0.0016973678,0.00095311645,0.00024753794,0.00025621877,0.00017707907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056131785,0.00040222958,0.00088954245,0.00021878335,0.00016202526,0.0007014584,0.00045322673,0.00036422166,0.0004542568],"category_scores_gemma":[0.008836899,0.00016191267,0.0007894355,0.00029550993,0.00030645775,0.00040872305,0.0003663658,0.00088547583,0.00008935317],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025893323,0.0069492366,0.3696718,0.00079403154,0.0017180484,0.0005471197,0.001182698,0.057864305,0.027831925,0.0046216818,0.008266396,0.4946595],"study_design_scores_gemma":[0.016109146,0.1528992,0.5313343,0.0006408872,0.0033755754,0.0048110522,0.00091505493,0.1791998,0.048452917,0.0038571113,0.057989314,0.0004156095],"about_ca_topic_score_codex":0.0021033208,"about_ca_topic_score_gemma":0.0017799989,"teacher_disagreement_score":0.0056131785,"about_ca_system_score_codex":0.00072797615,"about_ca_system_score_gemma":0.001715107,"threshold_uncertainty_score":0.029685676},"labels":[],"label_agreement":null},{"id":"W3212705536","doi":"10.1002/jcph.2002","title":"Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration: A Systematic Review and Model‐Based Meta‐Analysis","year":2021,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Macular degeneration; Medicine; Meta-analysis; VEGF receptors; Oncology; Ranibizumab; Disease; Internal medicine; Ophthalmology; Bevacizumab; Chemotherapy","score_opus":0.15278332571369319,"score_gpt":0.5262571782959821,"score_spread":0.3734738525822889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212705536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008847634,0.98728067,0.001203929,0.00028013828,0.00019727925,0.0003976745,0.0012660484,0.000051430496,0.00047518167],"genre_scores_gemma":[0.3509361,0.6391924,0.0037094015,0.0011268811,0.00032038987,0.0019317755,0.0019963675,0.0000711055,0.00071563513],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9899386,0.0058440412,0.0021202646,0.0010539095,0.0008005882,0.00024260838],"domain_scores_gemma":[0.97886,0.016288992,0.0025804024,0.00074968487,0.0012963508,0.00022463237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015168727,0.0021176785,0.014963881,0.004321511,0.0004920501,0.002782192,0.0022934251,0.0018921312,0.0037672531],"category_scores_gemma":[0.03032414,0.001192032,0.034960706,0.005767644,0.000549901,0.0014237867,0.0011236211,0.0014790172,0.0004013188],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017770765,0.00002466292,0.004261715,0.27599984,0.70808375,0.000114614355,0.00005738831,0.0011072562,0.00019833031,0.00019277356,0.0008027951,0.007379787],"study_design_scores_gemma":[0.00049776176,0.00014667571,0.0025612332,0.012181229,0.98254955,0.000058095156,0.000021024765,0.0004120326,0.000077405086,0.00018867997,0.0012891034,0.00001722867],"about_ca_topic_score_codex":0.007039329,"about_ca_topic_score_gemma":0.012970533,"teacher_disagreement_score":0.015168727,"about_ca_system_score_codex":0.002008662,"about_ca_system_score_gemma":0.0029061367,"threshold_uncertainty_score":0.08022088},"labels":[],"label_agreement":null},{"id":"W4210268673","doi":"10.1002/jcph.2034","title":"Physiologically Based Pharmacokinetic Modeling of Metformin in Children and Adolescents With Obesity","year":2022,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Physiologically based pharmacokinetic modelling; Metformin; Obesity; Medicine; Overweight; Pharmacokinetics; Childhood obesity; Population; Pediatrics; Pharmacology; Internal medicine; Endocrinology; Physiology; Environmental health; Diabetes mellitus","score_opus":0.09068643256873583,"score_gpt":0.4426168972715347,"score_spread":0.3519304647027989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210268673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85385996,0.0016251518,0.12639542,0.0009150655,0.000084041516,0.00021908416,0.0019414392,0.00015605584,0.0148038175],"genre_scores_gemma":[0.9833693,0.0013476134,0.0112114595,0.00019611108,0.000028035452,0.00021225262,0.0004968084,0.000029416595,0.0031091147],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998355,0.000068281355,0.000009070858,0.000029072567,0.000034449014,0.000023588047],"domain_scores_gemma":[0.99978477,0.00010864602,0.000046966336,0.000008522378,0.0000351104,0.000015991181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003365717,0.00031281408,0.0003813328,0.0001522589,0.00017521801,0.00058802444,0.00049876305,0.0005441043,0.0010879101],"category_scores_gemma":[0.0009594955,0.00018697107,0.0005930558,0.00021796029,0.00024728285,0.00030757237,0.00038661328,0.0005393046,0.00020496527],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014145845,0.00007053856,0.013081422,0.00006296294,0.00005335255,0.00028994682,0.00009954175,0.97249424,0.0026039218,0.003146797,0.00075272104,0.0072030863],"study_design_scores_gemma":[0.000045211225,0.00021327441,0.006967998,0.000019180734,0.00004644419,0.00016908265,0.00006977213,0.9870466,0.0008194929,0.0015358182,0.00305013,0.00001698875],"about_ca_topic_score_codex":0.013443494,"about_ca_topic_score_gemma":0.006011622,"teacher_disagreement_score":0.013443494,"about_ca_system_score_codex":0.00050228834,"about_ca_system_score_gemma":0.001093069,"threshold_uncertainty_score":0.026730478},"labels":[],"label_agreement":null},{"id":"W4232967244","doi":"10.1002/jcph.87","title":"Issue Information","year":2013,"lang":"en","type":"paratext","venue":"The Journal of Clinical Pharmacology","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Manitoba","funders":"","keywords":"Citation; Computer science; Information retrieval; World Wide Web; Library science","score_opus":0.06266177250645658,"score_gpt":0.4773903518258223,"score_spread":0.4147285793193657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232967244","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033837603,0.00057005277,0.0007531481,0.0042255465,0.011122337,0.0004310003,0.01944144,0.0023117291,0.96080637],"genre_scores_gemma":[0.00066362653,0.00025844772,0.00025515797,0.0008615939,0.00078271533,0.00010933466,0.005478489,0.00045407508,0.99113655],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872607,0.00018093214,0.00008105302,0.00012917153,0.00071875216,0.0001639624],"domain_scores_gemma":[0.99463,0.00081732374,0.00021623922,0.00037598435,0.0025053876,0.0014550708],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015396563,0.0011732337,0.001222886,0.0044572745,0.001996594,0.007265993,0.0017608126,0.0020760668,0.90516025],"category_scores_gemma":[0.009527394,0.00049900915,0.0006055725,0.0043721185,0.0006818001,0.004146815,0.0028134943,0.002199802,0.8669578],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015092922,0.000016573425,0.00003034846,0.00007139534,6.1542926e-7,0.000009337402,0.000008125104,0.000016229198,0.000050872255,0.0006353361,0.98184437,0.017301837],"study_design_scores_gemma":[0.000023293265,0.000019840261,0.00034671286,0.00011757686,0.0000017274489,0.000021489994,0.00005301768,0.00006841272,0.00009822116,0.0011023503,0.99814,0.000007296361],"about_ca_topic_score_codex":0.0030153552,"about_ca_topic_score_gemma":0.006011691,"teacher_disagreement_score":0.09483975,"about_ca_system_score_codex":0.0016297774,"about_ca_system_score_gemma":0.0032137886,"threshold_uncertainty_score":0.13527739},"labels":[],"label_agreement":null},{"id":"W4234129648","doi":"10.1002/jcph.72","title":"Issue Information","year":2013,"lang":"en","type":"paratext","venue":"The Journal of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; University of Manitoba","funders":"","keywords":"Citation; Computer science; Information retrieval; World Wide Web","score_opus":0.07487596288625405,"score_gpt":0.4982250255603367,"score_spread":0.4233490626740827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234129648","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032713113,0.00053445075,0.0008124918,0.003795714,0.008954751,0.00043212518,0.021807972,0.0023365044,0.96099883],"genre_scores_gemma":[0.0006174067,0.00023940814,0.00026013443,0.00072239136,0.00059746136,0.00010124464,0.0057522706,0.00043685784,0.99127275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986551,0.00018544597,0.00008317767,0.00013851363,0.00077835534,0.00015937744],"domain_scores_gemma":[0.9943189,0.0008703113,0.00022590643,0.00042707627,0.0026889408,0.0014688766],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015837966,0.0011564251,0.0011971957,0.00467273,0.001985559,0.0076086265,0.0017278501,0.002117898,0.9035238],"category_scores_gemma":[0.009913941,0.0005266992,0.00059521216,0.004574574,0.00071657,0.004309003,0.0028046865,0.0022567657,0.86516637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014563746,0.000017040176,0.00003243714,0.000074673866,6.522935e-7,0.000009007589,0.000008559225,0.000018163651,0.000057330984,0.0007772295,0.9808126,0.018177813],"study_design_scores_gemma":[0.000022126007,0.000018625464,0.00035982966,0.000117408454,0.0000017709779,0.000022099879,0.000053146614,0.000068917805,0.00010567451,0.0011716512,0.9980515,0.000007214087],"about_ca_topic_score_codex":0.0031380455,"about_ca_topic_score_gemma":0.006258445,"teacher_disagreement_score":0.0964762,"about_ca_system_score_codex":0.001710787,"about_ca_system_score_gemma":0.0034159853,"threshold_uncertainty_score":0.13761151},"labels":[],"label_agreement":null},{"id":"W4248028102","doi":"10.1177/00912700122010960","title":"Evaluating Possible Pharmacokinetic Interactions between Tobramycin, Piperacillin, and a Combination of Piperacillin and Tazobactam in Patients with Various Degrees of Renal Impairment","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Piperacillin; Tobramycin; Piperacillin/tazobactam; Pharmacokinetics; Medicine; Renal function; Crossover study; Tazobactam; Pharmacology; Antibacterial agent; Internal medicine; Antibiotics; Chemistry; Gentamicin; Pathology","score_opus":0.07063823566904713,"score_gpt":0.4405121916659936,"score_spread":0.36987395599694645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248028102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99899215,0.0004603989,0.0002621007,0.00003112539,0.0000045754346,0.000029571995,0.000024897605,0.0000048661605,0.00019025509],"genre_scores_gemma":[0.99926263,0.00016596811,0.0002987688,0.00005828229,0.00002120483,0.000020846814,0.00004901177,0.0000018803762,0.00012140552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993338,0.00031847865,0.00004199412,0.0000727521,0.00015451964,0.00007839312],"domain_scores_gemma":[0.99880755,0.000515222,0.0003246132,0.000054845856,0.00007634029,0.00022145208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000742435,0.00043648997,0.0010073386,0.0003028986,0.0004387675,0.00043753022,0.00013309739,0.00046257052,0.0008629334],"category_scores_gemma":[0.002976746,0.00023127215,0.0003713941,0.0003059434,0.00028246085,0.00034112978,0.00017414238,0.0005034339,0.00019129754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03875144,0.0027934152,0.8562358,0.00029669903,0.0007311541,0.0027477478,0.0007054735,0.0010861285,0.04627087,0.00008995533,0.0002731816,0.050018143],"study_design_scores_gemma":[0.001443941,0.10589212,0.8672741,0.000021439282,0.0008633158,0.0062849927,0.00045281043,0.002877385,0.012547996,0.00014430964,0.0021581259,0.00003945266],"about_ca_topic_score_codex":0.0005900391,"about_ca_topic_score_gemma":0.0009090521,"teacher_disagreement_score":0.0010073386,"about_ca_system_score_codex":0.0003033992,"about_ca_system_score_gemma":0.00032995167,"threshold_uncertainty_score":0.0039263964},"labels":[],"label_agreement":null},{"id":"W4248288235","doi":"10.1002/jcph.70","title":"Issue Information","year":2013,"lang":"en","type":"paratext","venue":"The Journal of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Impact","funders":"","keywords":"Citation; Computer science; Information retrieval; World Wide Web","score_opus":0.07487596288625405,"score_gpt":0.4982250255603367,"score_spread":0.4233490626740827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248288235","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032713113,0.00053445075,0.0008124918,0.003795714,0.008954751,0.00043212518,0.021807972,0.0023365044,0.96099883],"genre_scores_gemma":[0.0006174067,0.00023940814,0.00026013443,0.00072239136,0.00059746136,0.00010124464,0.0057522706,0.00043685784,0.99127275],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986551,0.00018544597,0.00008317767,0.00013851363,0.00077835534,0.00015937744],"domain_scores_gemma":[0.9943189,0.0008703113,0.00022590643,0.00042707627,0.0026889408,0.0014688766],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015837966,0.0011564251,0.0011971957,0.00467273,0.001985559,0.0076086265,0.0017278501,0.002117898,0.9035238],"category_scores_gemma":[0.009913941,0.0005266992,0.00059521216,0.004574574,0.00071657,0.004309003,0.0028046865,0.0022567657,0.86516637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014563746,0.000017040176,0.00003243714,0.000074673866,6.522935e-7,0.000009007589,0.000008559225,0.000018163651,0.000057330984,0.0007772295,0.9808126,0.018177813],"study_design_scores_gemma":[0.000022126007,0.000018625464,0.00035982966,0.000117408454,0.0000017709779,0.000022099879,0.000053146614,0.000068917805,0.00010567451,0.0011716512,0.9980515,0.000007214087],"about_ca_topic_score_codex":0.0031380455,"about_ca_topic_score_gemma":0.006258445,"teacher_disagreement_score":0.0964762,"about_ca_system_score_codex":0.001710787,"about_ca_system_score_gemma":0.0034159853,"threshold_uncertainty_score":0.13761151},"labels":[],"label_agreement":null},{"id":"W4322616597","doi":"10.1002/jcph.2220","title":"Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid Tumors","year":2023,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Pharmacokinetics; Population pharmacokinetics; Medicine; Solid tumor; Population; Pharmacology; Oncology; Internal medicine; Cancer","score_opus":0.027450406560598748,"score_gpt":0.3742140065343328,"score_spread":0.346763599973734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322616597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94813764,0.0019560829,0.045138717,0.00035593068,0.00002230619,0.00024791938,0.002215017,0.00025920352,0.0016672704],"genre_scores_gemma":[0.9931504,0.00047879518,0.0041670995,0.00012702112,0.00001650172,0.00012759793,0.0015117975,0.000021324895,0.00039943287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918205,0.00040399,0.000044956065,0.00020859741,0.000106056454,0.000054432545],"domain_scores_gemma":[0.9983365,0.0009535549,0.0003340328,0.00019711658,0.00012470293,0.000054047865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026060282,0.00038257954,0.0012917037,0.00029584736,0.00013951377,0.0008923231,0.0003952796,0.0004932019,0.0007120286],"category_scores_gemma":[0.0054010004,0.0003242012,0.0009789127,0.00036808362,0.00021798645,0.00064295967,0.0003134371,0.0009777509,0.00023282954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016729617,0.0010618661,0.4417292,0.00055772916,0.0047843545,0.0015078096,0.0010207873,0.38531658,0.021378199,0.0048231524,0.005665616,0.11542507],"study_design_scores_gemma":[0.0011363778,0.00665357,0.23855352,0.000078622645,0.0015523853,0.0018638682,0.00021315446,0.72249424,0.0060679456,0.010233245,0.011014818,0.00013830046],"about_ca_topic_score_codex":0.0025574933,"about_ca_topic_score_gemma":0.0014570423,"teacher_disagreement_score":0.0026060282,"about_ca_system_score_codex":0.00073256163,"about_ca_system_score_gemma":0.0007850803,"threshold_uncertainty_score":0.013782203},"labels":[],"label_agreement":null},{"id":"W4380627450","doi":"10.1002/jcph.2263","title":"Improving Racial and Ethnic Equity in Clinical Trials Enrolling Pregnant and Lactating Individuals","year":2023,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"National Institutes of Health; National Science Foundation","keywords":"Ethnic group; Generalizability theory; Clinical trial; Health equity; Equity (law); Inclusion (mineral); Medicine; Family medicine; Psychology; Nursing; Political science; Social psychology; Public health; Developmental psychology","score_opus":0.9337503286949025,"score_gpt":0.801550735169816,"score_spread":0.13219959352508648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380627450","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023809972,0.9663874,0.003807378,0.01792496,0.0011930347,0.0009593699,0.00010210666,0.000024599327,0.0072200843],"genre_scores_gemma":[0.053259682,0.90709955,0.016129548,0.018126233,0.0017287267,0.0025058563,0.00018226226,0.000032334217,0.0009359031],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.90443605,0.07640706,0.009252445,0.0018194271,0.0069214525,0.0011635886],"domain_scores_gemma":[0.77640736,0.19419739,0.014510468,0.004613786,0.008832062,0.0014389366],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.09940698,0.0005530653,0.00242395,0.0022672715,0.0011272326,0.0042644343,0.0014554454,0.0025322612,0.003297172],"category_scores_gemma":[0.18535016,0.00040541764,0.0019395439,0.0030491394,0.0025054633,0.003779747,0.0030422083,0.0033855462,0.0004131613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057011045,0.00017912482,0.003360255,0.09269624,0.0013101415,0.00014435574,0.002025982,0.00045340694,0.00066414534,0.035563737,0.014228207,0.8488043],"study_design_scores_gemma":[0.0010628777,0.0008983443,0.01101079,0.37661245,0.0040834537,0.0013913524,0.0026050974,0.0006652863,0.0016328798,0.040254727,0.55968696,0.00009579419],"about_ca_topic_score_codex":0.0015963682,"about_ca_topic_score_gemma":0.0040659164,"teacher_disagreement_score":0.99746776,"about_ca_system_score_codex":0.0022737482,"about_ca_system_score_gemma":0.018881485,"threshold_uncertainty_score":0.52572066},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4380627503","doi":"10.1002/jcph.2240","title":"Translating Clinical Pharmacology Data in Pregnancy to Evidence‐Based Guideline Recommendations: Perspectives From the HIV Field","year":2023,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Guideline; Medicine; Breastfeeding; Dosing; Pregnancy; Population; Drugs in pregnancy; Intensive care medicine; Family medicine; Pharmacology; Pediatrics; Pathology; Environmental health; Fetus","score_opus":0.6739421277657448,"score_gpt":0.6642842556393443,"score_spread":0.009657872126400457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380627503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044796997,0.8641085,0.0022390308,0.12543406,0.0033551916,0.00020165696,0.00020651789,0.00003500952,0.003972007],"genre_scores_gemma":[0.0078113223,0.93667525,0.01605699,0.036466356,0.0018000205,0.00037340212,0.00025471085,0.000027053375,0.00053492584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.94803256,0.028533723,0.010907177,0.0012915016,0.010186716,0.0010483434],"domain_scores_gemma":[0.7515535,0.1846481,0.011295647,0.0037167796,0.046218853,0.002567054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08592054,0.0010334182,0.003916793,0.0038408868,0.0010747572,0.008164488,0.004783133,0.007457279,0.0030354501],"category_scores_gemma":[0.22148533,0.0009476868,0.0029105642,0.0067154155,0.0022218144,0.0076921815,0.0033506863,0.011718164,0.0011129004],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116537645,0.0000984557,0.00092136615,0.12561308,0.00092655834,0.0004345254,0.0018870756,0.00089021015,0.00049351476,0.029753223,0.1295181,0.7093474],"study_design_scores_gemma":[0.00012214549,0.00012623318,0.0012689614,0.33368722,0.0012141586,0.00037089046,0.0013836292,0.00042717924,0.0003569718,0.014480541,0.6464915,0.00007045769],"about_ca_topic_score_codex":0.012816652,"about_ca_topic_score_gemma":0.02892117,"teacher_disagreement_score":0.08592054,"about_ca_system_score_codex":0.0064972695,"about_ca_system_score_gemma":0.038755864,"threshold_uncertainty_score":0.45439667},"labels":[],"label_agreement":null},{"id":"W4385753428","doi":"10.1002/jcph.2328","title":"Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P‐Glycoprotein and Breast Cancer Resistance Protein Substrates","year":2023,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Pharmacokinetics; Dabigatran; Pharmacology; Cmax; Bioequivalence; Rosuvastatin; Internal medicine","score_opus":0.04307763789947493,"score_gpt":0.3732406955613108,"score_spread":0.33016305766183585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385753428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985353,0.00037763253,0.00052205933,0.000032429314,0.000010030585,0.00004681205,0.0000610394,0.000020008332,0.0003946909],"genre_scores_gemma":[0.9987369,0.00014664569,0.00067598245,0.00002585857,0.0000113083815,0.000037692702,0.000072359384,0.000005378824,0.00028784346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995142,0.0003008027,0.000018795541,0.00006332827,0.00006395779,0.000038853563],"domain_scores_gemma":[0.999408,0.00031113578,0.00013770128,0.000037160396,0.000037820864,0.00006816149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008585905,0.00035349268,0.000661432,0.00013660036,0.00010104269,0.0005026732,0.00023702996,0.00023717781,0.0014771341],"category_scores_gemma":[0.001548077,0.00027271308,0.0003662165,0.00014768433,0.00025762393,0.00041035144,0.00014379637,0.00057507004,0.00023329949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19807687,0.009244668,0.024333097,0.00044131713,0.00071513595,0.0002814415,0.00034083083,0.007771439,0.6779547,0.0004990185,0.0007061296,0.07963527],"study_design_scores_gemma":[0.008928729,0.34693587,0.10161832,0.00003245485,0.0013391497,0.0009254979,0.0003013614,0.05728543,0.47636312,0.00033320373,0.005854249,0.000082522165],"about_ca_topic_score_codex":0.000642286,"about_ca_topic_score_gemma":0.0009945612,"teacher_disagreement_score":0.0014771341,"about_ca_system_score_codex":0.00037435602,"about_ca_system_score_gemma":0.0003601395,"threshold_uncertainty_score":0.0049414635},"labels":[],"label_agreement":null},{"id":"W4389869854","doi":"10.1002/jcph.2397","title":"Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103)","year":2023,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Pharmacokinetics; TIGIT; Dosing; Medicine; Pharmacology; Chemistry; Internal medicine; Cancer; Immunotherapy; Pembrolizumab","score_opus":0.09254291781798765,"score_gpt":0.4808868178622886,"score_spread":0.38834390004430097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389869854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942908,0.0026440532,0.00072947226,0.00016226033,0.000029073368,0.0002914806,0.00073253346,0.00014826209,0.00097202655],"genre_scores_gemma":[0.99657,0.00053059886,0.0007038929,0.00028665527,0.000029610474,0.0002431362,0.0010378837,0.00002336625,0.00057484646],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99957746,0.00017625449,0.000022176282,0.000078604506,0.000059069396,0.00008643759],"domain_scores_gemma":[0.9995547,0.00009246378,0.00012559947,0.000045026132,0.000036263176,0.00014592682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011443169,0.0007844873,0.0016459635,0.00028876992,0.00030643644,0.0010219981,0.00033190456,0.0006856001,0.0011653467],"category_scores_gemma":[0.0010194285,0.00045146878,0.001201861,0.00032168793,0.0003674098,0.00048317318,0.00023745996,0.0019591742,0.0005961563],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3361274,0.023786008,0.07708941,0.0010301035,0.0036309285,0.0015836913,0.00079767726,0.0052116057,0.32370526,0.00047001668,0.0104015665,0.2161663],"study_design_scores_gemma":[0.060242537,0.6442331,0.20804295,0.00012055753,0.00254509,0.0050692116,0.00022233151,0.010721423,0.04856885,0.00037858114,0.01970131,0.00015403259],"about_ca_topic_score_codex":0.0007737936,"about_ca_topic_score_gemma":0.0010308655,"teacher_disagreement_score":0.0016459635,"about_ca_system_score_codex":0.0010744823,"about_ca_system_score_gemma":0.00091809116,"threshold_uncertainty_score":0.00779593},"labels":[],"label_agreement":null},{"id":"W4391403778","doi":"10.1002/jcph.2401","title":"Population Pharmacokinetics of Nirsevimab in Preterm and Term Infants","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Respiratory viral infections research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi; AstraZeneca","keywords":"Medicine; Dosing; Pharmacokinetics; Pediatrics; Population; Cohort; Birth weight; Incidence (geometry); Palivizumab; Respiratory system; Internal medicine; Pregnancy","score_opus":0.12044596364402149,"score_gpt":0.5460979611921483,"score_spread":0.42565199754812677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391403778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877622,0.001569897,0.008792969,0.00010196788,0.0000073557244,0.000075236465,0.00073459424,0.000087688466,0.0008682128],"genre_scores_gemma":[0.99592364,0.0006659039,0.00206796,0.00006958623,0.00000783512,0.000117751806,0.00084628875,0.000011758007,0.00028918128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960715,0.00018310607,0.000020649157,0.00009402948,0.00006319323,0.000032030384],"domain_scores_gemma":[0.99911183,0.0005117022,0.00015361913,0.000075733595,0.00009411491,0.0000529995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017291065,0.000351131,0.00087631814,0.0001950713,0.000096002484,0.00058022357,0.00038613795,0.0004882635,0.00052457536],"category_scores_gemma":[0.0045667486,0.00021548665,0.0006339336,0.00017308473,0.0001708925,0.0004131365,0.0003074413,0.0007929923,0.00016580005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027442636,0.0012609235,0.48746824,0.000782865,0.0031751997,0.0032828266,0.0018222722,0.24905744,0.051662542,0.003139956,0.0044984333,0.1664067],"study_design_scores_gemma":[0.0008057237,0.025862554,0.35245857,0.000091177375,0.001694205,0.003948879,0.00040202538,0.5924291,0.010488959,0.004208058,0.00742686,0.00018396693],"about_ca_topic_score_codex":0.0026926156,"about_ca_topic_score_gemma":0.00094852055,"teacher_disagreement_score":0.0026926156,"about_ca_system_score_codex":0.0005307427,"about_ca_system_score_gemma":0.0005124286,"threshold_uncertainty_score":0.009144485},"labels":[],"label_agreement":null},{"id":"W4393277131","doi":"10.1002/jcph.2434","title":"Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Duke Clinical Research Institute; National Institute of Child Health and Human Development; Penn State College of Medicine; Wichita Medical Research and Education Foundation; Pennsylvania State University; GlaxoSmithKline; University of Louisville; Eunice Kennedy Shriver National Institute of Child Health and Human Development; University of North Carolina at Chapel Hill; National Institutes of Health; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; University of North Carolina; Children's Hospital of Philadelphia","keywords":"Dexmedetomidine; Medicine; Pharmacokinetics; Anesthesia; Population pharmacokinetics; Population; Pediatrics; Pharmacology; Sedation; Environmental health","score_opus":0.3331833706014728,"score_gpt":0.5510731270892614,"score_spread":0.21788975648778858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393277131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8418531,0.0018708423,0.14409414,0.0007016649,0.000093812974,0.000680254,0.004930249,0.001087441,0.0046885116],"genre_scores_gemma":[0.9562661,0.00057091255,0.038145088,0.00022779459,0.000021906486,0.0004303952,0.003821159,0.000109561064,0.00040706815],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.997329,0.0018030776,0.00018970716,0.00033981644,0.00025875896,0.00007965774],"domain_scores_gemma":[0.98338866,0.01277077,0.0015639354,0.000772646,0.0013548841,0.00014903753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010289093,0.000994683,0.00073932565,0.00074067677,0.00025968582,0.0014054619,0.0010853813,0.0008920616,0.0009627884],"category_scores_gemma":[0.02947994,0.00044047672,0.0011784806,0.0005959211,0.00037854785,0.00096999126,0.00078085996,0.0013273212,0.0002962832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087411085,0.0002796534,0.08069756,0.000473509,0.0009063226,0.00022841894,0.00029415934,0.87414306,0.0011247421,0.001852443,0.0024593326,0.036666777],"study_design_scores_gemma":[0.00015632839,0.00066037395,0.01671664,0.00014573839,0.00021085492,0.00016744595,0.00014833192,0.9747459,0.0019450121,0.0015326672,0.0035110298,0.000059720176],"about_ca_topic_score_codex":0.01357005,"about_ca_topic_score_gemma":0.006982762,"teacher_disagreement_score":0.01357005,"about_ca_system_score_codex":0.0012319877,"about_ca_system_score_gemma":0.0017068393,"threshold_uncertainty_score":0.05441457},"labels":[],"label_agreement":null},{"id":"W4394961878","doi":"10.1002/jcph.2444","title":"Quantitative Assessment of Drug Efficacy and Emergence of Resistance in Patients with Metastatic Renal Cell Carcinoma Using a Longitudinal Exposure‐Tumor Growth Inhibition Model: Apitolisib (Dual PI3K/mTORC1/2 Inhibitor) Versus Everolimus (mTORC1 Inhibitor)","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Everolimus; Discovery and development of mTOR inhibitors; mTORC1; Renal cell carcinoma; PI3K/AKT/mTOR pathway; Medicine; Oncology; Drug resistance; Cancer research; Drug; Sirolimus; Internal medicine; Pharmacology; Chemistry; Biology; Apoptosis","score_opus":0.07965369007208031,"score_gpt":0.4042599864395211,"score_spread":0.32460629636744076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394961878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95888984,0.00051891245,0.0367437,0.00026402267,0.000020433468,0.00008991636,0.0012281954,0.00023660972,0.0020082607],"genre_scores_gemma":[0.99632484,0.00013054778,0.002157046,0.00003751649,0.000002673618,0.00006967623,0.00033624386,0.000011166477,0.00093025714],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99983513,0.00005017695,0.00000767719,0.000047998503,0.000026268275,0.000032868018],"domain_scores_gemma":[0.9994336,0.0003271901,0.00012777609,0.000030793773,0.000051894644,0.00002877528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005801329,0.00047108612,0.00042270307,0.00023938721,0.00012182814,0.00045480297,0.00047999536,0.0007003062,0.0012981286],"category_scores_gemma":[0.0011039085,0.00022176099,0.00091414026,0.00020034635,0.00028679502,0.00026996725,0.00035651034,0.00073507713,0.00021573355],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013940328,0.00059730746,0.025521802,0.00019359186,0.00016398416,0.00026967045,0.000119040866,0.9238488,0.035107955,0.0014461875,0.0005557635,0.010781923],"study_design_scores_gemma":[0.0000392035,0.0008389744,0.006034287,0.000007791147,0.00006801015,0.00012859618,0.000026688891,0.9828494,0.009098326,0.00044776223,0.00044020652,0.000020622752],"about_ca_topic_score_codex":0.0070435265,"about_ca_topic_score_gemma":0.0027387843,"teacher_disagreement_score":0.0070435265,"about_ca_system_score_codex":0.00077275984,"about_ca_system_score_gemma":0.00054419483,"threshold_uncertainty_score":0.014005065},"labels":[],"label_agreement":null},{"id":"W4396238112","doi":"10.1002/jcph.2446","title":"Assessing Pharmacogenomic <i>loci</i> Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Congressionally Directed Medical Research Programs; European Commission; U.S. Department of Defense","keywords":"Duchenne muscular dystrophy; Pharmacokinetics; Pharmacogenomics; Muscular dystrophy; Medicine; Pharmacology; Internal medicine","score_opus":0.029416546559572168,"score_gpt":0.37590091025527056,"score_spread":0.3464843636956984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396238112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989392,0.00015045458,0.00045197541,0.000020309411,0.0000018529255,0.0000042747647,0.00026179952,0.000011490597,0.00015867228],"genre_scores_gemma":[0.99942255,0.000036140143,0.00023651824,0.00000839515,0.0000020836562,0.000003434756,0.0001681464,0.0000040536756,0.0001186797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995459,0.0001553304,0.00003831341,0.0001349399,0.000077597724,0.000047890808],"domain_scores_gemma":[0.998995,0.00040194942,0.0003899327,0.000048191265,0.000090891874,0.00007405436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047406962,0.00036194857,0.00035194034,0.00064702355,0.0001982048,0.00042611503,0.00020276605,0.0003449941,0.0016730623],"category_scores_gemma":[0.0012753827,0.0001828449,0.00044641533,0.0004500141,0.0002069818,0.00017276287,0.00024401404,0.0003405967,0.00017995815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019030485,0.000026970663,0.9919926,0.000016853523,0.000094949326,0.00028831302,0.00010968173,0.0003976307,0.003117486,0.00003055961,0.00007417475,0.0036604272],"study_design_scores_gemma":[0.000005231039,0.00025202634,0.99583876,0.000008175168,0.000059588845,0.00095460156,0.00018391118,0.0013426845,0.0010228759,0.000022927343,0.00030458538,0.0000046631235],"about_ca_topic_score_codex":0.0030830486,"about_ca_topic_score_gemma":0.0017452178,"teacher_disagreement_score":0.0030830486,"about_ca_system_score_codex":0.00022831981,"about_ca_system_score_gemma":0.00013022117,"threshold_uncertainty_score":0.0061302185},"labels":[],"label_agreement":null},{"id":"W4396661720","doi":"10.1002/jcph.2449","title":"A Simulation‐Based Assessment of Levetiracetam Concentrations Following Fixed and Weight‐Based Loading Doses: A Meta‐Regression and Pharmacokinetic Modeling Analysis","year":2024,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Dosing; Pharmacokinetics; Dose; Medicine; Levetiracetam; Therapeutic index; Status epilepticus; Loading dose; Pharmacology; Anesthesia; Epilepsy; Drug","score_opus":0.32061941574936764,"score_gpt":0.5961760026929708,"score_spread":0.27555658694360313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396661720","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49674964,0.33534357,0.1379372,0.0045502516,0.0015922711,0.004113571,0.012779448,0.001547486,0.005386568],"genre_scores_gemma":[0.9661682,0.012350467,0.015829999,0.0006128969,0.000118802505,0.0015008895,0.0021389297,0.00012521901,0.0011546717],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9780864,0.018267961,0.0010636428,0.0016003774,0.00069533964,0.00028624857],"domain_scores_gemma":[0.9463284,0.048124753,0.0023209944,0.0018803774,0.0010194627,0.00032597966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.042526193,0.002616098,0.008502588,0.00266429,0.0003553104,0.0026629635,0.0035964206,0.0023566117,0.0041146395],"category_scores_gemma":[0.04257918,0.001715445,0.043913115,0.002324583,0.00047497923,0.0013448443,0.0010357152,0.0033035178,0.00059628446],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016416075,0.00028922863,0.013640933,0.013783294,0.83926475,0.0003024912,0.000095192234,0.10311615,0.00091345597,0.0010564354,0.0010667382,0.010055317],"study_design_scores_gemma":[0.003890844,0.003046397,0.008024625,0.0010345734,0.84915966,0.00016229777,0.00007436638,0.12839822,0.0007554645,0.00213221,0.0032341783,0.00008707852],"about_ca_topic_score_codex":0.0067468686,"about_ca_topic_score_gemma":0.0032467642,"teacher_disagreement_score":0.042526193,"about_ca_system_score_codex":0.0015953901,"about_ca_system_score_gemma":0.0016277784,"threshold_uncertainty_score":0.22490275},"labels":[],"label_agreement":null},{"id":"W4401442309","doi":"10.1002/jcph.6108","title":"Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Duke Clinical Research Institute; National Institute of Child Health and Human Development; University of North Carolina at Chapel Hill; Pennsylvania State University; University of Louisville; University of Pennsylvania; Wichita Medical Research and Education Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Penn State College of Medicine; Children's Hospital of Philadelphia","keywords":"Medicine; Dexamethasone; Dosing; Pharmacokinetics; Population; Obesity; NONMEM; Internal medicine","score_opus":0.027996596203942375,"score_gpt":0.40349595216099476,"score_spread":0.3754993559570524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401442309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938061,0.0013727896,0.0033894517,0.00013014389,0.000009498416,0.00003302398,0.0004890737,0.000023262524,0.0007466824],"genre_scores_gemma":[0.99640334,0.0011330589,0.0017798713,0.00006900092,0.0000063646003,0.00003730096,0.00033512298,0.000009258541,0.00022662366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997881,0.00009044527,0.000010954483,0.000038694347,0.00005241,0.000019322862],"domain_scores_gemma":[0.99960715,0.00020190806,0.00010400604,0.000021610884,0.000035647998,0.000029692816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041648516,0.00018097149,0.00034683043,0.000116657524,0.00008324299,0.00040521688,0.0001618693,0.00022551867,0.0006385588],"category_scores_gemma":[0.0014128515,0.00013332258,0.00034388012,0.00020702148,0.00018387484,0.00020294052,0.00019480275,0.0005371978,0.00012590579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008103532,0.0006252585,0.7700107,0.000468159,0.0006561276,0.001735321,0.000925365,0.08791984,0.033339083,0.0020429983,0.0022353113,0.091938324],"study_design_scores_gemma":[0.0006681666,0.011982402,0.81154627,0.00018536623,0.00071960845,0.0055646314,0.0013306119,0.12137085,0.024795808,0.002063547,0.019671898,0.000100767924],"about_ca_topic_score_codex":0.0033837978,"about_ca_topic_score_gemma":0.0023391251,"teacher_disagreement_score":0.0033837978,"about_ca_system_score_codex":0.00039709877,"about_ca_system_score_gemma":0.0005467914,"threshold_uncertainty_score":0.0067281723},"labels":[],"label_agreement":null},{"id":"W4401573100","doi":"10.1002/jcph.6106","title":"Multiple‐dose pharmacokinetics of cenerimod and the effect of charcoal on its elimination","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fluidigm (Canada)","funders":"Idorsia Pharmaceuticals","keywords":"Pharmacokinetics; Pharmacology; Activated charcoal; Enterohepatic circulation; Oral administration; Pharmacodynamics; Medicine; Dosing; Chemistry; Internal medicine; Metabolism","score_opus":0.03504640256780736,"score_gpt":0.40463055372229934,"score_spread":0.36958415115449195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401573100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971015,0.000999438,0.0008360072,0.00003521348,0.000032317712,0.00015857429,0.00020126927,0.00004567318,0.0005899398],"genre_scores_gemma":[0.997352,0.00037957236,0.0008928288,0.000038864462,0.00002325728,0.000084253865,0.00020935287,0.000017215929,0.0010026825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995647,0.00017535694,0.000021552996,0.00006247061,0.00011505882,0.000060742226],"domain_scores_gemma":[0.9993104,0.00025902834,0.00015113574,0.00010086877,0.00008040472,0.00009809298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080403534,0.0004654987,0.0008703521,0.00023732688,0.00012177739,0.0004374526,0.00031845947,0.00047995328,0.0018530365],"category_scores_gemma":[0.0013827428,0.00022111366,0.00042386597,0.00028393508,0.0002724885,0.00042476997,0.00012520504,0.001137877,0.0003703864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2803447,0.0074221506,0.0039176214,0.00037816397,0.0004311591,0.00028270736,0.00017700724,0.00400437,0.64023966,0.0003619296,0.00076254085,0.06167804],"study_design_scores_gemma":[0.011409174,0.3375815,0.03890636,0.000055478973,0.0007098501,0.0007869128,0.00014534361,0.014747889,0.58744866,0.00026187426,0.007860781,0.00008614782],"about_ca_topic_score_codex":0.00076708186,"about_ca_topic_score_gemma":0.00062463724,"teacher_disagreement_score":0.0018530365,"about_ca_system_score_codex":0.00051511737,"about_ca_system_score_gemma":0.000572318,"threshold_uncertainty_score":0.006199062},"labels":[],"label_agreement":null},{"id":"W4403498878","doi":"10.1002/jcph.6139","title":"Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT‐P47 and Reference Tocilizumab: A Randomized, Double‐Blind, Phase 1 Study","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Celltrion","keywords":"Tocilizumab; Medicine; Adverse effect; Internal medicine; Pharmacokinetics; Randomized controlled trial; Bioequivalence; Clinical endpoint; Area under the curve; Confidence interval; Pharmacodynamics; Gastroenterology; Pharmacology; Rheumatoid arthritis","score_opus":0.09548188791577344,"score_gpt":0.4630843294698259,"score_spread":0.3676024415540525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403498878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950381,0.0006322587,0.00110251,0.00006613139,0.00006914982,0.0023712597,0.0002717074,0.000042216292,0.00040670065],"genre_scores_gemma":[0.9918835,0.00066237425,0.002103849,0.00027205647,0.00021504718,0.0038211457,0.0003741405,0.000020952111,0.0006468687],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987973,0.0006214783,0.000071744835,0.00020257599,0.00017739653,0.00012947527],"domain_scores_gemma":[0.9986003,0.00028636618,0.00049202086,0.00016530196,0.00012724825,0.00032874718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021737847,0.0012100892,0.0023852682,0.00037841816,0.00045448312,0.0006415594,0.0007251111,0.0012805016,0.0024472484],"category_scores_gemma":[0.002576299,0.0007570263,0.00093227124,0.00046215288,0.0012785413,0.0009743891,0.00024993045,0.0019265264,0.0005000474],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9002799,0.044937663,0.0014856501,0.0004481184,0.000448476,0.00006435813,0.00013869033,0.0006747888,0.025699273,0.0001315218,0.0005890846,0.02510254],"study_design_scores_gemma":[0.46235353,0.52139235,0.005732242,0.000027124179,0.00071371597,0.0001443063,0.00003848775,0.001601642,0.0067323633,0.00012707399,0.001096631,0.000040603896],"about_ca_topic_score_codex":0.00049061014,"about_ca_topic_score_gemma":0.0005475818,"teacher_disagreement_score":0.0024472484,"about_ca_system_score_codex":0.0008896214,"about_ca_system_score_gemma":0.0016734472,"threshold_uncertainty_score":0.011496186},"labels":[],"label_agreement":null},{"id":"W4403761371","doi":"10.1002/jcph.6147","title":"Exposure–Response Analysis of Tofacitinib in Active Psoriatic Arthritis: Results from Two Phase 3 Studies","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Psoriatic arthritis; Medicine; Dermatology; Internal medicine; Pharmacology; Psoriasis; Rheumatoid arthritis","score_opus":0.11727472354318765,"score_gpt":0.521850241729808,"score_spread":0.40457551818662035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403761371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952269,0.022478178,0.01230157,0.00083356496,0.00025025522,0.0032055923,0.0051599173,0.00036384148,0.0031380055],"genre_scores_gemma":[0.9865671,0.0025189915,0.003448641,0.0009877865,0.00021544799,0.001737031,0.0037047404,0.00008965351,0.00073075056],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.97308797,0.020357521,0.0014909925,0.0016711229,0.0026225545,0.0007699256],"domain_scores_gemma":[0.9657687,0.019215789,0.0075333803,0.003208108,0.003001525,0.0012725522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.050968934,0.0019458178,0.0034671086,0.0010057118,0.00059876154,0.0021002216,0.0011968736,0.0021705974,0.003210506],"category_scores_gemma":[0.029815065,0.000771137,0.012369603,0.0013102887,0.00089704746,0.0016178779,0.00085653417,0.0031119196,0.00049933465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63659465,0.017725123,0.077636585,0.0046260445,0.102729596,0.00029471028,0.0007771597,0.01131073,0.012981959,0.0006844548,0.004723367,0.12991557],"study_design_scores_gemma":[0.16855402,0.31886256,0.39428976,0.00062557094,0.06844605,0.0012143223,0.00049255084,0.021382868,0.008229475,0.0031605947,0.014226169,0.00051606924],"about_ca_topic_score_codex":0.0010492032,"about_ca_topic_score_gemma":0.0016536704,"teacher_disagreement_score":0.050968934,"about_ca_system_score_codex":0.0015563419,"about_ca_system_score_gemma":0.0021200962,"threshold_uncertainty_score":0.2695527},"labels":[],"label_agreement":null},{"id":"W4405994302","doi":"10.1002/jcph.6178","title":"Physiologically Based Pharmacokinetic Modeling and Simulation to Support a Change in the FDA‐Labeled Dosing Frequency of RHB‐105 Low‐Dose Rifabutin Triple Therapy for <i>Helicobacter pylori</i> Eradication","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"U.S. Department of Veterans Affairs","keywords":"Dosing; Rifabutin; Pharmacokinetics; Omeprazole; Pharmacology; Medicine; Physiologically based pharmacokinetic modelling; Amoxicillin; Helicobacter pylori; Antibacterial agent; Antibiotics; Chemistry; Clarithromycin; Internal medicine","score_opus":0.1081579009403272,"score_gpt":0.44559644932832276,"score_spread":0.3374385483879956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405994302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67309666,0.0007856799,0.30009615,0.0012132365,0.00014062184,0.000396272,0.001324662,0.0009438054,0.022002853],"genre_scores_gemma":[0.9797214,0.00027039618,0.016385462,0.00012842761,0.000012623091,0.00023566413,0.00027581397,0.000045809873,0.0029244095],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99987864,0.0000446437,0.000005774754,0.000020190078,0.00003466839,0.000016044547],"domain_scores_gemma":[0.9995957,0.00026039936,0.00005313644,0.000014501902,0.00006107585,0.000015147668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003734227,0.00043928795,0.00052083266,0.00020414338,0.0002275993,0.00071754376,0.00052759604,0.0009700398,0.0022809554],"category_scores_gemma":[0.00093313644,0.00034664714,0.00081480056,0.00016194324,0.0002179659,0.00033769343,0.0002766217,0.0008935257,0.0003215423],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009782979,0.000072611125,0.0007749151,0.00004331531,0.000018477813,0.000058877587,0.00001711995,0.9904683,0.0048834914,0.0009080668,0.00026287514,0.0023942234],"study_design_scores_gemma":[0.000014898419,0.000046579527,0.00015849996,0.0000026155235,0.000005808994,0.000006890776,0.0000033447884,0.99861777,0.00070472,0.000162036,0.00027335607,0.0000034349143],"about_ca_topic_score_codex":0.0082970895,"about_ca_topic_score_gemma":0.003710031,"teacher_disagreement_score":0.0082970895,"about_ca_system_score_codex":0.00073092367,"about_ca_system_score_gemma":0.0010752323,"threshold_uncertainty_score":0.016497612},"labels":[],"label_agreement":null},{"id":"W4406147362","doi":"10.1002/jcph.6179","title":"Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Maternal and Child Health Bureau; School of Medicine, Emory University; National Center for Advancing Translational Sciences; Health Resources and Services Administration; University at Buffalo; Scheme for Promotion of Academic and Research Collaboration; National Heart, Lung, and Blood Institute; Seattle Children's Research Institute; National Institutes of Health; U.S. Department of Health and Human Services; Cincinnati Children's Hospital Medical Center; Emory University; Nationwide Children's Hospital","keywords":"Medicine; Emergency department; Asthma; Exacerbation; Asthma exacerbations; Acute severe asthma; Pharmacokinetics; Anesthesia; Dosing; Pharmacodynamics; Placebo; Area under the curve; Refractory (planetary science); Intensive care medicine; Internal medicine; Respiratory disease; Lung","score_opus":0.02480889781505559,"score_gpt":0.41977642117432146,"score_spread":0.3949675233592659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406147362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974208,0.0011894163,0.00085441006,0.0000820786,0.0000071938416,0.000031897143,0.00012503646,0.00001563763,0.00027355595],"genre_scores_gemma":[0.99895763,0.0003330792,0.00047033528,0.000041645202,0.000011094246,0.000018344006,0.0000937169,0.0000045436304,0.00006949429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942833,0.00028566577,0.000028162647,0.00006113601,0.00015588375,0.000040876257],"domain_scores_gemma":[0.99877375,0.0004649845,0.00049556006,0.000068599344,0.00008805617,0.00010903652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007926604,0.00021479925,0.00054561894,0.00015935497,0.00009062601,0.0004891192,0.00022060363,0.00033650547,0.0003864808],"category_scores_gemma":[0.0028704104,0.00013850835,0.0002859767,0.00023083201,0.00020974607,0.00022834593,0.0001720791,0.000584631,0.0001003966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03125563,0.001462871,0.7749371,0.0004708245,0.0008760338,0.00093843637,0.0005627276,0.009725737,0.06468925,0.0005434323,0.0018426344,0.112695344],"study_design_scores_gemma":[0.0010486667,0.030042417,0.91832876,0.00006278321,0.00039689124,0.001543903,0.00032356702,0.023765946,0.020453503,0.00036501375,0.003636604,0.000031922416],"about_ca_topic_score_codex":0.001029779,"about_ca_topic_score_gemma":0.0008166275,"teacher_disagreement_score":0.001029779,"about_ca_system_score_codex":0.0003450255,"about_ca_system_score_gemma":0.00042094165,"threshold_uncertainty_score":0.0041920543},"labels":[],"label_agreement":null},{"id":"W4407758778","doi":"10.1002/jcph.70007","title":"The Impact of Augmented Renal Clearance on the Pharmacokinetics of Levetiracetam in Critically Ill Patients: A Literature Review","year":2025,"lang":"en","type":"review","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta; University of Alberta","keywords":"Levetiracetam; Medicine; Pharmacokinetics; Dosing; Regimen; Renal function; Arc (geometry); Creatinine; Pharmacology; Internal medicine; Intensive care medicine; Epilepsy","score_opus":0.10100579507946728,"score_gpt":0.5480106442864586,"score_spread":0.44700484920699135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407758778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035799408,0.99912745,0.000029261468,0.00016353953,0.00005219745,0.00001762606,0.00006186777,0.0000023824448,0.00018770494],"genre_scores_gemma":[0.002433368,0.99715865,0.000092322654,0.00016237874,0.00005745021,0.000021311953,0.00004129106,0.0000011193117,0.000032202315],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978759,0.00042226777,0.0009734618,0.0001884728,0.00045959663,0.00008025646],"domain_scores_gemma":[0.97991496,0.01541233,0.002758489,0.00015659859,0.0016058972,0.0001518334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026220146,0.0010170044,0.0035140621,0.013875427,0.0005825676,0.0022735568,0.0015097276,0.0018377596,0.0041536256],"category_scores_gemma":[0.013999545,0.00065213215,0.0033321355,0.01581888,0.00072730874,0.0023461953,0.0008778032,0.00092146697,0.0004099491],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016865639,0.00004220602,0.0012363088,0.7987123,0.0015665349,0.00042617624,0.0003312166,0.00014530912,0.00024149766,0.0005156421,0.0046008956,0.19201322],"study_design_scores_gemma":[0.00009796857,0.0002893733,0.010087371,0.8670998,0.02919694,0.0036672056,0.0008730587,0.0001640108,0.000419854,0.00077439495,0.08725649,0.000073528754],"about_ca_topic_score_codex":0.006120155,"about_ca_topic_score_gemma":0.01000133,"teacher_disagreement_score":0.013875427,"about_ca_system_score_codex":0.0019893867,"about_ca_system_score_gemma":0.0068514016,"threshold_uncertainty_score":0.01443404},"labels":[],"label_agreement":null},{"id":"W4409504187","doi":"10.1002/jcph.70033","title":"A Retrospective Analysis of PK and Response of Oral Ibuprofen in the Treatment of a Patent Ductus Arteriosus in Extremely Low Gestational Age Neonates","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Cardiovascular Conditions and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Impact; McMaster University; McMaster Children's Hospital","funders":"","keywords":"Ibuprofen; Medicine; Gestational age; Ductus arteriosus; Pharmacokinetics; Regimen; Population; Area under the curve; Gastroenterology; Retrospective cohort study; Anesthesia; Internal medicine; Pharmacology; Pregnancy","score_opus":0.07737114255945572,"score_gpt":0.43298089711152093,"score_spread":0.3556097545520652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409504187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99943215,0.00027202323,0.000117935386,0.0000064623846,0.0000015493313,0.000009821526,0.00006997036,0.000001605773,0.00008856148],"genre_scores_gemma":[0.99956137,0.00013615256,0.00009352454,0.000014210361,0.0000033176148,0.000010841667,0.00013353901,0.0000012856816,0.00004564538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920803,0.0002618248,0.00014378333,0.00017164258,0.00015802008,0.00005664259],"domain_scores_gemma":[0.9984505,0.0004878106,0.0006079502,0.00017989201,0.00015255375,0.000121220124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007903633,0.00016709528,0.00056258653,0.00035095512,0.00016686649,0.00036526273,0.0001947552,0.00020851972,0.00042496948],"category_scores_gemma":[0.0019902107,0.00017350228,0.00050989934,0.00038185847,0.00024339107,0.00021025464,0.00025113483,0.00031719657,0.000085071704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021068496,0.00013767711,0.98708177,0.0000620657,0.00021428184,0.0007423399,0.00013745316,0.00019853393,0.0024662712,0.00003351938,0.000060421542,0.0067588887],"study_design_scores_gemma":[0.000063292,0.004653167,0.98879623,0.000018282793,0.00022130951,0.003126643,0.00026206073,0.0005801194,0.0016433817,0.000028149794,0.00059683976,0.000010679343],"about_ca_topic_score_codex":0.0013115404,"about_ca_topic_score_gemma":0.0007516479,"teacher_disagreement_score":0.0013115404,"about_ca_system_score_codex":0.00038787787,"about_ca_system_score_gemma":0.00035804696,"threshold_uncertainty_score":0.0041798353},"labels":[],"label_agreement":null},{"id":"W4409900749","doi":"10.1002/jcph.70027","title":"Expansion of a Pharmacokinetic Model for Diazepam to Characterize Real‐World IV and Oral Data in Children With and Without Obesity","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Duke Clinical Research Institute; National Institute of Child Health and Human Development; National Institute on Alcohol Abuse and Alcoholism; Eunice Kennedy Shriver National Institute of Child Health and Human Development; University of North Carolina at Chapel Hill; National Institutes of Health; School of Medicine; Children's Mercy Hospital; Penn State College of Medicine; Wichita Medical Research and Education Foundation; University of South Carolina; Pennsylvania State University; University of Pennsylvania; Seattle Children's Research Institute; University of Louisville; Hospital for Sick Children; Tulane University; Children's Hospital of Philadelphia","keywords":"Dosing; Pharmacokinetics; Volume of distribution; Diazepam; Medicine; Status epilepticus; Population; Bolus (digestion); Obesity; NONMEM; Oral administration; Anesthesia; Pharmacology; Internal medicine; Epilepsy","score_opus":0.12106081851955071,"score_gpt":0.4889283812446854,"score_spread":0.3678675627251347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409900749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8622393,0.0003028518,0.1297485,0.0007019397,0.000049224996,0.00019306105,0.0018785419,0.0003847079,0.004501843],"genre_scores_gemma":[0.98016626,0.00016746171,0.015489605,0.00013368667,0.000017692568,0.00020828865,0.0011863613,0.00004994591,0.0025807824],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99971193,0.00010726077,0.000014962684,0.00007464993,0.00004195552,0.00004913595],"domain_scores_gemma":[0.99877447,0.00086929114,0.00012484429,0.000040896368,0.00015232422,0.000038153285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010541426,0.0006564351,0.000625943,0.00031322558,0.00023957262,0.0005811182,0.0007569751,0.00099305,0.0013434567],"category_scores_gemma":[0.003844574,0.0003452292,0.0011023517,0.00030105232,0.0003632019,0.00036850284,0.00050990155,0.0011676452,0.00022705072],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099225974,0.000041927382,0.0060704495,0.000024196128,0.00003045759,0.00020292893,0.000054500197,0.98812383,0.00070768927,0.00071951584,0.00040492613,0.0035202862],"study_design_scores_gemma":[0.000023094612,0.00004121173,0.0020499912,0.000005720298,0.000015238018,0.000052154763,0.000014724078,0.9969337,0.00020017232,0.00032331835,0.00033155142,0.000009135641],"about_ca_topic_score_codex":0.038570955,"about_ca_topic_score_gemma":0.014196517,"teacher_disagreement_score":0.038570955,"about_ca_system_score_codex":0.0009631159,"about_ca_system_score_gemma":0.0012096363,"threshold_uncertainty_score":0.07669288},"labels":[],"label_agreement":null},{"id":"W4412653397","doi":"10.1002/jcph.70084","title":"Four Pharmacogenomic Variants Strongly Linked to Corticosteroid‐Induced Avascular Necrosis in Children with Cancer","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Bone and Joint Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Health Canada; Genome British Columbia; Provincial Health Services Authority; BC Children's Hospital; Canadian Institutes of Health Research; Genome Canada","keywords":"Pharmacogenomics; Avascular necrosis; Corticosteroid; Medicine; Cancer; Oncology; Pharmacogenetics; Necrosis; Internal medicine; Pharmacology; Bioinformatics; Biology; Surgery; Genetics; Genotype; Gene","score_opus":0.0648231306296028,"score_gpt":0.424983250689048,"score_spread":0.3601601200594452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412653397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969357,0.000896662,0.0007535559,0.00013621218,0.0000145232025,0.0000085095435,0.000990941,0.000015976895,0.00024791196],"genre_scores_gemma":[0.99875116,0.00016076444,0.0004821703,0.000030933075,0.000010358101,0.000006839317,0.00044539486,0.000007720807,0.00010468028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931777,0.00019871509,0.000077665005,0.00022060375,0.000111939604,0.00007326686],"domain_scores_gemma":[0.9981762,0.0007892857,0.000663195,0.0000937089,0.00013789156,0.00013976906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057422987,0.00063488923,0.00046952782,0.00083210564,0.0004232803,0.0006882521,0.0003940349,0.00065023405,0.0028801307],"category_scores_gemma":[0.002858421,0.00023315342,0.0012008334,0.0017544241,0.00035966854,0.00023013954,0.00043212905,0.00077499956,0.00023474896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005139064,0.000032566095,0.98984325,0.000047149035,0.00061504234,0.0008447127,0.00010206672,0.0005397674,0.003004702,0.00011114965,0.00034070635,0.004005066],"study_design_scores_gemma":[0.000058105456,0.00015465514,0.99055314,0.00004164579,0.0007962718,0.0025782974,0.00022674803,0.0028902958,0.0013411816,0.00026197938,0.0010796695,0.00001809234],"about_ca_topic_score_codex":0.009325921,"about_ca_topic_score_gemma":0.00653596,"teacher_disagreement_score":0.009325921,"about_ca_system_score_codex":0.0004016573,"about_ca_system_score_gemma":0.00053844653,"threshold_uncertainty_score":0.018543303},"labels":[],"label_agreement":null},{"id":"W4414575052","doi":"10.1002/jcph.70114","title":"In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug Transporters","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"Digoxin; Rosuvastatin; Dosing; Prodrug; Therapeutic index; Organic anion-transporting polypeptide; Drug; In vitro","score_opus":0.043455882481146235,"score_gpt":0.4596680914543474,"score_spread":0.41621220897320116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414575052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98382497,0.010548163,0.0014696621,0.00030212058,0.0001034765,0.00017909444,0.00055447046,0.00004825753,0.0029697677],"genre_scores_gemma":[0.99245024,0.0035676276,0.0011829163,0.000093988645,0.00008037243,0.00010703603,0.0011313471,0.000012058492,0.0013744996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988834,0.00068010914,0.000062574836,0.000093145405,0.00017245335,0.00010822939],"domain_scores_gemma":[0.99955255,0.00017924106,0.00007221303,0.000049738188,0.00009282494,0.000053443942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011033088,0.00048409725,0.00082005595,0.00025314407,0.00027747353,0.0007149425,0.0003761664,0.00048413282,0.0020039226],"category_scores_gemma":[0.0009245269,0.00024267622,0.0003461089,0.00033612872,0.0003090232,0.0003497242,0.00018848844,0.00091372954,0.0005426443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014261709,0.004318444,0.0066552404,0.000564587,0.00019021232,0.0003816263,0.00026381054,0.0019924636,0.94383836,0.00034806159,0.001147972,0.026037367],"study_design_scores_gemma":[0.0011596057,0.07690876,0.024630932,0.000050184215,0.00041620783,0.0014868404,0.00024614763,0.0066888076,0.8761345,0.00020856914,0.012022207,0.00004711445],"about_ca_topic_score_codex":0.0009841669,"about_ca_topic_score_gemma":0.0013996443,"teacher_disagreement_score":0.0020039226,"about_ca_system_score_codex":0.00056717754,"about_ca_system_score_gemma":0.00037130067,"threshold_uncertainty_score":0.0067037344},"labels":[],"label_agreement":null},{"id":"W4414608578","doi":"10.1002/jcph.70107","title":"Physiologically Based Pharmacokinetic Modeling of Oxcarbazepine to Characterize Its Disposition in Children with Obesity","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Dosing; Physiologically based pharmacokinetic modelling; Oxcarbazepine; Pharmacokinetics; Population; Clinical trial; Obesity","score_opus":0.061016524939805354,"score_gpt":0.43088721315978307,"score_spread":0.3698706882199777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414608578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88955975,0.0008812656,0.10022859,0.00046210035,0.00002939418,0.00023770049,0.0018893003,0.00020869145,0.0065031503],"genre_scores_gemma":[0.98631686,0.00050598744,0.0106250355,0.00013540027,0.000010483472,0.0002516324,0.0008584977,0.000028544277,0.0012676562],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99982136,0.00007972896,0.000009726333,0.000035695717,0.00003185737,0.000021600472],"domain_scores_gemma":[0.9995752,0.00027268275,0.00007136123,0.000015165498,0.00004711474,0.000018545023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004850229,0.00044481605,0.00044712512,0.00021709148,0.0001465563,0.0005971011,0.0004494058,0.00052731653,0.0007756068],"category_scores_gemma":[0.0016559062,0.00024617653,0.00074282,0.00020506515,0.00022551115,0.00029954978,0.0003967584,0.0006049169,0.00016925721],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020732141,0.00007930403,0.012280812,0.000063565196,0.00007575995,0.0001984554,0.000074655356,0.97753966,0.0028986956,0.0011636944,0.00054000894,0.0048779096],"study_design_scores_gemma":[0.00005629065,0.00021606972,0.0045412946,0.000010763594,0.000042571206,0.00012372721,0.000028334476,0.9924722,0.0007918946,0.0006406314,0.0010632616,0.000013064529],"about_ca_topic_score_codex":0.012082187,"about_ca_topic_score_gemma":0.0044461605,"teacher_disagreement_score":0.012082187,"about_ca_system_score_codex":0.0006004013,"about_ca_system_score_gemma":0.0010152367,"threshold_uncertainty_score":0.024023712},"labels":[],"label_agreement":null}]}